Molecular analysis of WEHI-3B JCS myeloid leukemia cell differentiation induced by biochanin A and midazolam. by Szeto, Yuk Yee. & Chinese University of Hong Kong Graduate School. Division of Biology.
Molecular Analysis ofWEHI-3B JCS 
Myeloid Leukemia Cell Differentiation Induced by 
Biochanin A and Midazolam 
.:.i: 
by 
Szeto Yuk Yee 
A thesis submitted as partial fulfilment 
for 




THE CHINESE UNIVERSITY OF HONG KONG 
y ^ ^ V LL3^^S3^ 
|l i 0 m \w i| 
y^T" uNivERsirT''''^^ 
^ ^ ^ B _ SYSTEWy^ 
^ ^ ^ ^ 
Thesis Committee : 
Dr. M.C. Fung 
Dr. H. S. Kwan 
Dr. V.E.C. Ooi 
ii 
statement 
All the experimental work reported in this thesis was performed by the author, 
unless otherwise specified. 
Szeto Yuk Yee 
iii 
Acknowledgments 
Leukemic cell differentiation is a very complex process which one can never 
work out by his own. Each of us works on a small piece making a contribution to the 
whole picture. The field is ftill of speculations and unknowns which make our work 
particularly exciting and challenging. In addition, it allows one's association and 
imagination. Throughout this two year, I am greatly indebted to my supervisor Dr. 
M.C. Fung for getting me into the field. I am also very grateful to his patience, 
tolerance, stimulating criticism and encouragement, not to mention his care and 
technical assistance. A special thanks must also go to my thesis committee, Dr. H.S. 
Kwan and Dr. V.E.C. Ooi, for their care and for keeping me going. I also wish to 
express my gratitude to Dr. K.K. Mark for his interest and enthusiastic support on 
everything I have been doing. I would also like to thank Dr. N.K. Mak, at the Hong 
Kong Baptist University and Dr. K.N. Leung at the Department of Biochemistry, 
CUHK who have followed my project closely and gave appropriate suggestions 
through my supervisor. 
I would also like to acknowledge Miss Jessie, P.K. Lee for preparing the most 
valuable RNAs of mouse embryo. I should also appreciate the helpful technical 
assistance and advice from Mr. C.L. Cheung, Mr. Freddie, C.H. Kwok and Miss 
Denise F.Y. Ho. I would also like to thank Miss Pandora, M.C. Yip for preparing the 
early hour RNAs of the biochanin A-induced JCS cells, Mr. Bats, S.W. Wong and Mr. 
Alex, W.K. Cheung of the Hong Kong Baptist University for preparing me the JCS 
cells. 
My appreciation must also go to other former and present ‘labmates’，Miss 
S.C. Chan, Mr. Wilson, K.W. Lau, Miss F. Liu, Mr. Jack, C.S. Lo, Mr. Y.B. Chan, 
Miss Sandra J. Chapman, Mr. K.S. Cheung, Mr. W.L. Ng, Mr. Steven, H.K. Chung, 
Mr. N.H. Lau and Mr. Paul.C. Arkwright for sharing with me their 'inspirations', 
listening to all my complaints and exploring with me the life and ‘philosophy, of a 
graduate student. 
iv 
I should also remember all the cheerful faces and hearty care from all the 
teachers and fellow students in this department. It has been very nice to have their 
company. I am also grateful to my roommates and all the friends that care for me. 
Their care and attention are always at heart. 
This thesis would not be completed so smoothly without the support of my 
family. My parents have shown me ‘the greatest love of all’ so that I was strong 
enough to pass through every 'hard and stressful' time. My two younger brothers, in 
addition, have been very understanding. 
Finally, I would also like to express my thankfulness towards The Croucher 
Foundation for their full financial support and encouragement during the past two 
years and the Interlibrary Loan Service, University Library, CUHK for their efficient 
and excellent service. On this ground, I was able to concentrate on my study and 
research. 
Szeto Yuk Yee 1996 
XV 
Abbreviations 
The following abbreviations will be used without explanations : 
Abbreviation Full term 
A Adenine 
AGM Aortic/gonadAnesonephros region 
ALF Automatic Laser Fluorescent system 
ALP Alkaline phosphatase 
AML Acute myeloid leukemia 
Ampioo Ampicillin, 100 ^ig/ml 
AMV Avian myeloblastosis virus 
AP-1 Activator protein-l 
ara-C 1 -P-D-arabinofuransyl-cytosine (cytosine arabinoftu*anoside) 
Bas-CFC Basophils-colony-forming cells 
BFU-E Burst-forming units-erythroid 
BLAST Basic Local Alignment Search Tool 
bHLH Basic helix-loop-helix 
bHLH-Zip Basic helix-loop-helix leucine zipper 
BM Bone marrow 
bp Base pair(s) 
C Cytosine 
CBR Central benzodiazepine receptor 
CD Cluster of differentiation (e.g. CD34) 
cDNA Complementary DNA 
CFC-mixed Colony-forming cells-mixed 
CFU-A Colony-forming units-agar 
CFU-B1 Blast colony-forming units 
CFU-C Colony-forming units-culture 
CFU-E Colony-forming units-erythroid 
CFU-GEMM Colony-forming units-granulocytes, erythrocytes, macrophages and 
megakaryocytes 
CFU-GM Colony-forming units-granulocytes and macrophages 
CFU-Meg Colony-forming units-megakaryocytes 
CFU-S Colony-forming units-spleen 
CFU-T Colony-forming units-T cells 
CML Chronic myeloid (myelogenous) leukemia 
CMMoL Chronic myelomonocytic leukemia 
CRU Competitive repopulation unit 
CSF Colony-stimulating factor 
CSPD Disodium 3 -(4-methoxyspirol {1,2-dioxetane-3,2 ‘ -(5 ‘-
chloro)tricyclo[3.3.1.l^^]decan}-4-yl) phenyl phosphate 
dATP 2 ‘ deoxyadenosine 5 ‘-triphosphate 
dCTP 2 ‘ deoxycytidine 5 ‘ -triphosphate 
DDBJ DNA Data Bank of Japan 
ddH2O Double distilled water 
ddNTP 2',3 '-dideoxyribonucleotide triphosphate 
DDRT-PCR Differential display 
DEPC Diethyl pyrocarbonate 
dGTP 2'deoxyguanosine 5'-triphosphate 
DIG Digoxigenin 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acids 
dNTPs Deoxyribonucleoside triphosphate 
vi 
dpc Days postcoitum 
DTT Dithiothreitol 
dTTP 2，deoxythymidine 5 ‘ -triphosphate 
E2 i7p-Estradi0l 
EDTA Ethylenediamine-tetraacetic acid 
EF-la Elongation factor 
EMBL European Molecular Biology Laboratory 
Eos-CFC Eosinophils-colony-forming cells 
Epo Erythropoietin 
ES Embryonic stem cells 
FGF Fibroblast growth factor 
FTP File transfer protocol 
G Guanine 
GABA y-aminobutyric acid 
GAPDH Glyceraldehyde-3 -phosphate dehydrogenase 
G-CFU Granulocyte-colony-forming units 
G-CSF Granulocyte colony-stimulating factor 
GM-CFC Granulocytes and macrophages-colony-forming cells 
GM-CSF Granulocyte and monocytes-colony-stimulating factor 
HAP Hydroxylapatite column chromatography 
HIM Hematopoietic inductive microenviromnent 
HLA Human leukocytes antigen 
HPRT Hypoxanthine phosphoriboxyltransferase 
HPP-CFC High proliferative potential colony-forming cells 
HSC Hematopoietic stem cells 
LAP Intracistemal A particle 
IFN Interferon 
IL- Interleukin- (e.g. IL-3, interleukin-3) 
IL-1 RtI IL-1 receptor type I 
IL-1 RtII IL-1 receptor type II 
IPTG Isopropyl-p-D-thio-galactopyranoside 
JCS WEHI-3B JCS cells 
kb Kilobase 
LCM Lung-conditioned medium 
LF Lactoferritin 
LIF Leukemia inhibitory factor 
LPS Lipopolysaccharide 
LTC-IC Long term culture initiating cells 
LTRC Long term repopulating cells 
LTR-HSCs Long term repopulating-hematopoietic stem cells 
M-CSF Monocyte-colony-stimulating factor 
Meg-CFC Megakaryocytes-colony-forming cells 
M-MLV Molony murine leukemia virus 
MOPS Morpholinopropanesulfonic acid 
MPO Myeloperoxidase 
mRNA Messenger RNA 
MT Mouse transcript sequence 
NBT Nitroblue tetrazolium 
NCBI National Centre for Biotechnology Information 
NIH National Institute ofHealth 
O.D. Optical density 
P4 Progesterone 
PBR Peripheral benzodiazepine receptor 
PCI Phenol-chloroform-iso-amyl alcohol 
PCR Polymerase chain reaction 
PG Prostaglandins 
PGE2 Prostaglandin E2 
PHSC Primitive/pluripotent hematopoietic stem cells 
PLSC Pluripotent lymphoid stem cells 
vii 
PPSC Pluripotent stem cells 
PMA Phorbol 12-myristate 13-acetate 
PMN Polymorphonuclear cells 
PTK Protein tyrosine kinase 
PTx Pertussis toxins 
-R Receptor (e.g. LIF-R, LIF receptor) 
RA Retinoic acid 
RAP-PCR RNA fingerprinting by arbitrarily-primed PCR 
RNA Ribonucleic acid 
rpm Revolution per minute 
RPMI 1640 medium Roswell Park Memorial Institute Tissue Culture Medium 1640 
rRNA Ribosomal RNA 
RT-PCR Reverse-transcription polymerase chain reaction 
SCF Stem cell factor 
SDS Sodium dodecyl sulfate 
SSC Standard saline citrate 





TGF Transforming growth factor 
THSC Totipotent hematopoietic stem cells 
Tm Melting temperature 
TNF Tumor necrosis factor 
TPA 12-0-Tetradecanoylphorbol-13 -acetate 
U Unit 
UV Ultra violet 
Vit D3 Vitamin D3 
X-gal 5-bromo-4-chloro-3-indolyl-P-D-galactoside 
All genes described in the text will be written in small italic letters e.g. c-myb and proteins 
will be written in capital block letters e.g. MYB. 
viii 
Abstract 
WEHI-3B (JCS) cells could be induced to differentiate by either biochanin A 
or midazolam. While biochanin A led JCS cells to follow an entire monocytic 
pathway, midazolam drove the cells to produce both macrophages and granulocytes. 
Using reverse-transcription polymerase chain reaction (RT-PCR) followed by 
Southem/dot blot hybridization, cytokine and cytokine receptor gene expression 
profiles were revealed during the biochanin A- and midazolam-induced JCS cell 
differentiation. In particular, IL-la and IL-ip were induced after incubation with 
biochanin A for 46 hours. In contrast, the expression of IL-la remained undetected 
and that of IL-ip was decreased after midazolam treatment. TNF-a was slightly up-
regulated in biochanin A- but not midazolam-treated JCS cells. The expression ofLIF 
was increased significantly at 46 hours by biochanin A but unchanged by midazolam. 
Unlike the above genes, the expression levels of LIF-R and IL-4 were essentially 
undetectable during both biochanin A- and midazolam-induced differentiation. 
Differential gene expression during the midazolam-induced JCS cell 
differentiation was investigated by a modified protocol of RNA-fingerprinting by 
arbitrarily-primed polymerase chain reaction (RAP-PCR). Two rounds of cDNA 
probe screening were employed to eliminate ‘false positives', genes that were falsely 
taken as differentially expressed genes. A total of 142 differentially amplified 
fragments were obtained from the original fingerprints. After the second round of 
screening, only 12 fragments suggestive of differential expression were selected for 
study. Eight of these fragments (genes) were later confirmed to be differentially 
expressed in the midazolam-induced cells. One of the fragments contained a stretch 
of sequence aligned completely with the MT sequence repetitive element; two others 
aligned with mRNA sequences of glucocerebrosidase and ribosomal protein S25. The 
remaining five fragments had no significant homology with the reported sequences in 
the Genbank and are putative novel genes. 
ix 
The expression pattern of the isolated genes in midazolam-induced JCS cells 
can be classified into four types : (1) down-regulation at 5 hours (three genes); (2) 
steady down-regulation (two genes); (3) transiently up-regulation at 1 hour (one gene) 
and (4) gradual up-regulation (two genes). Interestingly, all these genes have a 
different expression pattern in the biochanin A-induced JCS cells as consistent with 
the study on cytokine and cytokine receptor gene expression. These differences in 
gene expression, including those of cytokine and cytokine receptor genes could be 
inducer-specific and/or lineage-specific. 
The expression profiles of these isolated genes during embryonic development 
were also studied using RT-PCR. Some of these genes were specifically up-regulated 
at 9.5, 11.5 and 17.5 days postcoitum (dpc). These time points coincided with the 
time of early organogenesis/hematopoietic precursor cell activity in the aortic-gonad-
mesonephros (AGM) region (9.5 dpc), organogenesis/fetal liver hematopoiesis (11.5 
dpc) and late fetal growth/bone marrow hematopoiesis in the fetus (17.5 dpc). Roles 
of these genes in the development of hematopoietic tissue and/or non-hematopoietic 
tissue of the embryo were suggested. 
Direct strategies are proposed to determine the exact function of these isolated 
genes in both myeloid cell differentiation and embryonic development. Hopefully, 
such studies, together with those done by others, would allow a greater appreciation of 
the hematopoietic system and perhaps, novel treatments for leukemia, based on 
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Chapter One General Introduction 
Cell differentiation is an indispensable process in hematopoiesis. To 
appreciate the importance of studying the process, a prior understanding of the 
hematopoietic system as well as some basic concepts of cell differentiation are 
necessary� 
1.1 Hematopoiesis 
1.1.1 Ontogeny of the hematopoietic system 
Hematopoiesis is commonly known as blood cell formation. It is an ordered 
process in which stem cells differentiate into mature blood cells through sequential 
divisions. The primary hematopoietic sites differ at different time during the 
development (Figure 1.1). In mouse, the first hematopoietic cells are derived from the 
blood islands (hemangioblast) ofthe yolk sac and the process is known as primitive or 
embryonic hematopoiesis. The detectable cells are mainly primitive nucleated 
erythrocytes and progenitors (CFU-C) capable of producing granulocytes and 
macrophages (Moore and Metcalf, 1970). Later, T- and B-lymphoid activities can be 
detected (Liu and Auerbach, 1991). Cells from the yolk sac then migrate to the fetal 
liver building up a large population and the process is known as the first wave of 
colonization (Moore and Metcalf, 1970). Stem cells, progenitor cells, embryonic 
erythroid cells, macrophages and B cells can then be found in the liver. Migration of 
progenitors (CFU-S) from the aortic/gonad/mesonephros region (AGM region) to the 
fetal liver makes up the second wave of colonization (Dzierzak and Medvinsky, 1995; 
Medvinsky et al, 1993). The colonization results in stem cell (LTR-HSCs) and 
progenitor activities (CFU-S) detectable in the liver (Medvinsky et al, 1993; 
Dzierzak and Medvinsky, 1995). Definitive hematopoiesis is fully established in the 
liver after two waves of colonization and population of cells into the developing 
spleen and bone marrow of the fetus starts. Shortly before birth and thereafter, the 
bone marrow becomes the major site ofhematopoiesis (95%). However, both splenic 
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and liver hematopoiesis can resume active if the bone marrow is diseased or the 
demand for blood cells is extreme during adulthood (extramedullary hematopoiesis). 
^ F e t a " i v e r Bone marrow 
Yolk-sac mesoderm ^^^^ '^^^ ie lpc-b i r th ) CConization day (16 dpc, 
lymphopoiesfe ^ _ _ U l ^ a j o r site of hematopoiesis 
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, J j S L | | = o P r c | Hematopoietic 
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Definitive erythropoiesis Hematopoietic 
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CFU-S and lymphoid 
precursors (9.5 dpc) 
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Figure 1.1. The ontogeny of the hematopoietic system (mouse). The large boxes represent 
the different hematopoietic organs during mouse development. The dark thin arrows 
represent cell differentiation. The large gray arrows indicate cell migration. Primitive 
hematopoiesis occur at around 7 dpc (days post coitum) in the yolk sac, CFU-S and lymphoid 
precursors can be detected in the AGM region at 9.5 dpc. Fetal liver hematopoiesis starts at 
11 dpc and continue until birth. After birth, the main site of hematopoiesis switches to the 
bone marrow. The first wave of colonization involves cells (thought to be committed 
erythroid progenitors) moving from the yolk sac to the liver while cells move mainly from 
AGM region to the liver in the second wave of colonization (adapted from Paulson and 
Bemstein, 1995). 
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1.1.2 Hierarchy of hematopoietic cells 
Although the maturing hematopoietic cells are not arranged in distinct layers 
and apparently situate in a random manner in the bone marrow and in the spleen, 
segregation of granulocytes and erythroid cells in the mouse marrow was observed 
(Lord and Wright, 1984). Moreover, stem cells seem to be concentrated at the 
periphery of the mouse marrow cavity (Metcalf, 1988) with blood cell precursors 
occupying a specific position (Pallister, 1994). Megakaryocytes are located adjacent 
to the venous sinus with their cytoplasmic processes projecting into the lumen ofthe 
sinus while red cell precursors lie adjacent to the venus sinus in erythroblastic islands. 
Granulocyte and monocyte precursors, however, tend to lie more deeply within the 
blood forming cavity. 
The maturing cells of each cell lineage in the hematopoietic tissue can be 
identified by their characteristic morphology and arranged into likely maturation 
sequences. Three major differentiation compartments (compartment for stem cells, 
progenitor cells and maturing cells) can be distinguished by using a number ofclonal-
analytical procedures (Figure 1.2). Cell population of each compartment is derived 
from cells of the preceding one and the cells gradually decrease in gene activity for 
proliferation and increase in gene activity for differentiation as they move from one 
compartment to the other. As a result, the cells lose their self-renewal capacities and 
display the antigenic, biochemical and morphological features specific to mature cells 
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Figure 1.2. A simplified diagram showing the hierarchy of hematopoietic cells. Three 
differentiation compartments can be identified : the stem cells, progenitor cells and maturing 
cells. Each of these compartment is very heterogeneous. The box shows the different 
description of stem cells by various clonogenic assays. The progenitors are also defined by 
different assays as either colony-forming units (CFU), burst-forming units (BFU) or colony-
forming cells (CFC). The stem cells are able to self-renew and give rise to various 
committed progenitors before differentiating into the numerous mature blood cells. The 
intermediate progenitors for lymphoid lineage (T and B cells) are omitted in the diagram. 
(Gunji and Suda, 1995; Metcalf, 1988; Metcalf and Nicola, 1995; Tsukamoto et al, 1995). 
Abbreviations : CRU, competitive repopulation units; LTRC, long term repopulating cells; 
HPP-CFC, high proliferative potential colony-forming cells; LTC-IC, long term culture 
initiating cells, CFU-A, colony-forming units-agar; CFC-mixed, colony-forming cells-mixed; 
CFU-S, D12-14, colony-forming units-spleen, day 12-14; CFU-B1, blast colony-forming 
units; CFU-S, D7-8, colony-forming units-spleen, day 7-8, CFU-T, colony-forming units-T 
cells; CFU-GEMM, colony-forming units-granulocytes, erythrocytes, macrophages and 
megakaryocytes; BFU-E, burst-forming units-erythroid; CFU-E, colony-forming units-
erythroid, CFU-GM, colony-forming units-granulocytes and macrophages, GM-CFC, 
granulocytes and macrophages-colony-forming cells; Meg-CFC, megakaryocytes-colony-




Stem cells occur at approximately 1 per 10^  to 1 per 10^ marrow cells. These 
refer to only about 0.2 % of the hematopoietic cells (Metcalf, 1988). Stem cells are 
self-renewable and multi-potential. They can produce progenies identical to 
themselves in appearance and differentiation potential and yield mature blood cells of 
all types. They are also remarkable in proliferative potential and a larger progeny 
population of lowered multi-lineage differentiation potential and self-renewal ability 
are produced. Despite their distinct self-generation and differentiation potentials, 
most of the stem cells are not in cell cycle (Go phase) and divide at a slow rate in vivo. 
Only 18-22 % of them are usually in the active phase of the cell cycle (S/G2/M phase) 
(Paulson and Bemstein, 1995). 
Stem cells have been defined in various clonogenic assays aiming at 
measuring their long-term repopulating ability and maximal differentiating ability. 
Because of the heterogeneity of the stem cell population, stem cells are operatively 
known as : 
• in vivo competitive repopulation units (CRU), 
• in vitro long term repopulating cells (LTRC), 
• high proliferative potential colony-forming cells (HPP-CFC), 
• long term culture initiating cells (LTC-IC), 
• colony-forming units-agar (CFU-A), 
• colony-forming cells-mixed (CFC-mixed), 
• colony-forming units-spleen, day 12-14 (CFU-S D12-14), 
• blast colony-forming units (CFU-B1) 
• colony-forming units-spleen, day 7-8 (CFU-S D7-8) 
arranged approximately in their ascending order of maturation (Figure 1.2) (Gunji and 
Suda, 1995; Metcalf, 1988; Metcalfand Nicola, 1995; Tsukamoto et al, 1995). 
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Stem cells are difficult to characterize morphologically. Generally speaking, 
they have large nucleus to cytoplasm ratio and prominent nucleoli inside the nuclei. 
The cytoplasm is not basophilic and contains no granules. The most primitive human 
stem cells are identified by being CD34+, Thy-1 + and Rhl23 i� . They are also CD71_, 
HLA-DR", CD45RA", CD45RO+, CD38", CD33", c-kit 1�and Lin_ (Tsukamoto et al.， 
1995; Weissman, 1995). Similarly, primitive stem cells are recognized by Thy'®, Lin' 
彻 and Sca-1+ in mouse (Spangrude et al, 1988). Distinct intermediate forms of stem 
cells can also be distinguished from each other by the stage-specific expression ofcell 
surface markers and their dependence on growth factors. 
Stem cells are recognized as hematopoietic stem cells (HSC), 
primitive/pluripotent hematopoietic stem cells (PHSC), pluripotent lymphoid stem 
cells (PLSC), pluripotent stem cells (PPSC/PSC) and totipotent hematopoietic stem 
cells (THSC). 
Progenitor cells 
Progenitor cells represent 1 % of the hematopoietic cells and occur at about 2-
5 per 1000 marrow cells (Metcalf and Nicola, 1995). They are a transit population 
formed by stem cells during the production of maturing progeny. Each of the 
progenitor cells is capable of generating up to 10^  maturing progeny. The cells are 
committed having restricted differentiation capacity. They usually go to a single 
lineage of differentiation but bi- and tri-lineage-committed progenitor cells may also 
exist. When the cells become committed to a certain differentiation lineage, the 
specific genetic programme for that lineage becomes activated. This commitment is 
irreversible so that progenitor cells cannot switch to another lineage or revert to multi-
potential stem cells in general. Progenitor cells appear to have minimal or no capacity 
for self-generation in vitro. However, they are usually in cell cycle giving rise to 
colonies of maturing progeny in response to hematopoietic growth factors in vitro. 
The progenitor cell population is heterogeneous. For example, progenitor cells in the 
erythroid lineage can be further subdivided into the erythroid burst forming units 
(BFU-E) and the erythroid colony-forming units (CFU-E) with BFU-E being less 
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mature. Granulocytes progenitors can also be arranged into granulocyte progenitor 
cells (CFU-GM) and cluster-forming cells (GM-CFC) with the latter being more 
mature� 
Progenitors cells were extensively studied by clonogenic culture system and 
have been described as colony-forming units : 
• CFU-GEMM (colony-forming units-granulocytes, erythrocytes, macrophages and 
megakaryocytes), 
• BFU-E (burst-forming units-erythroid), 
• CFU-E (colony-forming units-erythroid), 
• CFU-GM (colony-forming units-granulocytes and macrophages), 
• CFU-M (colony-forming units-macrophages), 
• CFU-G (colony-forming units-granulocytes), 
• CFU-Eo (colony-forming units-eosinophils) 
• CFU-Meg (colony-forming units-megakaryocytes). 
Progenitor cells are large mononuclear, blast-like cells with agranular 
basophilic cytoplasm. Alternatively, they can be identified by expression of specific 
lineage markers. 
Maturing cells 
The dividing and maturing populations are the majority of cells found in the 
hematopoietic tissues. They are the progeny of progenitor cells and form a 
recognizable sequence of cells by morphology within each lineage. The least mature 
of these cells have a considerable capacity for proliferation yielding about 2-200 
colonies in total in vitro (Metcalf, 1988). With progressive maturation, the cells 
gradually lose the proliferative potential and eventually mature to a postmitotic stage, 
after which no further cell division is possible generally. 
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A functional blood system consists of a minimum of eight distinct cell types : 
T-cell, B-cell/plasma cell, macrophage/monocyte, neutrophil, erythrocyte, 
megakaryocyte/platelet, mast cell and eosinophil. With regard to our special interest, 
the myeloid lineage, successive intermediates derived from granulocyte-macrophage 
progenitor cells can be recognized in increasing maturity (Figure 1.3). In granulocyte 
formation (granulopoiesis), the myeloblast is the earliest recognizable stage. 
Myeloblasts give rise to promyelocytes characterized by their content of azurophilic 
granules (primary granules). From the promyelocyte stage onwards, the relative 
proportion of primary granules progressively decreases concomitant with an increase 
in specific (secondary) granules. From the myelocyte stage through the 
metamyelocyte stage to mature granulocyte (neutrophils), the nucleus becomes 
increasingly segmented and the nucleus to cytoplasm ratio decreases. The immediate 
precursor ofmature granulocyte is called stab cell or band form which has an irregular 
horseshoe or ring-shaped nucleus. In monocyte formation (monopoiesis), the 
monoblast is the only recognizable precursor of the monocyte. Promonocyte, with 
round to oval nucleus is rare and difficult to be distinguished. Maturing monocyte has 
a progressively indented nucleus and increases in azurophil granules. It is also smaller 
than promonocyte and circulates in blood for one or two days before migrating into 
tissues as macrophage (Wheater et al., 1987; Krause and Cutts, 1994) (Figure 1.3). 
Besides morphological changes, both granulopoiesis and monopoiesis can be 
traced by following some antigenic, cytochemical or biochemical evidence. Antigenic 
markers like Mac I (CR3, CDllb), CD16 and cytochemical markers like chloroacetate 
esterase are expressed upon maturation of both granulocytes and monocytes. C3R, 
FcR, F4/80 and M-CSFR are early markers of macrophage differentiation while 
lysozyme is a late marker. Myeloperoxidase (MPO) lactoferritin (LF), alkaline 
phosphatase (ALP), defensin, cathepsin G, G-CSFR and Gr-1 are all markers for 
granulocytic differentiation. J l ld decreases in expression during monocytic 
differentiation but increases in expression during granulocytic differentiation (Fung et 
al, 1992). Biochemical assays for non-specific esterase is specific for macrophage 
and granulocyte differentiation while NBT reduction assay is designed for early 
monocytic and granulocytic differentiation. As mature granulocytes switch to the 
8 
utilization of glycolytic pathway for ATP production, lactate dehydrogenase activity 
can also be a marker of mature granulocytes. 
Finally, it is worth mentioning that to divide the hematopoietic cell population 
into discrete compartments in the above discussion may have over-simplified the 
hierarchies of these cells. In fact, hematopoiesis is likely to involve a continuous 
change rather than clear-cut steps. Thus, the stemy'progenitor cell hierarchy may exist 
as a spectrum of cell populations having a continuum of differentiation potentials and 
selfrenewal capacities (Till, 1976; Lemischka, 1992). 
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1.1.3 Characteristics of a functional blood system and the need for 
regulation 
There are several unique features of the blood system that make it different 
from other tissues in the body. The blood system is composed of at least eight very 
different mature blood cells modified to fit for their own functions. These cells are 
dispersed throughout the body. They have limited life span ranging widely from 
several hours (granulocytes) to weeks (erythrocytes) or years (memory cells). While 
the cells would finally die, they have gradually lost their ability to reproduce in the 
course of differentiation and maturation. In addition, as the whole system tums to the 
stem cells in the bone marrow for ultimate and continuous production of all blood 
cells, no more de novo hematopoiesis occurs after the liver definitive hematopoiesis 
has established. 
Hematopoietic regulation is necessary to maintain the required cell number 
and cell types in the system so as to meet the demands of the body at different 
situations. That is, the system needs not only to produce basal level of blood cells for 
daily consumption but also to respond at emergency (e.g. bleeding and pathological 
conditions). Such regulation would only be effective, however, if the distinct features 
of the blood system are also taken into considerations. Since no more de novo stem 
cells would be produced in adult, the 'already-present' stem cell population must be 
self-sustaining without being exhausted. The cell production rate is also important as 
different cell types have different half-lives and require different specific rates of 
renewal. At the same time, the degree of differentiation of each cell type must be kept 
up for proper function. As the hematopoietic tissues are dispersed widely, there must 
be some effective mechanisms to detect the needs of the body and blood cell 
production of the correct lineages can be carried out in the bone marrow. 
To suffice an effective regulation, various control points are monitored by 
different hematopoietic regulators and some pre-determined steps or programs are 
followed. For the arrangement of the hematopoietic subpopulations, (1) cell 
proliferation, (2) self-generative versus differentiative cell divisions, (3) 
differentiation commitment induction as well as (4) initiation and completion of 
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maturation are under control. In view of cell function, (1) regulation on the release of 
mature cells, (2) discharge of certain cell types to the tissues, (3) functional activation, 
(4) maintenance ofblood cell levels and (5) removal of wom-out cells are needed. 
One of the most deterministic aspects in hematopoietic regulation resides on 
the differentiation commitment induction of hematopoietic cells so that there is a 
balance between the degree of self-renewal and differentiation. Without sufficient 
levels of proliferation, there will be insufficient number of cells to carry out normal 
functions; without appropriate degree of differentiation, however, the functional 
specification is impossible to maintain. Differentiation commitment ensures a 
coupled proliferation. As a result, an increasing degree of expression of differentiated 
function is associated with a decreasing proliferative capacity of individual cells. A 
disruption of this fine balance of proliferative and differentiative programme may 
finally lead to disorders from lymphoproliferative or myeloproliferative phenotype, 
myelodysplasia to full-blown leukemia. 
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1.1.4 Interrupted hematopoiesis -- Leukemia 
Leukemia as uncoupled differentiation/proliferation process 
Leukemia can be viewed as a population of hematopoietic cells that has 
progressed to a certain distance in the maturation pathway but the processes of 
proliferation and differentiation have become uncoupled. The population, usually 
arise from a single cell, divide rapidly and extensively without completing their 
differentiation programme. Such diversion from the normal differentiation 
programme can occur at various stages between the stem cell and the fully 
differentiated state. 
Many of the leukemia arise from the stem cell population composed of the 
most malignant cells in poorly differentiated states (Sawyers et al., 1991). For 
instance, acute undifferentiated leukemia, with neither lymphoid nor myeloid lineage 
markers, probably result from a primitive stem cell. Acute biphenotypic leukemia, 
with markers of both lineages, may develop from a more committed bipotent cell. 
More commonly known leukemia are classified according to the predominant 
hematopoietic lineage manifested and their form of development (acute or chronic). 
Regarding myeloid lineage, acute myeloid (myeloblastic) leukemia (AML) probably 
arise from somewhere between pluripotent stem cell and myeloid progenitor, 
committed in varying degrees to erythroid, granulocytic-monocytic, and 
megakaryocytic lines. Chronic myeloid (myelogenous) leukemia (CML), on the other 
hand, probably derive from a stem cell capable of entering both the myeloid or 
lymphoid lineages, followed by an expansion of the myeloid compartment at the early 
onset of the disease. 
While acute myeloid leukemia involve both an increase in circulating blood 
cell number and defects in their normal maturation and function at the onset, the 
uncoupling of differentiation and proliferation is more gradual in CML. During the 
chronic phase CML, the myeloid progenitor and mature myeloid cell number 
increases with cell differentiation remained normal. At blast crisis CML, however, 
13 
differentiation is blocked at the progenitor stage as well. Other non-leukemic 
disorders also reveal disorders of either proliferation or differentiation but not both. 
Myeloproliferative syndrome represents abnormal growth expansion while 
myelodysplasia is blocked at differentiation. Both of these syndromes can finally 
develop into AML (Sawyers et al, 1991). As these phenomena suggest, although we 
seldom study differentiation without taking into consideration proliferation in normal 
hematopoiesis, the two processes appear to be independently controlled. Also, the 
malignant leukemia development seem to require abnormalities in both processes, or 
in other words, a defect in differentiation commitment. 
Leukemia as signaling and genetic defects 
Leukemia is a heterogeneous group of diseases caused by accumulation of 
multiple genetic alternations. These changes can occur in multiple steps and in 
various sequences of order. They are also influenced by both genetically-determined 
and environmental factors. Activation of oncogenes which signal proliferation in cells 
or inactivation of anti-oncogenes (tumor suppressor genes) which slow down cell 
growth and/or enhance cell differentiation may occur, in either the signal transduction 
pathway or the gene regulation program. Modulations in signal transduction are 
exemplified by oncogenes coding for growth factors {sis, platelet-derived growth 
factor), growth factor receptors {frns, M-CSF receptor; kit, SCF receptor) and intra-
cellular signal transducers {ras, G protein, raf, serine-threonine kinase, src family, 
cytoplasmic tyrosine kinases). On the other hand, changes in gene regulation 
programme are found in nuclear oncogenes encoding transcription factors {jun, fos, 
myc, myb, ets), nuclear tyrosine kinase (abP), hormone receptor (erb-A) along with 
tumor suppressor genes producing transcriptional activator (IRP-1, interferon-
regulatory factor-1) and nuclear phosphoproteins Qy53, Rb) (Clemens, 1991; 
Hoffbrand and Pettit, 1993; Pallister, 1994). The altered genes themselves may 
deviate from the normal structures, express at an improper level or in an inappropriate 
time. In general, transformation of hematopoietic cells needs at least two mutations. 
For example, over-expression of either IL-3 or HOX B8 (HOX 2.4) gene was not 
highly leukemogenic (but myeloproliferative in the case of IL-3) in normal bone 
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marrow cells. Cells enforced to express both genes result in myeloid leukemia in vitro 
and in vivo (Perkins et al” 1990). Other two-step combinations or co-operations in 
myeloid leukemia include myc/raf, myc/ras, mycAsA-CSF (Adams and Cory, 1992; 
Anfossi et al, 1989) and hox-a/Meisl (Nakamura et al, 1996). 
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1.2 Regulation of myeloid cell differentiation 
1.2.1 Regulation of hematopoiesis 
Given that both inappropriate signaling and/or deregulated gene expression 
result in leukemia, knowledge on normal hematopoiesis regulation, in particular, 
differentiation commitment may be useful to restore normal blood cell formation. 
As a general rule, regulation is effected by both positive signals that stimulate 
hematopoiesis and negative control system which checks excessive production or 
fluctuations after amplified response. Control of hematopoiesis is mediated by 
various hematopoietins or growth factors. In the microenvironment of bone marrow, 
stromal cells produce soluble factors which act on stenVprogenitor cells by paracrine 
stimulation or inhibition (Verfaillie, 1993). Alternatively, they can effect their actions 
through membrane-bound growth factors in a cell-cell contact manner (Toksoz et al, 
1992). This localized control prevents exhaustive proliferation of stem cells, triggers 
early differentiation and suppresses terminal differentiation of cells at primitive 
stages. More dramatic and rapid response of the system can be mediated by humoral 
growth factors during acute infections and immune response. These growth factors, 
produced by detector or immune cells in the circulation, stimulate generation of 
mature cells for body defence. For instance, GM-CSF, G-CSF, M-CSF, IL-1 and IL-6 
are produced by macrophages while IL-3, GM-CSF and IL-5 are produced by T cells. 
Humoral growth factors are also responsible for the final stage differentiation and 
maturation of circulating blood cells. 
Various colony-stimulating factor (CSF), interleukin (IL), erythropoietin 
(Epo), stem cell factor (SCF), leukemia inhibitory factor (LIF), transforming growth 
factor-beta (TGF-P), macrophage inflammatory protein-alpha (MIP-la) and tumor 
necrosis factor-alpha (TNF-a) are regulators of hematopoiesis. They are very potent 
acting at nano- to pico-molar concentrations. These growth factors can be stimulatory 
or inhibitory acting on different lineages (IL-4) or different stages (G-CSF) of cells. 
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On the other hand, the actions of some factors are restricted to certain lineage (M-
CSF, G-CSF, Epo) or stage (IL-3) of cells. In addition, these factors can act in a 
synergistic manner in triggering hematopoietic cell production. Generally speaking, 
early-acting factors in the stimulation of dormant stem cell cycling and differentiation 
consist of IL-6, G-CSF, IL-11, IL-12，LIF, SCF and flt3/flk-2 ligand. They can act 
synergistically with one another (SCF + IL-11) or with other intermediate-acting 
factors (IL-3, IL-4). Intermediate-acting factors such as IL-3, GM-CSF and IL-4 have 
overlapping functions to ensure the development of multi-potential progenitors. Late-
acting factors such as Epo, M-CSF, G-CSF and IL-5 mediate proliferation and 
maturation of committed progenitors. In contrast, lineage non-specific inhibitory 
factors IFN-y and TNF-a, together with lineage specific inhibitory factors TGF-P (acts 
predominantly on primitive hematopoietic cells and lymphoid cells) and MIP-la (acts 
on primitive myelopoietic cells) represent a negative system to control blood cell 
generation (reviewed in Metcalf, 1988; Metcalfand Nicola, 1995, Ogawa, 1993) 
Although regulatory role of hematopoiesis has been imposed on growth 
factors, the mechanism by which they act remain largely unknown. These growth 
factors may have acted by changing the gene expression of the cells, producing 
products necessary for growth and/or differentiation of the cells. Several models have 
been established trying to explain the control of hematopoiesis in terms of both 
differentiation commitment and lineage commitment. 
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1.2.2 Models of hematopoiesis 
Inductive model 
The inductive model proposed that receptor bindings of the hematopoietic 
growth factors, perhaps in combination with other components such as cell adhesion 
molecules and the extracellular matrix of the cellular microenvironment 
(hematopoietic inductive microenvironment, HIM), induce the differentiation and 
determine lineage choice from multi-potent cells. 
A couple of evidence indicated that differentiation and lineage commitment 
may have occurred under the control of growth factors in the environment (reviewed 
in Metcalf and Nicola, 1995). 
1. Mouse stem cells developed into different cell lineages according to where they 
were injected. The cells developed into T cells when they were injected intra-
thymically but committed into various lineages when they were injected intra-
venously (Spangrude et al, 1988). 
2. Stem cells developed into different lineages according to different combinations of 
growth factors added in vitro (Heimfeld et al, 1991; Metcalf, 1991; Metcalf, 
1993). 
3. Granulocyte-macrophage progenitor cells (Metcalf and Burgess, 1982) and certain 
multi-potential cell lines (Heyworth et al, 1990) developed into different lineages 
influenced by the colony-stimulating factors (CSFs). 
Stochastic model 
The stochastic model explained that stem cells express the genetic changes 
required for various events in hematopoiesis without exposing to extrinsic stimuli. 
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Growth factors simply permit the proliferation, development and maturation of these 
intrinsically committed cells. 
A number of observations suggested random processes have occurred in both 
the determination to differentiate (or to self-renew) and lineage specification during 
hematopoiesis (reviewed in Ogawa 1993). 
The decision of stem cells to either self-renew or to differentiate is a random event as 
suggested by the following evidence. 
1. The distribution of CFU-S formed from individual spleen colonies met the 
prediction of a stochastically-based birth and death model (Till et al, 1964). 
2. The same conclusion as in (1) resulted from analyzing secondary colonies formed 
by macroscopic erythroid colonies (Humphries et al., 1981) and individual blast 
cell colonies QSfakahata et al, 1982). 
Differentiation and lineage commitment may also be a random process according to 
the following findings. 
1. Multi-lineage colonies of single cell origin or from paired progenitors showed a 
variety of lineage combinations and a variation in lineage numbers (Suda et al., 
1983; Suda etal., 1984). 
2. The relative proportions of granulocyte-macrophage, erythroid and multi-potent 
progenitors remained similar irrespective of the added cytokine combinations 
(Mayani^r aL, 1993). 
3. Differentiation occurred independent of both proliferation and action of growth 




The major divergence between the inductive and stochastic models lies on the 
role of growth factors. Whereas the inductive model described growth factors as 
deterministic, the stochastic model considered it play a minor role. Given the conflict 
between the above models, the hybrid model considered aspects of both models. 
Growth factors alter the balance between proliferation and differentiation with 
differentiation lineage determined by the cells in a stochastic manner. This argument 
was based on the observation that at least two signaling pathways initiated by two 
different activated growth factor receptors were required to stimulate differentiation. 
While differentiation was blocked by one of the pathways, the other did not determine 
the lineage restriction (Just et al, 1991). 
Perhaps even the determination of stem cells to either self-renew or to 
differentiate is not an entirely random process. The random parameter, probability for 
self-regeneration is changeable after the pre-existing stem cell population is artificially 
destroyed (Metcalf, 1988). 
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1.2.3 Gene regulation of myeloid cell differentiation and its study 
Although no consensus can be reached on how the various events of 
hematopoiesis are initiated or signaled (by induction or by intrinsically-determined 
events, Figure 1.4), it is still beneficial and important to know the genetic mechanism 
underlying hematopoiesis. In particular, identifying master genes that determine 
differentiation commitment would finally find application in correcting disorders like 
leukemia. 
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(e.g. growth factors) 
^ Cell surface 
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Figure 1.4. A simplified diagram of signal transduction and cascades of gene regulation. The 
genetic program of differentiation may be triggered by external stimuli (inductive model) or 
intrinsically-determined events (stochastic model). Master gene(s) is/are the target of these 
signals/events resulting in the modulation of primary gene transcription. The increase or decrease in the 
master gene products (transcription factors) further initiates an array of changes in secondary gene 
transcription. The changing level of the responder gene products can then mediate the biological 
effects required for differentiation. (Clemens, 1991; Rabbitts, 1991) 
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Master genes refer to genes that control the expression of a set of responder 
genes (Figure 1.4). They are particularly important as they are at the top of the 
regulatory cascades, hence having maximum influence over differentiation. They are 
activated or suppressed (primary gene transcription) by either external stimuli or some 
yet undefined random events. The gene product of a master gene can be a positive or 
a negative transcriptional regulator which acts on the secondary transcription events of 
its responder genes. The gene products of the responder genes can then mediate their 
biological function necessary for differentiation (Figure 1.4). It is also worth noting 
that master genes may influence one another through dimerization or competition for 
binding to the same DNA sequences (Rabbitts, 1991). Changing the expression level 
of a particular master gene thus affects not only its own set of responder genes but 
also master genes that have interaction with it. This results in further cascades of 
change in gene activities. Therefore, ‘switching on or off critical master genes may 
be able to control the differentiation. Genes that are downstream to these master 
genes (responder genes) may also be important to differentiation commitment. For 
example, responder genes that code for growth factor receptors would allow fUrther 
modulation of the cells by external stimuli relevant to differentiation. 
To study the genetic mechanism of differentiation commitment, one of the 
possible approach is to examine the overall transcriptional activities (or gene 
expressions) in the cells after they are given a differentiating signal (either extrinsic or 
intrinsic). That is, to investigate which genes are being switched on or off during the 
differentiation. However, change in transcriptional activity (or mRNA level) of a 
gene represents only a correlation relationship of the gene with the differentiation 
process. It is expected that a lot of genes that are peripheral to in addition to those that 
are central to differentiation commitment would be isolated. The reason is that genes 
that are responsible for growth arrest, apoptosis as well as cell maturation and 
function would also be activated or suppressed during the differentiation process. 
Therefore, we should take further steps to identify genes that direct the differentiation 
commitment itself. 
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To prove whether certain genes are responsible for differentiation 
commitment, there are several direct strategies. Examination of some congenital 
mutations reveal the roles of some genes. Examples can be found in M-CSF {op 
mutation), stem cell factor {Steel, S1 mutation) and stem cell factor receptor {c-kit, W 
mutant). For genes where such mutations are not found, ectopic expression of the 
genes or inhibited expression of the genes by either anti-sense, antibody or dominant 
negative mutant approach can be used. These strategies interfere the endogenous 
expression of the genes and therefore give us a clearer idea of the gene functions. 
Alternatively, germ line mutation of the genes in animals can be established and any 
genes that are in suspicion of a role in cell differentiation commitment can be 
inspected. 
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1.2.4 Genes differentially expressed and involved in myeloid cell 
differentiation 
It has been noted that a significant proportion of leukemia has been classified 
as myeloid leukemia (Hoffbrand and Pettit, 1993). Thus, to understand differentiation 
commitment as a whole, the myeloid cell model sounds attractive to begin with. More 
specifically, we are concerned with how the myeloid progenitors give rise to 
macrophages and/or granulocytes. A vast number of genes have shown to be 
differentially expressed during myeloid cell differentiation. Some of these genes 
already have their roles in myeloid differentiation and lineage commitment be 
established while others still await for further investigation. Genes that are being 
regulated during an observed differentiation may code for growth factors, receptors, 
signal molecules, transcription factors, heat shock proteins and integrins. The 
following is a brief review stressing on genes that have shown differential expression 
during myeloid cell differentiation (in normal and/or leukemia cells) and the changes 
in expression have also been proved to be central to differentiation. These genes can 
be classified according to their gene products into four groups : cytokines, 
transcription factors, cyclin-dependent kinase inhibitors and proteins of unknown 
functions. (The characteristics of those myeloid cell lines involved in the studies 
described below are depicted in Appendix A2.) 
Transcription factors 
Transcription factors may be the main 'switches' for myeloid differentiation 
programme. Many of them are specifically induced or suppressed during myeloid cell 
differentiation. Their pivotal roles in myeloid cell differentiation were also verified by 
various gene function studies. Several DNA-binding motifs have been identified in 
transcription factors (reviewed in Locker, 1996) and these motifs have been used to 
categorize DNA binding proteins into families. In the followings, the family myb, 
myc (helix-loop-helix leucine zipper), basic helix-loop-helix, zinc fmger, ETS domain 
and homeobox-domain will be discussed. 
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The MYB Family -- c-myb 
The myb family codes for a unique type of transcriptional activators and 
comprises c-myb, B-myb, A-myb and the transforming gene w-myc. Cellular genes c-
myb, B-myb and A-myb contain three functional domains, a DNA-binding domain, a 
transactivation domain and a negative regulatory domain, w-myb, however, is 
truncated at both the N- and C-terminals. 
c-myb is a cellular counterpart of w-myb, an oncogene of avian retrovirus 
Avian myeloblastosis vims (AMV) and E26. Mutation of c-myb by protein truncation 
and deregulation of transcription cause myelogenous disease (Shen-Ong et al, 1986) 
and transformation of hematopoietic cells (Gonda et al, 1996) respectively. Its 
primary role in myeloid cell differentiation and leukemia was further supported by its 
expression pattern. Its abundant expression level was down-regulated upon terminal 
differentiation of normal myeloid precursors (Liebermann and Hoffman-Liebermann, 
1989; Sheiness and Gardinier, 1984). Similarly, during the monocytic differentiation 
of WEHI-3B, Ml and HL-60 cells (Liebermann and Hoffman-Liebermann, 1989; 
Magrinat et al, 1992) as well as granulocytic differentiation of 32Dcl3 cells, its 
expression level was down-regulated significantly (Wolffe^ al, 1996). 
Further evidence revealed that down-regulation of c-myb is specifically 
essential for the late differentiation of both monocytic and granulocytic lineages. 
Continuous expression of c-myb disrupted the monocytic differentiation ofMl cells at 
a very early myeloblast stage. The cells developed only partially into macrophages 
(Selvakumaran et al, 1992; Wolff et al, 1996). Constitutive expression ofthe gene 
induced differentiation of WEHI-3B (D+) cells to the promonocyte stages but not 
differentiation from promonocytes to monocytes (Yanagisawa et al, 1991). Similarly, 
over-expression of the gene in 32Dcl3 cells did not influence the early stages of 
granulocytic differentiation (promyelocyte to myelocyte) but inhibited the late stages 
of differentiation (metamyelocyte and neutrophils) (Wolff et al, 1996). Thus, down-
regulation of the gene is essential for terminal differentiation of both monocytic and 
granulocytic differentiation. 
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Miibition of the c-myb expression by anti-sense technique in bone marrow 
cells revealed that the expression of c-myb is required for erythroid and myeloid 
colony formation (Gewirtz and Calabretta, 1988). Severe impairment of 
erythropoiesis and myelopoiesis was also found in homozygous c-myb deficient mice 
(Mucenski et al, 1991). The knock-out mice were defective in fetal liver 
hematopoiesis and the subsequent adult-type hematopoiesis. They have reduced 
number of myeloid progenitors (and other progenitors) (Lin et al, 1996) and died at 
E15.5 day. In conclusion, c-myb expression is required for myelopoiesis and myeloid 
colony formation and the decreased expression of the gene is essential for terminal 
differentiation ofboth monocytic and granulocytic differentiation. 
c-myb represents one of the master genes of myeloid differentiation. Its 
responder genes included genes that are responsible for controlling both proliferation 
and differentiation. Some of them are mainly involved in growth control (e.g. cdc 2) 
while others are differentiation-related (e.g. mim-l). Putative downstream genes of c-
myb in myeloid differentiation include CD34 gene, c-myb (auto-regulation), c-myc, 
hsp70, DNA polymerase a gene and mim-1 (reviewed in Hesketh, 1995). Among 
these responder genes, CD34 and c-myc have been shown to be down-regulated 
during the myeloid cell differentiation and the decreased expression has also found to 
be essential to the differentiation (see below). 
The MYC family 
The myc family comprise c-myc, max (myn, murine homolog), mad and mxil. 
All the MYC family proteins contain a conserved structure, the basic region helix-
loop-helix leucine zipper (bHLH-Zip) which allows DNA binding and 
oligomerization with other proteins. MYC, in addition, has a transactivation domain 
in its N-terminal. Whereas MYC does not form homo-dimers or hetero-dimers with 
either MXI1 or MAD, MAX forms homo-dimers as well as hetero-dimers with all the 
other three members. In addition, all these dimers have shown to bind on the same E-
box sequence (reviewed in Locker, 1996). 
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c-myc, the best known member, was discovered as the cellular homolog of a 
transforming oncogene in a group of avian retroviruses. It is suggested to be a key 
regulator in mammalian cell proliferation, differentiation and apoptosis. Its 
expression level has been shown to decrease upon monocytic differentiation of normal 
mouse myeloblast (Liebermann and Hoffman-Liebermann, 1989) and various 
leukemia cell lines (e.g. Ml, HL-60, ML-1, K562 and U937 cells) or upon the 
granulocytic differentiation of HL-60 cells (Hoffman-Liebermann and Liebermann, 
1991; Larsson et al, 1994). This decrease in c-myc expression level is both essential 
for myeloid cell differentiation and sufficient to trigger differentiation. Over-
expression of c_myc was able to block the induced differentiation of several myeloid 
cell lines like murine J774, Ml and human U937 cells (Chisholm et al., 1992; 
Hoffman et al., 1996) whereas inhibition of c'myc expression by anti-sense oligomer 
alone was able to cause the differentiation ofHL-60 (Holt et aL, 1988). 
max, was identified by screening a cDNA expression library with the C-
terminus of human MYC. Its expression was decreased during the monocytic 
differentiation of normal myeloblasts (Nguyen et al, 1995), HL-60, Ml, ML-1 and | 
U937 cells, as well as during the granulocytic differentiation of HL-60 cells (Larsson 
Qt al., 1994). The action of max on myeloid cell differentiation appeared to be tightly 
linked to other family members. Blocking expression of either c-myc or max by anti-
sense oligomers in Ml cells inhibited proliferation and induced differentiation of the 
cells to the intermediate stage. Terminal differentiation was only observed when both 
genes were blocked in Ml cells. On the other hand, inhibition of either c-myc or max 
by anti-sense oligomer was sufficient to suppress growth and accelerate the 
differentiation of GM-CSF-stimulated myeloblast enriched BM cells along both the 
monocytic and granulocytic lineages. However, combined actions of both oligomers 
did not enhance the effect on differentiation (Nguyen et al, 1995). Taken together, 
decreased expression of either c-myc or max enhances the differentiation of bone 
marrow cells. In addition, down-regulation of both c-myc and max is essential for 
terminal differentiation of myeloid leukemia cells. 
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mad is isolated as a result of screening a A,gtl 1 expression library using MAX 
as probe (Ayer et al, 1993). The gene expression was up-regulated in various 
myeloid cell lines during their induced differentiation into macrophages (e.g. HL-60, 
K562, ML-1 and U937 cells) or granulocytes (e.g. HL-60) (Larsson et al., 1994). In 
normal myeloblasts and monoblasts, rapid induction of mad was also observed upon 
differentiation (Hurlin et al, 1994). Nevertheless, the exact role played by the gene 
has not been demonstrated. 
mxil was found as MXI1 specifically interacts with MAX (Zervos et al, 
1993). Its expression has shown to be increased and remained elevated at all times 
during monocytic differentiation ofU937 (Larsson et al, 1994; Zervos et al, 1993). 
In contrast, mxil expression was strongly reduced in the monocytic differentiation of 
K562 (Delgado et al, 1995). These different patterns of expression may suggest 
different action of the genes in cells at different differentiation stages but such view 
has not been established by solid evidence. 
The expression pattem of the myc family also suggested some degree of 
lineage specificity. While c-myc expression was consistently decreased during both 
the monocytic and erythroid differentiation of K562 cells, the expression level of max 
was down-regulated during erythroid differentiation but unchanged in expression 
during monocytic differentiation of K562 cells, mxil was down-regulated during the i 
monocytic differentiation of K562 cells but up-regulated during their erythroid 
differentiation. In contrast, the expression of mad was elevated during the monocytic 
differentiation of K562 cells but remained unchanged during its erythroid 
differentiation (Delgado et al, 1995). These expression patterns suggested the 
members of the myc family are regulated differently during different lineage 
specification. However, whether a decrease in expression of c-myc and mxil, an 
unchanged mRNA level of max and an increase in mad expression are causative to 
myelomonocytic in preference to erythroid differentiation are unknown. 
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Some potential target genes of c-myc such as ornithine decarboxylase (ODC) 
have been identified. However, none of them have been proved to be essential for 
myeloid cell differentiation (reviewed in Hesketh, 1995; Hoffman et al, 1996). 
Basic helix loop helix — SCL 
SCL gene, codes for a basic helix-loop-helix (bHLH) protein, was cloned from 
t(l;14) translocation of a patient with biphenotypic leukemia. Recently, deregulation 
of SCL gene was also suggested in myeloid leukemia cells (Tanigawa et al, 1994). 
During myeloid cell differentiation of K562 cells, there was an early transient fall in 
SCL mRNA levels. This level was then increased but dropped again at a later time 
(Green et al, 1993). In the induced differentiation of FDCPmix A4 cells to the 
granulocyte/monocyte lineage, a marked decrease in SCL mRNA was also observed 
(Cross et al, 1994). Similarly, a late and persistent decrease in mRNA levels was 
found during the monocytic differentiation of Ml cells (Begley, 1994). In contrast, 
the mRNA level of SCL gene was decreased only transiently, increased later and 
maintained throughout the erythroid differentiation of erythroleukemia MEL (Green et 
al, 1993). Up-regulation of SCL gene was also found during the erythroid 
differentiation of FDCPmix cells (Cross et al, 1994). Constitutive expression of 
SCL gene inhibited LIF- and OSM_ induced differentiation of Ml cells, indicating '‘ 
that down-regulation of SCL gene is specific for and essential to myeloid cell 
differentiation (Begley 1994; Tanigawa et al, 1993). 
Leucine zipper -- CCAAT / Enhancer Binding Protein -- C/EBP 
C/EBP is a family ofbasic leucine zipper binding proteins which bind DNA as 
homo- or hetero-dimers. The members of the family include C/EBPoc, C/EBPp P^F-
IL6, LAP, IL-6DBP, AGP/EBP and CRP2), C/EBPy (Ig/EBP-1) and C/EBP5 (CRP3). 
C/EBPa, C/EBPP and C/EBP5 mRNAs were detected and appeared to be restricted to 
myeloid cells Q^atsuka et al, 1992). Differentiation-related changes of the gene 
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expression further suggest their roles in myeloid cell differentiation. High level of 
C/EBPa expression was detected in myelomonocytic cells but the level was down-
regulated on maturation. Its expression was also decreased during monocytic 
differentiation of HL-60 cells and granulocytic differentiation of both HL-60 and 
32Dcl3 cells (Scott et aL, 1992). C/EBPp OS[F-IL6), in contrast, was increased in 
mRNA level during the monocytic differentiation of HL-60, Ml and U937 cells and 
during granulocytic differentiation of 32Dcl3 cells fNatsuka et al, 1992). 
Conversely, no change in expression level was accompanied with the granulocytic 
differentiation of HL-60 Q^atsuka et al, 1992). For C/EBP5, the expression was up-
regulated during the granulocytic differentiation of 32Dcl3 (Scott et al, 1992). 
C/EBP family also regulate certain myeloid-related or specific genes. C/EBPp 
has been shown to regulate IL-ip and TNF-a (Pope et al, 1994; Tsukada et al” 
1994). On the other hand, C/EBP binding sites have been located in the proximal 
promoter region of G-CSFR, GM-CSFRa and M-CSFR where PU.1 sites are also 
found (Zhang et al, 1996). Recent studies have pointed out that C/EBPa would be 
the major form that binds and activates such promoters in myeloid cell lines (Hohaus 
et al, 1995; Zhang et al, 1994). Regulation of GM-CSFRa by C/EBPa plus PU.1 
have been demonstrated in monocytic cells (Hohaus et al, 1995). The regulation of 
these receptor genes by C/EBPa (and other transcription factors) would probably alter 
the response of the myeloid cells to exogenous growth factor. However, it is also 
worth noting that other family members in addition to C/EBPa also target on this 
promoter site. In addition, homo- or hetero-dimers between the family members may 
form (Scott et al, 1992; Zhang et al, 1996). As a result, the relative amount of these 
members during myeloid differentiation may affect the expression of their target genes 
through binding competition and/or dimerization. Further studies on these genes may 
reveal a complex system of myeloid cell differentiation. 
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Leucine zipper — The FOS/JUN family 
The fos/jun family {c-fos, fosB, fral, fra2, c-jun, c-junB, c-junD) code for 
ubiquitous leucine zipper transcription factors, c-jun and c-fos are two prominent 
members. They are readily induced as primary response genes and activated in 
response to growth factors and agents like phorbol esters (e.g. PMA). Also, c-Jun can 
form homo-dimers or hetero-dimers with c-fos to become activator protein-1 (AP-1). 
The possible role(s) of the fos/jun genes and AP-1 complex in myeloid cell 
differentiation can largely be reflected in their expression patterns in myeloid cells. 
The expression levels of Q-fos and c-jun were readily increased during the leukemia 
cell differentiation of U937, HL-60 and some leukemic cell clones (Adunyah et al, 
1992; Hass et al, 1991; Shabo et al.’ 1990; Szabo et al, 1991). Besides, other family 
members like jmB and/or junD (having sequence homology with c-jun) were 
enhanced within hours in mRNA levels during the induced monocytic differentiation 
of HL-60, Ml, THP-1 and U937 cells (Datta et aL, 1991; Lord et al” 1990a; 
Mollinedo and Naranjo, 1991) or granulocytic differentiation of HL-60 cells 
(Mollinedo and Naranjo, 1991). 
The roles of fos/jun in myeloid cell differentiation were further supported by 
more direct evidence. Enforced expression of c-jun was capable of initiating ] 
differentiation of WEHI-3B (D+) cells (Li et al, 1994c) and partial differentiation of 
U937 cells (Szabo et al, 1994) in the absence of differentiating agent. Li addition, 
enforced expression of c-fos increased the propensity o fMl cells to differentiate and 
reduced their leukemic phenotype. c-fos anti-sense oligomer, on the other hand, was 
able to block in vitro terminal differentiation of normal myeloblasts significantly 
(Lord et al, 1993). Thus, c-jun alone is sufficient to trigger monocytic differentiation 
of leukemia cell lines while c-fos is essential for differentiation of normal myeloblasts 
and myeloid leukemia cells. 
c-jm and AP-1 binding may also determine the lineage choice ofmyeloid cells 
and progenitor cells. mRNA level of c-jun was increased during the induced 
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monocytic differentiation ofU937 and HL-60 cells but not granulocytic differentiation 
ofHL-60 cells (Mollinedo and Naranjo 1991; Gaynor et al, 1991). AP-1 binding 
activity was increased during the monocytic differentiation of HL-60 cells but not 
granulocytic differentiation of HL-60 cells (Mollinedo et al, 1993). Hence, it may be 
rewarding to conduct direct strategies like anti-sense technique or ectopic expression 
strategies (in an appropriate system) to see if the gene is deterministic in lineage 
commitment. 
Zinc finger - EGR-1 
egr-l, encodes a zinc finger transcription factor (EGR-1, Krox24, NGIF-A, 
Zif/268, Tis8), was first identified in 3T3 fibroblast-like cells. It is expressed during 
the differentiation of nerve, bone and myeloid cells and during the maturation of B 
cells. It is a primary response gene induced specifically during monocytic but not 
granulocytic differentiation. It is transiently expressed upon monocytic differentiation 
of HL-60, Ml and U937 cells O^guyen et al, 1993). However, no increase in 
expression was found during the granulocytic differentiation of HL-60 cells O^^ guyen 
et al, 1993). Similarly, the mRNA level of egr-1 was increased in normal myeloblast 
induced to follow the monocytic pathway but not in bone marrow cells induced to 
follow the granulocytic pathway (Nguyen et al, 1993). egr-1 is essential for 丨 
monocytic but not granulocytic differentiation. Inhibition of the gene expression by 
anti-sense oligomer blocked the monocytic differentiation of HL-60, U937, Ml and 
myeloblast-enriched bone marrow cells but not granulocytic differentiation of HL-60 
cells ^4guyen et aL, 1993). Enforced expression of the gene prevented HL-60 cells 
from moving along the granulocytic but not the monocytic lineage (Nguyen et al, 
1993). Taken together, increased expression of egr-1 is essential specifically in 
monocytic differentiation. Moreover, enforced expression of the gene can override 
the granulocytic differentiation program of the cells. 
One potential target gene of EGR-1 is c-myb (another important gene in 
myeloid cell differentiation, see above), c-myb is expressed when granulocytic 
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differentiation ofHL-60 was blocked by enforced expression of egr-7. Having at least 
one EGR-1 binding site on its promoter ^s[icolaides et al, 1991)，c-myb is suggested 
to be transactivated by EGR-1 and prevent the granulocytic differentiation (Nguyen et 
al, 1993). 
Zinc finger -- Myeloid Zinc Finger MZF-1 
While egr-1 is important for monocytic differentiation, another zinc finger 
gene mzf-1 is essential to granulopoiesis. 
mzf-1 was originally probed from a myeloid >,gtl 1 cDNA library made from a 
patient with CML, using conserved sequence of the zinc finger genes. (Hromas et al, 
1991). In fact, mzf-1 has been proved to be a typical zinc finger gene. Its zinc finger 
domain is also related to PLZF-1, part of a fusion protein with RAR-a, in t(ll;17) 
promyelocytic leukemia (Chen et al, 1993). 
The mzf-1 mRNA could be detected in various leukemia cell line including 
HL-60, KG-1, HEL and K562 (Hromas et al, 1991). The gene is also expressed 
exclusively in myeloid cells in normal bone marrow, from myeloblasts to 
metamyelocytes (Bavisotto et aL, 1991). Moreover, during the induced granulocytic 
differentiation of HL-60 cells, the gene increased in expression (Hromas et al, 1991). 
This increase in expression was later proved to be essential in granulopoiesis in vitro. 
Inhibition of mzf-1 by anti-sense oligomer decreased the formation of granulocyte 
colonies (G-CFU) but not erythroid colonies (BFU-E). Also, the formed granulocytic 
colonies were dysplastic in morphology (Bavisotto et al, 1991). Continuous over-
expression of mzf-1 in the FDCP.1 myeloid cell line, on the other hand, prevented 
apoptosis and altered the phenotype ofthe cells which caused tumor formation in mice 
(Hromas et al, 1996). These findings suggested the gene is crucial to myeloid colony 
formation and that deregulated expression of the gene causes transformation. 
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ETS family - PU.1 
PU.1 is a member of the ETS transcription factor family. PU.1 gene is 
expressed exclusively in the hematopoietic system, highly expressed in granulocytic, 
monocytic and B lymphocytic cells. It is positively auto-regulated in myeloid cells 
but not in T cells nor in non-hematopoietic cells (Chen et aL, 1995). PU.1 has been 
suggested to be a key regulator in myelopoiesis at both early and more mature stages. 
PU.1 is expressed in the earliest multi-potential progenitors and specifically up-
regulated during commitment to the myeloid lineage (Voso et al, 1994). Another 
report revealed that the gene was expressed in early myeloid precursors but declined 
in expression as the cells differentiated towards the granulocytic pathway (Hromas et 
al, 1993a). Inhibition of PU.1 function by competitor oligonucleotides blocked 
myeloid colony formation in human CD34+ cells (Voso et al, 1994). Also, 
inactivation of the gene by homologous recombination showed a multi-lineage defect 
in mice suggesting that PU.1 may have affected myeloid cell differentiation at the 
early multi-potential progenitor stage (Scott et al, 1994). Recent studies on 
examination of embryonic and fetal hematopoietic organ from PU.1"_ mice and in 
vitro differentiation of PU.1"_ ES cells, however, showed that PU.1 had a notable 
effect on late (CDllb, M-CSFR and CD64) rather than early myeloid gene 
I expression. This suggested PU. 1 may have an important role in later development of 
myeloid cells as well (Simon et al., 1996). 
Homeobox-containing genes 
The homeobox is a DNA region of 180/183 base pair long encoding a 
conserved 60/61 amino acid domain, the homeodomain. It has a structure very similar 
to the helix-turn-helix motif (Billeter et al., 1990). Homeobox genes can be divided 
into different classes, superclasses and families based on the structural similarities and 
evolutionary relationship (reviewed in Burglin, 1994). For simplicity, homeobox-
containing genes can be roughly divided into two main groups : the HOX clusters and 
the non-cluster members. Homeobox-containing genes have been well-known for 
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their roles in embryogenesis and now there is increasing evidence that these genes are 
also important in hematopoietic cell differentiation (Giampaolo et al, 1995; Lawrence 
and Largman, 1992; Magli et al, 1991; Sauvageau et aL, 1994; Shen et al.’ 1989; 
Vieille-Grosjean et al” 1992). 
The possible roles of individual homeobox genes in myeloid cell 
differentiation are suggested by the differentiation-related changes of gene expression. 
The most remarkable example is HOX B7. A rapid expression of HOX B7 was 
shown during the vitamin D3-induced monocytic differentiation of HL-60 cells (Lill et 
al” 1995). In addition, HOX B7 gene expression was detected in human bone marrow 
cells differentiating into the myeloid lineage (Lill et al, 1995). Over-expression of 
the gene was able to inhibit the granulocytic differentiation of HL-60 cells while no 
effect was observed on the monocytic differentiation (Lill et al, 1995). Inhibition of 
the HOX B7 gene expression by anti-sense oligomers was able to inhibit markedly the 
formation of colonies derived from GM-CSF-stimulated bone marrow cells. A similar 
observation had also been noted in murine bone marrow where anti-sense oligomer 
directed against mRNA of HOX B7 gene was able to block myeloid colony formation 
without affecting erythroid or megakaryocytic differentiation (Wu et al, 1992). These 
functional studies have proved that the gene is essential for myeloid colony formation. 
It can also override the granulocytic differentiation of myeloid cells when over-
expressed. However, the gene alone has no effect on monocytic differentiation. 
In addition to the HOX cluster, non-cluster homeobox genes may also play a 
role in myeloid cell differentiation. Prh (Proline-rich homeobox) is a novel human 
homeobox-containing gene isolated from a CD34+ cell line KG-lA. Its expression is 
mainly restricted to hematopoietic tissue (Hromas et al, 1993b). Prh mRNA was 
I found to express in early myelomonocytic and erythromegakaryocytic cell lines. 
I Upon in vitro differentiation of the cell line into mature monocyte/macrophage, Prh 
expression was lost. This down-regulation of expression level was also observed in 
normal monocyte but the gene was highly expressed in normal granulocytes 
(Manfioletti et al” 1995). Hlx (homology of human HB2A) may also be important in 
myeloid cell differentiation. Its expression was restricted to myelomonocytic and pre-
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B lineage and increased on maturation (Harvey and Adams, 1991). The phenotypic 
myeloid maturation of FDC-P1 was also associated with the induction of Hlx 
expression (Allen and Adams, 1993). However, the significance of the decrease or 
increase in expression of Prh and Hlx in relation to myeloid cell differentiation is not 
known until fiirther investigation is carried out. 
Cytokines 
Cytokines, in particular, the hematopoietins are regulators of hematopoiesis. 
Some of them, together with their receptors, are particularly important in the myeloid 
lineage. Exogenous effects of these cytokines on myeloid cell differentiation have 
been vigorously studied. They are also suggested to be external stimuli that drive the 
differentiation commitment and bias the lineage choice. Interestingly, newly 
transcribed cytokine genes (IL-1, IL-6 and TNF-a) were also found to be associated 
with the monocytic differentiation of both normal differentiating bone marrow-
derived colonies (Witsell and Schook, 1992) and monocytic leukemia cell lines 
(Ishizuka et al.，1995; Lotem and Sachs, 1989; Magrinat et al., 1992). One of the 
most notable examples was TNF-a. The expression level of the gene was increased 
significantly during the monocytic differentiation of U937 and HL-60 cells as well as 
PMA- or TNF-a induced differentiation of WEHI-3B JCS cells (Hass et al, 1991; 
Magrinat et al, 1992; Mak et al, 1993). In addition, its expression was also increased 
in the differentiating bone marrow-derived macrophage colonies (Witsell and Schook, 
1992). Further investigation suggested endogenous TNF-a is essential for monocytic 
differentiation of both the normal and leukemia cells. The PMA_ or TNF-a induced 
monocytic differentiation of WEHI-3B JCS cells could be abrogated by TNF-a 
neutralizing antibodies (Mak et al, 1993). Likewise, anti-sense oligomers against 
TNF-a messages were able to maintain the proliferation state of the growth factor-
induced bone marrow-derived macrophages without terminal differentiation (Witshell 
and Schook, 1992). 
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Cyclin-dependent kinase inhibitors (Cdk inhibitors) — p21 
p21^^^' ciPi, a cyclin-dependent kinase inhibitor, is involved in the blocking of 
cell cycle progression. Its gene expression was increased during the differentiation of 
several cell types including the myeloid leukemia cell lines HL-60 and U937 (Jiang et 
al, 1994; Liu et al, 1996). Unexpectedly, the gene is not only involved in events in 
the cell cycle but also initiates the myeloid cell differentiation. It was transcriptionally 
activated during the monocytic differentiation ofU937 cells induced by vitamin D3. In 
the absence of differentiation inducers, transient over-expression of the p21 gene was 
able to drive the cells to differentiate into mature stage (Liu et al, 1996). 
Nevertheless, the gene may not be essential to myeloid cell differentiation as p21"^ " 
mice showed only defects in the ability to arrest in Gi phase (Deng et al, 1995). 
Protein of unknown function— CD34 
CD34 is a well-known and widely-used marker for identifying hematopoietic 
stem/progenitor cells. However, its function remains unknown. It is thought to be a 
type I transmembrane protein and highly 0-glycosylated on the extracellular region. 
The ability of CD34 to bind to L-selectin (Baumheuter et al, 1993) suggested that 
CD34 might play a role in cellular interaction and adhesion in stromal 
microenvironment. CD34 has an alternative truncated form in addition to the 
membrane-bound form (Suda et al, 1992). While the full-length CD34 mRNA was 
detected in all CD34+ cell lines tested, the truncated form was not. 
CD34 gene expression was decreased during the monocytic differentiation of 
Ml cells (Fackler et al, 1995). Recent studies further revealed that CD34 is essential 
to myeloid cell differentiation. Enforced expression of transmembrane CD34 without 
cytokine induction could initiate the differentiation of Ml but not HL-60 nor 32D 
cells to an intermediate stage (Fackler et al, 1995). However, down-regulation of 
CD34 (transmembrane form) is essential to terminal differentiation of Ml cells. 
While over-expression of the truncated CD34 did not affect the induced terminal 
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differentiation of Ml cells, constitutive expression of the full-length form prevented 
the cells from terminally differentiated (Fackler et al, 1995). Taken together, down-
regulation of CD34 (full length) expression alone initiates Ml cell differentiation to 
an intermediate stage, and its down-regulation is required for mature monocytic 
differentiation. The important role played by CD34 in myeloid cell differentiation 
was further confirmed in transgenic studies. First, delayed erythroid and myeloid 
differentiation was found in yolk sac-like hematopoiesis in embryoid bodies generated 
from CD34"- ES cells. Second, the colony-forming activities decreased in both yolk 
sacs and fetal liver progenitors in CD34"_ embryo; in addition, there was also 
decreased colony-forming activities of hematopoietic progenitors in adult CD34"' 
mice (Cheng et al, 1996). In conclusion, CD34 is essential for progenitor cell 
formation including that of the myeloid lineage in both adult and embryonic 
hematopoiesis. 
Differentially expressed genes during myeloid cell differentiation ~ an 
overview 
A lot of genes have been described to date to be differentially expressed or 
transcriptionally activated or suppressed in the course of myeloid cell differentiation. 
In this review, we are concerned about genes that are specifically regulated during the 
differentiation of the relatively committed precursor cells which have already 
restricted their differentiation pathways to monocytic or granulocytic pathways. These 
genes that change in their mRNA levels during differentiation may be cytokines, 
cytoplasmic tyrosine kinases, cyclin-dependent kinase inhibitors, heat shock proteins, 
transcription factors or proteins of unknown functions. Among these genes, however, 
only some of them are relevant to the differentiation commitment. Gene products that 
have been proved to be primary to differentiation commitment were interestingly 
limited largely to transcription factors (summarized in Table 1.1). The phenomenon 
may be attributed to the fact that transcription factor genes are master genes that 
control the differentiation program at a top level. However, it may not be at all wise 
to restrict our search only to transcription factors, as responder genes like CD34, Cdk 
inhibitor and cytokines have also been proved to be either essential or sufficient 
factors to cause differentiation. Although genes for MyD88 (Lord et al, 1990b) and 
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heat shock proteins (hsp27, hsp70) (Minowada and Welch, 1995) were shown to have 
marked changes in expression level, their functions during myeloid cell differentiation 
remain to be determined. Hence, a comprehensive search for all differentially 
expressed genes during myeloid cell differentiation would be rewarding. 
It must also be stressed that both ‘switching on’ or ‘switching off of genes are 
important for myeloid cell differentiation program. Both up-regulation (c-j'un，c-fos, 
egr-1, mzf-l, HOX B7 gene, TNF-a and p21) and down-regulation {c-myb, c-myc, 
max, SCL gene, PU.1 and CD34) of genes have proved to be equally crucial in 
myeloid cell differentiation (Table 1.1). Thus, to obtain a complete picture of myeloid 
cell differentiation, studies on both type of genes are necessary. 
Finally, there are genes that have different actions on two different cell 
lineages (e.g. egr-1, HOX B7 gene). While they are essential for the differentiation of 
one lineage, they suppress the differentiation of another. As a result, studying genes 
that are specifically up-regulated in one lineage but not the other may reveal their 
differential effects on two lineages (e.g. egr-1). 
In short, we need to employ a searching strategy which aims at finding all 
differentially regulated genes during myeloid cell differentiation. The system should 
also allow the identification of up-regulated and down-regulated genes at the same 
time. A comparison of the expression patterns of these genes during both monocytic 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.3 Induced myeloid cell differentiation 
1.3.1 Induced myeloid cell differentiation 
Induced hematopoiesis has been observed in pathological processes, infections 
or treatment with cytotoxic drugs. This results in an increased production of cells 
largely restricted to a specific cell type in demand in response to an interplay of 
growth factors (CSFs and interleukins) 
Induced myeloid cell differentiation can be mimicked in vitro, in primary 
culture initiated from normal bone marrow cells maintained by multiple growth 
1 factors. Alternatively, many myeloid leukemia cell lines, derived from hematopoietic 
1 
I cells at different stages of development and commitment, have been proved to be very 
I useful tools for studying in vitro hematopoiesis. Very often, these cell lines are 
j 
growth factor-dependent. They rely on the appropriate factor(s) for both survival and 
i 
proliferation (factor-dependent cell lines, e.g. 32Dcl3). Some other leukemia cell 
lines, however, can produce or be engineered to produce the required growth factors 
themselves, acting in an autocrine manner. As autocrine growth factor production 
alone does not appear to play major roles in leukemogenesis / in the maintenance of 
一 the leukemic state, these leukemia cells often display response that reflect 
approximately the responses of normal cells from which the leukemia is derived. Like 
hematopoiesis in vivo, both primary bone marrow cell culture and leukemia cell line 
are able to be triggered to differentiate by certain growth factors (G-CSF), 
physiological inducers (retinoic acid, RA), pathogens or their derived products 
(lipopolysaccharide, LPS). Although leukemia cells cannot entirely represent the 
normal cells, they do retain some normal functions and responses of normal cells. 
Also, they are less vulnerable and easier to maintain, thus, providing us with very 
useful models for studying the properties ofboth normal and leukemia cells arrested at 
^ different stages. 
I 
Another flexibility of these cell lines is that they respond not only to different 
physiological growth factors but also to some non-physiological inducers (e.g. phorbol 
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12-myristate 13-acetate, PMA). It has been demonstrated that the same growth factor 
or non-physiological inducer can induce the differentiation of several cell lines to 
differentiate (e.g. G-CSF stimulates differentiation of WEHI-3B (D+), Ml and HL-60 
cells; PMA stimulates differentiation of U937 and WEHI-3B JCS cells). This 
suggests the cell lines are probably at similar stages of development, committed 
towards the same differentiation lineage, thus, receptive to the same inducing agent 
The same cell line can also be induced to differentiate by a repertoire of different 
physiological and non-physiological inducers but not the others (e.g. Ml cells can be 
induced to differentiate strongly by LIF but weakly by G-CSF while WEHI-3B(D+) 
cells differentiate in response to G-CSF but not LIF). This probably reflects the 
characteristics of the cell line arrested at a certain degree of maturation and arisen 
under certain environments. Each of the cell lines retains certain inducible normal 
i . . 
i pathways for differentiation and is defective in some other pathways. In addition, the 
] 
丨 cells may respond differently to different inducers in switching on different pathways 
i 
of differentiation towards either the same or different lineage (e.g. HL-60 cells can be 
triggered to undergo monocytic differentiation by PMA or Vit D3 or granulocytic 
differentiation by GM-GSF, DMSO or RA) resembling the differentiation potential of 
I 
normal cells. Therefore, by gathering the different responses of different leukemia 
I cell lines developed under different environments and arrested at different stages, we 
may be able to assemble a scratch of all possible responses and differentiation 
pathways of the normal cells during hematopoiesis. 
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1.3.2 WEHI-3B JCS cells 
WEHI-3B JCS is a recently isolated and characterized subclone of the WEHI-
3B (D_) line (Mak et al, 1993). While WEHI-3B (D+)，WEHI-3B (D_) and WEHI-3B 
JCS cells retained some common characteristics like producing IL-3 (Mak et al” 
1993), each of them has its unique characteristics and responses to different 
differentiation-inducing agent. For instance, WEHI-3B (D+) but not WEHI-3B (D') 
nor WEHI-3B JCS cells was able to give granulocyte-macrophage colonies upon post-
endotoxin serum stimulation (Mak et al, 1993). Interestingly, although all of these 
lines express mRNA for G-CSF receptor (Mak et al, 1993, authors' unpublished 
observation), only WEHI-3B (D+) cells showed cell differentiation towards 
granulocyte-macrophage upon G-CSF induction. Both WEHI-3B (D') and WEHI-3B 
JCS cells were unresponsive to the factor (Mak et al, 1993). 
On the other hand, WEHI-3B JCS is distinct in its ability to differentiate 
towards the monocytic lineage when incubated with non-cytotoxic concentration of 
TNF-a (600-1200 U/ml) (Mak et al, 1993). The cells also showed monocytic 
differentiation triggered by inducing agent like phorbol 12-myristate 13-acetate 
(PMA) (Mak et al, 1993)，lipopolysaccharide (LPS) (Chan et al” 1995) or growth 
factors such as IL-la or IL-ip (Chan et al, 1995). Synergistic actions of growth 
factors to induce differentiation of JCS cells were also observed. Sub-optimal 
‘ concentrations of TNF-a (50 U/ml) and IL-4 (100 U/ml) were able to induce 
monocytic differentiation of JCS cells (Leung et al, 1994). Similar interaction was 
also observed when the cells were treated with TNF-a (20 U/ml) plus IFN-y (300 
U/ml) (U2ket al, 1993). 
Differentiation of JCS cells and the degree of maturation have been monitored 
by some or all of the following methods. In general, JCS cells had significant 
morphological changes after 3-4 day incubation with the above mentioned inducers. 
There was an increase in cytoplasm to nucleus ratio, cell size and vacuolation (Mak et 
al, 1993, Leung et al, 1994). Flow cytometry analysis indicated that the expression 
of differentiation antigens such as Mac I (Mak et al, 1993; Leung et al., 1994), F4/80 
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(Leung et al., 1994) and FcR (Mak and et aL, 1993) were increased while that of J1 ld 
was decreased (Mak et al, 1993) as JCS cells were driven towards the monocytic 
lineage. Phagocytic activity demonstrated by the ability to engulf yeast particles was 
also increased as JCS cells differentiated (Mak et al., 1993, Leung et al, 1994). 
Functional assays investigating the NBT-reducing ability of the cells and non-specific 
esterase activity using fluorescein diacetate as substrate were also increased upon 
induction of JCS monocytic differentiation (Leung et al, 1994). Increase in 
percentage of plastic adherent cells is an another indication of differentiation (Leung 
et aL, 1994). Triggering by appropriate differentiation-inducing agents as mentioned 
above, the clonogenicity (the ability to form colonies) (Mak et al, 1993; Leung et al, 
1994) and tumorgenicity of the JCS cells (the ability to cause fatal leukemia in mice 
after intra-peritoneal injection of the treated cells) (Leung et al, 1994, Mak et al, 
1994) were found to be decreased. 
Pertussis toxins (PTx), which have been reported to interfere with the ADP-
ribosylation of G proteins, were found to augment the effect of sub-optimal 
concentration of TNF-a (25 U/ml) (Mak et al, 1994). Besides, preliminary findings 
suggested that prostaglandin E2 (PGE2) and cAMP, whose synthesis and accumulation 
respectively could be stimulated by PTx, were also capable of augmenting the TNF-a 
induced monocytic differentiation (personal communication with Dr. K.N. Leung), 
i This enhanced effect of PTx was not limited to TNF-a-induced monocytic 
differentiation but could also apply to LPS or PGE2-stimulated monocytic 
differentiation by JCS cells (Mak et al, 1993, authors' unpublished data). Taken 
together, PTx-sensitive G proteins may be involved in the signaling pathway of JCS 
cell differentiation initiated by various agents (Mak et al, 1994). 
Interplay of cytokines may also be involved in the differentiation of JCS cells. 
It has been shown that TNF-a or IL-ip—mediated monocytic differentiation could 
only be blocked by TNF-a or IL-ip neutralizing antibodies respectively (Mak et al, 
1993; Chan et al, 1995). Interestingly enough, the action of IL-la on JCS cell 
differentiation was able to be blocked by both IL-la and IL-ip neutralizing 
antibodies. In addition, during both LPS and TNF-a induced differentiation, there 
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was a significant up-regulation of IL-la, IL-ip, TNF-a and IFN-y gene expressions. 
Several conclusions can be drawn from these results. First, the differentiation-
inducing action of IL-la was mediated via the action of IL-ip during JCS cell 
differentiation. Second, the action of TNF-a on JCS cell differentiation may not be 
confined to direct signaling mechanism; TNF-a may drive the cells to differentiate via 
the production of other cytokines which can either work by themselves like IL-la, IL-
ip or work in synergy with TNF-a, like IFN-y (Mak et al., 1993) in an autocrine 
manner. Third, TNF-a may form a positive auto-regulation loop to enhance its action 
in stimulating differentiation of JCS cells (Chan et al., 1995). 
Besides cytokines or bacterial products, the effects of two distinct classes of 
molecules, flavonoids and benzodiazepines, on JCS cell differentiation are currently 
investigated. Plant flavonoids like nobiletin and tangeretin (methoxylated flavones) 
have been identified from the extracts of the pericarpium of Citrus reticulata (cv Jiao 
Gan) which are capable of inducing JCS cell differentiation towards macrophages and 
granuolcytes (Mak et al, 1996). Biochanin A, belonging to the subclass isoflavones 
of flavonoids, drive JCS cells towards the monocytic lineage (personal 
communication with Dr. N.K. Mak). In contrast to biochanin A and other defined 
inducers of JCS cells reported so far, midazolam, a member of the benzodiazepines, 
led the cells towards the granulocytic pathway in addition to the monocytic pathway 
^>ersonal communication with Dr. N.K. Mak). 
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1.3.3 Chemical Inducers ~ FIavonoids and benzodiazepines 
Flavonoids and biochanin A 
Main classes of flavonoids 
Flavonoids can be synthetic or natural-occurring. Over 4000 chemically 
distinct flavonoids have been identified in various plant sources (fruit, pollen, roots 
and heartwood). Flavonoids are also widely consumed in food of plant origin and the 
amount can be up to lg daily. The compound is a benzo-y-pyrone derivative taking 
the form of Ce-Cs-Ce . They comprise a benzene ring A and six-member ring C 
carrying a substituent phenyl ring B either in the 2-position (flavonoid) or the 3-
position (isoflavonoid). Flavonols and flavanones differ from each other by a 
hydroxyl group in the 3-position and a C2-C3 double bond. Ring C could either be a y-
pyrone or its dihydro-derivative in flavonols and flavonones (Figure 1.5). Flavonoids 
may occur as aglycons (the basic form), glycosides (with sugar residues) or 
methylated derivatives (Havsteen, 1983; Das, 1994). 
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Figure 1.5. The main classes of flavonoids. The basic structure contains a benzene ring A and a six-
member ring C carrying a ring B either in the 2-position (flavonoid) or the 3-position (isoflavonoid). 
Flavonols and flavanones differ from each other by a hydroxyl group in the 3-position and a C2-C3 
double bond (Havsteen, 1983; Das, 1994). 
i 
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Isoflavones and their distributions 
The isoflavonoids are a large and distinct subclass of the flavonoids (Dewick, 
1993). However, their distributions are almost limited to the subfamily 
Papilionoideae of the leguminosae. Only a few plants in the subfamilies 
Caesalpinioideae and Mimosoideae of the Leguminosae (beans) have been reported to 
contain isoflavonoids. A number of non-legume dicotyledon families are known to 
produce isoflavonoid derivatives; they are found in isolated plants or genera with 
more limited range of structures. Iridaceae is the major source of isoflavonoids 
among the monocotyledons while Juniperus and Podocarpus are known to produce 
isoflavonoids among the gymnosperms. A moss {Bryum capillare) has also been 
reported to produce several isoflavonoids and oligomeric derivatives. Marine coral 
{Echinopora lamellosa) is also a producer of isoflavonoids. Microorganisms and 
mammals fed with leguminous materials also produce isoflavonoids (reviewed in 
Dewick，1993). 
Isoflavones constitute the largest group of natural isoflavonoids. One of the 
members is biochanin A (5‘,7'-dihydroxy-4‘methoxyisoflavone) (Figure 1.6). 
Biochanin A was found in a number of plant sources. These include cotyledon, seed 
and cell suspension culture of Cicer arietinum (chickpea plant), root of Cicer 
mongoltavicum, root, leaf and flower of Dalbergia sissoides, branch of Dalbergia 
volubilis, seed of Glycine max, stem of Milletiia dielsiana, Ononis spinosa, wood gall 
of Wisteria brachybotrys (reviewed in Dewick, 1993) and Trifolium pratense L. (red 
clover) (Cassady et al, 1988). 
O H \ ^ ^ Y ^ 
W V x 
^ 0 C H 3 
Figure 1.6. Structure of biochanin A. 
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Isoflavones and their biological activities 
Flavonoids consist of a vast number of members and mediate a lot of 
biological and pharmacological actions. Many of them are potent antioxidants. They 
are also anti-inflammatory, anti-allergic, anti-hemorrhagic, anti-toxic and 
hepatoprotective. Their endocrine effects and effects on smooth muscles were also 
noted. They inhibit as well as induce several important enzymes (reviewed in 
Middleton and Kandaswami, 1993; Stavric and Matula, 1992). Isoflavones share 
some of these properties and one of the prominent member, genistein is well-known 
for its inhibition on protein tyrosine kinase (PTK) and topoisomerase. Many 
biological effects of genistein can be attributed to its activity on protein tyrosine 
kinase. Inhibition ofT cell and mononuclear cell proliferation, production ofIL-2 and 
various effects on the signal pathway are some of the examples (Middleton and 
Kandaswami, 1993). Besides, the compound mediates activities that are unrelated to 
its effect on PTK. Genistein or daidzein (another member of isoflavones) was able to 
reduce the platelet response while genistein or biochanin A could inhibit Epstein barr 
vims (EBV) activation (reviewed in Middleton and Kandaswami, 1993). Isoflavones 
also affected the endocrine systems. Genistein inhibited IL-l-stimulated PGE2 
synthesis and the induction of PG endoperoxides. They (e.g. formononetin) can also 
act as phytoestrogens causing infertility syndrome of sheep (reviewed in Middleton 
and Kandaswami, 1993). 
Apart from these biological actions, we are interested in the cancer-related 
activities of isoflavones. The cytostatic effect of isoflavones (genistein) has been 
demonstrated in human T lymphocytic leukemia cell line MOLT-4 and HL-60 (Hirano 
et al, 1994). These compounds also inhibited the mitogen-induced blastogenesis of 
lymphocytes (Hirano et al, 1994). Moreover, genistein inhibited growth factor-
induced mitogenesis of mouse lOTl/2 fibroblasts, rat liver T51B cells and the ras-
transformed NIH 3T3 fibroblast cells (reviewed in Middleton and Kandaswami, 
1993). Isoflavones have shown notable differentiating effect on different cell lines. 
For instance, genistein was able to induce the differentiation of TS12 and SJNKP 
neutroblastoma cell lines (Rocchi et al, 1995), HL-60 (Constantinou et al, 1990; Jing 
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and Waxman, 1995; Watanabe et al, 1991) and K562 cells (Watanabe and et al. 
1991). Another isoflavone, daidzein was also a growth inhibitor and potent 
differentiation inducer oferythroleukemia cells (Jing and Waxman, 1995). 
Biochanin A and its biological activity 
Biochanin A has been found in soy-based diet which is associated with lower 
incidence of tumor formation. It is also one of the active compounds in Trifolium 
pratense L. (red clover) described as the 'Top ten herbs in medical practice' in 
Medical Herbalism : A clinical newsletter for herbal practitioner Vol 6 Spring 1994. 
Trifoliumpratense L. or the red clover was also believed to be a cure for various types 
of cancer fifty years ago (Hunt, 1994) and has been used in treatment of breast and 
I ovary cancer (Mills, 1994) in addition to its alterative and expectorant effect. The 
extract of the plant was recently found to be anti-carcinogenic and the active 
component was biochanin A (Cassady et al, 1988). The anti-carcinogenic effects of 
isolated biochanin A was also studied. The compound decreased the metabolism and 
DNA-binding ability of benzo[a]pyrene (a carcinogen) in V79 hamster embryo cell 
culture (Cassady et al, 1988; Chae et al, 1991, 1992). Anti-mutagenic activity of 
ij 
biochanin A in Salmonella typhimurium against two carcinogens, 2-aminoanthracene 
(Wall et al, 1988) and aflatoxin B! (Francis et al, 1989a) and one direct-acting 
carcinogen, A^-methyl-7V-nitro-7V-nitrosoguanidine (Francis et al, 1989b) was also 
observed. Biochanin A is a growth inhibitor of MCF-7 and MCF-7-D-40 human 
breast cancer cells (Peterson and Bames, 1991), HSC-45M2 and HSC-41E6 
(Yanagihara et al, 1993) gastrointestinal cancer cells and erythroleukemia MEL (Jing 
and Waxman, 1995). Besides, the compound is an inhibitor of tyrosine protein 
phosphorylation (Besterman and Schultz, 1990) which is frequently involved in cell 
proliferation and /or differentiation. In addition to anti-tumor effects, biochanin A can 
also act as phytoestrogen inhibiting male copulating behavior in Japanese quail 
{Coturnix coturnix) (Man and Peeke, 1982) and increasing progesterone synthesis in 
bovine granulosa cells (Kaplanski et al, 1981). However, whether such estrogenic 
property is related to the involvement of estrogen receptor in inhibiting the growth of 
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human breast cancer cells is unknown (Peterson and Barnes, 1991). Finally, biochanin 
A also showed hypolipidemic activity in rats (Sharma, 1978, 1979). 
Although growth inhibitory effect of biochanin A in different cell lines has 
been shown, the effect was cytostatic at low concentration and cytotoxic at high 
concentration (Yanagihara et al, 1993). As far as we know, the differentiation-
inducing effect of biochanin A (an isoflavone) was first demonstrated in JCS cells 
(personal communication with Dr. N.K. Mak). Hence, the gene expression it 
triggered is of much interest. 
Benzodiazepines and midazolam 
i 
Major classes of benzodiazepines and midazolam 
i 
i 
Benzodiazepines are widely prescribed drugs for their hypnotic, anxiolytic, 
anticonvulsant, muscular relaxant and amnesic actions. Their general structures are 
shown in Figure 1.7. The drugs can be classified according to their metabolic paths in 
the body into 'pro-nordiazepam' compounds, nitro-compounds and ‘short-acting， 
compounds (Bellantuono et al., 1980). 'Pro-nordiazepam' benzodiazepines such as 
diazepam (Figure 1.7) and medazepam yield nordiazepam or its halogenate 
homologues by hepatic N_dealkylation. The N-dealkyl derivatives are usually 
hydroxylated to oxazepam or its halogenated homologues. Finally, they are 
conjugated with glucuronic acid and excreted. Nitro-benzodiazepines like 
clonazepam (Figure 1.7) have no known active metabolites. Reduction ofthe nitroso 
group and acetylation are involved in the metabolic pathway. ‘Short-acting, 
benzodiazepines like lorazepam (Figure 1.7) have no active metabolites and directly 
conjugated with glucuronic acid for excretion. Benzodiazepines can also be classified 
according to their binding activities to different receptors. Central benzodiazepine 
receptors (CBR) are located in the CNS and coupled with y-aminobutyric acid 
(GABA) receptors and C1" channels. It has been suggested that the therapeutic effects 
mentioned above are mediated through these receptors. Peripheral benzodiazepine 
receptors (PBR) differ from CBR that they did not couple to GABA receptors and 
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distributed in neuronal as well as non-neuronal tissues. As opposed to CBR, PBR do 
not have stereochemical preferences in binding (Parola et al., 1993). CBR-speciflc 
ligand like clonazepam binds at high affinity with CBR but very low affinity with 
PBR. On the contrary, Ro5-4864 (4‘-chorodiazepam) binds specifically to PBR. 
Lastly, there are some compounds like diazepam that bind both CBR and PBR with 
similar affinity. 
Midazolam (8-Chloro-6-(2-flurorphenyl)-1 -methyl-4H-imidazo [ 1,5-a] [ 1,4: 
benzodiazepine) is a short-acting derivative of diazepam. It is a water soluble 
benzodiazepine having a shorter duration action than diazepam. It is anxiolytic, 
sedative and currently used in anesthesia. It inhibits the rise of ACTH and 
corticosterone (Freire-Garabal et al, 1992). It decreases arterial pressure without 
changing the heart rate. It is also a respiratory depressant. 
Basic structure Midazolam 
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Benzodiazepine 1 3 7 2’ 4， 6’ Classification 
g ^ ^ ^ ^ ^ W ^ ^ - - - "“™- ~"~™~ff"""""^_""^^:^j^;^cTigand 
Diazepam CH3 H C1 H H H 'Pro-nordiazepam' compounds 
Clonazepam H H NO2 C1 H H Nitro-compounds 
Oxazepam H OH C1 H H H Short-acting compounds 
Lorazepam H OH C1 C1 H H Short-acting compounds 
Figure 1.7. Structures of the benzodiazepines and some selected compounds. Benzodiazepines can 
be classified into ‘pro-nordiazepam‘compounds, nitro-compounds and short-acting compounds 
according to their metabolisms. There are also compounds that bind specifically to peripheral 
benzodiazepine receptors (Bellantuono et al., 1980). 
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Biological action and therapeutic use 
Benzodiazepines are employed in the treatment of insomnia (e.g. loprazolam), 
anxiety (diazepam), epilepsy (clonazepam), motor disorders, acute psychoses and used 
in anesthetic practice (midazolam). The drugs are able to suppress the noradrenergic 
and/or serotonergic pathways. They suppress activities in many limbic and other brain 
areas, decreasing the turnover of neurotransmitters in these areas. They also change 
the sleep pattem (Ashton, 1994), alter the neuroendocrine and autonomic nervous 
system (Schlumf et al, 1992). Besides, the drugs have actions on other non-neural 
tissues (reviewed in Gavish et al, 1992). Notably, diazepam stimulated human 
monocytic chemotaxis (Ruff et al, 1985), broke down the cytokine network (TNF-a, 
IL-2 and IL-6) (Schlumpf et al, 1992) and induced persisting depression of cellular 
immune responses by prenatal exposure (Schlumpf et al, 1988). In addition, 
diazepam was found to inhibit synthesis of myosin heavy chain in cultured muscle 
cells and decreased cardiac muscle contractility (reviewed in Gavish et al, 1992). 
The drugs like diazepam and Ro5-4864 can also modulate other cardiac fimctions. 
While diazepam can increase corticosterone and testosterone secretion, both diazepam 
and Ro5-4864 induce P4 and E2 secretion in placental explants (reviewed in Gavish et 
al, 1992). Finally, induction of ornithine decarboxylase was also observed (Morgan 
etal” 1985). 
Benzodiazepines and tumor 
Besides the biological actions and therapeutic effects mentioned above, 
benzodiazepines modulate proliferation and/or differentiation of some tumor cell 
lines. Diazepem (Valium), medazepam, lorazepam and to a lesser extent the CBR-
specific ligands imposed a cytostatic effect in a dose dependent manner on Swiss 3T3 
cells(Clarke and Ryan, 1980). Peripheral type benzodiazepines Ro5-4864 (4-
chlorodiazepam) and diazepam inhibit growth of human lymphocytes and lymphoma 
cell line CCRF-CEM (Alexander et al, 1992) as well as DNA synthesis of mouse 
spleen lymphocytes (Pawlikowski et al., 1988). Anti-proliferative effect mediated by 
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various benzodiazepines was also found in thymoma cell AKR (cytostatic effect by 
Ro5-4864) (Wang et al, 1984a), B103 and B104 neuroblastoma and Friend 
erythroleukemia cells (Wang et al, 1984a, authors' unpublished data). Moreover, 
peripheral type benzodiazepines inhibit NGF-induced neurite outgrowth in PC12 cells 
in a dose-dependent manner (Curran and Morgan, 1985; Morgan et al., 1985) and 
accelerate the onset of melanogenesis of melanoma B16/C3 (Matthew et al, 1981). 
Cell differentiation of Friend erythroleukemia cells (DS19FEL) and HL-60 (Ishiguro 
et al, 1987) induced by benzodiazepines were observed (Wang et al., 1984b). 
Having observed the biological actions of benzodiazepine on immune systems 
and its effects on tumor cell lines, we should not be surprised to see the differentiating 
effect of midazolam on the leukemia cell line JCS. However, reports on 
differentiating effects of benzodiazepines are very limited and there are none for 
midazolam. Also, midazolam drives JCS cells to a different lineage preference from 
the previously known inducers (personal communication with Dr. N.K. Mak); it is 
our interest to study the molecular mechanism of the differentiation process. 
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1.4 The aim of study 
Differentiation commitment occurred at different points during hematopoiesis. 
Multi-potent stem cells reduce/abolish a pre-existing capacity for self-generation and 
produce committed progenitors restricted to a limited number of cell lineages (or more 
often to a single lineage). In bipotent granulocyte-macrophage progenitor cells, the 
commitment limits the cells to form only the granulocyte or macrophage progeny. 
Such commitment can be reproduced in leukemia cell model like WEHI-3B JCS 
which upon induction differentiate towards the granulocytic or monocytic pathway 
with observable phenotypes. Precise control of hematopoiesis is important for normal 
function of the blood system and preclusion of disorders (leukemia). With the help of 
a leukemia cell model, we are able to dissect the control mechanism of cell 
differentiation and/or proliferation. Such investigation will be rewarding in 
understanding both normal hematopoiesis and leukemic situation. 
WEHI-3B JCS cell line was developed only recently and many ‘proposed, 
inducers have been tested to accumulate more basic information about the cell line. 
Among these inducers, biochanin A and midazolam drove JCS cells into monocytic 
and monocytic/granulocytic differentiation respectively. Previous induction of 
! 
j WEHI-3B JCS cells by TNF-a resulted in endogenous production of various cytokine 
mRNA. These cytokines (IL-la and IL-ip) not only expressed at high levels during 
the TNF-a stimulated differentiation but also directed cell differentiation of JCS cells 
themselves. In particular, the action of IL-la was proved to be indirect and mediated 
through the activity of IL-lp (Chan et al., 1995). Consistent with these findings, 
cytokines have also been shown to be important participants in myeloid cell 
differentiation. Hence, studying cytokine gene expression should give us insight into 
the mechanism of JCS cell differentiation. As biochanin A and midazolam represent 
two distinct types of molecules and are entirely different from TNF-a, it is anticipated 
that different differentiation pathways may be triggered by each of them. While both 
TNF-a and biochanin A lead JCS cells to monocytic lineage only, midazolam allows 
the production of granulocytic cells in addition to monocytic cells. These different 
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lineage commitment are likely to be controlled by different genes (including 
cytokines). On the other hand, biochanin A and TNF-a-induced JCS cells have the 
same lineage preference; thus, there may be some genes including cytokine genes that 
are commonly involved in both differentiation process. To examine and to compare 
the cytokine expression pattern triggered by biochanin A or midazolam in JCS cells, 
we employ a semi-quantitative protocol using reverse-transcription-polymerase chain 
reaction, cycle titration and specific hybridization. The protocol is simple, fast, 
flexible and more sensitive than conventional methods. 
The role of cytokines in differentiation remain controversal; evidence has been 
accumulated to question the influence of cytokines on both differentiation 
commitment and hematopoiesis. With a view to delineate the molecular mechanism 
of myeloid cell differentiation, we are interested in studying the possible involvement 
of different types of genes in myeloid cell differentiation. 
I Midazolam is a very unique inducer of JCS cells; it triggers the cells to enter 
I 
I 
both the monocytic and granulocytic lineages. As no studies on granulocytic 
j differentiation of JCS cells have been done, we started by searching genes that change 
in mRNA levels during the differentiation process stimulated by midazolam. 
Different approaches like differential screening and subtractive hybridization can be 
used for the purpose but it is the technique RNA fingerprinting by arbitrarily-primed 
PCR (RAP-PCR) that allows a time course study. Genes that are up-regulated or 
down-regulated during differentiation can also be identified at the same time. The 
protocol is fast, simple and requires a small amount of starting RNAs. The initially 
obtained short fragments representing differentially regulated genes, can be used as 
probes to obtain full cDNA sequences. Effective screening system is necessary to 
remove false-positives (genes later proved not to be regulated during the 
differentiation) so that at least a couple of differentially expressed genes during the 
differentiation can be revealed at last (proved by RT-PCR). These isolated genes may 
belong to characterized genes or novel genes. To extend our understanding of these 
isolated genes, we propose to study at the same time the expression profile of these 
isolated genes during biochanin A-induced JCS cell differentiation and during embryo 
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development. This allows us to examine the gene in normal tissue as well as to 
speculate the function of the novel genes in embryo development and differential 
effects of the isolated genes on different lineages. 
The differentially regulated genes (in the form of short fragments) resulted 
from the current study need further characterization. One of our final goal is to find 
out the causative genes that direct the myeloid differentiation and/or bias the lineage-





Chapter Two Cytokine Expression in Biochanin A 
and Midazolam-treated JCS cells 
2.1 Introduction 
2.1.1 Cytokine and myeloid differentiation 
As discussed earlier, cytokines are the main regulators of hematopoiesis. In 
addition to the colony-stimulating factors GM-CSF, M-CSF, G-CSF and multi-CSF 
(IL-3) which are particularly important in myeloid cell differentiation, various 
interleukins, tumor necrosis factors and interferons have been reported to (1) modulate 
the growth and differentiation of the progenitor cells, (2) exert anti-proliferative 
activities on myeloid leukemia cells in vitro or (3) bias the lineage choice of the 
differentiating cells. Synergistic and negative effects of cytokines were also observed. 
In this section, we will concentrate on several cytokines that have previously been 
studied in JCS cells; their actions on bone marrow cells and other myeloid leukemia 
cells are summarized below. 
Interleukin-1 (IL-1) has many biological activities in immune and 
inflammatory responses (reviewed in Dinarello, 1994). It is produced by a variety of 
cell types including hematopoietic progenitor cells (Watari et al, 1996), stimulated 
i 
monocytes/macrophage and induced myeloid cell lines such as U937 and HL-60 
j (Giavazzi et al., 1995; Hass et al, 1991; Mori et al.，1992; Nishida et aL, 1988). It 
j 
affects hematopoietic stem/progenitor cells directly or indirectly through potent 
factors produced by bone marrow stromal cells or other cell types (Ikebuchi et al, 
1988). It acts synergistically with M-CSF, GM-CSF, IL-3 and SCF (Heimfeld et 
a/.,1991; Jacobsen et al, 1994) to stimulate proliferation and development of stem 
cells and progenitors. In vivo, the molecule increases the circulating neutrophils, 
multipotent and committed granulocyte-macrophage precursors (reviewed in Whetton, 
1990). The molecule also induced differentiation of myeloid leukemia cells indirectly 
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(Lotem and Sachs, 1989) or in co-operation with TNF-a in vitro (Weinberg et al, 
1992). Differentiation effect of the molecule (IL-la) was also found in vivo (Lotem 
and Sachs, 1992). Lastly, mitogenic effect on early stage leukemia cell line and 
hematopoietic progenitors were also observed (Sakai et al, 1987; Silvennoinen and 
Hurme, 1990). 
Interleukin-4 (IL-4) has both stimulatory and inhibitory actions on myeloid 
cells (Kasukabe et al, 1994). While it enhanced the granulocytic and monocytic 
colony formation induced by M-CSF and G-CSF respectively, it inhibited those 
triggered by IL-3 in vitro (Rennick et al, 1987). Regarding the effect on myeloid 
leukemia cells, IL-4 influenced the balance between self-renewal and differentiation 
of leukemic stem cells (Miyauchi et al, 1991). In addition, IL-4 alone either 
stimulated the growth of chronic myelomonocytic leukemia (CMMoL) cells after 
transformation (Yanagisawa et al, 1995) or inhibited the growth of JCS, Ml, FDCP-1 
and 32Dcl-23 cells (Leung et al, 1994, authors' unpublished data). It triggered 
monocytic differentiation of myeloid leukemia cell line (Imai et al, 1991), co-
operated with other cytokines like TNF-a to suppress the proliferation (Totpal and 
Aggarwal, 1991) and initiated the differentiation of myeloid leukemia cells (Leung et 
al, 1994). Besides the proliferation-inhibitory and differentiation-inducing effects, 
IL-4 together with IFN-y may also specify the cell lineages (Snoeck et al, 1996). 
Tumor necrosis factor-a (TNF-a), like IL-1, mediates a lot of actions in 
inflammation and immune responses. The two cytokines also share similar signal 
pathway (Verma et al, 1995). TNF-a is produced in monocytes/macrophage, bone-
marrow cell-derived colonies (Witsell and Schook, 1992) and myeloid cell lines (Hass 
et al, 1991). It suppresses the growth of myeloid progenitors and stem cells in 
general (Selleri et al, 1995; Witsell and Schook, 1992). The effect of this suppression 
is enhanced in the presence ofIFN-y (Selleri et al, 1995). TNF-a enhanced IL-3- and 
GM-CSF- but inhibited G-CSF and SCF-dependent (Rusten et al, 1994a; 1994b) 
proliferation of immature hematopoietic progenitor cells. It induced the monocytic 
differentiation of myeloid leukemia cells (Bloch et al, 1995). The molecule also co-
operated with IL-1 or IL-4 (Leung et al, 1994; Tamatani et al, 1987) to induce 
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myeloid leukemia cell differentiation. The molecule in combination with IFN-y 
switched the eosinophilic differentiation of EoL-1 to monocytic differentiation 
suggesting an action on lineage commitment (Nakajima et al, 1995). 
The role of leukemia inhibitory factor (LIF) on leukemia cells is partially 
explained by its name. LIF is a potent inducer of Ml cell differentiation (Lord et al, 
1991). It also stimulated the differentiation of U937 in combination with ara-C or 
GM-CSF (Brach et al, 1990, 1993). Besides, LIF prolonged the doubling time of 
some leukemia cell lines (Wang et al, 1990). In the presence of GM-CSF or G-CSF 
it reduced the colony formation of HL-60 cells (Maekawa and Metcalf, 1989). 
Although LIF did not seem to affect the proliferation and/or differentiation of the most 
primitive stems cells (Leary et al, 1990; Schaafsma et al., 1992), it stimulated growth 
and proliferation of the multi-lineage, erythroid and eosinophil progenitor colonies 
(Verfaillie and McGlave, 1991). It also supported IL-3-dependent colony formation 
ofblast colony-forming cells (Leary et al, 1990). 
All the cytokines mentioned above mediate their actions through specific 
receptors. These receptor genes may be developmentally regulated, induced upon 
stimulation (Dubois et al, 1993) or restricted to myeloid cell lines (reviewed in 
Callard and Gearing, 1994). As a result, studying the cytokine and cytokine receptor 
gene expressions gives us insight into how these cytokines influence the JCS cells at 






2.1.2 Phenotypic studies biochanin A- and midazolam-treated JCS 
cells 
Isoflavones and benzodiazepines are two distinctive groups of compounds. 
Each of them has distinguishing biological effects and therapeutic values as detailed 
in section 1.3.3. On the other hand, they both affect the growth and differentiation of 
tumor cells. Recently, the effect of two specific compounds, biochanin A and 
midazolam, members of isoflavones and benzodiazepines respectively were tested on 
the myeloid leukemia cell model WEHI-3B JCS (personal communication with Dr. 
N.K. Mak). 
Both biochanin A (0-200 ^M) and midazolam (0-40 i^gy'ml) suppressed the 
growth of JCS cells in a dose-dependent manner. Close to 100 % growth inhibition of 
JCS cells were achieved using either 200 ^M biochanin A or 40 ^gy'ml midazolam as ^ 
examined by H-methylthymidine incorporation assay. 
The two compounds also induced differentiation of JCS cells. Biochanin A at 
50 ^M or midazolam at 10 jig/ml increased the percentage of phagocytic cells from a 
few % to almost 40%. On close examinations, the differentiation conducted by the 
two compounds were different. While biochanin A drove the blast cells entirely to the 
monocytic lineage, midazolam led the cells to produce both granulocytes (neutrophils) 
and monocytes. 
JCS cells started to show their differentiation characteristics after they have 
been incubated with 50 juM of biochanin A for 2 days. The percentage of blast cells 
decreased from 99.7 土1.2 % to 94.5 土 3.0 %. In contrast, the percentage of cells at 
I intermediate stage rose from 0.3 ±1.2 % to 4.5 土 3.0 % and that of the macrophage 
！ 
I was also slightly increased from 0 to 0.8 土 0.6 %. On day 3 after biochanin A 
丨 incubation, the differentiating effect of biochanin A became obvious. The blast cell 
percentage dropped markedly from 96.2 土 6.4 % to 79.2 土 3.8 %. The proportion of 
i 
cells at intermediate stage also increased significantly from 3.7 土 5.8 % to 13.3 土 2.1 





The effect of midazolam on JCS cells was different. After midazolam at 10 
jag/ml was added to the cells for two days, the percentage of the blast cells dropped 
dramatically from 98.5 土 0.5 % to 0.8 土 0.8 %. The proportion of cells at intermediate 
stage, however, increased significantly after midazolam treatment from 1.5 土 0.5 % to 
56.7 土 6.5 % and that of the macrophage increased from 0 % to 35.7 土 5.3 %. 
Notably, 6.5 土 1.5 % of metamyelocytes and 0.3 土 0.6 % PMN (neutrophils) were 
found. On day 3 of midazolam incubation, the proportion of cells are predominantly 
macrophage (91.2 土 4.9 %). No blast cells were found and a small percentage of cells 
at intermediate stage (8.0 土 4.5 %) and metamyelocytes (0.8 土 1.0 %) were observed. 
No more PMN could be detected in the population on day 3. 
The different differentiation-inducing effect of biochanin A and midazolam 
were also shown in the expression of antigenic markers. The expression level of 
monocytic specific markers Mac I and F4/80 were up-regulated after JCS cells have 
been incubated with biochanin A for 3 days. Conversely, the expression level of a 
granulocytic marker Gr-1 was slightly down-regulated after the treatment ofbiochanin 
A. For JCS cells treated with midazolam for 3 days, the expression of Gr-1 (specific 
for granulocytic pathway) was enhanced in addition to that ofMac I and F4/80. 
Taken together, biochanin A-induced cells were driven to an entire monocytic 
pathway while midazolam-induced cells were led to produce both granulocytes and 
macrophage. 
Briefly, both biochanin A and midazolam were able to inhibit the growth and 
j to induce differentiation of JCS cells as evidenced by morphological examination, 
differentiation marker expression and functional assays. The next important step is to 
i 
1 
I find out the signaling pathway and/or mechanism that makes up the changes. Besides, 
JCS cells respond quite differently to biochanin A and midazolam in terms of lineage 
commitment. Thus, it will be very crucial to know what different genes did the two 
inducers switch on or switch off and how these differences in gene expression can be 
related to the differentiation and/or lineage commitment. We started by studying the 
mRNA levels of some chosen cytokines, those that have been found to be involved in 
JCS cell differentiation (Chan et al, 1995). We aim to correlate the change of mRNA 
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levels of these cytokine genes with the differentiation program of JCS cells as 





2.1.3 Cytokine regulation at transcriptional level 
With the exception of some cell lines like WEHI-3B that constitutively 
produce IL-3, most of the cytokine mRNAs are undetectable in cells unless they are 
stimulated by proper inducers like infectious agent, mechanical injury or toxic 
stimulus. Thus, such genes are likely to be controlled at the transcriptional level. 
Most of the transcriptional machinery of cytokine genes are uncharacterized but it is 
anticipated that both positive and negative regulators, constitutive and inducible 
factors are required. For instance, constitutive factors like NF-KB as well as inducible 
factor AP-1 are involved in cytokine transcription while glucocorticoid hormone is a 
classical inhibitor of cytokine gene expression (for reviews, see Callard and Gearing, 
1994; Taniguchi, 1988; Tumer and Feldmann, 1990). Also, most of these cytokine 
genes (IL-la, IL-ip, IL-2, IL-5, TNF, IL-6, IL-8 and TGFp) represent early response 
genes peaked at 1 to 6 hours at least in activated blood mononuclear cells and T cells. 
These genes have half-lives ranging from 15 minutes to over 5 hours (reviewed in 
Tumer and Feldmann, 1990) although exceptions are found in other cytokines like LIF 
which has a long half-life in activated monocytes (Anegon et al, 1990). These 
cytokine genes can be induced to transcribe with or without de novo protein synthesis 
depending on different situations and different cell systems (reviewed in Tumer and 
Feldmann, 1990). 
Similar to previous investigation on cytokine gene expression, JCS cells 
i 
treated with either biochanin A or midazolam for 18 hours (one cell cycle of JCS 
I cells) and 46-48 hours (when differentiation phenotypes exhibit) were chosen for 
i 
j study in this investigation. 
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2.1.4 Cytokine mRNA phenotyping by a semi-quantitative approach 
Semi-quantitative PCR 
There are numerous methods for studying the level of mRNA expression, for 
example, Northern blots, RNA dot/slot blots, nuclease protection assays, nuclear run-
on assays and in situ hybridization. In this report, we use a more recent method, 
reverse-transcription polymerase chain reaction (RT-PCR) to study the mRNA level 
of cytokines. Generally, three problems are encountered in the study of cytokine 
mRNA. As mentioned before, cytokine genes are not constituitvely expressed and the 
mRNAs are degraded rapidly after the induction is removed. Thus, expression at 
different intervals must be examined. Moreover, cytokine is usually expressed at low 
levels. Hence, a sensitive detection system is required. Conventional techniques like 
Northern blot represents a simple approach but lacks sensitivity in detecting cytokine 
mRNA as commented in Dallman et al. (1991). RNase protection assay is a more 
sensitive technique but large amount of mRNA is often required. Nuclear run-on 
assay gives a reasonably accurate measurement of mRNA transcription level at 
specific time point but again relatively large amounts of materials are required (5X10^ 
cells per assay). In situ hybridization needs no RNA or DNA preparation from the 
cells and the spatial distribution of the mRNA can be determined. It is sensitive and 
the number of mRNA copies per cell can be estimated. In addition, it is readily 
combined with immunohistochemistry to detect the gene products simultaneously. 
Nevertheless, it is technically demanding. 
! 
j 
I The starting materials for reverse-transcription polymerase chain reaction are 
I ‘ 
I total RNAs (or cytoplasmic RNAs or mRNAs) which are converted into cDNAs. The 
.i 
i 
cDNAs in tum are used as templates for PCR using gene-specific primers. This is a 
very sensitive method detecting genes ofless than one part per 10^  copies (reviewed in 
Mason et al, 1993) or 0.003-0.1 copies per cell (reviewed in Kohler, 1995). Besides, 
the amount of samples needed for detection is much smaller. However, the method is 
not readily quantitative. Various techniques have been devised to correlate the initial 
amount of the gene under study with the amount of the final products or with the 
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number of amplification cycles. Either an internal (in the same tube as the target 
cDNA) or an external standard (in different tubes separate from the target cDNA) 
serves the purpose. Both internal and external standards can be exogenous or 
endogenous. Endogenous standards are usually house-keeping genes which do not 
change in the samples being compared. Exogenous standards are sequences that are 
artificially introduced and the amount added is precisely known. For external 
standards, tube-to-tube variations must be kept to a minimum and comparison must be 
made within the exponential phase of the PCR. Internal endogenous gene has 
different primer requirements and hence no competition with the target gene. On the 
other hand, the priming efficiency of the two genes may be different and the two genes 
may reach the plateau phase at different times. To solve the problem, exogenous gene 
having same primer requirement but differs in size or restriction site can be used. 
Competitive PCR is also an alternative in which increasing known amount of the 
exogenous competitive standard is added to replicate reactions containing the target 
cDNA. The concentration of the target cDNA is equal to the standard when the 
amounts ofboth amplification products are equivalent. 
Cycle titration 
In many cases, it may be sufficient to compare the relative amount of a 
particular gene in the samples. A simpler method was described in Dallman et al 
(1991) and Dallman and Porter (1992) for this purpose. Aliquots of PCR products 
I amplified from different cDNA samples were taken out at multiple PCR cycle 
I numbers so that the plateau phase of the reactions could be monitored. The PCR 
j 
I products of different cycle numbers from different samples could then be analyzed by 
agarose gel electrophoresis followed by Southern blotting or dot-blotting. The PCR 
products blotted on the membrane were hybridized to an internal oligomers that lies 
within the target sequence between the two original primers. Using this method, 10-
fold difference of the starting mRNA levels between samples could be detected at five 
PCR cycle intervals. Numerous reports have been successful in comparing the 
expression of cytokine genes using this method/principle (Dallman et al, 1991; 
Murphye^ al, 1993) 
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Filter hybridization 
To verify the PCR products obtained and to compare amount of PCR products 
from different samples at different PCR cycle numbers, Southem/dot blotting 
followed by filter hybridization is most suitable. To avoid the inconvenience and 
hazards posed by radioisotopes and to allow immediate detection and multiple 
exposures, non-radioactive labeling together with chemiluminescent detection is 
preferred. Among the non-radioactive labels, digoxigenin (DIG) occur specifically in 
the Digitalis plant and avoids non-specific binding caused by the use of ubiquitous 
vitamin like biotin. DIG system employs anti-DIG alkaline phosphatases which couple 
the DIG label with the chemiluminescent substrates. The system is also highly 
sensitive; it allows the detection of 0.1 pg ofhomologous DNA after Southern blotting 
(reviewed in Hughes et al, 1995). 
Hence, cycle titration and Southem/dot blotting followed by filter 
hybridization conform a convenient and sensitive method for studying cytokine gene 






2.2.1 Cell line 
The murine myeloid leukemia cell line WEHI 3B (JCS) (Mak et al, 1993) 
was cultured in RPMI 1640 supplemented with 10 % fetal calf serum (FCS, Gibco)，2 
mM glutamine, and 50 U/ml penicillin, 50 ^g/ml streptomycin, and 10 ^ig/ml 
neomycin. The cultures were maintained under a humidified atmosphere of 95 % air 
/ 5 % CO2 at 37�C. 
2.2.2 Chemicals and buffers 
1. Agarose type I : Low EEO Sigma A6013 
2. Biochanin A Sigma D2016 
(5, 7-dihydroxy-4 ’ -methoxyisoflavone) 
3. Bromophenol blue ^max 595 nm Bio-Rad 161 -0404 
4. Cesium chloride Sigma C4036 
5. Diethyl pyrocarbonate, DEPC Sigma D5758 
6. Ethidium bromide Sigma E8751 
7. Ethanol, absolute Ajax 214 
8. Hydrochloric acid, 36% Ajax 1367 
9. Lauryl sulfate/ Sodium dodecyl sulfate, SDS Sigma L5750 
10. N-Lauroyl sarcosine Sigma L5125 
11. Lithium chloride Sigma L8895 
12. Magnesium chloride Sigma M9272 
13. Maleic acid Fluka Chemika 63180 
14. P-mercaptoethanol Sigma M7154 
15. Midazolam Roche 
16. Mineral oil Sigma M5904 
17. RPMI 1640 Sigma 
18. Sodium chloride Sigma S9625 
19. Sodium citrate, trisodium salt Sigma S4641 
) I 
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20.Sodium hydroxide Sigma S5881 
21.Synergel Diversified Biotech Syn-100 
22. Tris-acetate-EDTA (TAE), 25X liquid concentrate Amresco 0796-1.6L 
23. Tris-base Boehringer Mannheim 604205 
24. Tween 20 Bio-Rad EIA 
25. Xylene cyanole FF Xmax 615 nm Bio-Rad 161 -0423 
2.2.3 DIG system (Appendix A3) 
1. DIG oligonucleotide 3 ’ end labeling kit Boehringer Mannheim 13 623 72 
2. DIG luminescent detection kit Boehringer Mannheim 1363514 
2.2.4 Enzymes and nucleic acids 
1. lkb DNA ladder GIBCOBRL 15615-024 
2. M-MLV reverse transcriptase GIBCOBRL 28025-013 
• 5X reverse transcriptase buffer : 250 mM Tris-HCl pH 8.3, 375 mM KC1, 15 
mM MgCl2, 
• Dithiothreitol (DTT) 
3. Oligo-dTi2-i8 Pharmacia 7858-5A-260 
4. Primer oligo (see also Table 2.1) Integrated DNA technologies 
I 5. rRNAsin PromegaN2512 ] 
6. Thermal prime plus polymerase Advance Biotechnology AB301 
• 1 OX reaction buffer : 200 mM GSfH4)Sa^ ,750 mM Tris-HCl pH 9.0, 0.1 % 
Tween 
• 25 mM MgCl2 
1 
7. Ultrapure dNTP set 2'-deoxynucleoside Pharmacia 27-2035-01 
5'triphosphate minimal diphosphate 
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2.2.5 Solutions 
1. Agarose gel, 2 % 2 % (w/v) agarose in IX TAE buffer 
2. Alkaline transfer buffer 1 M NaCl, 0.4 M NaOH 
3. Blocking solution 1 X blocking reagent diluted by maleic acid buffer 
4. Blocking stock solution 10 % (w/v) blocking reagent in maleic acid buffer 
5. Detection buffer 0.1 M Tris-HCl, 0.1 M NaCl, 50 mM MgCl2, pH 9.5 
(20 o C ) 
6. GT solution 4 M guanidinium thiocyanate, 0.1 M p-mercaptoethanol 
7. Maleic acid buffer 0.1 M maleic acid, 0.15 M NaCl, adjusted to pH 7.5 
(20 ^C)withsolidNaOH 
8. Hybridization buffer 5X SSC, 1% (w/v) blocking solution, 0.1% N-lauroyl-
sarosine, 0.02% sodium dodecyl sulfate 
9. Standard saline citrate 3 M NaCl, 0.3 M sodium citrate; pH 7.0 
(SSC), 20 X 
10. Washing buffer maleic acid buffer, 0.3 % (v/v) Tween 20 











2.3.1 Isolation of total RNA by guanidinium thiocyanate/cesium 
chloride isopycnic gradient 
All the cell cultures used in this study were kindly maintained by Mr. Alex, 
W.H. Cheung and Mr. Bats, S.W. Wong in the Department of Biology, the Hong 
Kong Baptist University. 
Cellular total RNA was obtained by guanidinium thiocyanate and cesium 
chloride gradient method (Chirgwin et al, 1979). 
Untreated JCS cells, cells treated with 10 ^ig/ml midazolam for 18 and 48 
hours, and cells treated with 50 i^M biochanin A or its solvent (0.25 % ethanol) for 18 
and 46 hours were harvested and collected by centrifugation at 200 g for 5 minutes at 
room temperature. The supernatant was decanted and the cells were washed once in 
RPMI 1640. The cells were resusupended in 200 ^1 of RPMI 1640 and the suspension 
n 
was added drop by drop to 4 ml (per 10 cells) GT solution under vortex. The 
resulting cell lysates of different samples were stored at -70 °C until use. Freezed cell 
lysates were recovered in a 65 ®C water bath with constant vortexing until it is 
completely thawed. The thawed lysate was then squeezed through a 15 gauge needle 
5 times by a sterilized syringe. 
1 ml cushion of 5.7 M cesium chloride (CsCl) was pipetted into a 4.4 ml 
polyallomer ultracentrifuge tube (Bechman). The treated cell lysates were laid 
！ carefully on top of the CsCl cushion until the tube was completely filled. The 
preparations were centrifuged in a Bechman rotor SW60Ti at 32,000 rpm for 18 hours 
at 18 ®C. At the end of the run, all the supernatant at the top (~1 cm from the pellets) 
i 
! was removed by aspiration. The tube was then quickly inverted and remained in its 
inverted position to drain out the remaining liquid. The most recalcitrant droplets 
were aspirated without disturbing the pellets at the bottom of the tube. The inverted 
j 
tube was left air-dried for 5 minutes. The top portion of the tube was then cut off, at 
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about 0.7 cm from the bottom, with a sterile scalpel. Translucent RNA pellets were 
then dissolved in 40 |il at a time (in a total of 400 i^l) of DEPC-treated water. The 
solution was transferred to a sterile 1.7 ml eppendorf tube each time and vortexed to 
ensure complete dissolution. The RNA solution was separated from insoluble 
contaminants, if any, by centrifugation at 14 000 rpm on a bench-top microcentrifuge 
for 1 minute at room temperature (Eppendorf). The RNA was then precipitated by 45 
[i\ of 3 M sodium acetate and 1 ml of absolute ethanol. The mixture was centrifuged 
using a bench-top microcentrifuge at 14 000 rpm for 30 minutes at room temperature 
(Eppendorf). The precipitate was washed once by 70 % and once by 100 % ethanol. 
After being dried in a speed vacuum concentrator (Savant) for 10 minutes, the 
precipitate was resuspended in DEPC-treated water. The amount of RNA was 
estimated by spectrophotometry at 260 nm UV light and 1 absorbance unit was taken 
as an equivalent of 40 |ig RNA. 
2.3.2 Reverse-transcription polymerase chain reaction (RT-PCR) 
The cytokine expression of uninduced and induced cells at different time 
points was assessed by reverse-transcription polymerase chain reaction (RT-PCR). 
1 i^g of total RNA isolated from each treatment of cells was heated to 65 °C 
for 10 minutes and reverse-transcribed at 3 7 � � f o r 1 hour by adding 10 i^l master mix 
having 40 U RNase inhibitor, 0.1 [ig oligo dTj2-i8' 0.5 mM dNTP mixture, 1 X 
reverse transcriptase buffer, 10 mM DTT and 200 U Moloney murine leukemia vims 
I (M-MLV) reverse transcriptase. This reaction could be scaled up for 5 i^g total RNA 
i 
per reaction by increasing the amount of each components in proportion. 
After being heated at 94 ^C for 10 minutes and chilled on ice for 3 minutes, 2 
^1 of the reverse transcription solution of each sample was amplified in a 50 i^l PCR 
reaction containing 1.5 mM MgCl2, IX reaction buffer, 0.2 mM of each dNTP, 1 
pmolyGL of each primer and 0.25 U Thermoprime+ DNA polymerase. All the 
components except the templates were pipetted from the same master mix for all 
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samples to be compared. The thermal cycle profile was : denaturation at 94 ^C for 1 
minute, annealing for 1 minute at temperature optimized for each pair of primers (Tm-
10 ^C, see Table 2.1) and extension at 72 ^C for 1 minute. 
The sequence of primer pairs, melting temperatures and the predicted sizes of 
the amplified PCR fragments are shown in Table 2.1. 
The efficiency of RNA isolation and RT-PCR was confirmed by amplifying 2 
^1 of the same reverse transcription solution with GAPDH (glyceraldehyde-phosphate 
dehydrogenase)-specific primers for 20 cycles. GAPDH was also used as an external 
control for normalization among different samples. The PCR products, together with 
a molecular marker (1 Kb ladder), were loaded into a 1.5 % TAE Synergel and 














Table 2.1 : List of speciflc primer for various genes. 
Gene Sequence (5' to 3，) Tm* ~ ~ P r o d u c t “ 
CO size (bp) 
~ ~ G A P D H ~ ~ upper primer ACC ACA GTC CAT GCC ATC AC — 62 452 
lower primer TCC ACC ACC CTG TTG CTG TA ^ 
IL- la upper primer ACA GTA TCA GCA ACG TCA AGC AA ~ ^ 546 
lower primer "CCG ACT TTG TTC TTT GGT GGC A ~ 6 6 
internal probe GGC AAC TCC TTC AGC AAC ACG ~~^~~~ 
IL - ip upper primer GAG CTT CAG GCA GGC AGT ATC “ ^ 3 ^ 
lower primer GTA TAG ATT CTT TCC TTT GAG GC 64 
internal probe CAC TTG TTG GTT GAT ATT CTG TC ~~^""" 
i C 3 upper primer AAG CTC CCA GAA CCT GAA CTC — 64 ^ 
lower primer "TGA AGA CCC CTG GCA GCG CA ~ ^ ~ 
internal probe ATT CGC AGA TGT AGG CAG GCA ~ ~ M ~ ~ 
IL-4 upper primer TGA CGC ACA GAG CTA TTG ATG G ~ ~ ^ 422 
lower primer _ATG ATG CTC TTT AGG CTT TCC AG ~ ~ ^ ~ 
internal probe AGC TGG GGG TTG AGA CC — 5 6 
~ T N F - a ~ upper primer TCC CCA AAG GGA TGA GAA GTT C “ ^ 4 U 
lower primer "TCA TAC CAG GGT TTG AGC TCA G ~ ^ ~ 
internal probe CAC ACT CAG ATC ATC TTC TC “ 58 
U F upper primer TCT CTT CAT TTC CTA TTA CAC AGC 6 6 — i B 
lower primer "cAC CAC CAC ACT TAT GAC TTG C ~ ^ ~ 
internal probe CAC GGT ACT TGT TGC ACA GAC “ 64 
J U d upper primer GAC ATG GGC AGA GCG ATG GTG GCC AG — 86 1 ^ 
lower primer GGA CCT GTT TCT TCC TGA TCA CAT TGG AC “ 8 6 ~ ~ 
intemal probe AGA GAG AGC CAG GAG ACC AG 64 
~ ~ I L - l R t I ~ upper primer ATG GAA GGG ATG ACT ATG TTG GA — 66 506 
lower primer GCT GCA GCC TCT TAT GAT GGG ~ ^ ~ 
internal probe TGA TCT CCG TTG GGC TGG CA 64 
~ I L l - R t I I ~ upper primer AAG GAA. CAA CCA CGG AAC CCA T 66 446 
lower primer AGC CCT GCG TTT ACA CCG TCT ~ ~ ^ ~ 
intemal probe C6C AAT GCT CCA GGA GAA CGT ~ ^ ~ ~ 
IL-3R upper primer TAC ACA CGA TTT TCT AAT GGA GAT A _ 66 ^ 
(AIC2A) lower primer TAG ATG CTG TTG GGT AGG AAT AG 66 — 
intemal probe GAG CTG AAG GAG GAA CCT GAC ~ ~ ^ ~ 
IL-3R upper primer ATA CAC GAT TTT CCA TCA CAA. ACG “ 66 3 ^ 
(AIC2B) lower primer TAG ATG CTG TTG GGT AGG AAT AG _ 66 
intemal probe GAG CTG AAG GAG GAA CCT GAC 66 
~ ~ ~ I L - 3 R a ~ ~ upper primer TGC T C A TTC CAG TCG CTC TCC 一 6 6 5 ^ 
lower primer AGG AGG CCA TGG TGG AAT CTG ~ ~ ^ “ 
intemal probe AGC CGT TGC ACT TCC ACT TGT CA 66 
LIF-R(S)# upperprimer TCA TCA CCA CCT TCG AAA ATA GC 66 340 
lower primer GCG CAA CAA TGG GAG CCA GT 64 
intemal probe ^ G TGC AAC TCA TCT CGG TCT 64 
L I F - R ( D ^ upperprimer TCA TCA CCA CCT TCG AAA ATA GC 6 6 — 4 ^ 
lower primer CCG CAT ATT TTA AGT GAC CGC T 64 
I internal probe TGG TGC AAC TCA TCT CGG TCT — 64 
1 *Tm : calculated from 2 � C (A+T) + 4°C (G+C) 
# transmembrane form 





2.3o3 Southern blotting 
PCR products were electrophoresed and stained with 0.5 |igAnl ethidium 
bromide in a 2 % TAE agarose gel. A photo of the gel (Polaroid 667) was taken under 
UV excitation with a fluorescent scale laid alongside the gel. The gel with the unused 
parts removed was depurinated in 0.25 M HC1 for 10 minutes and briefly rinsed with 
distilled water. The DNA on the gel was transferred onto a positively-charged nylon 
membrane (Boehringer Mannheim 1209299) by upward capillary action (Figure 2.1) 
in 0.4 M NaOH for 4 hours. The gel was then stained in 1 \xg/m\ ethidium bromide 
for 30 minutes and examined under UV light to confirm a complete transfer of DNA. 
The nylon membrane was neutralized in 2 X SSC for 10 minutes, air-dried and baked 
for 30 minutes at 120 ®C. The membrane was stored at room temperature until 
hybridization. 
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Figure 2.1. Setup for Southern blotting. 
2.3.4 Cycle titration and dot blotting 
Cycle titration / dot blotting is a semi-quantitative approach for studying the 
level of gene expression (Dallman et al, 1991; Dallman and Porter, 1992). 6 identical 
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tubes of 50 |il PCR reaction of each sample under comparison were set up as 
described in section 2.3.2. One tube of each sample was removed from the PCR 
machine every five cycles from 10-35 cycles (or otherwise specified). The PCR 
products were then analyzed by dot blotting. A positively-charged nylon membrane 
(Boehringer Mannheim 1209299) cut to fit (10 X 13 cm) the BioDot microfiltration 
apparatus (Bio-Rad) was laid on the gasket of the apparatus with all holes covered. 
The apparatus was assembled as described by the manufacturer. Briefly, the sample 
template was put on top of the membrane following the glide pins. The sealing 
screws were tightened in a diagonal crossing manner (Figure 2.2). 200 ^1 of distilled 
water was applied to all sample wells to pre-wet the membrane while the vacuum was 
on. 10 jil of PCR products from each sample and cycle number was denatured in 0.2 
M NaOH in a total volume of 200 ^1 solution for 15 minutes. The denatured products 
were applied to the wells and drained. Then, 400 p,l of 20 X SSC was applied to each 
well and drained. The micro-filtration apparatus was dismantled in the presence of 
vacuum. The membrane was air-dried on a piece of blotting paper before baking for 
30 minutes at 120�C. 
^ L^^  /^ ~^  
^ /y / ,l f i i I \ \ f ^ y ^ \ \ sample templats with 
/ / ^ Q ^ 1 j L t ^ ^ l X \ ^achad saallng scr«ws 
^ ^ ¾ ^ “ ‘ ^^^ 
i \ ^ membrane 
^<^^ >/f5N � 
f j ^ ^ ‘ ‘ ： ： ： \ ： \ \ ••• ^ V v ^ ~ " sealing gasket 
^^====^^ga^ y^ist2j=^ 
^ ^ ^ ^ ¾ - ^胁射 suPP- _ 
y:grs r7>r^  ^ ~ vacuum manifold 
i ^ ^ ^ ¾ ^ ^ 
I ' ' r = S ^ , N S f ^ r ^ ^ ^ L 5 ^ 
� 1 \ ‘ ^ ^1 ' y i^ I^^ Ttubing and (low valv9^ 
I Figure 2.2. Setup for dot-blotting. (Reproduced from manufacturer's manual, BioDot Apparatus, Bio-





2.3.5 DIG 3' end labeling of probes 
Oligonucleotides ranging from 16-22 nucleotides in length were labeled with 
digoxigenin-ddUTP (DIG-ddUTP) using the DIG oligonucleotide 3’ end labeling kit 
(Appendix A3) and designated as internal probes (Table 2.1). For each probe, 100 
pmol of oligonucleotides in 8 ^1 of DEPC-treated water was mixed with 12 ^1 of a 
master mix containing IX tailing buffer, 5 mM cobalt chloride solution, 0.05 mM 
DIG-ddUTP and 50 U terminal transferase. The labeling reaction was done for 15 
minutes at 37 ®C and placed on ice immediately. 2 jid of 1 mg/ml glycogen in 0.2 M 
EDTA solution pH 8.0 was added to stop the reaction. The labeled oligonucleotides 
were precipitated by 2.5 ^1 of 4 M lithium chloride solution (LiCl) and 75 \x\ of pre-
chilled (-20 ®C) absolute ethanol, left for 2 hours at -20 ®C and centrifuged for 30 
minutes at room temperature. The pellets were carefully washed with 70 |il of cold 70 
% ethanol, air-dried and dissolved in 50 ^1 of DEPC-treated water to a final 
concentration of 2 pmol/^il. The labeled probes were stored at -20 ®C until use. 
2.3.6 Hybridization and stringency wash 
Nylon membranes having immobilized PCR products were put in 50 ml plastic 
centrifuge tubes (Falcon) and pre-hybridized with 20-25 ml of hybridization solution. 
The tubes were rotated constantly for 2 hours at hybridization temperature in a 
hybridization chamber. After hybridization, the hybridization solution was replaced 
with 5 ml of fresh hybridization solution added with 4 pmol/ml labeled probe. The 
hybridization was done for 12 hours at 10 ®C below the melting temperature of the 
probes (Table 2.1). Membranes were then washed twice with 20-25 ml of 2 X SSC, 
0.1 % SDS (w/v) followed by 0.5 X SSC, 0.1 % SDS (w/v) for 15 minutes at 
hybridization temperature. After that, the membranes were ready for signal detection. 
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2.3.7 Chemiiuminescent detection 
Chemiluminescent detection was done as described by the manufacturer using 
the luminescent detection kit (Appendix A3). The nylon membrane was first removed 
from the falcon tubes and rinsed for 5 minutes in a plastic box containing washing 
buffer. The membrane was then incubated in 100 ml of blocking solution for 30 
minutes followed by 40 ml of diluted anti-DIG-AP conjugate (75 mU/ml) for another 
30 minutes with constant mixing at room temperature. The membrane was 
subsequently washed twice in 100 ml of washing buffer for 15 minutes, equilibrated 
in 100 ml of detection buffer for 5 minutes and incubated in 40 ml of CSPD solution 
(120 X dilution) for 5 minutes at room temperature. After excess solution was 
dripped and blotted off, the damp membrane was sealed in 2 pieces of Saran wrap 
followed by incubation for 15 minutes at 37 °C. The sealed membrane was exposed 
to an X-ray film (Kodak X-OMAT AR) for 5-10 minutes. The membrane after 
detection was kept at 4 °C in sealed plastic bag. 
2.3.8 Quantitation by densitometry 
The image of the blots developed on the X-ray film was scanned using a GS-
670 imaging densitometer (Bio-Rad) in transmittance mode. Each dot on the scanned 
image was individually selected and analyzed using the volume integration function in 
T1V1 
the software Molecular Analyst (Bio-Rad). The signal of each dot was presented as 
2 
the integrated volume = [OD X area (mm )]. After a background region was 
identified, the value of the integrated volume was adjusted for global background 
removal and output as adjusted volume. To minimize the effect of non-uniform 
background, the command ‘Local Background Subtraction' was performed so that the 
mean background value around the perimeter of each dot was subtracted. The 
quantitative information of each dot was summarized in the volume object list. 
Unless otherwise stated, all the signal comparison of the images in this report was 
done based on the values of the adjusted volume with local background subtraction. 
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2.4 Results 
2.4.1 Analysis of total RNA 
Total RNA isolated by method adapted from Chirgwin et al (1979) was 
analyzed. The absorbance of UV light at 260 nm and 280 nm were measured. 
A260/A280 calculated was almost constant among the samples (1.43-1.53) (Table 2.2). 
Table 2.2. Spectrophotometric analysis of the isolated RNAs. 
Sample A260/A280 
Biochanin A sample set 
Untreated JCS cells 1.52 
JCS cells treated with 0.25 % ethanol for 18 hours 1.43 
JCS cells treated with 0.25 % ethanol for 46 hours 1.47 
JCS cells treated with Biochanin A (50 i^M) for 18 hours 1.50 
JCS cells treated with Biochanin A (50 i^M) for 46 hours 1.48 
Midazolam sample set 
Untreated JCS cells 1.53 
JCS cells treated with midazolam (10 ^ig/ml) for 18 hours 1.53 
JCS cells treated with midazolam (10 jig/ml) for 48 hours 1.54 
Absorbance at 260 nm and 280 nm was measured for each RNA sample. These RNAs were 
isolated from cells treated with either biochanin A (50 ^iM) or midazolam (10 ^g/ml) for 
different period of time as indicated. A260/A280 = ratio of absorbance at 260 nm to 
absorbance at 280 nm. 
j 
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RT-PCR on each type of total RNAs was performed for the constitutively 
expressed gene GAPDH as described in section 2.3.2. The same reaction master mix 
was used for samples to be compared (i.e. those within the same sample set). The 
level of GAPDH gene expression analyzed by 20 cycles of PCR and gel 
electrophoresis was essentially the same for all the samples in either the biochanin A 
or the midazolam sample set (Figure 2.3). 
Biochanin A-induced Midazolam-induced 
JCS cells JCS cells 
(Incubation Time) (Incubation Time) 
M 0 C18C46 18 46 M 0 18 48 
•暑 
Figure 2.3. Normalization of samples by GAPDH gene expression. 20 cycles of RT-PCR 
using GAPDH gene specific primers were performed on RNA samples isolated form control 
JCS cells, JCS cells treated with 0.25 % ethanol for 18 and 46 hours (C18 and C46), JCS 
cells treated with biochanin A for 18 and 46 hours (18, 46) or midazolam for 18 and 48 hours 
(18，48 ). 10 |ul o f t h e PCR products was electrophoresed on a 1.5 % TAE Synergel. The 
expected PCR product size was 452 bp. M = marker lane, 1Kb ladder. 
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2.4.2 mRNA phenotyping 
Cycle titration together with either dot blot hybridization or Southern blot 
hybridization were used to characterize the expression of some chosen cytokines in a 
semi-quantitative approach (Dallman et al, 1991; Dallman and Porter, 1992). The 
expression patterns of these cytokines during the induced myeloid cell differentiation 
fell into three categories : 
1. No detectable or very low expression throughout the differentiation 
2. Constitutive expression without significant change during the 
differentiation 
3. Detectable change in expression level during the differentiation 
Biochanin A-treated samples 
In biochanin A-treated JCS cells, genes for LIF-R (transmembrane form) and 
LIF-R (soluble form) were undetectable using 35 and 50 cycles of RT-PCR and 
Southern blot hybridization and that for IL-4 was only barely detectable (after 50 
cycles of RT-PCR and Southern blot hybridization) at 46 hours during the myeloid 
cell differentiation into monocytes (Figure 2.4). The expected PCR product size for 
IL-4, LIF-R (transmembrane form) and LIF-R (soluble form) were 422, 340 and 415 
bp respectively as shown in the lanes of the positive controls. 
In contrast to the genes described above, both types of IL-1 receptor, IL-lRtI 
and IL-lRtII (Figure 2.5), together with one form of the IL-3R p subunits AIC2B 
(Figure 2.8) showed constant levels of mRNA throughout the monocytic 
differentiation triggered by biochanin A as detected by RT-PCR and dot-blot 
hybridization. 
Further, the expression of IL-la and IL-ip was increased after JCS cells were 
treated with biochanin A for 46 hours (Figure 2.6), the time when the cells 
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demonstrated morphological changes (section 2.1.2). Unlike IL-la, IL-ip showed 
also a basal level of expression in untreated JCS cells. In addition to IL-1, up-
regulation of expression levels were observed in IL-3, TNF-a and LIF (Figure 2.7). 
Different from LIF expression, the level of IL-3 and TNF-a dropped at 18 hours 
followed by a rebound at a later time (46 hours). Moreover, this pattem of change 
was found in cells treated with solvent (0.25 % ethanol) alone though to a lesser 
extent. LIF expression, on the other hand was enhanced significantly at 46 hours after 
biochanin A treatment. The expression of LIF was unaffected by the solvent 0.25% 
ethanol (Figure 2.7). 
Despite the constant expression of AIC2B of IL-3R (Figure 2.8)，AIC2A, 
another form of p subunit was up-regulated in expression level after the cells were 
treated with biochanin A for 18 hours; the level dropped slightly at 46 hours after the 
treatment. Such change was not duplicated in JCS cells treated with solvent alone 
although a slight up-regulation of the gene was found after incubation with the solvent 
for 46 hours (Figure 2.8). Quite distinctive from the above observations, the 
expression of IL-3Ra subunits was up-regulated steadily from 18 hours to 46 hours of 
incubation with biochanin A while 0.25 % ethanol caused a down-regulation of the 
gene at 18 hours (Figure 2.8). 
Finally, J1 ld, a differentiation marker was down-regulated steadily from 18 to 
46 hour incubation in both the solvent and biochanin A-treated samples (Figure 2.7). 
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Figure 2.4. Gene expression levels of IL-4, LIF-R (transmembrane form) and LIF-R 
(soluble form) during biochanin A-induced JCS cell differentiation. RT-PCR was 
performed on RNA samples obtained from control JCS cells, JCS cells treated with 0.25 % 
ethanol for 18, 46 hours (C18, C46) or JCS cells treated with 50 i^M biochanin A for 18, 46 
hours (18 and 46) at the indicated no. of PCR cycles. PCR on DNA fragments having a 
partial sequence the same as the endogenous gene were included as a positive control (+). 
PCR products of these samples were electrophoresed on a 2 % TAE agarose gel. Southern 
blot hybridization was done using DIG-labeled internal probe specific for each gene. 
Chemiluminescent detection was done and the signals were developed on an X-ray film. The 
specific product sizes for the genes IL-4, LIF-R (transmembrane form) and LIF-R (soluble 
form) was 422，340 and 415 bp respectively. M = position of the marker lane. 
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Q C18 C46 18 46 Q C18 C 4 6 _ _ l S ^ ― 
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y 
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Figure 2.5. Gene expression levels of type I and type IIIL-1 receptors during biochanin 
A-induced J C S cell differentiation. JCS cells were untreated (0), incubated with solvent 
0.25 % ethanol for 18 (C18) and 46 (C46) hours or treated with 50 ^M biochanin A for 18 
(18) and 46 (46) hours. RT-PCR was performed on the RNAs isolated from these untreated 
and treated JCS cells at different cycle number as indicated. 10 ^1 of each type of RT-PCR 
products was dotted onto positively-charged membranes and hybridized to DIG-labeled 
internal probe specific for each gene. Chemiluminesent detection was performed and 
quantitative analysis of signal demonstrated by each dot was done by densitometric scanning. 
Each of the signals was converted into numerical value in terms of Volume [OD X area 
(mm2)]. For PCR cycles, 5+N means 5 touchdown PCR cycles starting from (Tm-10) °C as 
annealing temperature at the first cycle of reaction which dropped 1 °C per each consecutive 
cycle for a total of 5 cycles followed by N cycles having an annealing temperature of (Tm-5) 
°C (see 3.1.3 for touchdown PCR). 
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Figure 2.6. Gene expression levels of I L - l a and IL- lp during biochanin A-induced JCS 
cell differentiation. 35 cycles of RT-PCR using either IL - l a and IL- ip gene specific 
primers were performed on RNA samples isolated from control JCS cells, 0.25 % ethanol-
treated cells for 18 and 46 hours (C18 and C46) or biochanin A-treated JCS cells for 18 and 
46 hours (18 and 46). The PCR products were electrophoresed on a 2 % TAE agarose gel 
and Southern blot hybridization was done using DIG-labeled internal probes specific for the 
genes. Chemiluminescent detection was done and signals were developed on X-ray film. 
The expected product size for IL- l a and IL-lp were 546 and 382 bp respectively. M= 
position of the marker lane. 
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Figure 2.7. Gene expression levels of IL-3, TNF-a, LIF and J l l d during biochanin A-
induced JCS cell differentiation. JCS cells were untreated (0), incubated with solvent 
control 0.25 % ethanol for 18 (C18) and 46 (C46) hours or treated with 50 ^M biochanin A 
for 18 (18) and 46 (46) hours. RT-PCR were performed on the RNAs isolated from these 
untreated and treated JCS cells at different cycle numbers as indicated. 10 ^1 of each type of 
the RT-PCR products was dotted onto positively-charged membranes and hybridized to DIG-
labeled intemal probe specific for each gene. Chemiluminesent detection was performed and 
quantitative analysis of signal demonstrated by each dot was done by densitometric scanning. 
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Figure 2.8. Gene expression levels ofH^-3R subunits, IL-3Ra, IL-3Rp (AIC2A) and IL-
3RP (AIC2B) during biochanin A-induced JCS cell differentiation. JCS cells were 
untreated (0), incubated with solvent control 0.25 % ethanol for 18 (C18) and 46 (C46) hours 
or treated with 50 ^iM biochanin A for 18 (18) and 46 (46) hours. RT-PCR were performed 
on the RNAs isolated from these untreated and treated JCS cells at different cycle number as 
indicated. 10 ^1 of each type of the RT-PCR products was dotted onto positively-charged 
membranes and hybridized to DIG-labeled internal probes specific for each gene. 
Chemiluminesent detection was performed and quantitative analysis of signal demonstrated 
by each dot was done by densitometric scanning. Each of the signals was converted into 








Similar to biochanin A-induced JCS cells, the expressions of IL-4, LIF-R 
(transmembrane form) and LIF-R (soluble form) were undetectable in midazolam-
treated samples. However, as opposed to biochanin A，midazolam did not enhance 
the expression of IL-la which remained undetectable throughout the monocytic / 
granulocytic differentiation of JCS cells (Figure 2.9). 
LIF, TNF-a (Figure 2.10) and IL-3Ra (Figure 2.13) had a constitutive 
expression during the midazolam-induced differentiation while IL-lp and IL-3 (Figure 
2.11) showed a slight down-regulation of the expression levels. Transient down-
regulation of type IIIL-1 receptor was observed at 18 hours while type I receptor was 
up-regulated in expression at 48 hours after induction by midazolam (Figure 2.12). 
Also, a significant up-regulation of P subunits of IL-3 receptor was found 
(Figure 2.13). Both AIC2A and AIC2B were elevated slightly in expression after JCS 
cells were treated with midazolam for 48 hours, in contrast to the unchanged 
expression illustrated by the a subunit. 
The expression of J l l d was also studied; the marker had steady increase in 
expression during the midazolam-induced differentiation (Figure 2.11) as opposed to 
that during the biochanin A-induced differentiation. 
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Figure 2.9. Gene expression levels of IL- la , IL-4, LIF-R (transmembrane form ) and 
LIF-R (soluble form) during midazolam-induced JCS cell differentiation. 35 and 50 
cycles of RT-PCR were performed on the RNAs isolated from untreated JCS cells, JCS cells 
treated with 10 ^ig/ml midazolam for 18 and 48 hours. PCR done on DNA fragments having 
a partial sequence of the endogenous gene were included as a positive control (+). All these 
PCR products were electrophoresed on a 2 % TAE agarose gel. Southern blot hybridization 
was done using DIG-labeled internal probe specific for each gene. Chemiluminescent 
detection was done and the signal were developed on an X-ray film. The specific product 
sizes for the genes IL- la , IL-4, LIF-R (transmembrane form) and LIF-R (soluble form) were 
546, 422, 340 and 415 bp respectively. M = position of the marker lane. 
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Figure 2.10. Gene expression levels of LIF and TNF-a during midazolam-induced JCS 
cell differentiation. RT-PCR were performed on control JCS cells, JCS cells treated with 10 
p,gy'ml midazolam for 18 and 48 hours at the PCR cycles indicated. 10 p,l of each type of the 
RT-PCR products was dotted onto positively-charged membranes and hybridized to DIG-
labeled internal probe specific for each gene. Chemiluminesent detection was performed and 
quantitative analysis of signal demonstrated by each dot was done by densitometric scanning. 
Each of the signals was converted into numerical values in terms of Volume [OD X area 
( m m � ] . 
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Figure 2.11. Gene expression levels o f I L - i p , IL-3 and J l l d during midazoIam-induced 
J C S cell differentiation. RT-PCR were performed on control JCS cells, JCS cells treated 
with 10 ^g/ml midazolam for 18 and 48 hours at the PCR cycles indicated. 10 ^1 of each 
type of the RT-PCR products was dotted onto positively-charged membranes and hybridized 
to DIG-labeled internal probes specific for each gene. Chemiluminesent detection was 
performed and quantitative analysis of signal demonstrated by each dot was done by 
densitometric scanning. Each of the signals was converted into numerical values in terms of 
Volume [OD X area (mm^)]. 
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Figure 2.12. Gene expression levels of type I (IL-lRtI) and type H (IL-lRtII) D^-1 
receptors during midazolam-induced JCS cell differentiation. RT-PCR were performed 
on control JCS cells, JCS cells treated with 10 p^gAnl midazolam for 18 and 48 hours at the 
PCR cycles indicated. 10 ^1 of each type of the RT-PCR products was dotted onto 
positively-charged membranes and hybridized to DIG-labeled internal probes specific for 
each gene. Chemiluminesent detection was performed and quantitative analysis of signal 
demonstrated by each dot was done by densitometric scanning. Each of the signals was 
converted into numerical values in terms of Volume [OD X area (mm�)] . For PCR cycles, 
5+N means 5 touchdown PCR cycles starting from (Tm-10) °C as annealing temperature at 
the first cycle of reaction which dropped 1 °C per each consecutive cycle for a total of 5 
cycles followed by N cycles having an annealing temperature of (Tm-5) °C (see section 3.1.3 
for touchdown PCR). 
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Figure 2.13. Gene expression levels of IL-3R, a subunits (IL-3Ra), P subunits (AIC2A) 
and (AIC2B) during midazolam-induced JCS cell differentiation. RT-PCR were 
performed on control JCS cells, JCS cells treated with 10 ^g/ml midazolam for 18 and 48 
hours at the PCR cycles indicated. 10 i^l of each type of the RT-PCR products was dotted 
onto positively-charged membranes and hybridized to DIG-labeled internal probes specific 
for each gene. Chemiluminesent detection was performed and quantitative analysis of signal 
demonstrated by each dot was done by densitometric scanning. Each of the signals was 
converted into numerical values in terms ofVolume [OD X area (mm�)]. 
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2.4.3 Summary of mRNA phenotyping results 
Comparing biochanin A-and midazolam-induced JCS cells (Table 2.3)，there 
were genes that showed the same types of expression pattern. As mentioned, IL-4 and 
both forms of LIF receptor were not expressed or expressed at a very low level after 
either kind of treatment. However, there were more genes that were affected by the 
two compounds differently. While IL-la was up-regulated in biochanin A-induced 
JCS cells at 46 hours, the gene was not expressed throughout the treatment of 
midazolam in JCS cells. For IL-lp, the expression pattem went in an opposite 
direction. While IL-ip gene expression was up-regulated by biochanin A, the gene 
was down-regulated by midazolam. The expression level of IL-1 receptor was also 
different under different kinds of induction. Both types ofIL-1 receptors had constant 
level of expression despite biochanin A treatment. In contrast, the expression oftype I 
receptor was up-regulated while that of type II receptor was transiently down-
regulated at 18 hours. Discrepancies of mRNA levels ofIL-3 and its receptor between 
biochanin A-induced and midazolam-induced JCS cells were also found. IL-3 was 
up-regulated in expression during biochanin A-stimulated differentiation but down-
regulated during midazolam-mediated differentiation. Although a subunit of IL-3 
receptor was unchanged in expression during midazolam-induced differentiation, the 
gene was increased in expression induced by the combined action of biochanin A and 
0.25 % ethanol. By contrast, both forms of p subunits were up-regulated in 
midazolam-treated cells but unchanged in biochanin A-treated cells. With respect to 
TNF-a, the gene was up-regulated by biochanin A plus its solvent but remained 
unchanged in midazolam-induced cells. While LIF gene expression was up-regulated 
by biochanin A, the expression level remained unchanged after midazolam treatment. 
As for J l ld , the expression was decreased in biochanin A-treated JCS cells but 
enhanced in midazolam-treated cells. 
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Table 2.3. Expression profiles of the cytokines, cytokine receptors and marker gene 
studied. 
Genes Biochanin A sample set Midazolam sample set 
— — 0.25% ethanol Biochanin A (50 uM) Midazolam 7lO ug7ml) 
Ohr 18hr 46hr 18hr 46hr Ohr 18hr 48hr 
IL-la - - - - + - - -
IL-ip + + + + ++ ++ + + 
IL-3 ++ + ++ + +++ ++ ++ + 
IL-4 - - - - - - - 一 
TNF-a ++ + ++ + ++ + + + 
LIF + + ++ ++ +++ + + + 
IL-lRtI + + + + + ++ ++ +++ 
IL-lRtII + + + + + ++ + ++ 
IL-3RP + + + + + + + ++ 
IL-3Ra ++ + ++ ++ +++ + + + 
LIF-R - - - - - - - -
J l l d ++ ++ + ++ + + + ++ 
‘+，indicates expression. ‘-，indicates no expression. The increasing or decreasing number of 
‘+” indicates the relative increase/decrease in expression of the same gene only, there was no 
comparison of gene expression among different genes. 
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2.5 Discussion 
2.5.1 mRNA phenotyping 
Numerous cytokines have been implicated in myeloid cell differentiation. 
Both the direct and indirect effects of exogenously added cytokines and endogenously 
produced cytokines have been studied. (Hass et al, 1991; Jacobsen et al, 1994; 
Lotem and Sachs, 1989). 
Following previous studies, we continued to examine the expression of 
cytokines in terms of mRNA levels in JCS cells and evaluate their possible 
involvements in induced myeloid cell differentiation. 
The exogenouly added TNF-a has been shown to suppress proliferation of 
early hematopoietic progenitors ofbone marrow cells and the autocrine effect ofTNF-
a allowed the cells to undergo terminal differentiation (macrophage) (Witsell and 
Schook, 1992). Exogenously added TNF-a was shown to be a potent inducer of JCS 
cells differentiating into monocytes previously (Mak et al, 1993). The cytokine itself 
stimulated further elevated expression of endogneous TNF-a (Chan et al, 1995). In 
the current studies, we are interested to know whether such induction is specific for 
the cytokine TNF-a stimulation or for the monocytic differentiation of the cells. From 
the expression profile analyzed by RT-PCR, it appeared that such TNF-a induction 
was unique in differentiation stimulated by TNF-a. There was no observable change 
in expression associated with the monocytic/granulocytic differentiation stimulated by 
midazolam (Figure 2.10). Although TNF-a was slightly up-regulated by the 
combined effect of biochanin A and 0.25 % ethanol, the change did not seem to be 
correlated with the differentiation commitment triggered by biochanin A (Figure 2.7). 
This is because the same pattem of change occurred in JCS cells treated with 0.25 % 
ethanol alone where no phenotypic changes of differentiation were observed. Despite 
the degree of change was higher in the experimental samples, the increase occurred 
only at 46 hours which would be too late for influencing the differentiation program. 
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The increase in TNF-a gene expression in biochanin A-induced but not midazolam-
induced sample may be related to the different effect of the two inducers. 
Alternatively, it is possible that TNF-a production is required in greater demand for 
cells committed entirely to monocytes (biochanin A induced cells) than cells 
committed to produce both granulocytes and monocytes (midazolam-induced cells). 
Two other important inducers of JCS monocytic differentiation, namely IL-la 
and IL-lp, were also induced by TNF-a. In addition, the differentiation-inducing 
action of IL-la was mediated through the action of IL-ip (Chan et al, 1995). From 
the present studies, IL-la was not expressed during the monocytic/granulocytic 
differentiation triggered by midazolam (Figure 2.9) while IL-ip showed a little down-
regulation (Figure 2.11). However, it is doubtful to see such slight change ofIL-ip 
expression would have any particular effect in determining the 
monocytic/granulocytic differentiation. Elevated mRNA levels ofboth IL-la and IL-
ip were shown in biochanin A-induced JCS cells. Nevertheless, the change did not 
occur until after 46 hour of induction. Since IL-1 is readily produced by macrophage, 
increased production of IL-1 at a late time point (46 hours) triggered by biochanin A 
may be correlated with cell maturation and function. This induced IL-1 production is 
biochanin A specific as no expression of IL-1 and decreasing mRNA level of IL-ip 
were observed in midazolam-induced cell population, having monocytic cells (in 
addition to granulocytic cells). 
The expression of IL-1 receptors (both types) were unchanged (Figure 2.5) 
during biochanin A-induced cell differentiation and suggested that the response of 
JCS cells to IL-1 was not changed throughout the differentiation. On the other hand, 
the response of midazolam-induced JCS cells to IL-1 would have been increased 
slightly at 18 hours as the expression of decoy receptor IL-RtII (reviewed in Dinarello, 
1994) was decreased transiently at 18 hours (Figure 2.12) The response to IL-1 may 
also be increased significantly at 46 hours as the expression of the signaling receptor 
IL-lRtI was increased markedly at 46 hours (Figure 2.12). Since the increase in 
signaling receptor (IL-lRtI) and decrease in non-signaling receptor (IL-lRtII) did not 
accompany with an increase in IL-1 production in midazolam-treated cells, the 
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differentiating action of IL-1 on monocytic/granulocytic JCS cell differentiation, if 
any (at 18 hours), could possibly be effected only through exogenous source of IL-1. 
The increase in expression of type I receptors at 46 hours may be related to the 
function of neutrophils in the cell population of midazolam-induced JCS cells. 
Neutrophils are frequently recruited to the site of inflammations by IL-1. 
TNF-a and IL-1 have been suggested to have very similar biological functions 
in many aspects and both of them stimulated monocytic differentiation of JCS cells 
(Chan et al, 1995). While TNF-a and IL-lp probably signaled the cells in two 
independent pathway, IL-la effect its action through IL-ip (Chan et al, 1995). As 
TNF-a caused increased expression ofboth forms ofIL-l, interacting cytokine actions 
in JCS monocytic differentiation were suggested. In contrast, the current studies 
indicated a third unique pathway of monocytic differentiation (initiated by biochanin 
A) that involved neither TNF-a nor IL-1. Similarly, both TNF-a and IL-1 played no 
part in midazolam triggered monocytic/granulocytic differentiation but this does not 
preclude the involvement of these cytokines in granulocytic differentiation of JCS 
cells. In short, the present data and previous report suggested that TNF-a and IL-1 
mRNA induction was unique in TNF-a triggered pathway of monocytic 
differentiation. 
IL-4 is a pleiotropic cytokine having various effect on B cells, T cells, 
monocytes, endothelial cells and fibroblasts. It is involved in the expansion and 
recruitment of early myeloid progenitors together with other cytokines (IFN-y, IL-1 
and IL-3) (Snoeck et al., 1996) and modulates the growth of hematopoietic progenitor 
cells (Rennick et al, 1987). During terminal differentiation, the increased level ofIL-
4 (relative to IFN-y) preferentially gives rise to granulocytes rather than monocytes 
(Snoeck et al, 1996). Based on the previous published work, IL-4 and TNF-a have 
synergistic effect in inducing JCS cells to undergo monocytic differentiation (Leung et 
al.’ 1994). In addition, IL-4 was enhanced in expression during the TNF-a-induced 
differentiation ofJCS cells after 18 hour of induction (Chan et al, 1995). By contrast, 
IL-4 was not expressed during either the biochanin A-or midazolam-stimulated 
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differentiation in the current investigation (Figure 2.4, 2.9) and thus excluded the 
effect ofIL-4 on JCS cell differentiation induced by the two compounds. 
Autocrine loop of IL-3 production is a characteristic of this cell model. Its 
parent cell line WEHI-3B has an intracistemal A particle (IAP) inserted with its 5' 
long terminal repeat (LTR) close to the promoter region of the IL-3 gene leading to a 
continuous production of the growth factor. Such phenomenon has been shown to 
contribute to the leukemic phenotype of the cells (Perkins et al, 1990). During the 
midazolam-induced monocytic/granulocytic differentiation of JCS cells, a slight 
down-regulation of gene expression level was observed (Figure 2.11). This 
observation may be correlated with the anti-proliferative effect of midazolam. It has 
been reported that several peripheral benzodiazepine receptor-specific ligands which 
suppressed the induced proliferation of human mononuclear cells were able to inhibit 
interleukin-3-like activity secretion (Besseler et al, 1992), although such activity of 
midazolam has not been studied. 
The a subunit of the IL-3 receptors determines the specificity was 
unresponsive to midazolam but the P subunit AIC2A which binds weakly to IL-3 and 
AIC2B which causes signal transduction and complexes with other cytokine receptor 
subunits were slightly up-regulated at 48 hours (Figure 2.13). Whether such kind of 
receptor expression suggested an increasing demand for IL-3 on maturation, or 
associated with the function of other cytokine receptors (GM-CSFR and IL-5R) which 
share AIC2B with IL-3 receptor was unknown. Likewise, the increase in IL-3 gene 
expression did not seem to be correlated with the observed differentiation induced by 
biochanin A (Figure 2.7). Instead of differentiation-related, the increased level ofIL-3 
expression induced by both 0.25 % ethanol (solvent control) and biochanin A may 
reflect an increase demand for IL-3 as a survival factor. Unlike the midazolam 
treatment, biochanin A did not alter the expression of the p subunits of IL-3R. 
Instead, elevated expression was found in the a subunit. This increase in expression 
ofIL-3Ra may help in competing for AIC2B (P subunit) with GM-CSFRa or IL-5Ra 
(^icola and Metcalf, 1991). Hence, the response of JCS cells to IL-5 or GM-CSF 
would be significantly decreased (Walker et al, 1985). It was also found that 0.25 % 
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ethanol suppressed the expression of IL-3Ra but no significant differentiation nor 
inhibited proliferation was observed. This result is worth noting as weak 
differentiation-inducing effect of ethanol at higher concentration has been observed 
(1%) (personal communication with Dr. N.K.Mak, unpublished data). It is suggestive 
that ethanol-induced differentiation may effect through inhibited proliferation of JCS 
cells caused by a decreased response to IL-3. 
LIF, leukemia inhibitory factor, as the name implied was first discovered to 
cause monocytic differentiation of Ml leukemia cell line. However, both the 
differentiation-inducing effect of LIF and its expression in JCS cells have not been 
investigated. In the present study, LIF gene expression was detected in untreated JCS 
cells and was increased as the cells differentiated along the monocytic lineage induced 
by biochanin A (Figure 2.7). Howver, no change in LIF gene expression was 
observed during the monocytic/granulocytic differentiation caused by midazolam 
(Figure 2.10). On the other hand, both forms of LIF-R were not expressed in either 
the treated or untreated sample. This ruled out the possible involvement of LIF in 
affecting the differentiation ofJCS cells despite an elevated level ofLIF expression in 
biochanin A-treated cells. The unresponsiveness of cells to exogenous LIF to 
differentiate has also been shown in the related cell line WEHI-3B(D+) (Hilton et al., 
1988). 
The increased LIF expression at 46 hours during the monocytic differentiation 
of JCS cells induced by biochanin A (Figure 2.7) may correlate with the function of 
the mature cells. Cells of the myelomonocytic lineages are producers of LIF (Anegon 
et al, 1990) which in tum mediates a lot of diverse biological functions (reviewed in 
Hilton, 1992). Dissimilar from other's work where LIF-R was found on monocytes, 
we cannot detected the receptors under the current system. This probably suggests 
defective expression ofLIF-R in this cell line or such receptors are expressed at a very 
late stage ofmaturation (after 2 days of induction). 
The marker gene J1 ld expression was also studied. J l ld antigen is thought to 
be attached to a glycosylphosphatidyl-inositol membrane anchor. The antigen is 
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expressed in neutrophils but is absent in mature macrophages. In a report on Ml cells, 
both the J l l d mRNA level and antigen expression were significantly decreased during 
the LIF-induced monocytic differentiation (Fung et al., 1992) suggesting that J l l d 
may be used as a lineage-specific (monocytic) and differentiation-related marker. 
Increase in mRNA levels of J1 ld in midazoIam-induced JCS cells committed to give 
granulocytes (in addition to monocytes) further supports such view. However, the 
differentiation-associated decrease in expression of J l ld induced by the combined 
action of biochanin A and its solvent is arguable since the degree of down-regulation 
of J l l d expression was essentially the same as that in the solvent control sample 
where no differentiation of the cells was observed. 
After examining the mRNA phenotypings, we concluded that the cytokines 
studied, namely IL-1, IL-3, IL-4, LIF and TNF-a, did not play an important role in 
signaling the monocytic and monocytic/granulocytic differentiation induced by 
biochanin A and midazolam respectively. Nevertheless, the results demonstrated that 
gene expression could be altered by inducers in JCS cells; some of these changes 
should be accounted for the differentiation commitment. Also, different gene 
expression patterns were triggered by different inducers driving cells to different 
lineages; some ofthese differences should be decisive in lineage specification. These 
observations led us to initiate the search for differentially expressed genes during the 
induced differentiation of JCS cells in Chapter 3 and 4. 
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2.5.2 Cytokine gene regulation 
Using the current method in studying cytokine regulation, we should be careful 
about the interpretation because studying mRNA level of the genes does not give 
insight into how the genes are regulated. For instance, an increase in cytokine mRNA 
levels can be due to an increase in transcription rate or stability of the pre-existing 
mRNAs. The induced increase of some cytokine mRNAs like that of GM-CSF has 
been suggested not only due to an enhanced level of transcription but also a significant 
increase in the stability of the mRNA (reviewed in Greenberg and Belasco, 1993). 
Further, we should not overlook the control of cytokine genes other than that at the 
transcriptional level. Cytokine gene regulation can also be done at translation level, 
through glycosylation (Opdenakker et al, 1995), precursor processing (e.g. IL-1 and 
TNF-a) (Carinci et al, 1992)，sequestration by soluble factors/receptors (e.g. TNF and 
IL-1) or extracellular matirx (e.g IL-1 and LIF), receptor modulation and receptor 
antagonist (IL-1). 
As differentiation needs a very precise control, both initiation and shut-off of 
cytokine genes are important. Many cytokine genes have been shown to have an AU-
rich destablizing elements at the 3，untranslated region. These genes are induced 
within minutes and are rapidly degraded having half-lives of minutes to a few hours as 
demonstrated in activated mononuclear cells (reviewed in Turner and Feldmann, 
1990). LIF which has been found important in hematopoiesis was also transiently 
regulated in murine bone marrrow stromal cells. With AU-rich motifs at the 3’ 
untranslated region, the LIF mRNA has a short half-life of 30 minutes (Derigs and 
Boswell, 1993). In contrast to the expression of LIF and that of IL-ip in activated 
mononuclear cells, the mRNA expression profile of IL-lp in differentiating U937 
cells was different. The gene was induced within 4 hours after treatment ofPMA and 
the elevated mRNA level was maintained from 8 hours to 3 days after PMA 
stimulation OSfishida et al, 1988). High levels of mRNA transcripts of endogenous 
XNF-a, IL-la and IL-ip were also maintained at 18 hours after induction by 
exogenous TNF-a in JCS cells (Chan et al, 1995). These findings demonstrated that 
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expression profile of the same gene in myeloid cell differentiation can be different 
from that in other processes. Moreover, different genes that are important to cell 
differentiation or hematopoiesis may also have different degree of mRNA stability and 
expression time range. 
In short, the above discussion does not invalidate the conclusion that biochanin 
A or midazolam-induced JCS cells followed a different differentiation pathway from 
that ofthe TNF-a-induced JCS cells. The only problem is that we cannot exclude the 
involvement of the examined cytokines during early hours of the differentiation. As 
many genes like proto-oncogenes and transcription factors other than cytokines 
showed transient expression at early hours, it is necessary for us to extend the range of 
our time course study in the following studies (Chapter 3 and 4). Hence, we will have 
a more conclusive view ofthe overall effect ofboth the transcriptional activation rate 
and transcript degradation of a particular gene. 
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2.5.3 mRNA quantitation using the current method 
The current method is good for detecting dramatic changes of mRNA 
expression among samples. However, small changes or marginal changes may not be 
readily shown using five PCR cycle intervals. As a result, careful titration of different 
cycle numbers within the exponential phase and the cycle interval must be empirically 
determined for each gene. In this report, Southern blotting and dot-blotting were 
employed in different situation. Southern blotting is used for genes that have shown 
no or very low expression. The specificity of the primers giving products ofexpected 
size was demonstrated in the lane of positive control even though no signal or weak 
signal is detected in the experimental lanes (Figure 2.4, 2.9). On the other hand, PCR 
products might be analyzed by dot blot hybridization if amplification conditions had 
been optimized to yield single product (that hybridized to the internal probe). 
Obtaining single product is critical as conditions in the amplification may become 
limiting before a maximal amount of specific product is generated. Hence, the 
comparison ofmRNA levels among samples may become invalid. Designing primers 
spanning the splice junctions in the RNA may help in avoiding undesirable products 
amplified from the genomic DNA. More importantly, amplification conditions like 
temperature, MgCb concentration should be optimized to eliminate non-specific 
products. The touchdown PCR protocol employed in this report was empirically 
tested for the primer used; it is very effective for obtaining single PCR products. 
With reference to the non-radioactive detection methods, high background and 
non-specificity at region of labeled nucleotides have been claimed (Hopman et al, 
1995). However, these problems have not been encountered in our protocol, probably 
because the labeling region is kept to a minimum (end-labeling). Different from 
radioactive detection, shortened exposure time to the X-ray film may not help in 
improving the non-linearity of X-ray film in the current system. As a result, the 
experiment may need to be repeated with lower cycle numbers to show the changes. 
i 
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Although standards for quantitation of target DNA was omitted in the current 
method, an external endogenous gene is used to ensure the conversion of RNAs to 
cDNA and PCR amplification are equivalent among samples. P—actin, p -
microglobulin, aldolase A, elongation factor EF-la, GAPDH (glyceraldehyde-3-
phosphate dehydrogenase, HPRT (hypoxanthine phosphoriboxyltransferase), histone 
H3.3 or ribosomal protein L19 appeared to be good choices as controls. However, the 
expression ofthese genes may be affected by experimental or physiological conditions 
(Bereta and Bereta, 1995; Mansur et al, 1993); and the presence of psuedogenes may 
also influence the PCR amplification (Dimhofer et al, 1995). In addition, it seems 
that no single control gene can be completely free of these problems. Luckily, we 
have not observed such problems of GAPDH in our cell system; the gene showed 
unchanged mRNA levels at low PCR cycle number (20) in untreated as well as 
biochanin A- or midazolam-treated JCS cells. 
In conclusion, the current method is able to compare the mRNA levels with 
notable change among different samples and is fast, simple, sensitive and readily 
applied to different genes with minimal optimization of conditions (temperature, 
touchdown PCR). Moreover, the steps involving manipulation of RNAs were 
minimized. 
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Chapter Three Identification and Isolation of Genes 
that are Differentially Expressed 
During MidazoIam-induced JCS 
Cell Differentiation 
3.1 Introduction 
3.1.1 Methods for studying differentially expressed genes 
To study differentially expressed genes in cells under different conditions, an 
efficient method is very crucial. Methods depending on biological assay of phenotype 
or gene function would be very useful but these assays are difficult to devise in most 
of the cases. Thus, a universal method to all genes meeting the following criteria is 
much more desirable: (adapted from Liang et al., 1994) 
1. It should allow comparison of mRNAs from different sources or different time 
point of treatment at the same time. 
2. The mRNAs or cDNAs, in full-length or in partial length, that have been isolated 
could be used as a starting point to trace the corresponding genes. 
3. All or most of the mRNAs in the cell could be visualized. 
4. The method should be highly reproducible. 
5. It should be sensitive, fast and easy. 
There are a number of approaches and methods that suit some or most of the 
above criteria. Notably, differential screening strategies, subtractive hybridization and 
its derived strategies, as well as RNA fingerprinting and differential display by 
arbitrarily-primed PCR have been proved to be successful in isolating important 
genes. 
Differential screening involves the construction of a cDNA library from source 
A whose gene expression is of particular interest. This library is then screened with 
110 
labeled cDNA from a second source, B. The non-hybridizing clones are then further 
I analyzed by a suitable method like northern blotting. Only those clones that 
j 
reproducibly give greater hybridization to RNA from source A than source B are 
forther sequenced and characterized. Alternatively, a cDNA library made from source 
A were screened with labeled cDNA from both sources in parallel. Only clones that 
hybridized with probe A but not probe B were isolated. Differential screening suffers 
i I 
from two major drawbacks. The unmanipulated cDNA probes exhibit significant 
background hybridization and can only be used to isolate very abundantly expressed 
sequences (at least 0.1 % of messages) that can be identified above background 
hybridization. Second, large amounts of RNA from both sources are needed. 
Recently, the differential screening procedures are incorporated with the PCR 
techniques to reduce the required amount of starting materials without affecting the 
relative abundance of individual mRNA species. In some protocols, the cDNA from 
source A is amplified before it is cloned into the vectors (Smith and Gridley, 1992)， 
while in others both cDNA populations designated to make probes and libraries were 
amplified by PCR (Brunet et al, 1991) before screening. 
To improve the sensitivity and to reduce the background, subtractive 
hybridization may be a choice. The method was designed to enrich moderate (0.01-
0.1 % messages) to low abundance (less than 0.01 % of messages) genes. Slightly 
different from differential screening and other methods, subtractive hybridization 
technology aims at removing sequences common to both samples and enriching for 
clones that represent differentially expressed genes. To perform a typical subtractive 
hybridization, a population of molecules containing the desired message (target), say 
source A is hybridized with a 10- to 30-fold excess of molecules having messages to 
be removed (driver), source B. The unhybridized or enriched target molecules (A) are 
then separated from the hybrid molecules and the excess drivers. The enriched target 
molecules (A) can then be used to make either subtractive probes or a subtractive 
library. Subtractive probes enriched with target sequences can be used to screen a 
library made from the desired sequences (A) (Travis and Sutcliffe, 1988). 
Alternatively, if a subtractive library is made, desired sequences can be identified by 





hybridized only with the subtractive probes are picked for further investigation 
j (Hajnal et al, 1994). There are many variations in subtractive methods in terms of 
starting materials for subtraction. Originally, subtraction was done between cDNA 
target sequence and poly(A)+ driver sequences (Sargent, 1987; Sargent and Dawid, 
1983). Then, subtractions were done between single-stranded DNA (ssDNA) from 
two libraries (Duguid et al.，1988; Rubenstein et al.’ 1990), ssDNA from one library 
and cRNA from the other library (Tanaka et al, 1994; Li et al, 1994a), ssDNA from 
one library and isolated cDNA form another source (Rivolta and Wilcox, 1995) or 
cRNA from one library and cDNA from another library (reviewed in Lawler et al, 
1993). Again, PCR technology has been introduced and combined with subtractive 
hybridization to improve the method. Frequently, PCR amplification was done on the 
subtractive cDNA population (Schweinfest et al, 1993; Timblin et al, 1990). PCR 
may also be performed to amplify both the driver and the tester before and after 
subtraction (Duguid and Dinauer, 1989). Subtractive protocol also deviates from each 
other by the method of separating (removing) the unhybridized species from the 
hybridized ones. Hydroxylapatite column chromatography (HAP) (Sargent and 
Dawid, 1983), phenol extraction of biotin-streptavidin-crosslinked polynucleotides 
(Duguid and Dinauer, 1989), magnetic beads (Aasheim et al, 1994; Lonneborg et al, 
1995; Lopez-Femandez and del Mazo, 1993) and enzymatic degradation (Rivolta and 
Wilcox, 1995; Zeng et al, 1994) were employed by different authors. Alternatively, 
PCR techniques can be used to amplify preferentially the enriched target sequences in 
an exponential ratio but not the excess driver sequence or the hybrid sequence 
(Representational difference analysis or RDA) to circumvent the loss during 
separation procedures (Hubank and Schatz, 1994; Tsuchiya et al., 1994). 
Despite the improvement of the subtractive methods since its first use in mid-
1970s, the technical aspect of the method is still very challenging. Subtractive 
methods have a high sensitivity and are good for rare messages. However, they are 
time-consuming, laborious and technically difficult. Moreover, they allow only one-
way comparison. It is also impossible to compare several samples at the same time. 
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3.1.2 RNA fingerprinting by arbitrarily-primed PCR (RAP-PCR) 
and differential dispiay (DDRT-PCR) 
Two very similar protocols were devised in 1992, namely, RNA fingerprinting 
by arbitrarily-primed PCR (RAP-PCR) by Welsh et al. (1992) and differential display 
(DDRT-PCR) by Liang and Pardee (1992). As the names implied, both methods 
make use of PCR technique. They are semi-quantitative and allow multiple samples 
to be analyzed simultaneously. These protocols have found applications in many 
research areas including embryogenesis (Zimmermann and Schultz, 1994), cancers 
(Wu et al, 1995), heart diseases (Utans et al, 1994), diabetes ^Sfishio et al.，1994), 
brain and neurology (Dalal et al, 1994; Livesey and Hunt, 1996), growth factor 
stimulation and inhibition (Ralph et al, 1993), plant systems (Momiyama et al, 1995) 
and bacterial system (Wong and McClelland, 1994). 
RNA fingerprinting by arbitrarily-primed PCR (RAP-PCR) allows a semi-
quantitative comparison of the abundance of several hundred randomly sampled 
RNAs (Welsh et al, 1992). Three steps are generally required. The first step 
involves the first strand cDNA synthesis by reverse transcription initiated from 
arbitrarily-chosen primer at RNA sites best-matched with the primer. Second-strand 
cDNA was then synthesized by thermal enzymes starting at sites having adequate 
match on the first-strand cDNA with the same arbitrarily-chosen primer. Next, the 
cDNA products are further amplified by PCR and resolved by a sequencing gel. 10-50 
bands can be generated per fingerprint. The differences in the pattem of bandings 
reflect the differences in abundance of individual RNAs. As one gel can display many 
fingerprints, it allows a simultaneous comparison of several hundred RNAs. The 
protocol did not change much since the first report except some variations in the use 
of primers. For example, fully degenerated 6-mers oligo were used as primers during 
the first strand cDNA synthesis followed by two or three longer, arbitrary but defined 
primers employed in the second strand cDNA synthesis (Sokolov and Prockop, 1994). 
Notable attempts were also made to bias sampling of a particular gene family like 
serine/threonine protein kinase or zinc finger family (reviewed in McClelland et al, 
1995). In such adaptations, one primer designed according to certain motifs or 






Differential display (DDRT-PCR) differs slightly from RAP-PCR but still 
involves three basic steps. Using a set of anchored primers, reverse transcription is 
done in either 4 or 12 fractions. In Liang and Pardee (1992)，12 different primers Tn 
VN were used (where V can be A, G, C and N can be any of the 4 nucleotides). A 
cDNA fraction generated by each primer represents 1/12 of the total messages. Since 
the terminal 3, base of the primers provided most of the specificity, the original 12 
cDNA fractions was reduced to 4 using 4 degenerate primers T12MN (M is a 
degenerate mixture of A, G, C) (Liang et al” 1993). Then, second strand cDNA 
synthesis and subsequent amplification of each fraction was done by using a set of 
arbitrary primers and anchored primers. Next, the PCR products were displayed by 
polyacrylmide gel electrophoresis. Up to 50-100 bands can be displayed per lane. 
Again, the differences of pattem between samples suggest differences in abundance of 
individual mRNAs. Also, these patterns provide a picture of the mRNA composition. 
Variations, mainly in the use of primers, from the original protocols were reported. 
For instances, the anchored oligo-dT primer has been replaced with a second 
arbitrarily chose primers in the second strand cDNA synthesis (Haag and Raman, 
1994). Also, modified long composite primers (10 bases longer) replaced the typical 
anchor oligo dT primers in the first strand cDNA synthesis (Zhao et al, 1995). 
In short, RAP-PCR and DDRT-PCR represent methods that are fast and 
simple. They allow the identification of differentially expressed genes and detection of 
individual mRNA species in unlimited number (as far as a gel can handle) of samples. 
They can also, in principle, represent the whole complexity of messages. Several 
adaptations have been used to improve the efficiency of the methods such as the 
introduction of agarose gel (Hsu et al, 1993; Sokolov and Prockop, 1994)， 
chemiluminescent detection (An et al., 1996), automated DNA sequencer (Bauer et 
al, 1993; Ito et al, 1994) in the display of fingerprints. On the other hand, the 
methods suffer from non-reproducibility and under-representation of rare mRNA 
species in general. To tackle non-reproducibility and false positives generated by the 
methods, various procedures have been carried out (as detailed in section 3.1.4). With 
regard to the rare species sampling, some authors have been very successful 
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(Guimaraes et al.，1995). Also, nested priming of fingerprints may improve such 
sampling. A small aliquot of the original fingerprint is re-amplified with a primer 
shifted from the original primer 3' and with one or more extra arbitrary bases at the 3' 
end. These extra bases allow the selection of a subset of the original products 
including those that are too rare to be observed originally (McClelland et al” 1995). 
After comparing and considering the advantages and disadvantages of each 
protocol for studying differential gene expression (Table 3.1), we found RAP-PCR 
suit us best. First, five JCS samples of different time point after midazolam 
incubation were intended to compare at one time. Second, no specific primer oligo is 
needed to be synthesized as different sequences of primers ranging from 19-24 mers 
used previously for gene-specific amplifications are readily available in our 
laboratory. Third, a fast, technically simple method is desired. However, two 
problems must be solved in order to make this strategy a success. One of them is to 
eliminate most, if not all, false positive bands (section 3.1.4). Another one is to 
develop an efficient procedure to reproduce the desired DNA fragment for further 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.1.3 Re-amplification of PCR products by touchdown PCR 
We found that touchdown PCR is an ideal method of avoiding spurious bands 
or non-specific bands generated during re-amplification procedures without 
optimization of different components in the reaction. 
Touchdown PCR optimizes the reaction entirely by elevated annealing 
temperature at start followed by decreasing temperature in successive cycles. The 
originally described amplification profile (Don et al., 1991) started with an annealing 
temperature well above the estimated melting temperature of the primer-template 
complexes. The annealing temperature was lowered 1 ®C every second cycles for 10 
cycles. Finally, the reaction continued with an annealing temperature allowing for the 
formation of stable primer-template complexes. (5-10 ®C below the melting 
temperature). Various modulations on this protocol are possible (e.g. stepdown PCR 
with fewer but steeper incremental declines in annealing temperature). 
This method/principle has proved to be effective in increasing both the 
specificity and yield of the PCR (Hecker and Roux, 1996). The priming is initiated 
well above the optimum annealing temperature (Hecker and Roux, 1996) which 
favors the amplification of the specific target molecules. As the cycling program 
progresses, the lowered annealing temperature (< Tm) allows the specific product 
yield to be increased, which would otherwise be unfavorable by following ordinary 
thermal profiles. 
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3.1.4 Strategies to avoid false positives 
As mentioned in section 3.1.1 and 3.1.2, RNA fingerprinting by arbitrarily-
primed PCR or the related method, differential display has been very useful in 
isolating differentially expressed genes in different systems. One major problem of 
these methods is the heterogeneity of the PCR fragments isolated from the resolving 
gels. Different species of DNA of similar size would migrate as a single amplified 
band on the gel. Thus, the differentially amplified products of interest (recovered 
from the gel) are always contaminated with species irrelevant. Also, false positives 
may be generated by genomic contamination, infrequent imperfect annealing of 
primers to sequences within the mRNA pool (Rohrwild et al, 1995) and operational 
errors like degradation of mRNA and inconsistency in pipetting. Three strategies 
were attempted to avoid these false positives : 
1. Comparing fingerprints generated from two or more RNA concentrations for each 
sample in parallel to eliminate intra-sample variation due to slight differences in 
the quality or concentration of the RNA (Welsh et al, 1992). 
I 
2. Repeating the fingerprints with once or twice new RNA preparation to increase 
i the certainty of detecting real difference in gene expression (Sompayrac et al, 
i 1995). 
3. Introduction of primers having a universally pairing base (e.g. inosine) to reduce 
mis-primings (Rohrwild et al, 1995). 
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! RAP-PCR and DDRT-PCR have been applied to the study of myeloid cells 
and other hematopoietic cells. Bum et al. (1994) studied genes activated by retinoic 
acid in myeloid cells HL-60. An up-regulated gene, monocyte-chemoattractant 
protein-1 was isolated and confirmed. Dom et al (1994) investigated genes 
differentially expressed during megakaryocyte differentiation into platelets. Both up-
regulated genes (Cdw44 adhesion molecules and plectin cytoskeletal protein) and 
down-regulated gene (glutathione sulfydryl peroxidase) were isolated. Having 
considered the success of these reports, we employed the strategy of RAP-PCR in 
studying gene expressions during WEHI-3B JCS cell differentiation triggered by 
midazolam. The strategy allowed us to monitor the change in mRNA levels at 
different time points in JCS cells after the drug was added. Since midazolam, 
different from other inducers, induced granulocytic differentiation in addition to 
monocytic differentiation of JCS cells, such strategy is certainly valuable in finding 







Materials which have been mentioned in Chapter 2 will not be presented here. 
3.2.1 Cell line and bacterial culture 
1. Escherichia coli (DH5a) 
2. WEHI-3B JCS myeloid leukemia cell line 
3.2.2 Chemicals 
1. Acetic acid, glacial Ajax 1 
2. Agar Ajax 863 
3. Ampicillin Sigma A9518 
4. Ammonium acetate SigmaA1542 
5. Calcium chloride, hydrated form Sigma C3881 
6. Chloroform Ajax 152 
7. Ethylenediamine-tetraacetic acid (EDTA) Sigma ED2SS 
8. Ethanol, absolute Ajax 214 
9. Glycerol Sigma G5516 
10. Isoamyl alcohol Ajax 64 
11. Isopropyl-P-D-thiogalactopyranoside (IPTG) Sigma 16758 
12. Magnesium chloride Sigma M9272 
13. Magnesium sulfate Sigma M2773 
14. Manganese chloride, tetrahydrate Sigma M3634 
15. Morpholinopropanesulfonic acid (MOPS) Sigma M8899 
16. Rubidium chloride Sigma R2252 
17. Phenol SigmaP1037 
18. Potassium acetate Sigma P1147 
19. Potassium chloride Sigma P4504 
20. Propanol-2-ol / isopropanol Ajax 425 
21. Tryptone Oxoid L42 
22. 5-bromo-4-chloro-3-indolyl-P-D-galactoside (X-gal) Amresco 7240-90-6 
� 121 
i 
23. Yeast extract Oxoid L21 
3.2.3 Enzymes and nucleic acids 
1. ATP Pharmacia 27-1006-01 
2. [a^^]-dCTP Amersham AA0005 
3.pBluescriptSK(-) Strategene 212206 
4 . R N a s e I (lOU/jid) Promega M4261 
5. SmaI, lOXbufferJ PromegaR612/l,2 
6. T4 DNA ligase, 10X One-Phor-All buffer Pharmacia 27-0870 
7. T4 DNA polymerase, 5X buffer Pharmacia 27-0718 
3.2.4 Kits (Appendix A3) 
r p » * 
1. Megaprime DNA labeling system Amersham RPN 1606 
2. Nick column Pharmacia Biotech 52-2076-00 
3. QIAGEN plasmid midi kit Qiagen 12143 
3.2.5 Solutions 
1. LB+Ampi00broth 10 g tryptone, 5 g yeast extract and 10 g NaCl per lL of 
water, autoclaved at 121 ®C under 1 kgcm"^ pressure for 
20 minutes. A final concentration of 100 ^g/ml 
ampicillin was added to the medium cooled to hand-
tolerable temperature 
2. LB+Ampioo plate LB+Amp_ broth + 10 g/L agar 
I 3. Phenol, equilibrated 5 ml phenol aliquot from -20 ®C storage was equilibrated 
'I with equal volume of 1 M Tris-HCl, pH 8.0 at room 
temperature. 
4. Phenol-chloroform- Freshly equilibrated phenol, pH 8.0，chloroform and iso-




5. SOB broth 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM 
KC1 were first combined and autoclaved for 30 minutes 
1 
under 1 kgcm" pressure, 10 mM MgCl2 and 10 mM 
MgSO4 were then added from a 2 M stock of Mg�+ filter-
sterilized through a 0.22 ^m membrane. The medium 
was used within 3 weeks 
6. SOB agar plate SOB broth + 10 g/L agar 
7. RF1 solution 100 mM RbCl, 50 mM MnCl2.4H2O, 30 mM potassium 
acetate, 10 mM CaCl2.2H20, 15% (w/v) glycerol, pH 
5.8 adjusted by acetic acid and filter-sterilized by 0.22 
|am membrane 
8. RF2 solution 10 mM MOPS, 10 mM RbCl, 75 mM CaCl2.2H2O, 15% 
(w/v) glycerol, pH 6.8 adjusted by NaOH and filtered 
through a 0.22 jLun membrane. 
9. TioEo.i buffer, pH 7.5 10 mM Tris-HCl, pH 7.5; 0.1 mM EDTA, pH 7.5 




3.3.1 Isolation of total RNA 
Total RNA was isolated from midazolam-induced JCS cells using the same 
method as described in section 2.3.1. JCS cells were incubated with 10 jugAnl 
midazolam for 0, 1, 5, 18 and 48 hours before harvest. The cell culture was kindly 
maintained by Mr. Bats, S.W. Wong and Dr. N.K. Mak in the Department of Biology, 
Hong Kong Baptist University. 
3.3.2 First strand cDNA synthesis 
10 p,g total RNA from each of the 5 samples of different time points was 
diluted to 0.1 i^g/^ il in a total volume of 100 i^l. The solution was heated to 65 ®C for 
10 minutes and quickly chilled on ice. 100 p,l of reaction solution from the same 
‘cocktail, was then added to and well-mixed with each of the RNA solutions, making 
up the reverse transcription solution (RT solution). The cocktail contained various 
components in the final concentrations as described: 40 U RNase inhibitor per jug 
RNA, 0.1 i^g oligo dTi2-i8 per ^g RNA, 0.5 mM of each dNTP, IX reaction buffer, 
10 mM DTT and 200 U Moloney murine leukemia virus (M-MLV) reverse 
transcriptase per jig RNA. The final RT solutions were incubated for 1 hour at 37 ®C. 
3.3.3 RNA fingerprinting by arbitrarily-primed PCR (RAP-PCR) 
(i) RAP-PCR 
The method was adapted from Welsh et al (1992). cDNA made from 0.1 jiig 
total RNA of each sample was diluted 5 times in a total volume of 10 ^1. The diluted 
templates were boiled for 10 minutes and chilled on ice immediately. After the 
evaporated droplets at the cap of the tube was collected by centrifugation, a 50 ^1 PCR 
I -
f f * 
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was set up for each sample having a final concentration of 1.5 mM MgCl2, IX 
reaction buffer, 0.2 mM of each dNTP, 2 pmol/L of one arbitrarily-chosen primer 
(ranging form 19 to 24 bases ) and 0.25 U Thermoprime+ DNA polymerase in the 
reaction mixture. 5 low stringency cycles followed by 45 high stringency cycles were 
performed in a programmable PCR machine (MJ Research). The thermal profile for 
low stringency cycles was 94 °C denaturation for one minute, (Tm of the chosen 
primer-20) ®C primer annealing for one minute and 72 ®C extension for one minute 
while that for high stringency cycles was 94 ®C for one minute, (Tm of the chosen 
primer - 1 0 ) � � f o r one minute and 72 °C for one minute. 
(ii) Recovery and re-ampliflcation of PCR fragments 
15 ^1 of the resulting PCR products from the five samples of different time 
points were loaded in parallels into a 1.5 % TAE Synergel. PCR fragments of 
different sizes were resolved on the gel. Fragments that were differentially amplified 
among the samples were cut and recovered from the gel. For each piece of gel, 450 i^l 
of sterilized ultra-pure water (10 times of the gel volume) was added and boiled for 10 
minutes. The boiled gel solution with eluted DNA was then stored at -20 ®C and used 
within a week or amplified immediately. 2 p,l of the eluted DNA solution was used as 
template and amplified in a 50 i^l PCR reaction with 1.5 mM MgCl2, IX reaction 
buffer, 0.2 mM of each dNTPs, 2 pmol/L of the primer originally chosen and 0.25 U 
i Thermoprime+ DNA polymerase. Touchdown amplification profile of 35 cycles was 
used in this reaction. While the denaturation and extension steps were kept at 94 ° C 
i 
i and 72 °C for 1 minute respectively, the annealing temperature kept for 1 minute was 
• ！ 
j 
I equal to (Tm of the chose primer) °C at start and reduced by 1 °C at each of the 
5 ! 
following cycles until the fifth cycle. The annealing temperature would be (Tm-5) ®C 
by the fifth cycle and this temperature for primer annealing was kept for further 30 
cycle amplification. Two identical reactions were prepared for each fragment isolated 
and the two final reaction solutions were combined into one tube at the end. 
i 
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3.3.4 First round cDNA probe screening 
(i) Preparation of cDNA probe 
5 |Lig of total RNA from each of the 5 samples was reverse-transcribed as 
described previously (section 3.3.2), except that each reaction components was scaled 
down accordingly to obtain the first strand cDNA. The 100 jul of reverse-transcribed 
reaction solution from each sample was added with equal volume of PCI and vortexed 
thoroughly. The aqueous and the organic phases were separated by brief 
centrifugation (Eppendorf). The upper aqueous phase of about 100 ^1 was pipetted 
out and transferred to a new tube. 55 ^1 of 7.5 M ammonium acetate and 400 jid of 
absolute ethanol were added to precipitate the nucleic acids. The solution was well-
mixed and spun at 14 000 rpm on a bench-top microcentrifuge at room temperature 
for 30 minutes. The pellets were washed with 70% ethanol and resuspended in 50 i^l 
ofTioEo.i buffer, pH 8.0. The solution obtained from the 5 different time points were 
stored at -20 °C until use. 
(ii)32p-labeling 
To label cDNAs in the RT solution with ^^P, random-primed DNA labeling 
was used. By using the Megaprime labeling system (Amersham) following the new 
megaprime protocol, two 50 i^l reactions were set up for each type of RT solution. 
Each reaction contained 20 i^l of the RT solution prepared in (i) (derived from 2 ^g 
total RNA), 5 jil of random nanomers, 10 ^1 of labeling buffer, 2 fil of DNA 
^^ 
polymerase, Klenow fragment, 6 i^l of [a -P]-dCTP of radioactivity 10 ^Ci/^l (=20 
pmol, specificity activity 3000 Ci/mmol) and 7 jid of H2O making up the reaction 
volume to 50 i^l (see also Appendix A3). Master mix I containing primers and H2O 
was first dispensed to each of the 20 i^l of RT solution. The tubes were then boiled 
for 5 minutes, spun down and cooled down to room temperature for primer annealing. 
Master mix II with labeling buffer, enzyme and radioactive label was added to each 
reaction subsequently and mixed thoroughly by pipetting up and down. The final 
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labeling reaction solution was spun down and incubated for 10 minutes at 37 °C. The 
two identical reactions for the same probes were pooled together and 4 ^1 of 0.5 M 
EDTA, pH=8,0 was added to stop the polymerization. 
(iii) Probe purification by nick column 
The labeled DNA from the previous section can be purified by nick column 
(Pharmacia). 3 ml of equilibration buffer, TioEo.i pH 7.5 was applied to the column 
until it entered the gel bed completely. The total 100 ^1 of each labeling reaction mix 
was applied at the centre of the filter on the top of the column and let to enter the gel 
bed. The first elution mn-out fraction by adding 400 ^1 of TioEo.i pH 7.5 buffer was 
discarded but the second eluted (400 ^1 ofTioEo.i buffer) fraction containing most of 
the labeled DNA was collected. 
(iv) Pre-hybridization and hybridization 
PCR products obtained in section 3.3.3 was further amplified by PCR. Each 
of the products was dot-blotted in equal amount onto 5 sets of nylon membranes. A 
‘control dot, having equal amount of a GAPDH fragments amplified by specific 
primers (Table 2.1) was also applied to the membranes where the hybridization 
signals were compared. The membrane was fitted in the dot-blot apparatus according 
to the instructor's manual (see also Figure 2.2). 200 i^l ofH2O was added to each well 
to pre-wet the membrane and drained using vacuum force. 15 ^1 of each PCR 
amplified product was first denatured in 0.2 M NaOH in a total volume of 200 ^1 
solution for 15 minutes at room temperature and applied to each well under vacuum. 
400 i^l of 20X SSC was then added to each well to wash off any sticky droplets on the 
wall of the well and to neutralize the membrane. The membrane was removed from 
the dot-blot apparatus, air-dried and baked for 30 minutes at 120 °C. The membranes 
were stored in cool, dry place at room temperature until use. 
Before hybridization, the membranes were completely wet with hybridization 
buffer. The membranes destined to the same time point of cDNA probe were curled 
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up together with meshes in between. The curled membranes were put into an 
appropriate glass tube (Hybriad) pressed against the wall by a glass pipette in a 
rotatory manner opposite to the curl. 20 ml of hybridization buffer was added to each 
tube and pre-hybridized for 10 hours at 68 ®C in a hybridization oven (Hybriad). The 
used buffer was then replaced with 10 ml of new buffer. 400 |iil of the purified 
radioactively-labeled probe of each time point, namely 0, 1, 5，18 and 48 hour, was 
then added at the centre of the buffer, swirled to mix and rotated to ensure complete 
coverage of the membrane. The membranes were hybridized for 18 hours at 68 ®C 
with continuous rotation. About 20 ml o f 2 X SSC; 0.1 % (w/v) SDS was added to 
each tube at 68 ®C for two stringent washes, each for 15 minutes. Another two 
washings were done using 0.5 X SSC; 0.1% (w/v) SDS at 68 ^C each for 15 minutes. 
The membranes were then removed from the tubes, sealed with Saran wrap and 
exposed to the same piece of X-ray film (Kodak 165-1512) at room temperature in an 
X-ray film cassette (X-Omatic cassette, Kodak) for 12 hours at room temperature. 
The film was developed and fixed to obtain an autoradiograph. 
(v) Quantitation by densitometry 
Dots on the autoradiograph were scanned by a densitometer (Bio-Rad) and 
quantitized in integrated volume = [OD X area (mm^)] using Volume Analysis in the 
丁\/1 
Molecular Analyst software (Bio-Rad). Background subtraction was done as 
described in section 2.3.8. After background subtraction, the value of the ‘control dot， 
on membranes of different time points were normalized. The value of other dots on 
each membrane was then adjusted in direct proportion to this normalized value of the 
control. Dots showing a 2-fold difference (or more than a 2-fold difference) in the 






I 3,3.5 SubcIoning of differentially amplified fragments 
(i) Preparation of vectors 
i j 
25 ml of DH5a-pBluescript SK(-) ovemight culture using LB+Amp^^^ broth 
was prepared at 37 ®C. Plasmid DNA was isolated using QIAGEN plasmid midi kit 
(Appendix A3). Briefly, the bacterial cells were pelleted at 7000 rpm (6000 g) in a 
JA-20 rotor (Bechman) for 15 minutes at 4 °C. The supernatant was decanted and the 
tube was inverted to drain on absorbent paper. The pellets were resuspended in 4 ml 
of P1 solution added with 20U RNase I. 4 ml of P2 solution was then added and 
mixed by gentle inversion (4 times) to lyse the cells. The mixture was incubated for 5 
minutes at room temperature and 4 ml of P3 solution was added to neutralize the cell 
lysate by immediate gentle inversion (4 times). The neutralized lysate was then 
transferred to the barrel of a 10 ml syringe which is connected to a filter unit with a 
piece of large pore filter (Millipore AP1002500) outlet to the Qiagen-column (Figure 
3.1). The column was equilibrated with 4 ml of QBT solution and allowed to empty 
by gravity flow just before use. The lysate was settled in the set-up at room 
temperature for 5 minutes before the stopper was removed. The plunger of the syringe 
was then pushed through to filter out the precipitates. The lysate was let to enter the 
resin of the column under gravitational force. The column was then washed twice, 
each with 10 ml of QC solution. The DNA was eluted out with 5 ml of QF solution. 
The eluted DNA was precipitated with 3.5 ml of isopropanol at room temperature and 
centrifuged immediately in a JA-20 rotor (Bechman) at 12 000 rpm (15 000 g) for 30 
minutes at 4 °C. The resulting supernatant was removed and the pellets were washed 
with 2 ml of 70 % ethanol. The washed pellets were ftirther centrifuged at 12 000 rpm 
(15 000 g) in a JA-20 rotor for 10 minutes at 4 ®C. The supernatant was discarded and 
the pellets were vacuum-dried (Savant) and resuspended in 400 ^1 of H2O. The 
solution was then analyzed and quantitized by spectrophotometry at 260 nm and 280 
nm UV light. 1 O.D. unit at 260 nm was taken as 50 ^g/ml. 
20 i^g of plasmid DNA was digested by Sma I (blunt-end digestion) for 1 hour 
at 25 °C in a total volume of 200 i^l. Plasmid DNA concentration was kept at 0.1 
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jig/^d and Sma I enzyme concentration was 1.5 U/^ig DNA. After the digestion, 200 
i^l of PCI was used for purification. The mixture was vortexed thoroughly and 
centrifuged to separate the two phases. The upper phase was pipetted out to a new 
tube. 110 i^l of 7.5 M ammonium acetate and 775 jil of 100 % ethanol were added for 
1 precipitation. The solution was centrifuged at 14 000 rpm on a bench-top 
I 
I microcentrifixge (Eppendorf) for 30 minutes. The supernatant was discarded and the 
I I 
i pellets were washed with 1 ml of 70 % ethanol and vacuum-dried (Savant). The dried 
pellet was resuspended in 350 i^l of ddH2O making up to a final concentration of 
. ， 
about 0.05 ^ig/jil ofDNA. 
i 
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Figure 3.1. Set -up for plasmid purif ication. 
(ii) Preparation of inserts 
PCR fragments showing a change of about two-fold difference or more in 
hybridization signal among the time points were further amplified by PCR as 
described in section 3.3.3 using 2 i^l ofPCR products as template. Two PCR (50 jiU) 
for each fragment were performed and the resulting products were combined 
afterwards. One PCI extraction was done and the PCR products were precipitated by 
60 i^l of 7.5 M ammonium acetate and 375 ^1 of 100 % ethanol. The solution was 
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centrifiiged at 14 000 rpm for 30 minutes and the pellets were washed once with 70 % 
ethanol. The pellets were vacuum-dried (Savant) and resuspended in 55 ^1 of ddH2O. 
11 i^l of this purified PCR products was first mixed with 4 ^1 of 5 X buffer and 10 U 
ofT4 DNA polymerase and waited exactly for 30 seconds. Then, 4 ^1 of 10 mM each 
dNTPs was added making the final concentration to 2 mM each dNTP and final 
i 
I 
I volume to 20 i^l. The mix was incubated for 30 minutes at 37 °C，spun down and 
chilled on ice. 20 ^1 of PCI was added, mixed and the upper aqueous layer was 
•i 
pipetted out to a new tube. 10 |il and 75 jil of 7.5 M ammonium acetate and absolute 
ethanol were added respectively and the tube was spun at 14 000 rpm for 30 minutes 
(Eppendorf). The supernatant was removed and the pellets were washed with 0.5 ml 
of 70% ethanol and dried in vacuum. The dried pellets were resuspended in 10 i^l of 
I H2O. 
(iii) Blunt-end ligation 
4 |al (about 0.2 i^g) of pBluescript/Sma I prepared in section 3.3.5(i) was 
mixed with 10 |il of blunt-ended PCR fragments obtained in section 3.3.5(ii), 2 ^1 of 
10 X One-Phor-All buffer, 2 i^l of 10 mM ATP and 16 Weiss Unit ofT4 DNA ligase 
making up the final volume to 20 jid. The reaction mix was incubated in a PCR 
machine for 16 hours at 16 °C (MJ Research). A PCI extraction was done and the 
nucleic acids were precipitated with 10 i^l of ammonium acetate and 75 ^1 ofabsolute 
ethanol followed by centrifugation at 14 000 rpm for 30 minutes (Eppendorf). The 
final pellets were washed with 0.5 ml of 70% ethanol, vacuum-dried (Savant) and 
resuspended in 15 ^1 ofH2O. 
(iv) Preparation of competent cells 
Several DH5a colonies 2-3 mm in diameter were picked from a SOB agar 
’ plate, suspended in 1 ml of SOB broth and grown for 18 hours at 37 ®C. The culture 
was then diluted in 99 ml of SOB medium in a 2000 ml flask. The diluted culture was 
then incubated with moderate agitation at 37 °C until the cell density equals to 4-7 X 
7 
10 /ml. For DH series, this cell density corresponds to an absorbance ofO.45-0.55 at 
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550 nm. The absorbance ofthe growing culture was checked at a 30 minute interval 
and the cell density required reached after about 2 hours. The culture was collected 
and incubated on ice for 15 minutes. The cells were then harvested at 3000 rpm in a 
jA-20 rotor (Bechman) for 15 minutes at 4 ^C. The supernatant was discarded and the 
remaining droplets were absorbed on tissue paper upon inversion. The cells were then 
resuspended with 30 ml of RF1 solution and mixed moderately by vortex. The cell 
suspensions were incubated on ice for 15 minutes and centrifuged at 3000 rpm in a 
JA-20 rotor (Beckman) for further 5 minutes at 4 "C. The cell pellets were dispersed 
in 8 ml of RF2 solution and incubated on ice for 15 minutes. The resulting cell 
suspension was then pipetted in 110 i^l aliquot by pre-chilled pipette tips into pre_ 
chilled screw cap tubes. The tubes were then flash-freezed by liquid nitrogen. These 
cells were made competent and stored at -70 °C until use. 
(v) Transformation 
An aliquot of competent cells (110 i^l) removed from -70 "C was thawed at 
room temperature until the cell suspension become just liquid. The 15 ^1 of ligated 
plasmids prepared as described in section 3.3.5 (iii) was added to the cell suspension 
and swirled to mix evenly. The tube was kept on ice for 1 hour. The cells were then 
heat-shocked by placing the tube in a 42 "C water bath for 90 second and chilled on 
ice immediately afterwards. 800 i^l of pre-warmed LB broth was then added and 
incubated at 37 T for another hour. The cells were then plated out on LB+Amp_ 
plates with 8 i^l of0.5 MIPTG and 4 ^1 of250 mg/ml X-gal in a volume of50 ^1, 100 
1^1 or 200 i^l and incubated at 37 °C overnight. The white colonies were spotted and 
further studied. 
(vi) Selection, screening and confirmation by PCR 
10 white colonies were picked randomly on LB+Amp^ plates with IPTG and 
X-gal as described in section 3.3.5(v). The picked colonies were spotted on a master 
LB+Ampioo plate and at the same time each colony was resuspended in 100 i^l of H2O. 
The colonies were named according to the primer number, fragment number and 
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colony number (e.g. 44/3.1). The master plate incubated at 37 ®C ovemight and the 
i 
1 
resuspended colonies were boiled for 10 minutes, chilled on ice and spun for 1 
i 
I minute. 10 i^l of each bacterial lysate was used as template for PCR amplified for 50 
I cycles following the thermal profile : 94 ®C for 1 minute, 56 ®C for 1 minute and 72 °C 
for 1 minute. The products were analyzed on a 1.5 % TAE Synergel and those which 
showed different sizes on the gel were selected for a second screening. The master 
plate were kept at 4 ®C as stock and spotted onto a new plate twice a month. 
3.3.6 Second round cDNA probe screening 
The screening followed basically the procedure described in section 3.3.4 
except that the PCR fragments to be screened were generated using the plasmids with 
the subcloned fragments as templates. The resulting products were then further 
amplified and dotted onto the membranes. As in the first screening, fragments with 
normalized value having 2-fold difference or more among samples of different time 










Total RNAs from 6 different samples (Table 3.2) obtained by the guanidinium 
thiocyanate-cesium chloride isopycnic gradient method (Chirgwin et al, 1979) were 
analyzed by measuring the absorbance of UV light at 260 nm and 280 nm. The ratio 
of the 2 values defined an approximate purity of the samples. In these preparations, 
the ratio was roughly the same. 
i 
Table 3.2. Spectrophotometric analysis of the RNAs isolated from 6 different samples 
after midazolam treatment. 
Sample A260/A280 
CorSrofjCS^ 1.53 
Control JCS cells (Batch 2) 1 _56 
JCS cells incubated with midazolam (10 i^g/^ il) for 1 hour 1.54 
JCS cells incubated with midazolam (10 ^ig/^l) for 5 hours 1.41 
JCS cells incubated with midazolam (10 [xg/[d) for 18 hours 1.53 
JCS cells incubated with midazolam (10 [xg/[xl) for 48 hours 1.54 
Total RNAs were prepared from untreated JCS cells and JCS cells incubated with 10 [ig/ml 
midazolam for 1, 5，18 and 48 hours. A260 and A280 are the absorbance o f U V light at 260 and 
280 nm respectively. The ratio of the two values were calculated as shown. 
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3.4.2 Normalization of samples 
The 6 samples of different treatments were normalized by GAPDH gene 
expression detected by RT-PCR amplified for 20 and 25 cycles followed by 
electrophoresis on a 1.5 % TAE Synergel. The expression of GAPDH was essentially 
I the same among the samples under the detection (Figure 3.2). 
M 01 02 1 5 18 48 01 02 1 5 18 48 
m m i i i i i i i i i i i i H i ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ B 
|iljj|j^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ 2 ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ H^|^^^^^^^^^ H^|^^^^^^^^^^^^^^^^^^^^^^^^^ |^^^^^^^^^^HB^g-
^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ H^ H： 
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PCR cycle 20 25 
Figure 3.2. Normalization of samples by GAPDH gene expression. 20 and 25 cycles of 
RT-PCR using GAPDH gene specific primers were performed on RNA samples isolated 
from untreated JCS cells (Batch 1 (01) and Batch 2 (02)) or JCS cells incubated with 
midazolam (10 ^ig/ml) for 1 (1), 5 (5), 18 (18) and 48(48) hours. 10 ^1 of each of the PCR 
products were electrophoresed on a 1.5 % TAE Synergel. The expected product size was 452 
bp. M = 1Kb ladder. 
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3.4.3 RNA fingerprinting by arbitrarily-primed PCR 
Six populations of polymorphic fragments generated from total RNA samples 
were amplified with a modified RAP-PCR protocol as described in section (3.3.3(i)). 
The arbitrarily primers chosen were 19-24 bases long. The RNA fingerprints were 
i 
size-fractionated on a 1.5 % TAE Synergel and run side-by-side for comparison. 
1 
Different kinds of polymorphism were observed as exemplified in Figure 3.3. Some 
i 
I fragments were only amplified in samples of early hours and peaked at the time point 
i 
5 (Figure 3.3, arrow 1 and 3). Other polymorphic bands were abundant at 0 and 1 
I 
I hour samples and in lower abundance at later time points (Figure 3.3, arrows 2 and 3). 
j 
j There were also bands that appeared exclusively in samples of 0 and 1 hour (Figure 
3.3，arrow 5). A total of44 primers have been used to generate 142 such differentially 
j 
amplified fragments. 0-9 polymorphic bands were produced per arbitrarily-chosen 
I • 
I primer and an average of 3 bands could be generated per primer. The number of 
resolved bands per fingerprint ranged from 1 to 12 bands and most of them gave 6-9 
bands. The size of the resolved bands distributed between the 201 and 2036 bp 
I 
marker band of the 1Kb ladder. It was also noted that different batches of untreated 
JCS cell sample resulted in different banding pattem at the same measured 
concentration. Unless otherwise stated, the bands determined to be polymorphic were 
based entirely on the untreated JCS cells-batch 2 and samples of the other time points. 
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Figure 3.3. RNA-fingerprinting by arbitrarily-primed PCR. Six populations of 
differentially amplified fragments were generated by RAP-PCR using total RNAs from 
control JCS cells (batch 1 (01) and batch (02)) and JCS cells incubated with midazolam (10 
^g/ml) for 1, 5, 18 and 48 hours. For each set of reaction, 5 low stringency cycles and 45 
high stringency cycles were performed with the arbitrarily-chosen primers indicated. The 
resulting products were loaded into a 1.5 % Synergel. The numbers on the side of the photo 
are the size of the marker bands. Some of the polymorphisms among the samples were 
indicated by arrows and recovered as described in section 2.3.3(ii). M=lKb ladder. 
MF 228 5 ' AGA AGT GAA GGC TGG CAT GGC 3 , 
MF 172 5 ' ATG GAA GGG ATG ACT ATG TTG GA 3 ' 
M F 2 4 0 5 ' TCA TCA ACC ACC TTC GAA AAT AGC3' 
MF230 5' GAA TGT CCA CAA ACT GAT ATG CTT 3' 
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3.4.4 Re-amplification of PCR product 
The differentially amplified bands were directly recovered from the gels under 
UV illumination. The small pieces of gel were boiled immediately for 5 minutes and 
1 
i ‘ 
2 |al of the eluted and diluted DNA solution was re-amplified by touchdown PCR as 
i detailed in section 3.3.3(ii). The re-amplified products were shown in Figure 3.4. 
i I 
i While most of the products remained homogenous in size (Lane 1-6, 8-12), some 
j 
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Figure 3.4. Re-amplification of the differentially amplified fragments isolated. The 
fragments that were differentially amplified on the RNA fingerprints were cut and eluted by 
boiling. 2 \d of the eluted and diluted (10 times) DNA solution was re-amplified by 35 
cycles oftouchdown PCR using the original arbitrarily-chosen primers (section 3.3.3(ii)) and 
the products were visualized on a 1.5 % TAE Synergel. Lanes 1-6, 8-12 showed some 
homogeneous products after amplification while the rest (7, 13-16) illustrated products which 
were more heterogeneous. Most of these isolated fragments have size fell in the range of 
201-1018 bp. M=lKb ladder. 
138 
3.4.5 First round cDNA probe screening 
The re-amplified PCR products of each isolated band, despite their 
heterogeneity was dot-blotted in equal amounts onto 5 sets of membranes. Each set of 
the membranes was then hybridized with one type of the cDNA probes derived from 
the total RNAs of JCS cells treated with 10 jig/ml midazolam for 0, 1，5, 18 or 48 
hours (see section 3.3.4) (Figure 3.5). The hybridization signal of each dot was 
scanned and converted into numerical value by densitometer and the affiliated 
software (see section 3.3.4(iv)). The converted values were further normalized 
according to the control dot GAPDH. The slopes between values of the GAPDH dots 
were established and all other values were adjusted according to the slopes. The two 
membranes of each set were normalized separately with respect to individual control 
dot on the membranes. Referring to the normalized value, fragments that have 
corresponding PCR products showing a change in hybridization signals of 2 folds or 
more than 2 folds across the time points were subjected to further analysis. Table 3.3 
i 
i showed all the selected PCR fragments. The expression profile as presumed from the 
i 
.i 
I normalized values of the selected fragments can be summarized into 3 types (Figure 
3.6). Ofthe 10 fragments examined, one fragment was found to have slight transient 
up-regulation at 1 hour followed by down-regulation (A). Six of them were found 
down-regulated at the time point 18 hours (B). Finally, three of them were steadily 
up-regulated throughout the treatment (C). 
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Figure 3.5. First round cDNA probe screening. 142 differentially amplified bands on the 
RAP-PCR gels were recovered and re-amplified. The re-amplified products and control 
GAPDH fragment (for normalization) were dotted in equal amounts onto 5 sets of 
membranes. ^^P- labeled cDNA probes derived from total RNAs of midazolam-induced JCS 
cells of different time points as indicated were each hybridized with one of the membrane 
sets for 18 hours at 68 °C. The hybridization signals were visualized by autoradiography (12 
hour exposure at room temperature) and analyzed by densitometric scanning (section 3.3.4 
(iv), Table 3.3). 
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Table 3.3. Hybridization signals in numerical values resulted from the first round 
cDNA probe screening 
Fragment Volume = IODXarea(mm2)j Expected 
expression 
pattern * 
Time point (hours) 
Raw data Normalized data 
0 1 5 18 48 0 1 5 18 48 
GAPDH (1) 25.28# 27.5Q# 26.54 25.77 29.54 25.28 25.28 25.28 25.28 25.28 -
44/3 8.57 13.49# 7.32 1.33 1.84 8.57 12.40^ 7.00 1.30 1.57 A 
147/1 10.19 12.00 11.45 1.96 5.83 10.19 11.03 10.90 1.93 5.00 B 
240/3 13.19 14.61 13.80 3.54 8.20 13.19 13.43 13.14 3.47 7.02 B 
172/2 9.16 17.22 12.52 4.72 7.84 9.16 15.83 11.93 4.63 5.71 A 
172/3 10.40 15.49 12.85 4.84 9.37 10.40 14.24 12.24 4.75 8.02 B 
172/4 11.30 14.68 13.77 2.97 7.36 11.30 13.50 13.11 2.91 6.30 B 
172/5 10.00 14.53 13.76 3.31 7.07 10.00 13.36 13.11 3.25 6.05 B 
GAPDH (2) 30.51 29.04 24.08 19.55 29.13 19.55 19.55 19.55 19.55 19.55 -
230/5 12.24 12.58 13.86 13.95 25.07 7.84 8.47 11.26 13.95 16.83 C 
228/2 13.64 18.19 13.99 13.89 21.39 8.74 12.25 11.36 13.89 14.35 C 




I Hybridization signal of each dot from the first round screening was scanned and converted into 
j numerical values which was then normalized according to the value of the control dot GAPDH (see also 
text). GAPDH (1) and GAPDH (2) corresponds to control dots on 2 different membranes. Fragments 
selected for further analysis were presented here. cDNA probes were made from total RNA of the JCS 
cells having been incubated with midazolam (10 ^ig/ml) for 0, 1，5, 18 or 48 hours. 
* Expression pattem A : Slight transient up-regulation at 1 hour followed by down-regulation. B : 
Constitutive expression at early hours followed by down-regulation at the time point 18 hours. C : 
Steady up-regulation during the midazolam-induced differentiation, see also Figure 3.6. 
# Illustration of value adjustment : The normalized data 12.40 was calculated by multiplying the raw 
data 13.49 to the slope of the raw GAPDH dot value for 0 hour against that for 1 hour. (25.28/27.50) 
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Figure 3.6. Expression patterns of the selected gene fragments deduced from the first 
round cDNA probe screening in midazolam-treated JCS cells. Three major expression 
patterns of the isolated differentially amplified fragments were observed. A. Slight up-
regulation at a 1 hour followed by dramatic down-regulation starting at the 5th hour. B. 
Constitutive expression at early hours followed by down-regulation at the time point 18. C. 
Steady up-regulation during the incubation. 
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3 A 6 Subcloning of the differentially amplified fragments 
The differentially amplified gene fragments (Table 3.3) were subcloned into 
the pBluescript SK- vector using the corresponding re-amplified products (see section 
3.3.5). Ten randomly picked white colonies labeled as clone .1 to .10 from 
LB+Amp^ plates were lysed in sterilized H2O. The lysates were used as templates 
for standard PCR using the original arbitrarily-chosen primers (see section 3.3.5 (vi)). 
All the colonies were confirmed to have inserts and examples were shown in Figure 
3.7. However, the ten 'clones' resulted from the same preparation of subcloning and 
transformation may have inserts of the same size (Figure 3.7, 44/3), slightly different 
sizes (Figure 3.7, 228/5 and 147/1) or very different sizes (Figure 3.7, 230/5) on gel 
analysis. Clones that appeared to have different sizes were considered unique and 
treated individually. Each of these fragments were re-amplified by touchdown PCR 
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Figure 3.7. Subcloning of the differentially amplified gene fragments and confirmation 
by 50 cycles of PCR. 10 randomly chosen white colonies on LB+Amp • + IPTG + X-gal 
plate (section 3.3.5(vi)) were picked and lysed in double distilled water as described in 
methods. 10 ^1 of the lysate was used as template for 50 cycles of PCR and the products 
were analyzed on a 1.5 % TAE Synergel. Different colonies ( 'clones') may have 
recombinant plasmids harboring inserts of the same size (44/3 series), slightly different sizes 
(228/5 and 147/1 series) or entirely different sizes (230/5 series). M=lKb ladder. 
！ 
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3.4.7 Second round cDNA probe screening 
The dot-blotted PCR products corresponding to the subcloned fragments were �<^  
hybridized by P-labeled cDNA probes as in the first round screening (Figure 3.8). In 
contrast to the previous one, each dot of signal was resulted from a single 
homogenous DNA fragment in this screening. As before, the signals were presented 
in numerical terms, normalized with reference to the ‘control dot’ GAPDH (Table 
3.4). Subcloned fragments with PCR products showing significant changes (2-fold) in 
hybridization signals across the time points were further characterized. The 
expression patterns of these subcloned fragments were also analyzed based on the 
normalized value of the hybridization signal. Four patterns were observed (Figure 3.9 
and Table 3.4) A. Constitutive expression at early hours of midazolam treatment but 
the level down-regulated starting at the 5th hour (8 fragments). B. Steady down-
regulation (3 fragments). C. Transient up-regulation at 1 hour (2 fragments) and D. 
Steady up-regulation (4 fragments). The expression patterns for uninterpretable dots 


























































































































































































































































































































































































































































































































































































































































































































Table 3.4. Hybridization signals in numerical values resulted from the second cDNA 
probe screening. 
^ u b c I o n e d Volume = [OD X area (mm�)] Expected 
fragment expression 
pattern * 
Time point (hours) 
Raw data Normalized data 
0 1 5 18 48 0 1 5 18 48 
GAPDH 24.11 25.34 28.40 27.27 31.85 24.11 24.11 24.11 24.11 24.11 -
44/3.1 14.35 12.97 9.70 7.44 10.38 14.35 12.35 8.24 6.58 7.86 A 
147/1.4 14.91 18.72 11.99 20.64 33.32 14.91 17.82 10.18 18.26 25.23 D 
147/1.5 6.04 3.88 1.88 2.06 3.35 6.04 3.69 1.60 1.83 2.53 B 
147/1.6 1.05 1.04 0.62 0.02 2.31 1.05 0.99 0.52 0.02 1.75 B 
172/2.8 4.05 8.58 1.86 1.53 5.30 4.05 8.16 1.58 1.35 4.02 C 
172/3.1 3.37 5.81 1.15 1.43 2.68 3.37 5.53 0.98 1.26 2.03 A 
172/3.2 5.01 6.93 2.09 1.95 4.16 5.01 6.60 1.77 1.73 3.15 A 
172/3.8 4.81 8.44 2.33 1.30 4.15 4.81 8.04 1.98 1.15 3.15 C 
172/4.1 2.66 2.87 1.18 0.74 1.54 2.66 2.73 1.00 0.65 1.17 A 
172/4.6 4.07 7.17 1.81 1.54 3.05 4.07 6.83 1.54 1.36 2.31 A 
172/5.2 2.59 3.85 1.39 0.84 1.22 2.59 3.66 1.18 0.75 0.93 A 
172/5.6 3.60 4.39 1.60 1.18 2.33 3.60 4.17 1.36 1.04 1.76 A 
172/5.8 5.61 8.48 1.48 2.08 3.92 5.61 8.07 1.26 1.84 2.30 A 
228/5.1 32.98 33.87 44.09 54.44 74.53 32.98 32.23 37.43 48.14 56.43 D 
228/5.2 28.23 17.47 17.37 - - 28.23 16.62 14.74 - - D 
228/5.3 - - 3.80 6.60 6.95 - - 3.23 5.83 5.26 D 
228/5.6 - - 6.54 8.69 10.69 - - 5.55 7.69 8.09 D 
Dots on autoradiograph were scanned and quantitized in terms of Volume by Molecular Analyst 
software (Bio-Rad). These values were then adjusted according to the normalized value of the 'control 
dot，GAPDH. Only fragments that were subjected to further characterization are shown. '- ' indicated 
dots that were uninterpretable due to signal masking by the neighboring dots. Expression pattem A : 
Constitutive expression at early hours of midazolam treatment but the level down-regulated at the 5th 
hour. B : Steady down-regulation. C. Transient up-regulation at 1 hour. D. Steady up-regulation. * see 
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Figure 3 .9 : Expression patterns of the subcloned fragments predicted f rom the second 
round cDNA probe screening. Four patterns were shown. A. Constitutive expression at 
early hours of midazolam treatment but down-regulated at the time point 5. B. Steady down-
regulation. C Transient up-regulation at 1 hour. D. Steady up-regulation. 
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3.4.8 A comparison of the first and second screening 
The expression patterns of the subcloned fragments predicted from the 
hybridization signals of the second screening can be traced approximately in the first 
screening. Some subcloned fragments like 172/2.8 and 228/5.1, 5.2, 5.3 and 5.6 
showed exactly the same pattem of change in expression as their parent fragment 
172/2 and 228/5 respectively (Table 3.5). Most of the subcloned fragment also 
followed the general trend of changes as their parent fragments (either being up-
regulated or down-regulated) but variations occur at certain time points or in the 
degree of changes. However, there was also one subcloned fragment 147/1.4 which 
deviated completely from its parent fragment in expression (Table 3.5). Subcloning 






Table 3.5. Expression profiles o f the isolated fragments predicted from the 
hybridization signals o f the 1st and the 2nd round screening. 
Fragment Predicted expression pattern Independent Predicted expression pattern of 
before subcloning in the first subcloned the subcloned fragment in the 
screening fragments * second screening 
^ ^ii^^Tup-regulation at 1 hour 44/3.1 Down-regulation starting at 5 
followed by down-reguation hour 
starting at 5 hour 
147/1 Dramatic down-regulation at 18 147/1.4** Steady up-regulation 
hour 
147/1.5 Steady down-regulation 
147/1.6 
172/2 Slight up-regulation at 1 hour 172/2.8 Slight up-regulation at 1 hour 
followed by down- reguation followed by downreguation 
starting at 5 hour starting at 5 hour 
172/3 Dramatic down-regulation at 18 172/3.1 Down-regulation starting at 5 
hour 172/3.2 hour 
172/3.8 Transient up-regulation at 1 hour 
followed by subsequent down-
regulation 
172/4 Dramatic down-regulation at 18 172/4.1 Down-regulation starting at 5 
hour 172/4.6 hour 
172/5 Dramatic down-regulation at 18 172/5.2 Down-regulation starting at 5 
hour 172/5.6 hour 
172/5.8 




228/2 Steady up-regulation Failure in subcloning procedure 
230/5 Steady up-regulation Failure in subcloning procedure 
240/3 Dramatic down-regulation at 18 Failure in subcloning procedure 
hour 
* subcloned fragments derived from fragments in column 1 
** subcloned fragments showing opposite expression pattem from their parent fragment. 
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3.5 Discussion 
3.5.1 Towards the steps to isolate differentially expressed genes 
RAP-PCR 
Reproducibility ofthe RNA fingerprints has been questioned in many reports 
and it was found that even slight differences in concentration and quality ofthe same 
samples may result in different patterns of fingerprint (Sompayrac et al, 1995; Welsh 
et al, 1992; McClelland et al, 1995). In the current investigation, it was found that 
two batches of total RNA from untreated JCS cells generated different patterns of 
polymorphic bands (Figure 3.3). This difference in banding patterns reflected that the 
method is highly sensitive to small variations among individual preparation. This 
explained partially why false positives were almost unavoidable. To minimize 
confusion, we stuck to the same batch of total RNA samples throughout the study. 
Each lane of fingerprint generated was composed of bands both of high 
intensities and low intensities. Although the more abundant species ofcDNAs may be 
amplified more frequently than the relative rare species, there were far more factors 
that would affect the amplification efficiencies of different species of cDNAs (even in 
the same tube), for instance, the sequence of the cDNA and length of the amplified 
sequence. Thus, no meaningful relationships between the intensities of bands and the 
original template concentration can be established within the same lane of fingerprint 
(McClelland et al, 1995). Conversely, the relative concentration of the same template 
cDNA among different samples could be correlated roughly with the band intensities 
on the gel (McClelland and Welsh, 1994). In fact, this semi-quantitative nature 
constitutes the basics of isolating differentially expressed genes on RAP-PCR gel. 
Primers of different sequences but of similar size (19-24 mers) gave different patterns 
ofbands including slightly different size range and different number ofbandings. The 
size, number and the specificity of polymorphic bands were also affected by other 
factors like MgCl2, dNTPs and primer concentration (Guimaraes et al, 1995), the 
kind of enzyme used (Haag and Raman, 1994) and the annealing temperature. Some 
1 authors have tried to optimize these conditions. 4 mM MgCl2 was found optimum in 
I . 
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the first strand cDNA synthesis (Welsh et al, 1992) while 2 ^M each dNTP improved 
the specificity during amplification (Liang and Pardee, 1992). M-MLV RNase H" RT 
(reverse transcriptase) used in the first strand cDNA was also superior to AMV RT in 
generating highly reproducible bands (Shoham et al, 1996) (see also Table 3.6 for 
comparsion of these parameters of our method with others). With regard to the use of 
1.5 % Synergel in displaying the fingerprints, it appears that we enhance the speed and 
ease of the method at the expense of resolving power. However, our choice was 
justified. Using the current protocol, about 10 or more observable bands were 
generated. This number of polymorphic fragment was comparable to that using 
polyacrylmide gel (Hadman et al, 1995; Welsh et al, 1992; Wong and McClelland, 
1994, see also Table 3.6). Although more co-migrating products were expected in our 
case, the problem cannot be completely solved even with gels of higher resolving 
power. Besides, fairly successful examples in isolating differentially expressed 
fragments by using 2 % or 4 % agarose (having similar resolving power of 1.5 % 
Synergel) have been demonstrated (Hsu et al, 1993; Sokolov and Prockop, 1994). 
Re-ampliflcation 
A rather simple procedure of DNA elution from the gel slices was adopted in 
our protocols. By boiling each gel slice (usually within 50 i^l in volume) in 450 i^l 
sterilized H2O, the gel was melted and the DNA was released and diluted to about 10-
fold; gel debris could be effectively removed by simple centrifugation. Different from 
some other protocol, we did not ethanol-precipiated the eluted DNA. Thus, to keep 
any potential inhibitors for further reactions (from the gel or previous reactions) to a 
minimum, dilution of templates is a ‘must’ for re-amplification. Using high 
concentration of the eluted DNA as template has proved to affect PCR leading to low 
yield of products (unpublished observation). Also, the eluted DNA cannot be kept for 
too long though eluted DNA stored for one week at -20 °C was still suitable for use. 
In an effort to get rid of possible non-specific contaminiated products, touchdown 
protocol was followed in re-amplification of isolated bands. The current thermal 
profile described in methods has been proved successful in eliminating non-specific 
products in normal PCR in our laboratory. Nevertheless, in the course of re-
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amplification, several problems or observations were still encountered by us and 
others. Namely, some fragments (especially fragments > 1Kb) were unable to be re-
amplified. This was also observed in Sokolov and Prockop (1994) and mentioned in 
Wong and McClelland (1994). Occasionally, single eluted fragments gave multiple 
bands after re-amplification as also seen in Sokolov and Prockop (1994). Besides, 
with the number of re-amplification increased, some contaminated bands close in size 
to the desired band became prominent. 
cDNA probe screening 
The strategy of screening a large number of isolated gene fragments recovered 
from RAP-PCR (or differential display) simultaneously by cDNA probes derived from 
RNA samples being compared has been termed by some authors as ‘reverse northern 
blot, (Mou et al, 1994; reviewed in Liang and Pardee, 1995; Livesey and Hunt, 
1996). The principle of such procedure was to make DNA fragments dot-blotted (or 
slot-blotted) in equal amounts onto membranes in several identical copies. Each copy 
was then hybridized with cDNA probes generated from samples being compared. 
Since the same DNA fragments on each copy of membrane was indentical in amount 
and in excess (relative to the amount of the same sequence present in the probes), any 
difference in hybridization signal of the same dot on different copies of membranes 
should be due to the relative amount of that sequence present in the different probes 
and in tum in the original RNA samples. The meaning ‘reverse，can be easily seen 
from the ‘exchange, in position of the probes and the sequence to be probed with 
reference to the normal northern blot procedure. In addition, there were other 
differences between the procedures. In northern blot, different samples are hybridized 
in the same reaction under the same condition. In contrast, 'reverse northem blot, 
must be done in separate reactions and it is crucial to keep each separate reaction to 
have same hybridization conditions and the probes must also be normalized before 
used. Besides, the probes used in northem blots are single defined sequences. All the 
hybridizaiton signals should be due to that sequence only. On the other hand, the 
probes used in our screening procedures are heterogeneous. How the complexity of 
probes would affect the hybridization procedure is not readily foreseeable. 
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Nevertheless, our procedures are powerful in tackling a large amount of fragments 
concurrently without using excessive amount ofRNA. 
As mentioned earlier, re-amplification may produce some undesirable or 
spurious bands either due to contamination with some co-migrating species in the gel 
or some unknown reasons. Instead of undergoing further purification, these 
heterogeneous reamplifed PCR products were blotted onto the membrane and screen 
altogether. Since the products of the desired band usually remained dominant, 
hybridization signal in the screening should largely reflect the expression level ofthe 
band interested. Even if no dominant bands emerged, we were still interested in 
knowing the expression level of these products among the different samples. 
However, the first screening of those heterogenous products would render 
meaningless without the subcloning procedures and the second screening. Here, the 
subcloning procedures were not only important for further characterization of the 
fragment but also necessary as a kind of purification. The same PCR products used in 
the first screening, either apparently homogenous or heterogeneous, were used as the 
starting material for subcloning procedures. Despite the heterogeneity in a particular 
tube of PCR products, each bacterial clone contained only one type of recombinant 
plasmid harboring only one species of the fragments. Thus, PCR products derived 
from these plasmids or the corresponding bacterial lysate should be uniform and pure 
(Figure 3.7). Among the fragments cloned, most of them corresponded to the starting 
material. Ifthe PCR products were pure enough, most of the cloned fragments would 
be equivalent having the same size (Figure 3.7, 44/3.1 series). On the contrary, if the 
input re-amplified PCR products were heterogeneous, the cloned fragments would 
have different sizes (Figure 3.7, 230/5.3 series). In addition, there may be some 
recombinant plasmids containing unrelated sequences generated somehow in the 
subcloning procedures in both cases. Thus, to encompass all the DNA species present 
or more importantly to isolate the species that were responsible for the differential 
signals among different samples during the first screening, enough bacterial colonies 
must be picked. Of course, the actual number of recombinant clones that should be 
picked were justified with the time and effort required. No matter how many clones 
that we picked, we were never completely sure if all the fragments present on the 
interested dots selected in the first screening were included. As a result, a second 
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screening was introduced aiming at discerning fragments which still showed 
differential expression among different time point of treated JCS cell sample. Since 
the PCR fragments on the blot were relatively pure in the second screen, the 
hybridization signal should more truly represent the expression profile of the 
fragments. In some cases, the expression profile of some fragments predicted in the 
second screening can be traced in the first screening. However, even if we failed to 
establish a relationship between the two screenings, the results of the second screening 
can still be interpreted independently. Two screening procedures were not redundant 
although they required the same techniques. The first screening was designed mainly 
to eliminate 'false-positives' generated by RAP-PCR while the second screening was 
set to remove those contaminiated and/or co-migrating bands on the RAP-PCR gel 
and spurious bands produced during the subcloning steps. Only the most robust 
fragments 'surviving' two rounds of screening would be further characterized. In 
spite of the rationale behind, one may argue that such method may overlook certain 
differentially expressed fragments. As we aimed at a large scale production of 
differentially amplified bands observable on RAP-PCR gels finally, it is more 
beneficial and practical to design a screening system that are reasonably strict that 
favored no 'false-in' elements (though'false-out' may occur). As a matter of fact, the 
‘false-out, problem commonly exists in other methods for seeking differentially 
expressed genes (e.g. differential screening and subtractive hybridization). 
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3.5.2 Expression profile predicted at different stages of the procedure 
Almost all kinds of expression pattern possible for the isolated bands (genes) 
as predicted from the gels of RAP-PCR were shown. Expression only at early hours 
typical of some transcription factors (e.g. c-myc), steady and gradual up-regulation or 
down-regulation resembling some integrin genes (e.g. CD1 lc) and biphasic regulation 
like SCL gene were observed (Murrell et al, 1995; Noti and Reinemann, 1995). 
There were also some differentially amplified bands that occurred at only one 
particular time point (see Figure 3.3 for examples). In view of false positives and 
non-reproducible bands on RAP-PCR gels, the true expression patterns of these 
isolated bands (genes) need further elucidation. 
After the first screening, the expression patterns of the potential fragments 
(genes) that may have differential expression during midazolam-induced 
differentiation were narrowed down into three types (Figure 3.6). Expression profile 
type A and type B described a dramatic decrease in hybridization signal at 5 and 18 
hour respectively while expression profile type C depicted a relatively gradual and 
moderate up-regulation. Fragments (genes) showing expression at only one particular 
time point were not observed in this screening. This intense decrease in the types of 
expected expression profile of the fragments (genes) further stressed that a high 
proportion offalse positives and/or non-reproducible bands were generated during the 
RAP-PCR procedure. 
In the second screening more expression patterns (four) were found. (Figure 
3.9). While two described down-regulation, two illustrated up-regulation. On close 
examination, the expression pattem of individual subcloned fragments (genes) on the 
second screening can be traced in the first screening (Table 3.5). However, variations 
in the degree of change and hybridization signal at a certain time point were observed. 
Such differences can be accounted for, by the fact that subcloned fragments were 
purer (in terms of no. of DNA species) than their parent fragment (re-amplified 
products). Hybridization signal from each dot in the first screening could have been 
contributed by several different DNA sequences showing the same type of expression 
profiles. This was exemplified by the independent subcloned fragment derived from 
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the same parent fragment (re-amplified products) 172/4，172/5 and 228/5 (Table 3.5). 
Conversely, there were parent re-amplified products composed of DNA species 
having different or even opposite expression profiles like that shown by 147/1.4, 1.5 
and 1.6 (Table 3.5). This demonstrated the heterogeneity of the original re-amplified 
products studied in the first screening. Besides the purity of the fragments under 
investigation, the variation in probe preparation and method of data processing may 
also affect the relative final hybridization value (volume) of different time points. As 
mentioned, the cDNA probes used were very complex. Although every effort was 
made to keep the preparation of probes of different time points as similar as possible, 
it is conceivable that small variations of each step in the multi-step procedure would 
accumulate. In addition, the adjustment ofhybridization values ofeach dot (according 
to the slopes between ‘GAPDH, dots on membranes of different time point) (Table 
3.3, 3.4) may not be appropriate as the signal response of the X-ray film was not 
linear, especially for the highest exposure (Wygant and Nelson, 1995). 
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3.5.3 Representation of the total mRNA in the cell 
It was suggested that most of the mRNAs are represented as one band in RAP-
PCR. In this report, each lane of fingerprint had 1-12 bands and most of the 
fingerprints gave 6-9 bands per lane. Thus, each lane of fingerprint generated by a 
single primer represented 6-9 messages. In a typical eukaryotic cell, there is 
approximately 1 pg of mRNA equivalent to about 10^  molecules, transcribed from 
about 15,000 different genes (i.e. a total complexity of 15,000) (reviewed in Sargent, 
1987). If each of the single primer in our experiment produced 9 bands and a total of 
44 primers were used, 396 messages were produced. That is, 396/15,000 X 100% = 
2.64 % ofthe total messages were represented. Without considering the abundance of 
a particular message in the total mRNA, we calculate the probability of missing a 
message P(0) 二 e"^ . To detect a particular message with 95% chance i.e. P(0)= 0.05 
without taking into consideration the abundance of the message in the total mRNA, i^ 
would be equal to 3. That means the number of bands that is three times of the total 
complexity (15,000 X 3) must be obtained. If on average 9 bands/messages could be 
sampled per single primer, the whole complexity of the cell could be represented 
using (15,000/9) X 3 = 5000 primers at a 95 % confidence level. If 4 sets of RAP-
PCR reaction each using one primer could be displayed in a gel, a total of 1250 gels 
would be needed (McClelland and Welsh, 1994). 
This calculation illustrated that it is almost impossible to obtain a particular 
message, especially that of the rare species, if our sampling is as low as less than 3% 
of the total message. However, it is expected that many genes are involved in the 




3.5.4 Comparison of the original and modified protocol of RAP-PCR 
As an evaluation of our methods, we compare our protocol with the original 
protocol first devised by Welsh et al (1992). The two protocols are the same in 
principle although there are some variations (Table 3.6). 
Total RNA was found sufficient in general for RAP-PCR and used in both 
methods as starting materials. Total cellular RNA and poly(A)^ RNA used with 
anchored oligo-dT primers generated essentially the same banding pattem in 
differential display (Liang et al, 1993). Thus, different from the protocol used in 
Welsh et al (1992), we tried using oligo-dT primers ranging from 12-18 bases instead 
of arbitrarily-chosen primers (20-mers) to make the first strand cDNA. Using 
arbritrary primers in the first strand cDNA synthesis had a potential problem that the 
more abundant rRNAs or even the tRNAs may be amplified. Although most of these 
RNAs are not generally differentially expressed (Wong and McClelland, 1994) 
affecting the interpretations of the fingerprints, a prior selection of mRNAs by oligo-
dT would diminish these abundant sequences from competing for primers and 
substrates with the messenger sequence. On the other hand, using arbritrary primers 
for the first strand cDNA synthesis increases the chance of obtaining product sequence 
away from the 3'end untranslated region. In the second strand cDNA synthesis and 
subsequent amplification, arbitrarily-chosen primers (about 20 bases) were used in 
both cases. During the amplification, however, one long low stringency cycle (each 
step lasting for 5 minutes) was used in the original protocol instead of 5 normal length 
(each step lasting for 1 minute) low stingency cycles in our methods. A total of 30 or 
40 (in later protocol by the same authors) of high stringency cycles were performed in 
the orginial protocol but 45 high stringency cycles were done in ours. Using our 
protocol, the number of low stringency cycles (from 2-10) did not alter the pattem of 
fingerprints significantly (unpublished observation) and the mean number 5 was taken 
to secure sufficient priming. Alternatively, extended period of each amplification step 
as described in Welsh et al (1992) for a lower number of cycle(s) can be used. The 
fragments generated during the low stingency cycle(s) were further fixed by 
subsequent high stringency cycles. Increasing the number of high stringency cycle in 
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this report was necessary to compensate for the relatively low sensitivity of ethidium 
bromide staining. However, this increase did not seem to affect the identification of 
differentially amplified fragments across the samples. As explained previously in 
McClelland et al. (1995), the ratio ofstarting materials between samples is maintained 
even the cycle number is sufficient to lead the amplification to the plateau phase. 
By comparing some statistics of the fingerprints, appreciable differences were 
found between the two protocols. On a high resolution 4-6 % polyacrylamide gel in 
the original protocol, the number of resolved bands were 2-4 fold more than what we 
could be obtained in the Synergel per fingerprint (Table 3.6). Nevertheless, the sizes 
of the polymorphic bands that could be generated and resolved in Synergel were 
significantly larger (about 2 to 3 -fold) than those observed in Welsh et al. (1992) 
(Table 3.6). Such observations in the fingerprints could be explained by the 
amplification reacion itself. Since our method have selected for mRNAs during 1st 
strand cDNA synthesis, non-mRNAs sequence amplification should be mininimized 
and less bandings may thus be produced. In addition, the relatively more efficiently 
amplified small bands (a few hundred base pairs) may be able to give way to the 
longer sequence (larger than 1Kb) under our conditions. The resolution and the size 
range that the gel could resolve may also contribute to the explanation. 4-6 % 
polyacrylmide gel is optimized for fragment size below � 6 0 0 bp while 1.5 % Synergel 
are suitable for fragments of �0.1-5K bp. Thus, larger fragments may not be easily 
recognized in the polyacrylamide gel. On the other hand, the resolving power of 1.5 
% Synergel was much lower, bands of very similar size (within a few tenths of base 
pairs) might not be readily separated and gave an apparently less number offragments 
in the fingerprints. Our method has also abandoned the use of radioactive label in 
visualizing the polymorphic bands but relied on ethidium bromide staining. Boiling 
the gel pieces for 5 minutes was also found sufficient for Synergel despite the long 
elution period employed in the original protocol for polyacrymide gel (see Table 3.6 
for details). Since the polymorphic bands across the different samples could be 
identified immediately under UV excitation (without the need of developing 
autoradiographs) and recovered easily, our method saved time and reduced potential 
hazard. 
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In avoiding false positives, different strategies were employed. In Welsh et al 
(1992), efforts were made to prevent false positives caused by intra-sample variations. 
In our protocol, two rounds of cDNA probe screening or known by others as 'reverse 
northern blotting, (Mou et al, 1994; reviewed in Liang and Pardee, 1995; Livesey and 









Table 3.6. A comparison ofthe original RAP-PCR protocol and our method. 
~ ~ ~ ~ ~ ~ ~ ~ i ^ I ? ^ T 7 ^ S 1 7 Z (1992) RAP-PCR in this report 
l i ^ S i i i ^ i e 7 i S s f o t a f m A ™ ^ Total RNA 
Primers in 1st strand cDNA One arbitrarily-chosen primer Oligo dT 
synthesis 
MgCl2 concentration in 1st 4 mM 3 mM 
strand cDNA synthesis 
Reverse transcriptase M-MLV (Strategene) M-MLV(GIBCO) 
Primers in 2nd strand One arbitrarily-chosen primer (same as One arbitrarily-chosen primer 
cDNA synthesis the one in 1 st cDNA synthesis) 
dNTPs concentration in 2nd 50 ^M each dNTP 200 ^M each dNTP 
cDNA synthesis 
Length ofprimers 20 bases 19-24 bases 
Amplification enzyme AmpliTaq, Cetus Thermoprime" DNA polymerase, AB 
Low stringency cycle One cycle, each step for 5 minutes Five cycles, each step for 1 minute 
High stringency cycle 30 cycles (denaturation, primer 45 cycles (each step for 1 minute) 
annealing for 1 minute, extension for 2 
minutes) 
Fragment size fractionation 4 % - 6 % TBE polyacrylamide gel 1.5 % TAE synergel 
Visualization of a- [ '^] -dCTP label Ethidium bromide staining 
polymorphism 
Isolation of diffemtially Gel pieces eluted at room temperature Gel pieces boiled in 450 i^l ofH2O for 5 
amplified PCR product for 1 hr into 50 i^l ofTE minutes 
No. ofresolved bands per 10-20 (Welsh et al., 1992) 1-12 
fingerprint 10-40 (Perucho et al., 1995) 
10-50 (Welsh etal., 1995) 
Size distribution ofthe -200-600 -200-2000 
resolved bands -50-1000 (McClelland and Welsh, 
1994) 
Strategies to reduce the Comparing polymorphic bands Two rounds of cDNA probes screening 
occurrence of false positives generated from different concentrations 
ofthe same sample Re-amplification by touchdown PCR to 
remove false positives caused by 
Single low stringency cycle to prevent infrequent imperfect primer annealing 
genomic DNA contamination 
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3.5.5 Advantages ofthe modified protocol and further refmements 
As a summary of what we have discussed in previous sections, several strong 
ideas ofour procedures are highlighted here. One of the most powerful refmements in 
our protocol was to adopt two rounds of cDNA probe screening (or reverse northern 
blotting). The strategy allowed a preliminary estimation of expression ofthe isolated 
fragments and should eliminate a large number of 'false positives' and fragments 
having no detectable expression, especially in the first round screening. The second 
round screening further took away unrelated sequence introduced in the subcloning 
procedures. The importance of performing selection proceudure after subcloning was 
also noted by others (Callard et al, 1994; Zhao et al, 1996). Different from our 
procedures, they used the PCR fragments before subcloning to probe the recombinant 
plasmids obtained from several independent clones. Another important improvement 
of this method was that we selected also those co-migrating or contaminating bands 
instead of avoiding them. The reasons is obvious. First, it is practically difficult to 
remove or separate these bands completely. Second, for co-migrating species, it is 
unable to tell which DNA species within 'one' band are responsible for the change in 
band intensities across the time points. Thus, it is certainly ‘safer’ to include all 
possible fragments. However, such strategies would not be a success without an 
effective (quick and easy to perform) selection system that could deal with enormous 
amount of fragments at the same time. The use of primers in our method also 
deviated from a typical RAP-PCR protocol. With the use of oligo-dT primers in the 
first strand cDNA synthesis, we avoided sequences other than messenger RNA. At 
the same time, we would not miss out sequence outside 3'end region completely 
having the use of arbitrary primers in the second strand cDNA synthesis (Haag and 
Raman, 1994). The use of radioactive labels have been minimized in our methods and 
high-voltage polyacrylmide gel were replaced with easily prepared 1.5 % Synergel. 
Our system represented a safer, quicker and simpler method. 
The current protocol and selection system are not intended for isolating all the 
mRNA species (section 3.5.3) or picking a certain sequence but are good for seeking a 
group of sequence fragments that are differentially expressed among the samples 
163 
being studied. RAP-PCR has been said to under-represent the rare mRNA species 
(McClelland and Welsh, 1994). Thus, it is also important to know if the fragments 
isolated from our procedures and screening systems came from the rare population. 
Also, it may be beneficial to optimize the conditions for the first strand cDNA 
synthesis and RAP-PCR. Efforts have been made to optimize conditions like MgCl2 
concentration in the first strand cDNA synthesis (Welsh et al, 1992)，MgCl2 
concentration relative to dNTPs concentration (Bauer et al, 1993), dNTPs 
concentration (Guimaraes et al, 1995), types and sequences of the primers (Bauer et 
al, 1993; Haag and Raman, 1994; Zhao et al, 1995), brands or batches of reverse 
transcriptase and thermal enzymes (Haag and Raman, 1994), temperature and time for 
primer annealing (Bauer et al, 1993; Zhao et al, 1995). It seemed that it became 
absolutely necessary to optimize conditions for the production of robust and 
reproducible bands on the RAP-PCR gel after we have employed the cDNA probe 
screening system. Nevertheless, optimized conditions allowed the maxmium 
utilization of each components in the reaction and increased the representation of 
mRNA species (bands) in the cell per primer used (section 3.5.3). As a result, the 
chance of obtaining differentially expressed genes, especially those belonging to the 
rare species would be enhanced. 
In conclusion, to make our current system a success, it is important to generate 
enough amount of polymorphic fragments during the step of RAP-PCR. Besides, 
reducing the times of reampification may be helpful. With a good planning and 
estimation ofthe experiment, enough PCR products can be amplified at one time for 
both subcloning and selection procedures. Keeping the conditions the same for probe 
preparation from different samples is also very crucial. Finally, it is necessary to 
mention that the selection system using cDNA made from total RNA of different 
samples cannot be a final proof of the expression profile of the fragments under 
investigation (and their corresponding genes) because of the heterogeneity of the 
probes and the complex hybridization kinetics. Further characterizations of the 
isolated fragments after the two round screening are indispensable. 
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Chapter Four Characterization of the Putative 
Differentially Expressed Genes in 
Midazolam-induced JCS Cells 
4.1 Introduction 
Two types of characterization are essential for the cloned and selected gene 
fragments obtained as described in the last Chapter. One of these is to determine 
whether the gene fragments belonged to a known or a novel gene. This can be 
accomplished by sequencing followed by homology search against the Genbank. 
More importantly, it is necessary to prove (or to confirm) the isolated gene fragments 
are indeed differentially expressed during the midazolam-induced JCS cell 
differentiation. Several strategies can be employed for confirmation and RT-PCR 
represents one of the most convenient and sensitive methods. 
4.1.1 DNA sequencing 
Sequencing of nucleic acid can be traced back to 1960s after the double-helix 
structure of DNA was discovered in 1953. The major work before 1965 was 
concentrated on small and relatively available tRNAs. They are broken down into 
small pieces of a few nucleotides long and each of them was sequenced using 
chromatographic methods. The first sequence of an intact molecule was an 80-base 
yeast tRNA published in 1965 (reviewed in Chen, 1994). 
DNA sequencing was only possible after the discovery of restriction enzyme 
and DNA polymerase around 1970. In the mid-1970s, two independent DNA 
sequencing techniques were developed and increased greatly the rate of sequencing. 
One of them was the chain termination method invented by Sanger et al (1977). The 
method was successfully used to sequence the 16.5 kb human mitochondria genome in 
1981. Another one was the chemical degradation method developed by Maxam and 
Gilbert (1977). It was then successfully applied to the analysis of the 40kb T7 
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bacteriophage sequence. Since then, sequencing data have become more and more 
important in understanding the biological systems (reviewed in Chen, 1994). 
The chain termination method was also known as dideoxy sequencing. The 
DNA strand to be sequenced was first annealed by a primer, usually a synthetic 
oligonucleotide to make a complementary strand catalyzed by a DNA polymerase. 
The method employed the dideoxynucleotides, which lacks the hydroxyl group at the 
3’ position ofthe sugar residue, and thus terminates the elongation reaction. Since the 
modified nucleotides incorporate as efficient as the normal nucleotide into the 
growing strand, they can compete with the normal substrate in the DNA 
polymerization process. For each sequencing reaction, four independent DNA 
synthesis reactions are carried out in parallel, each containing a small amount ofeither 
dideoxyadenoside, dideoxycytoside, dideoxyguanoside or dideoxythymide. The 
random and low level incorporation of a specific dideoxynucleotide gives a mixture of 
DNA fragments of different lengths ending with the respective dideoxynucleotides. 
The reactions can then be chased out to longer fragments with increased 
concentrations of normal analogue to ensure all the fragments stopped at the specific 
dideoxynucleotide. The fragments can be visualized on a polyacrylmide gel by 
replacing one of the normal nucleotides with a radioactive-labeled counterpart in the 
reactions or by using an end-labeled primer. 
There are still several variations that one can follow for chain termination 
method. For instance, different DNA polymerases can be used like Klenow fragment 
of E. coli of DNA polymerase I, reverse transcriptase, bacteriophage T7 DNA 
polymerase without 3，to 5’ exonuclease activity (Sequenase and Sequenase version 
2.0) and thermostable DNA polymerase (e.g. Taq polymerase). Klenow fragment is 
only good for DNA within 250 bases while reverse transcriptase is only occasionally 
employed to resolve problems caused by homopolymeric A/T or G/C. Sequenase and 
thermal polymerase are more commonly used nowadays with good processivity and 
high rate of polymerization. For cycle sequencing, thermal enzyme is the only choice 
(Sambrook et al, 1989). 
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The template for sequencing can also be treated in several ways. The re-
amplified PCR products from RAP-PCR fragments can be cloned into phagemid 
vector to generate single-stranded DNA or into plasmid vector for double-stranded 
sequencing. Alternatively, the raw products can be directly sequenced or cycle_ 
sequenced. Single-stranded sequencing usually yield good result but double-stranded 
templates are more convenient and simple to prepare. Sequencing without cloning 
procedures needs additionally synthesized primers. Cycle sequencing needed 
considerably less amount of templates but additional purification steps to remove 
excess primers and dNTPs are necessary before the sequencing reaction can be 
performed (Sambrook et al., 1989). 
The chemical degradation method (Maxam and Gilbert, 1977), instead of 
synthesizing new DNA fragments, breaks down the terminally-labeled starting 
material into fragments. Special chemicals are added to four separate reaction 
mixtures so that the DNA molecules are cleaved preferentially at guanines, at 
adenines and guanines equally, at cytosines and thymines equally, and at cytosine 
alone. The reactions are done at limiting conditions and only one cleavage is made on 
each molecule on average. When the fragmented products are resolved by 
polyacrylmide gel electrophoresis, the length of the product will identify the positions 
of a particular base. Although the chain termination method is much quicker and 
easier to perform nowadays, the chemical method are still used by some scientists. 
The advantages of chemical method include (1) It is not affected by long runs ofthe 
same nucleotides like poly C. (2) Synthetic oligonucleotide can also be sequenced 
directly without cloning procedures. (3) It also allows studies like analyzing DNA 
modification e.g. methylation, examination of DNA secondary structure and 
proteiny'DNA interaction by chemical protection/modification interference 
experiments (Barker, 1989). 
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4.1.2 Automated DNA sequencing and analysis 
Automation 
The application of automation to DNA sequencing and analysis involves a 
tremendous range of techniques and strategies. The first software tools for 
interpreting DNA sequence data were developed in the late 1970s and early 1980s. 
Software for assembling sequence fragments into contigs began to appear in the mid-
1980s. Since 1985, several automated sequencers were developed with a view to 
automate gel electrophoresis, raw data acquisition, and base-calling (Smith et al, 
1986). Automated DNA sequencers based on fluorescence detection of 
electrophoretically separated fragments were available commercially in 1987 and in 
the same year the first gene determined by automated sequencing method was 
published (reviewed in Chen, 1994). Other aspects of automation have also been 
developed. Computer-operated robotics workstations and more sophisticated 
softwares have been applied to prepare sample, to handle the sequencing reactions and 
to assemble data (reviewed in Bankier, 1993; Hunkapiller et al, 1991). Commercial 
sequencing reaction robots with automated cycle sequencing was available in 1991 
and sample preparation robots were introduced in 1992 (reviewed in Chen, 1994). 
Integrated systems that carry out the entire DNA sequence analysis process without 
manual intervention are vigorously discussed and developed by several groups. 
Automated sequencers and their dye chemistry 
There are currently two different instrumental designs of automated 
sequencers. One of them utilizes densitometric film scanner digitizing images of 
sequence ladders from film or autoradiograms, exposed and developed after fixed 
periods of electrophoresis. The other systems employed fixed or scanning detectors 
which can monitor the electrophoretic transport of labeled fragments through the gel, 
giving digital signals of the sequencing ladders in real time. 
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According to the number of fluorescent dyes used, the commercially available 
automated sequencers can be classified into two types. The first type uses single-
label, four-lane separation and has 10 to 12 channel capacity (Brumbaugh et al, 1988) 
while the second type applies four-label, single lane separation, and currently has 36-
capacity per run (Connell et al, 1987). The commercial brand belonging to the first 
type include Pharmacia ALF, LI-COR 4000 and Millipore Basestation while ABI 
373A sequencer is classified as the second type. The fluorescent dye can also be 
labeled either at the primers (dye-primers) for four-tube reaction but single lane 
loading or at the terminators (dye-terminators) for single tube reaction and single 
loading (reviewed in Chen, 1994). 
Automated Laser Fluorescent (ALF) system 
The system generally utilizes chain termination method with the application of 
fluorescent label. Single type fluorescent label can be attached to the sequencing 
primer and excited by a laser beam. The laser beam of the ALF is directed through 
the gel across its width. The emitted fluorescence is collected by 40 fixed detectors 
(one per lane) near the bottom of the gel in real time as the fragments migrate during 
an electrophoresis. Simultaneous recording of ten sequences can be performed in 
about 6 hours (relative short compared to other systems) (Figure 4.1). Active 
temperature control of the gel is provided for a more consistent electrophoretic 
separation. The optical system of ALF is optimized for a single dye and the detection 
is relatively sensitive for all four lanes. Also, the labeling chemistry can be used with 
conventional automated DNA synthesis as well as chemical DNA sequencing. 
Lengthy purification is unnecessary even with crude labeled primers (Ansorge et al, 
1993; Hunkapiller et al, 1991). 
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Figure 4.1. Automatic Laser Fluorescent (ALF) system. A water thermostated 
polyacrylamide gel is used for fragment separation. A laser beam is projected across the 
entire width of the gel at a fixed distance from the top of the gel. As soon as fluorescently 
labeled fragments enter the beam, they become excited and emit fluorescent light that is 
continuously measured by the optical detector for each single lane. A maximum of ten 
sequence (4 lane per sequence) can be performed at one time. Off line evaluation allows 
automated sequence determination. (Reproduced from Ansorge et al, 1993) 
f 
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4.1.3 Genbank and BLAST homology search 
Genbank 
Genbank, a trademark ofthe U.S. Department ofHealth and Human Services, 
is a comprehensive repository of sequence data and associated annotation sponsored 
by the U.S. National Institutes ofHealth (NlU). It is built, maintained and distributed 
by the National Centre for Biotechnology Information O^CBI). Genbank is also 
collaborated with the EMBL data library sponsored by the European Molecular 
Biology Laboratory and the DNA Data Bank of Japan (DDBJ) sponsored by National 
Institute of Genetics, Mishima, Japan. These three major DNA databases exchange 
sequence information and submissions on a daily basis and very often, the term 
Genbank are used in a boarder term to include the databases Genbank, EMBL and 
DDBJ. 
GenBank has been expanded to encompass all known sequences of 20 
nucleotides long including all published DNA sequences since early 1990. The data 
are distributed six times a year on CD-ROM and by anonymous FTP (file transfer 
protocol) on the internet. There are also RETRIEVE and BLAST server for users to 
retrieve database records and perform sequence similarity searches respectively. 
Genbank is not only a DNA but also a protein database. It maintains all 
known protein sequences together with all published peptide sequences of at least six 
amino acid long. It is also combined with a subset of the MEDLE^E bibliographic 
database, the Molecular Sequence Data Subset, retrievable through Entrez system 
(Ouellette and Boguski, 1995). 
Blast sequence search 
BLAST, stands for ‘Basic Local Alignment Search Tool’ (Altschul et al, 
1990), is a series of programs designed for database similarity searching. A query 
sequence can be fed in and the program will compare it with all known sequences in a 
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database and output a ranked database sequence list according to the closeness with 
the query sequence. The BLAST programs include 'blastp' which compares amino 
acid query sequence against a protein sequence database, ‘blastn，，on the other hand, 
compares a tested nucleotide sequence against a nucleotide sequence database. Other 
variations are 'blastx' which compares the six-frame conceptual translation products 
of a fed-in nucleotide sequence against a protein sequence database and 'tblastn' 
which compares a protein query sequence against a nucleotide sequence database 
dynamically translated in all six reading frames, 'tblastx' compares the six-frame 
translations of a nucleotide query sequence against the six-frame translations of a 
nucleotide sequence database. 
Sequencing database searching programs can be exhaustive or can take 
shortcuts to reduce the time needed. The time taken to compare two sequences is 
proportional to the product oftheir lengths whereas the time taken to locate identities 
between sequences is proportional to the sum of their lengths. 
There are three main ways to access BLAST search. The first one is through 
E-mail at the server address (blast@ncbi.nlm.nih.gov). The service is also available at 
a WWW interface (http:Wwww.ncbi.nlm.nih.gov) or as an Internet service using a 
command-line interface. E-mail service is convenient and well-suited for occasional 
search. The WWW interface allows the use of 'copy and paste’ sequences for 
searching. The command-line interface is the most powerful way and is easy to 
incorporate into automated systems for high-throughput analysis (Recipon et al, 
1995). 
In this report, only BLASTN program will be used. There are several outputs 
for BLASTN algorithm. The following is a summary of their definition (Altschul et 
al, 1990; Recipon et al, 1995): 
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Table 4.1. A summary of the output parameters in a BLASTN search. 
Parameters Definitions 
B The maximum number of database sequences for which high-scoring 
segment pairs will be reported. 
Bits Raw score conversion by Lambda value 
E (Expectation Threshold) The upper limit of the expected frequency of chance occurrence of a 
HSP within the context of the entire database search. 
E2 The expected number of HSPs that will be found in comparing two 
sequences that each has the same length. 
Effective length The real length minus the expected length of the HSP. The expected 
length is calculated from its score 
H The relative entropy of the target and background residue frequencies. 
High Score The best ungapped local alignment score, based on the scoring matrix 
used 
HSP(High-scoring Segment Pair) It consists of two sequence fragments (one from the query sequence, 
one from the database) of arbitrary but equal length. Their alignment is 
locally maximal meeting/exceeding a threshold or cutoffscore. 
Identities The number and fraction of total residues in the HSP which are identical 
K Karlin-Altschul parameter 
Lambda The expected increase in reliability of an alignment associated with a 
unit increase in alignment increase. 
MSP (Maximal-scoring Segment Pair) Highest-scoring of all possible segment pairs from two sequences. 
N The number of HSPs in the sets that resulted in the lowest p-value. 
p The probability that the match could have occurred by chance 
P(N) (Smallest Sum Probability) The lowest P-value ascribed to any set o f H S P s for each database 
sequence 
Positives The number and fraction of residues for which the alignment scores 
have positive values. 
S The score at which a single HSP would by itself satisfies the significant 
threshold E. 
S2 The score expected for the MSP between two sequences. 
X Neighborhood word score threshold 
V The maximum number of database sequence for which one-line 
descriptions will be reported. 
W Short word length that satisfies some positive-valued threshold score T 
X Positive integer representing the maximum permissible decay of the 
accumulating segment score during word hit extension 
173 
4.1.4 Internal primer design for RT-PCR 
Several methods have been employed to confirm expression pattem of the 
gene fragments isolated in either RAP-PCR or DDRT-PCR including the conventional 
northern blotting (Ralph et al, 1993), RNase protection assays, nuclear run-on assays 
(Bauer et al., 1994) and reverse-transcription polymerase chain reaction (RT-PCR) 
(Momiyama et al, 1995). The advantage ofusing RT-PCR to study gene expression 
over other methods have been discussed in section 2.1.4. In contrast to other methods 
where sequencing can be done after the gene fragments have been confirmed to be 
differentially expressed in the model under study, sequencing must be done in 
advance for selection/design of primers used in RT-PCR. 
The choice of primers is one of the most important factors in determining the 
quality of a polymerase chain reaction. Generally speaking, the more information 
about the DNA template is available, the better the primers for the reaction could be 
designed. In selecting PCR primers, there are some essential parameters that needed 
to be considered. First, the primer selected can form stable duplex with the specific 
site on the target DNA. Second, the primer should not have duplex formation with 
another molecules. Third, the primer should not prime on any other target site (false 
priming). To examine the duplex stability, the free energy of duplex formation (AG = 
AH-TAS) can be calculated where T, AH and AS are the temperature in K, enthalpy 
and entropy of duplex formation respectively. To minimize primer-dimer artifacts 
which reduce product yield, the PCR primers selected should be free from 
complementarity especially at the 3' termini. Self-complementarity leading to intemal 
primer extension should also be noted; intra-molecular duplexes with negative AG 
should generally be avoided. To eliminate false priming, primer structure with a 
stable 5, termini but an unstable 3, termini was effective (Rychlik, 1993). This is 
because the priming on non-target DNA site at the 3' end is inefficient to initiate an 
extension unless stable duplex could be formed at the 5' end and the central part of the 
primer, as in the case of the target DNA. 
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Other small ‘tricks，ofselecting suitable primers include avoiding 3' T. As T is 
the least discriminating nucleotide at the 3，position，primers with a 3，T have greater 
tolerance of a mismatch. It is also advisable for each primer to have at least one A or 
T within the 3，most triplet to prevent mismatch tolerance of primers with consecutive 
Gs or Cs. The melting temperature of the primer pair in a PCR should be roughly the 
same (土 2 ° C). The size ofthe amplified products should at best fall in the range of 
100-600 base pairs for efficient amplification (Sharrock, 1994). 
Besides general considerations of primer design, attention should also be 
undertaken for gene fragments amplified by RAP-PCR. Up to two to four mismatches 
were found in comparison to the original cDNA towards the 5’ end of 10-mer 
arbitrary primers (Liang et al, 1995). Thus, to ensure specific primer annealing in 
RT-PCR done on total RNA, the region of the arbitrary primer sequence or at least 
those towards the 5, end should be avoided in primer selection. 
Since a lot of parameters have to be taken into account and many calculations 
need to be performed in designing primers, computer-aided PCR primer design like 
using programme OLIGO fNational Biosciences) which calculates the annealing 
temperature of PCR reaction, taking into consideration the stability of the PCR 
products as well as the primer Tm values has greatly facilitated the process. Finally, it 
is also worth mentioning that PCR primer sequence is only one of the determining 
factors in generating clean and specific products. Other factors like substrate 
complexity, the length of the product, the annealing temperature, the cycle profile, the 
buffer composition and the enzyme also affect the reaction. Varying some of these 
conditions may help improving the specificity of the primer (see also touchdown PCR 
described in section 3.1.3). 
After suitable primers are designed, the expression pattem of the genes 
represented by the isolated gene fragments can be determined during the midazoIam-
induced JCS cell differentiation. In addition, the primers can be readily applied to 
expression profile studies on other RNA samples. It is our interest to examine the 
expression pattem of the isolated genes during biochanin A-induced JCS cell 
differentiation. Biochanin A, as opposed to midazolam, induced JCS cells to produce 
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monocytes only; studying the expression profiles of the isolated genes during the 
biochanin A-induced differentiation, when compared to those in midazolam-induced 
cells, may allow us to speculate roles of these genes on lineage commitment. 
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4.1.5 Genes involved in both myeloid cell differentiation and 
embryonic development 
To extend our understanding towards the isolated gene fragments, we suggest 
to study at the same time the expression ofthese gene fragments at different stages of 
the mouse embryos. There are at least two reasons for initiating such studies. First, 
leukemic cells are abnormal cells; not all oftheir gene expressions are comparable to 
normal tissues. Consequently, by studying the expression of the isolated gene 
fragments (or the corresponding genes) in normal tissues like that in the embryos may 
allow us to give an account on whether the expression is specific to leukemia cells or 
is occurred in normal tissues in general. Second, examining the expression profiles of 
these gene fragments during embryonic development gives us more suggestions on the 
possible fonction ofthe genes (especially for those previously unknown genes). Two 
indications proposed that genes responsible for myeloid cell differentiation may also 
be developmentally regulated. (1) Embryonic development involved considerable 
highly ordered differentiation process. Thus, myeloid cell differentiation and 
embryonic development may have common machinery that dictates cell proliferation 
and/or differentiation (Pavelic et al, 1991). Ubiquitously expressed genes involved in 
myeloid cell differentiation (e.g. c-myc and c-fos) belonged to this group. Growth 
factors (e.g. FGF, TGF-P, LIF, SCF), their receptors (FGF-R) and transcription factors 
(e.g. c-myb) are all possible common genes involved in both processes. (2) Unlike the 
differentiation-related genes, there are other genes that involved in myeloid cell 
differentiation but are expressed in embryo carrying out entirely different gene 
function (e.g. Hox family). Hence, it is certainly fruitful to conduct expression profile 
studies ofthe isolated genes on embryonic development. 
The time points chosen to be studied represent different stages of development 
.7.5 dpc (gastrulation), 9.5 dpc (early organogenesis), 11.5 dpc (organogenesis), 15.5 
and 17.5 dpc (fetal growth and development). Distinct features at 7.5 dpc include late 
primitive streak, appearance of allantois, blood islands in visceral yolk sac, foregut 
pocket and neural plate. At 9.5 dpc, 21-29 somites are seen and forelimb buds formed 
at somites 8-12. There are also common ventricle, atrium and fused dorsal aortae. 
Lung primordia, pancreas evagination, and vitelline ducts also formed. Posterior 
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neuropore closes; optic and otic vesicles are observed. At 11.5 dpc, the embryo is 6-7 
mm in size with forefoot plates. There are partitioned atriums and unpaired ventricle. 
Bucconasal membrane and lens vesicles are also detached and ureteric buds formed. 
At 15.5 dpc, the embryo grows larger to 12-14 mm in size. The coronary vessels 
formed and palatine processes fused. At 17.5 dpc, the embryo is 17-20 mm large. 
The alveolar ducts of lung develop and the ciliary body is delineated (reviewed in 
Hogan et al, 1994). 
During the early post-implantation period of the embryo (5-10 dpc), many 
genes controlling differentiation and organogenesis are gradually brought into play. 
Some ofthem have already shown their involvement in myeloid cells. For instance, c-
kit is essential for the formation of myeloid progenitors and CFU-S activity in adult 
(reviewed in Paulson and Bernstein, 1995). In embryo, however, SCF and c-kit affect 
not only hematopoietic tissues but also primordial germ cells and neural crest cells 
(reviewed in Hogan et al, 1994). LIF was first described to induce myeloid leukemia 
cell differentiation; however, it inhibits ES cells differentiation and present at day 4 
dpc during the mouse development (Hilton, 1992). The myb gene family coding for 
transcription factors have previously been shown to be essential for myeloid cell 
differentiation, in particular, c-myb (section 1.2.4) was expressed at high levels in 
immature hematopoietic cells and decreased in expression during terminal 
differentiation. In embryo, the expression of c-myb was very low before 10.5 dpc but 
detected from 10.5 dpc onwards and at a similar level throughout all stages of 
embryonic development. On close examination, c-myb is strongly expressed in the 
developing liver and thymus (but not yolk sac) at 10 dpc (hematopoietic organs), and 
non-hematopoietic tissues like nasal region, respiratory tract and the developing eyes 
(Sitzmann et al, 1995). Another myeloid specific DNA binding protein 
( P E B P 2 a B / C B F a ) involved in myeloid leukemia and myelopoiesis (Okuda et al., 
1996) was also found to be important in embryogenesis. Its Drosophila homolog runt 
(a pair-rule gene) is involved in defining compartments of the embryo. In mouse 
embryo, CBFa expression was detected from 9.5 dpc and the highest levels of 
expression were found in the neural tube, sensory ganglia, specialized sensory 
epithelial structures, all chondrogenic centres，genital system and thymus from 10.5 
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dpc (Simeone et al, 1995). These examples clearly demonstrated that genes that first 
appeared to be restricted to myeloid tissues or hematopoietic tissue, may also be 
involved in the development of other tissues in embryos. 
Another group of genes, hox, are involved in myeloid cell differentiation (Lill 
et al, 1995; Shen et al, 1992; Wu et al, 1992); they do not seem to contribute to cell 
differentiation and/or proliferation events in embryo, hox are arranged in 4 clusters. 
Their order ofalignment along the 5, to 3, end define their expression on the anterior-
posterior axis which are responsible for determining segment identity during 
embryogeneisis. 
Briefly, the isolated gene fragments obtained as described in Chapter 3 can be 
characterized preliminary in the following ways. First, by sequencing and homology 
search, we can see ifthese fragments belong to a known gene or not. Following that, 
the expression pattem of these genes in midazolam-induced JCS cells can be 
confirmed by a fast and sensitive method, RT-PCR. 
Further, studying the expression profile of these genes in biochanin A-treated 
cells may be rewarding. As discussed in section 1.2.4, certain genes (e.g. egr-1 and 
HOX B7 gene) may have different effects on cells committed to different lineages 
(Lill et al, 1995; Nguyen et al, 1993). By comparing the expression pattem ofthese 
genes in midazolam-induced (committed to both monocytic and granulocytic 
differentiation) and biochanin A-induced (committed to monocytic differentiation) 
JCS cells, the differential effect of these genes on lineage commitment may be 
revealed. 
Lastly, to increase our understanding of the isolated genes (especially for those 
putative novel genes), their expression pattem during embryonic development are 
proposed to be studied. 
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4.2 Materials 
(See also earlier chapters for materials which have already been mentioned) 
4.2.1 Selected recombinant plasmids 
17 isolated recombinant plasmids were selected for further studies in this 
Chapter, namely, 44/3.1, 147/1.4, 147/1.5, 147/1.6，172/2.8, 172/3.1, 172/3.2, 172/3.8， 
172/4.1, 172/4.6, 172/5.2, 172/5.6, 172/5.8, 228/5.1，228/5.2, 228/5.3 and 228/5.6 
(Table 3.4) 
4.2.2 Total RNAs 
1. Total RNAs from biochanin-A induced JCS cells at time point 0，1, 5, 18 and 46 
hours kindly prepared by Miss Pandora, M.C. Yip in our laboratory. 
2. Total RNAs prepared from midazolam-induced JCS cells. 
Total RNAs from embryo at different developmental stages generously provided 
by Miss Jessie, P. K. Lee in our laboratory. The embryos were obtained from 
pregnant ICR mice in the Animal House of the Chinese University ofHong Kong. 
Decidum (from 7.5 dpc embryos) and placenta (from 9.5, 11.5, 15.5 and 17.5 dpc 
embryo) were removed. 
4.2.3 Chemicals 
1. Ammonium persulfate Pharmacia biotech plus one 17-1311 -01 
2 Boric acid Pharmacia 80-1128-86 
3. EDTA, disodium salt Pharmacia 80-1128-85 
4. Primer oligo (see also Table 4.5) Integrated DNA Technologies 
5. ReadyMix Gel, ALF grade Pharmacia 17-1035-01 
6. Sodium acetate Sigma S8750 
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7 Xris Pharmacia 80-1128-82 
4.2.4 Enzymes and nucleic acids 
1 � B a m H I , l O X b u f f e r K Amersham E1010YH 
2. Pst I, 10X buffer H Amersham E1073YH 
4.2.5 Kits (Appendix A3) 
1. AutoRead sequencing kit Pharmacia XY-056-00-02 
4.2.6 Solutions 
1. Sodium acetate, 3M, pH 4.8 Aqueous sodium acetate with pH adjusted by 
glacial acetic acid 
2 TBE 10X 1 M Tris, 0.85 M Boric acid, 10 mM EDTA 
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4.3 Methods 
4.3.1 Preparation of selected recombinant plasmid DNA 
Plasmid DNA of each isolated clone was prepared from 50 ml of bacterial 
culture using the Qiagen column as described in section 3.3.5(i). Each Qiagen column 
was used to purify the plasmid DNA from 25 ml ofbacterial culture (section 3.3.5(i)) 
and regenerated by 5 ml of additional QF solution. The regenerated column was 
immediately used to purify plasmid DNA from another 25 ml of bacterial culture. 
The used Qiagen columns were washed with 5 ml of QF solution, submerged using 
excess volume of 70 % ethanol and stored at 4 °C. A collection of the treated columns 
were rinsed with distilled water, autoclaved, dried at 37 ^C and kept at room 
temperature for future use. 
1 |ig of each isolated plasmid was digested by Bam H1 alone or by Bam HI + 
PstIfor 1 hour at 37 ^ C. 
4.3.2 Sequencing 
(i) Preparation of gel cassette and sequencing gel 
Thermostatic plate, notched glass plate, spacers and comb (A.L.F.™ DNA 
sequencer) were thoroughly cleaned with non-fluorescent detergent, rinsed with 
running tap water followed by Ultrapure water and wiped with lint-free Kimwipe as 
suggested by the manufacturer. Then, the plates were rinsed with 70 % commercial 
grade ethanol and polished dry with Kimwipe. After that, they were rinsed again with 
ultrapure water and polished dry with Kimwipe. This ethanol-water cycle was 
repeated for three times. The items were then carefully examined under reflected light 
to ensure no gel residues and dust remained. The light coupler was cleaned with 
ultrapure water and dried with Kimwipe and should be free of crystals, cracks and 
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marks on the polished ends. The gel cassette was then assembled with thermoplate, 
notched plates, spacer and light coupler in place fastened by four gel clamps on a 
horizontal support. 
A bottle of ReadyMix gel removed from 4 ^C was equilibrated to room 
temperature and added with 450 i^l of 10 % (w/v) freshly prepared ammonium 
persulfate. The solution was then mixed by gentle rocking the bottle in a horizontal 
manner for 30 seconds without introducing bubbles. The solution was subsequently 
applied into the gel cassette from the top side to make a 0.5 mm thick gel. The 
cassette was slightly tapped just behind the gel front for an even spread of gel 
solution; any bubbles introduced were removed by a thin plastic strip. The comb was 
inserted in position and the gel was left for polymerization (45 minutes). According 
to the instructor's manual, the upper reservoir was attached to the electrophoresis unit. 
This unit was in tum rested on the lower reservoir connecting to the anode. The gel 
assembly was then connected to the cathode and the inlet/outlet of the thermoplate. 
Both reservoirs were filled with 0.6 X TBE buffer. The laser beam was tuned to 
maximum intensity passing through the centre of each detector by visual inspection. 
The electrophoresis conditions were set inside the ALF manager v 2,6 (Pharmacia 
Biotech) programme. The conditions were voltage 二 1500 V，current = 38 mA，power 
=34 W, temperature 二 40 ^C and laser power 二 3 mW. The sampling interval was 2 
seconds and the running time was 6 hours. The assembly was then ready for sample 
loading. 
(ii) Sequencing reaction 
The plasmids with the subcloned fragments were first diluted to a 
concentration of 5-10 昭 / 32 i^l as suggested in the instructor manual of the 
AutoRead sequencing kit (Pharmacia) (see also Appendix A3). Two sets of solution 
were prepared for the M13 universal and the reverse primer reaction. The template 
solution was then added with 8 i^l of 2M NaOH. The mixture was vortexed, 
centrifuged to bring down droplets on the cap and incubated at room temperature for 
10 minutes. 7 ^1 of 3 M sodium acetate, pH 4.8 plus 4 i^l of ultrapure H2O were 
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added to neutralize the solution. 120 i^l of 100% ethanol was then added, mixed and 
incubated on ice for 15 minutes. The reaction solution was centrifuged at 14 000 rpm 
for 15 minutes in a bench-top microcentrifuge (Eppendorf). With the supernatant 
discarded, the pellets were rinsed with 70% ethanol and centrifuged at 14 000 rpm for 
further 15 minutes. The supernatant was removed and the pellets were dried in 
vacuum (Savant). The dried pellets were resuspended in 10 i^l ofH2O and mixed with 
2 |il offluorescent primer (either the M13 universal or the reverse primer) and 2 i^l of 
annealing buffer to make the annealing reaction solution. The mixture was vortexed, 
centrifuged for a while and pre-heated at 65 "C for 5 minutes. It was then immediately 
incubated for 10 minutes at 37 "C and left at room temperature for 10 minutes. 
Further 1 i^l of extension buffer, 3 i^l of DMSO and 8U/2^il diluted T7 DNA 
polymerase were added to the annealing reaction solution. For each sequencing 
reaction, 2.5 i^l of each sequencing mix (A, T, C, G) was pipetted into separate 
eppendorftubes and incubated on ice for 5 minutes. The tubes were then transferred 
to a 37 oc heat block (Thermolyne) for at least 1 minute. 4.5 i^l of the annealing 
reaction solution with T7 DNA polymerase added was dispensed to each sequencing 
mix and incubated at 37 "C for 5 minutes. 5 i^l of stop solution with loading dyes was 
subsequently added to each tube and kept on ice until loading. Just before the reaction 
solutions were loaded into the gel, the reaction mix were heated to 90 ^C for 3 minutes 
to detach the chain-terminated molecules and snap-freezed onto the ice. The well of 
the gel was washed twice with 0.6 X TBE buffer and 8 |il of each mix was loaded 
into the gel. 
4.3.3 Data analysis and assessment by ALF manager and DNAsis 
Every four lanes of the A, C, G, T reactions were grouped and named as a 
clone. The fluorescent signal of the four lanes in each clone were detected by the 
photodetectors during the electrophoresis and converted into serial digital data. The 
data were fed into the computer and saved in a file (ALF file). The data was also 
processed and the base sequences were determined according to the intensity peaks of 
the four bases relative to each other on the time scale. The sequence ofthe clone was 
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then exported in ASC II format and further analyzed using the software DNAsis for 
Window (Hitachi). 
The forward sequence ofaclone extended from the M13 universal primer and 
the reverse sequence extended from the M13 reverse primer were connected together 
through the ftmction Contig Manager in the DNAsis program with a minimum overlap 
of 30 base pair and a minimum matching of 90 % within the overlapping region. A 
consensus sequence with the overlapping sequences merged was generated. In the 
case of unmatched base in the overlapping region, an ambiguity code would be 
reported in that position. The consensus sequence was then saved in ASC II format. 
The vector sequence, the region between the sequencing primer and the cloning site, 
was removed manually by visual examination from the file. The resulting sequence 
was then ready for primer design and matching in the Genbank. If the forward and 
reverse sequences could not be connected in the middle, they were artificially joined 
in the same orientation with a middle gap in between. A pair of primers were 
designed across the gap for further investigation. 
4.3.4 Sequence search by BLASTN program 
The consensus sequence in ASC II format (section 4.3.4) was kept in files for 
BLAST E-mail search requested at the address blast@ncbi.nlm.nih.gov. Only 
program 'blastn' matching the input DNA sequence with the DNA sequence database 
was used in this investigation. The subject line was left blank. The search command 
begins with the mandatory parameter ‘PROGRAM，followed by the value blastn. The 
next line was the mandatory search parameter ‘DATALIB, and the value was input as 
‘nr，standing for non-redundant database. The third line is an optional parameter 
‘EXPECT’ and our value was set at 0.75. The fourth line was the mandatory 
'BEGnv[' directive indicating the beginning of the query sequence. This was followed 
by a filename and the query sequence was enclosed with the E-mail message. The 
following demonstrates a typical request mail, the letters in bold being automatically 
created by the E-mail program. 
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From : yyszeto@cuhk.edu.hk 
Date : 29 June 1996 12:00:00 











4.3.5 Primer design by Oligo™ ver. 3.4 
The same sequence file (section 4.3.4) in ASC II format was retrieved in the 
software OLIGO™ (National BioSciences). Primers were selected intemal to the 
arbitrary primers used to generated the fragment concerned. Several parameters were 
checked in the software including false priming, intemal stability, primer dimer 
formation and self-complementarity; the melting temperature (Tm) ofeach primer was 
kept between 62-66 °C calculated from the formula 2 ^(A+T) + 4 Y(G+C). The 
difference ofTm between each pair of primers was kept at a maximum of2 ®C. 
4.3.6 Differential expression confirmed by RT-PCR 
After specific primer pairs were designed, RT-PCR were performed as 
described in section 2.3.2 to compare the expression level of each gene represented by 
the isolated gene fragments in JCS cells induced by midazolam at various time points 
(0, 1, 5, 18 and 48 hours). Two to three different cycle numbers ranging from 20-35 
were done for each gene fragment depending on the expression level of individual 
i 
gene. The expression level of these gene fragments were also studied in other samples 
i 
:JCS cells treated with biochanin A for 0, 1, 5, 18 and 46 hours and embryos at 
I 
I 




4.4.1 Analysis of selected recombinant plasmid DNA 
Preparation of recombinant plasmid DNA 
DNA of each recombinant plasmid was prepared from 50 ml of bacterial 
culture as described in section 4.3.1. The yield of each preparation was also estimated 
according to 1 unit A260 = 50 i^gy^ ml double-stranded DNA. The ratio A260 to A280 
among the different preparations varied from 1.4 to 1.6 and the yield (p,g) per 50 ml of 
bacterial culture also ranged from 13.2 to 288 as shown in Table 4.2. 
Table 4.2 : Spectrophotometric analysis of recombinant plasmid preparation. 
Fragment no. A260/A280 yield (^g)/ 50 ml culture 
44/3.1 1.367 234 
147/1.4 1.381 110 
147/1.5 1.592 13.2 
147/1.6 1.623 14 
172/2.8 1.378 86 
172/3.1 1.424 104 
172/3.2 1.441 105 
172/3.8 1.423 204 
172/4.1 1.382 104 
172/4.6 1.455 122 
172/5.2 1.326 170 
172/5.6 1.399 288 
172/5.8 1.376 194 
228/5.1 1.341 150 
228/5.2 1.632 168 
228/5.3 1.420 116 
228/5.6 1.370 112 
Plasmids harboring subcloned fragments as indicated were isolated by the Qiagen plasmid 
midi kit and the column was used 2 times consecutively in one preparation for 50 ml culture 
(section 4.3.1). Absorbance at 260 nm to 280 nm (A260 丨 A280) and the yield / 50 ml culture 
were also calculated (see also text). 
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Restriction digestion ofthe subcloned fragments from the plasmid vector 
The size of insert in each recombinant plasmid was analyzed by Bam H1 and 
Pst I restriction enzyme digestions. Bam HI and Pst I sites are two unique restriction 
sites closest to the chosen cloning site Sma I; thus the incised fragments gave an 
approximation of the size of the subcloned fragments. Two incised fragments were 
found in plasmids containing fragment 147/1.4, 172/3.8 and 172/5.6. The estimated 
size of the incised fragments were summarized in Table 4.3. The mobility ofthe linear 
recombinant plasmids (Figure 4.2, lane 2) relative to the plasmids with the inserts cut 
were shown (Figure 4.2, larger band, lane 1). Notable decreases in mobility at lane 2 
were found in plasmid harboring fragment 44/3.1, 172/2.8 and 172/3.8. The 
I 
subcloned fragments were relatively large in size (>500 bp). Two small incised bands 
were also found in lane 2 of fragment 172/5.6 containing plasmid where only Bam HI 
was added for digestion. Lane 3 (Figure 4.2) showed the undigested plasmid having 
negligible contamination of genomic DNA and undetectable level of RNA. The 
preparations also contained rather intact plasmids where linear form or nicked form 
was not detectable. 
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Table 4.3. Sizes ofthe subcloned fragments estimated by restriction enzyme digestion 
or determined by sequencing� 
Gene Sizes of the fragment* (estimated by Sizes of the fragments (bp) (determined 
fragments restriction digestion, BamHI + Pst I) by sequencing) 
44/3.1 870 >690 (690 with gap in between) 
147/1.4 239+208 = 447 393 
147/1.5 479 >315 (315 with gap in between) 
147/1.6 389 311 
172/2.8 512 515 
172/3.1 398 393 
172/3.2 275+186 = 461 413 
172/3.8 749 840 
172/4.1 213 197 
172/4.6 371 397 
172/5.2 323 324 
172/5.6 372+245 = 617 659 
172/5.8 339 397 
228/5 • 1 316 >263 (263 with gap in between) 
228/5.2 417 340 
228/5.3 389 301 
228/5.6 389 300 
*1 ^g of each recombinant plasmid was digested by Bam HI and Pst I for 1 hour at 37 °C. 
The digested fragment was loaded into a 1 % TAE agarose gel. The fragment size was 
estimated from the migrating distance by the standard curve Logio (nucleotide pair) = 4.5-
0.59 (distance migrated in cm) constructed by the marker standard loaded in parallel. The 
actual fragment size determined by sequencing is illustrated and compared. 
i 
I 
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172/2.8 172/3.1 172/3.2 172/3.8 172/4.1 172/4.6 172/5.2 172/5.6 172/5.8 
Figure 4.2. Digestion of subcloned fragments inserted at Sma I from the plasmid vector 
pBluescript SK-. 1 p,g of recombinant plasmid digested by Bam HI + Pst I (lane 1), Bam H1 
alone (lane 2) or 0.3 p,g plasmid DNA without digestion (lane 3) were electrophoresed on a 1 
o/o TAE agarose gel. Names of the fragment were designated as follows : arbitrary primer 
number/fragment number assigned in RAP-PCR . clone number assigned according to the 
different sizes of inserts. M = l K b ladder. 
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4.4.2 Sequencing results 
Automated sequencing by ALF system was done for the following 17 
fragments. Double-stranded sequencing following the protocol in the AutoRead 
sequencing kit (see also section 4.3.2 (ii)) was performed. Recombinant plasmids of 
pBluescript SK- inserted with each of these fragments were denatured and annealed 
with either a M13 fluorescent universal or reverse primer. 4 separate reactions for 
each nucleotide A, C, G, T were performed and loaded separately on different lanes on 
the gel. The fluorescent signals from each lane were detected, analyzed, saved in an 
ALF file and presented as curves (electropherograms) (see also section 4.3.3) (Figure 
4.3). The system could read 270-580 bp without ambiguities and an average of about 
400 bp under the methods described and the fragment used in this investigation. The 
sequencing result in ASC II format of the same fragment initiated by the universal 
primer and the reverse primer were combined together as described in section 4.3.3. 
Sequences that did not meet in the middle were artificially joined in the same 
orientation. In the following, ******** indicates the sequence of the arbitrarily 
chosen primer used to generate the sequence. This short sequence occurred at both 
ends.——GAP——indicates the undetermined sequences of unknown size stuffing in 
between. > indicates the upper primer designed for further experiments (RT-
PCR) while < indicates the lower primer (see also Table 2.5). A，C, T, G 
represents the four dideoxynucleotides and ambiguity codes were explained in 
Appendix A1. The length of these subcloned fragments were summarized in Table 
4.3. 
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Figure 4.3.(opposite page) A typical output of automated sequencing by ALF system. The 
fluorescent signals from each ofthe four lanes, A, C, G, T were detected, analyzed and presented as 
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Fragment 44/3.1 
Length of the fragment: estimated to be 870 bp (Table 4.3) 
Arbitrary primer : 5‘ ATA CAC GAT TTT CCA TCA CAA ACT 3' 
I 
i 1 0 2 0 3 0 4 0 5 0 6 0 * * • • * • • • * * * * * • • * • * • * * * * * * 
! TACACGATTT TCCATCACAA ACGGTCTCAG TCCCTGCACA TGTCTGTGAA AATTATTTAA 
ATGTGCTAAA AGGTAGTGTT TGCCAGAGTC AGGGACGTGT ACAGACACTT TTAATAAATT 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 > 
ATGAGGTAAC TGATGTGGGA CAACCTACTA TAAGTATGGG CTATATGTTA CAATAGGTGA 
TACTCCATTG ACTACACCCT GTTGGATGAT ATTCATACCC GATATACAAT GTTATCCACT 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
TTATACTGCT CAAATCACCC CACAGTTGTT AGTTGTTGGC ATATATTCCT TGCTGCCCTC 
AATATGACGA GTTTAGTGGG GTGTCAACAA TCAACAACCG TATATAAGGA ACGACGGGAG 
1 9 0 2 0 0 2 1 0 2 2 0 230 240 
ATCAATGTTC TGGAAATGAA AGACACACAC CTGACATTTT GATCTTAGCC ATTCTAACTG 
TAGTTACAAG ACCTTTACTT TCTGTGTGTG GACTGTAAAA CTAGAATCGG TAAGATTGAC 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
GTAAAAGATA GAATCTCAAG GTCATTTTGA TTTGCATTTC TCTGATCACT AAGAACATTT 
CATTTTCTAT CTTAGAGTTC CAGTAAAACT AAACGTAAAG AGACTAGTGA TTCTTGTAAA 
< 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
CTTTAGGTGC TTCTCAGCCM aTBCGAGATY C G A P GTGGAAADVC 
GAAATCCACG AAGAGTCGGK tAVGCTCTAR G G A P CACCTTTHBG 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 > 
CCCCATGAGA TCTAGCTGTA AGGCATTTTC TCAATTAGTG ATCAAGGGGG AAAGGCCCCT 
GGGGTACTCT AGATCGACAT TCCGTAAAAG AGTTAATCAC TAGTTCCCCC TTTCCGGGGA 
4 3 0 4 4 0 4 5 0 4 6 0 4 7 0 4 8 0 
TGTGGGKGGG ACCATCTCTG GACTGGCAGT CTTGGGTTCT ATAAGAGAGC AGGCTGAGCA 
ACACCCMCCC TGGTAGAGAC CTGACCGTCA GAACCCAAGA TATTCTCTCG TCCGACTCGT 
4 9 0 5 0 0 5 1 0 5 2 0 5 3 0 5 4 0 
AGCCAGGGGA GGCAAGATAG TAAGGAACAT CCCTTCATGG CCTCTGCATC AGCTCCTGCT 
TCGGTCCCCT CCGTTCTATC ATTCCTTGTA GGGAAGTACC GGAGACGTAG TCGAGGACGA 
5 5 0 5 6 0 5 7 0 5 8 0 5 9 0 6 0 0 
TCCTGACCTG CTTGAGTTCC AGGCCTGACT TCCTTTGGTG ATGAACAGCA GCATGGAAGT 
AGGACTGGAC GAACTCAAGG TCCGGACTGA AGGAAACCAC TACTTGTCGT CGTACCTTCA 
6 1 0 6 2 0 6 3 0 6 4 0 6 5 0 6 6 0 
GTAAGCCAAA TAAACCCTTT CCTCCCCAAC TCGCTTCTTG GTCATGATGT TTGTGCAGGA 
CATTCGGTTT ATTTGGGAAA GGAGGGGTTG AGCGAAGAAC CAGTACTACA AACACGTCCT 
< 
6 7 0 6 8 0 6 9 0 7 0 0 7 1 0 7 2 0 
ATAGAGACCT TGACTAAGAC AGGTCGTTTG TGATGGAAAA TCGTGTAT 
TATCTCTGGA ACTGATTCTG TCCAGCAAAC ACTACCTTTT AGCACATA 
* • • * * • * • * * * • * * • * • • • * * * * * • * 
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Fragment 172/3.2 
I Length of the fragment =393 bp 
Arbitrary primer used : 5 ’ ATG ATG CTC TTT AGG CTT TCC AG 3， 
1 0 2 0 3 0 4 0 5 0 6 0 
* • * • • • • * * * * * • * • * * * * * * * • * 
ATGATGCTCT TAGGCTTTCC AGAAGAGGGT GTCAGATCTC ATTACGGATG GTTGTAAGCC 
TACTACGAGA ATCCGAAAGG TCTTCTCCCA CAGTCTAGAG TAATGCCTAC CAACATTCGG 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 > 
ACCATGTGGT TGCTGGGATT TGAACTCAGG ACCTTTGGAA GAGCAGTCGG TGCTCTTAAC 
TGGTACACCA ACGACCCTAA ACTTGAGTCC TGGAAACCTT CTCGTCAGCC ACGAGAATTG 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
CATTGAGCCG TCTCTCCAGC CCCTCAACAC YGTAAACYTA CYTAAGCATG AACYAAATTT 
GTAACTCGGC AGAGAGGTCG GGGAGTTGTG RCATTTGRAT GRATTCGTAC TTGRTTTAAA 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
AAAAATTCTT TGACATTTAC YTAWTCATAG ATKGTATGTG GTAGTKGAGG TKGGGGATSC 
TTTTTAAGAA ACTGTAAATG RATWAGTATC TAMCATACAC CATCAMCTCC AMCCCCTASG 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
TGCAGAGCCT TGTGTGGAGG TCAGAGGGGA GGTAGAGGGG GTCGGTTCTC AGACATGTGA 
ACGTCTCGGA ACACACCTCC AGTCTCCCCT CCATCTCCCC CAGCCAAGAG TCTGTACACT 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
CTGTGTGACA GACTGCAAGC AGGCAGAGAA CATCTCTCTT TGTCTTCTTG TGACATGCTG 
GACACACTGT CTGACGTTCG TCCGTCTCTT GTAGAGAGAA ACAGAAGAAC ACTGTACGAC 
< 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 
TCATTGTCAG CTGGAAAGCC TAAAGAGCAT CAT 
AGTAACAGTC GACCTTTCGG ATTTCTCGTA GTA • * • * • * * * * * * * * • • • • • * • * * * • • 
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Fragment 147/1.5 
Lenght of the fragment = estimated to be 479 bp (Table 4.3) 
Arbitrary primer used : 5 , ATG ATG CTC TTT AGG CTT TCC AG 3 ‘ 
1 0 2 0 3 0 4 0 5 0 6 0 
* • • * • • • * * • • • * • * * * * * * * • * * > 
TGATGCTCTT TAGGCTTTCC AGACCCCCAA AATCAGAGTA GACATATTAG AAAGTAAAAC 
ACTACGAGAA ATCCGAAAGG TCTGGGGGTT TTAGTCTCAT CTGTATAATC TTTCATTTTG 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
CCACAGTGCA CTCTCCTGCC TGTGGCCAGA CTTGGACTTC TCTCCTCTAA AGAAAAGAGG 
GGTGTCACGT GAGAGGACGG ACACCGGTCT GAACCTGAAG AGAGGAGATT TCTTTTCTCC 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
TCGACTWAAG GGAAGAAGCC TTyCARGCYT G A P CTAACCTTGG 
AGCTGAWTTC CCTTCTTCGG AArGTYCGRA G A P GATTGGAACC 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
TTTGGRAARG GGGTTTTTKG SCTTCCCAGG TTACAGTCCA TCATCATGGG ATATCTGTAT 
AAACCYTTYC CCCAAAAAMC SGAAGGGTCC AATGTCAGGT AGTAGTACCC TATAGACATA 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
AAACTGCCAA CACGCCCACT CCATGGTGTG GGAAGGTTTT ATTGTAGAGG AGAGGGAGAG 
TTTGACGGTT GTGCGGGTGA GGTACCACAC CCTTCCAAAA TAACATCTCC TCTCCCTCTC 
< 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
CAGCCAGAAG CATCTGGAAA GCCAAAGAGC ATCAT 
GTCGGTCTTC GTAGACCTTT CGGTTTCTCG TAGTA 











； Length of the fragment = 311 bp 
Arbitrary primer used : 5 ‘ ATG ATG CTC TTT AGG CTT TCC AG 3' 
‘ 1 0 2 0 3 0 4 0 5 0 6 0 
— > 
* * * * * * * * * * * * * * * * * * * * * * * * * 
I ATGATGCTCT TTAGGCTTTC CAGAAGCACC ACTCTCAGGG GAATCCAAGG CCACTGCTTC 
I TACTACGAGA AATCCGAAAG GTCTTCGTGG TGAGAGTCCC CTTAGGTTCC GGTGACGAAG ] 
:| 7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
； TCTGGCCCTK ATTCACTGTT TGATAGTAAA CTGGACTTAC CTKAAATTAG TCCCAGAGGT 
I AGACCGGGAM TAAGTGACAA ACTATCATTT GACCTGAATG GAMTTTAATC AGGGTCTCCA 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
1 GGGTCCTTCT GTCACTGAGT TCATATGCTT KGCCCCTGCC AGTACCACTG GGGAAACAGT 
CCCAGGAAGA CAGTGACTCA AGTATACGAA MCGGGGACGG TCATGGTGAC CCCTTTGTCA 
190 200 210 220 230 240 
CACTAATGCT ATGGTWTCTA CCCATAGAAC TACTGGTTGA CTCTGCATGG GGTAGTACTG 
GTGATTACGA TACCAWAGAT GGGTATCTTG ATGACCAACT GAGACGTACC CCATCATGAC 
< 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
i TTTGGAGTMA CAGCTCTTGA GCTGGCATTA GACAGACTCT GTGTGGTCCT GGAAAGCCTA 
AAACCTCAKT GTCGAGAACT CGACCGTAAT CTGTCTGAGA CACACCAGGA CCTTTCGGAT 
* * * • * * * • * * * * * 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
丨 AAGAGCATCA T 
I TTCTCGTAGT A 












Length of the fragment = 515 bp 
Arbitrary primer used : 5，ATG 6 A A GGG A T G A C T A T G T T G GA 3 ‘ 
1 0 2 0 3 0 4 0 5 0 6 0 
* * * * * * * * * * * * * * * * * * * * * * * * * 
ATGGAAGGGA TGACTATGTT GGAGTAGGTG TATCACTGTG GATGTGGGCT TTACGATCCT 
TACCTTCCCT ACTGATACAA CCTCATCCAC ATAGTGACAC CTACACCCGA AATGCTAGGA 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
CATCCTAGCT TCCCAGAAGC CAGTATTCCA CTAGCAGCCT TCAGATGAAG ATGTAGAACT 
GTAGGATCGA AGGGTCTTCG GTCATAAGGT GATCGTCGGA AGTCTACTTC TACATCTTGA 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
CTCAGCTCCT TCTCTAGCAC CATGTCTGCC GGCATGCCAC CATGCTTCCC ACCATGATGA 
GAGTCGAGGA AGAGATCGTG GTACAGACGG CCGTACGGTG GTACGAAGGG TGGTACTACT 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
TAATGGACTG AACCTCTGAA CCTGTAAGCC TGTVCCAGTA AAATGTTTTC CATTATAAGA 
ATTACCTGAC TTGGAGACTT GGACATTCGG ACABGGTCAT TTTACAAAAG GTAATATTCT 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
GTTGTCATGG TCATGGTGTC TCTTCAGAGC AGTAAAACCC TCACTAAGAG AGTTGTGTTG 
CAACAGTACC AGTACCACAG AGAAGTCTCG TCATTTTGGG AGTGATTCTC TCAACACAAC 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
CATGGATCAG GACTGTVGCT CACTTAGGAG GNCVNGAGGA AGATGTCACC CTGGTAACTC 
GTACCTAGTC CTGACABCGA GTGAATCCTC CNGBNCTCCT TCTACAGTGG GACCATTGAG 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 
CAGGTTCCAA CATAGTCATC CCTTCCATAA CTCTGCTAAT GAAGTGGATC TTCTGGGYCC 
GTCCAAGGTT GTATCAGTAG GGAAGGTATT GAGACGATTA CTTCACCTAG AAGACCCRGG * * * * * * * * * * * * * * * * * * * * * * * * * 
4 3 0 4 4 0 4 5 0 4 6 0 4 7 0 4 8 0 
AAACCAGAAT GGTTCTGAGG GCTTAGCCCR AGCTGACSCR AGVCSAATGG TGCCAAGCCT 
TTTGGTCTTA CCAAGACTCC CGAATCGGGY TCGACTGSGY TCBGSTTACC ACGGTTCGGA 
4 9 0 5 0 0 5 1 0 5 2 0 5 3 0 5 4 0 
GTGGAGGATT TCTCCAACAT AGTCATCNNT DTVAT 









1 :| 1 
Fragment 172/3.1 
Length of the fragment = 393 bp 
Arbitrary primer used : 5‘ ATG GAA GGG ATG ACT ATG TTG GA 3' 
1 0 2 0 3 0 4 0 5 0 6 0 
************************* 
ATGGAAGGGA TGACTATGTT GGACTAGGTG TGCCACTGTG GGAGTGGGCT TTGAGACCCT 
TACCTTCCCT ACTGATACAA CCTGATCCAC ACGGTGACAC CCTCACCCGA AACTCTGGGA 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
CCTTCTAGCC GGGTGGGACG AAGCCCAGTC TTCTTCTGGG TTCCCTTGAA TAAGACATGG 
GGAAGATCGG CCCACCCTGC TTCGGGTCAG AAGAAGACCC AAGGGAACTT ATTCTGTACC 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
AACTCTCAGC TCCTTCTCTA GCGCCATGTC YTGCCGGCAT GCCACCATGY TTCCCACCAT 
TTGAGAGTCG AGGAAGAGAT CGCGGTACAG RACGGCCGTA CGGTGGTACR AAGGGTGGTA 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
GATGATAATG GACTGAACCT CTGAACCTGT AAGCCTGTGC CAGKAAAAKG TTTTCCATTA 
CTACTATTAC CTGACTTGGA GACTTGGACA TTCGGACACG GTCMTTTTMC AAAAGGTAAT 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
TAAGAGTTKT CATGGTCATG GTGTCTCTTC AGAGCAGTAA AACCCTCACT AAGAGAGTTG 
ATTCTCAAMA GTACCAGTAC CACAGAGAAG TCTCGTCATT TTGGGAGTGA TTCTCTCAAC 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
TGTTGCATGG ATCAGGACTG TGGCTCACTT AGGAGGTCAT GAGGAAGATG TCACCCTGGT 
ACAACGTACC TAGTCCTGAC ACCGAGTGAA TCCTCCAGTA CTCCTTCTAC AGTGGGACCA 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 
AACTCCAGGT TCCAACATAG TCATCCCTTC CAT 






Length of the fragment = 413 bp 
Arbitrary primer used : 5 ‘ ATG GAA GGG ATG ACT ATG TTG GA 3 ‘ 
1 0 2 0 3 0 4 0 5 0 6 0 
************************* > 
ATGGAAGGGA TGACTATGTT GGAGTAGGTG TGGCCTTGCT GGAAGAAGTG CGTCACTGTG 
TACCTTCCCT ACTGATACAA CCTCATCCAC ACCGGAACGA CCTTCTTCAC GCAGTGACAC 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
AGGGCAGGCT TTAAGGTCTC ATACTCTCAA GCTACAGCCA GCGTGACAGT CTCTTTCTGC 
TCCCGTCCGA AATTCCAGAG TATGAGAGTT CGATGTCGGT CGCACTGTCA GAGAAAGACG 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
TGCCTGCAGA TCAAGATGTA GAACTCTCAG CTCCTTCTCT AGCACCATGT CTGCCGGNAT 
ACGGACGTCT AGTTCTACAT CTTGAGAGTC GAGGAAGAGA TCGTGGTACA GACGGCCNTA 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
GCCACCATGC TTCCCACCAT GATGATAATG GACTGAGCCT CTGAACCTGT AAGCCTGTGC 
CGGTGGTACG AAGGGTGGTA CTACTATTAC CTGACTCGGA GACTTGGACA TTCGGACACG 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
CAGTAAAATG TTTTCCATTA TAAGAGTTGT CATGGTCATG GTGTCTCTTC AGAGCAGTAA 
GTCATTTTAC AAAAGGTAAT ATTCTCAACA GTACCAGTAC CACAGAGAAG TCTCGTCATT 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
AACCCTCACT AAGAGAGTTG TGTTGCATGG ATCAGGACTG TGGCTCACTT AGGAGGTCAT 
TTGGGAGTGA TTCTCTCAAC ACAACGTACC TAGTCCTGAC ACCGAGTGAA TCCTCCAGTA 
< 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 
GAGGAAGATG TCACCCTGGT AACTCCAGGT TCCAACATAG TCATCCCTTC CAT 
I CTCCTTCTAC AGTGGGACCA TTGAGGTCCA AGGTTGTATC AGTAGGGAAG GTA 













Lenght of the fragment = 840 bp 
Arbitrary primer used : 5‘ ATG GAA GGG ATG ACT ATG TTG GA 3' 
1 0 2 0 3 0 4 0 5 0 6 0 
* • • • * * • • * * • • • • * * * * • * * * * * * 
ATGGAAGVBA TGACTATGTT GGAGTAGGTG TGGCCTTGCT GGAAGAAGTG CGTCACTGTG 
TACCTTCBVT ACTGATACAA CCTCATCCAC ACCGGAACGA CCTTCTTCAC GCAGTGACAC 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
AGGGCAGGCT TTAAGGTCTC ATACTCTCAA GCTACAGCCA GCGTGACAGT CTCTTTCTGC 
TCCCGTCCGA AATTCCAGAG TATGAGAGTT CGATGTCGGT CGCACTGTCA GAGAAAGACG 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
• * • * * * • * * * * * * * * * * * * • • • * • • 
TGCCTGCAGA TCAAGATGTA GAACTCTATG GAAGGGATGA CTATGTTGGA GTAGGTGTGG 
ACGGACGTCT AGTTCTACAT CTTGAGATAC CTTCCCTACT GATACAACCT CATCCACACC 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
CCTTGCTGGA AGAAGTGCGT CACTGTGAGG GCAGGCTTTA AGGTCTCATA CTCTCAAGCT 
GGAACGACCT TCTTCACGCA GTGACACTCC CGTCCGAAAT TCCAGAGTAT GAGAGTTCGA 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
ACAGCCAGCG TGACAGTCTC TTTCTGCTGC CTGCAGATCA AGATGTAGAA CTCTCAGCTC 
TGTCGGTCGC ACTGTCAGAG AAAGACGACG GACGTCTAGT TCTACATCTT GAGAGTCGAG 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
CTTCTCTAGC ACCATGTCTG CCGGCATGCC ACCATGCTTC CCACCATGAT GATAATGGAC 
GAAGAGATCG TGGTACAGAC GGCCGTACGG TGGTACGAAG GGTGGTACTA CTATTACCTG 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 
TGAACCTCTG AACCTGTAAG CCTGHGCCAG TAAAATGTTT TCCATTATAA GAGTTGTCAT 
ACTTGGAGAC TTGGACATTC GGACDCGGTC ATTTTACAAA AGGTAATATT CTCAACAGTA 
4 3 0 4 4 0 4 5 0 4 6 0 4 7 0 4 8 0 
GGTCATRGTG TCTCTYCAGA GCAGTAAAAC CCTCACTAAG AGAGTTGTGT TGCATGGATC 
CCAGTAYCAC AGAGARGTCT CGTCATTTTG GGAGTGATTC TCTCAACACA ACGTACCTAG 
4 9 0 5 0 0 5 1 0 5 2 0 5 3 0 5 4 0 
GGGACTGTGG CTCACTTAGG AGGTCATGAG GAAGATGTCA CCCTGGTAAC TCCAGGTTCC 
CCCTGACACC GAGTGAATCC TCCAGTACTC CTTCTACAGT GGGACCATTG AGGTCCAAGG 
* * * • 
5 5 0 5 6 0 5 7 0 5 8 0 5 9 0 6 0 0 
AACATAGTCA TCCCTTCCAT TTGGAGACAT GCTGGAAAAA GCTGCCGAGC TGCTGATGAG 
TTGTATCAGT AGGGAAGGTA AACCTCTGTA CGACCTTTTT CGACGGCTCG ACGACTACTC • * * * * * • * • * • * • • * * • • * • • 
6 1 0 6 2 0 6 3 0 6 4 0 6 5 0 6 6 0 
CTGCTTCCGA GTCTGTGCCA GTGACACGTG AGTGAGKTCT GGGGGCAACG TGCTCACCGT 
GACGAAGGCT CAGACACGGT CACTGTGCAC TCACTCMAGA CCCCCGTTGC ACGAGTGGCA 
6 7 0 6 8 0 6 9 0 7 0 0 7 1 0 7 2 0 
CAGAGCATGT GTTGCTCTCC CTGTACTCGG TCCTTGGTGC CGGCCACACT TTCTGCCTTC 
GTCTCGTACA CAACGAGAGG GACATGAGCC AGGAACCACG GCCGGTGTGA AAGACGGAAG 
7 3 0 7 4 0 7 5 0 7 6 0 7 7 0 7 8 0 
ACTTTGGAAG GTCTCTGCCC AGTGCACGCA GCCTGGCTTT CTCTACCTGT CAGTGCTCTG 
TGAAACCTTC CAGAGACGGG TCACGTGCGT CGGACCGAAA GAGATGGACA GTCACGAGAC 
201 
790 800 810 820 830 840 
AGCAGTGCCC TTGTCTGGCT TTGACAGCCA GGCCCCCTCC AACATAGTCA TCVNTTCCAT 
TCGTCACGGG AACAGACCGA AACTGTCGGT CCGGGGGAGG TTGTATCAGT AGBNAAGGTA 






Length of the fragment =197 bp 
Arbitrary primer used : 5‘ ATG GAA GGG ATG ACT ATG TTG GA 3' 
1 0 2 0 3 0 4 0 5 0 6 0 
• • * * • • * * * * • • • • • * * * • • • * • * • > 
ATGGAAGGGA TGACTATGTT GGAAGAGGAG GCGGCTGCGG AAAGGGTCTG GGTCTGGGTT 
TACCTTCCCT ACTGATACAA CCTTCTCCTC CGCCGACGCC TTTCCCAGAC CCAGACCCAA 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
TGCAGATTAG GACGACAAGG AGTTGGTTAC AAGGCCTGGT GAAGAGCTAG CTGGATAGGA 
ACGTCTAATC CTGCTGTTCC TCAACCAATG TTCCGGACCA CTTCTCGATC GACCTATCCT 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
TCGGTGGCCA TCCTGACTCA GGCCAGCTTC AGGAACTCCT GCAGTGTGTC CTGCTCCAAC 
AGCCACCGGT AGGACTGAGT CCGGTCGAAG TCCTTGAGGA CGTCACACAG GACGAGGTTG 
< * * * * * * 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
ATAGTCATCC CTTCCAT 




















Fragment 172/4.6 or 172/5.8 
Length of the fragment = 397 bp 
Arbitrary primer used : 5 ‘ ATG GAA GGG ATG ACT ATG TTG GA 3 ‘ 
1 0 2 0 3 0 4 0 5 0 6 0 * * * * * • • * • * * * * * * * * * * • • * * * * > 
ATGGAAGGGA TGACTATGTT GGACTAGGTG TGCCACTGTG GGAGTGGGCT TTGAGACCCT 
TACCTTCCCT ACTGATACAA CCTGATCCAC ACGGTGACAC CCTCACCCGA AACTCTGGGA 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
CCTTCTAGCC GGGTGGGAND DAGCCCAGTC TTCTTCTGGG TTCCCTTGAA TAAGACATGG 
GGAAGATCGG CCCACCCTNH HTCGGGTCAG AAGAAGACCC AAGGGAACTT ATTCTGTACC 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
AACTCTCAGC TCCTTCTCCA GTGCCATGCC CGCCTGGATG CTGCCATGCT TCCCACCTTG 
TTGAGAGTCG AGGAAGAGGT CACGGTACGG GCGGACCTAC GACGGTACGA AGGGTGGAAC 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
ATGATAATGG ACTGAACCTC AGAACCAGTA AGCAGCCACA GTGAAATGCT GCCTTGGTCA 
TACTATTACC TGACTTGGAG TCTTGGTCAT TCGTCGGTGT CACTTTACGA CGGAACCAGT 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
TGGTGTCTGT TCACAGCAAT GGAACCCTAA GACAAGGTTC TTAACCCACA GGTATACCTT 
ACCACAGACA AGTGTCGTTA CCTTGGGATT CTGTTCCAAG AATTGGGTGT CCATATGGAA 
！ 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
CTGTCATCTG AACACTCACC AACTTTGACC ACTGTGACTG STTCCCCCAT TTCAGAGCCT 
I GACAGTAGAC TTGTGAGTGG TTGAAACTGG TGACACTGAC SAAGGGGGTA AAGTCTCGGA 
< 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 
I TTTCTCCTAG GVSCYMCAAC ATAGTCAYCC CTYCCAT 




Length of the primer = 324 bp 
Arbitrary primer used : 5 ’ ATG GAA GGG ATG ACT ATG TTG GA 3， 
1 0 2 0 3 0 4 0 5 0 6 0 * * • • * * * * * * • * * * • * * * * * * * • * • 
ATGGAAGGGA TGACTATGTT GGAGCTGGAA CTTCCCATGT AGACTATGGT AGTTTAGAAA 
TACCTTCCCT ACTGATACAA CCTCGACCTT GAAGGGTACA TCTGATACCA TCAAATCTTT 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 > 
CCACAGAGAT CTAACCGGCT TTGCCTCCCA GATCCTAAYY CTAAAGGGSG ACCCCACCCT 
GGTGTCTCTA GATTGGCCGA AACGGAGGGT CTAGGATTRR GATTTCCCSC TGGGGTGGGA 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
ATCCCTGCTC CCTTTTCTCT CTTAGCTTCC TTTATCAACC CAAGACCGAT CTTCCCACAG 
TAGGGACGAG GGAAAA6A6A GAATCGAAGG AAATAGTTGG GTTCTGGCTA GAAGGGTGTC 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
GATGGAGCAC AGGGATTGAC GAGTGACACT TGTCTGTACA GAGATTCCGA GGCCTTGAGT 
CTACCTCGTG TCCCTAACTG CTCACTGTGA ACAGACATGT CTCTAAGGCT CCGGAACTCA 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
TTGGGAATCT TCACCTAGGT AATACACTGC TCTTCCCCCT CCAACTCCCA CTCTCTCCCC 
AACCCTTAGA AGTGGATCCA TTATGTGACG AGAAGGGGGA GGTTGAGGGT G A G A 6 A 6 6 6 6 
< 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
CTCCAACATA GTCATCCCTT CCAT 
GAGGTTGTAT CAGTAGGGAA GGTA 
* * * * * * * * * * * * * * * * * * * * * * * * * * 
205 
Fragment 172/2.8 
Length of the primer used = 659 bp 
Arbitrary primer used : 5‘ ATG GAA GGG ATG ACT ATG TTG GA 3' 
1 0 2 0 3 0 4 0 5 0 6 0 * * * * * * * * * * * * * * * * * * * * * * * * * > 
ATGGAAGGGA TGACTATGTT GGATTAAACA TGCATCACTG TGGAGGCAGG GCTTTGGGGA 
TACCTTCCCT ACTGATACAA CCTAATTTGT ACGTAGTGAC ACCTCCGTCC CGAAACCCCT 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
AATGTATGTA TACTCAGGCT CTGCCAAAGG TGAGACACAG TAATCTCATT TTCTGCCTTT 
TTACATACAT ATGAGTCCGA GACGGTTTCC ACTCTGTGTC ATTAGAGTAA AAGACGGAAA 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
GAATTGGGAG AGGGAGGCAA GCAGTTATCT GATATAGAAA ATCCTAGTCT GTAGAGAGAG 
CTTAACCCTC TCCCTCCGTT CGTCAATAGA CTATATCTTT TAGGATCAGA CATCTCTCTC 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
TTCCAGGGCA GCCTGGAGTA CACAGAAAAG CCCTATCTCA GAAAGAAATA ATGATCTTTC 
AAGGTCCCGT CGGACCTCAT GTGTCTTTTC GGGATAGAGT CTTTCTTTAT TACTAGAAAG 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
TTACTTGTGT CTTAGTCCTC CTTCAAAGAA GATGGTACTC ACCAGGTAGG TTGTTGATTC 
AATGAACACA GAATCAGGAG GAAGTTTCTT CTACCATGAG TGGTCCATCC AACAACTAAG 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
AGTTTCTGGT TATGGAATGG TCTTGGAGTA CAAATATTTT GCATTTTTTT TTACGGGGAT 
TCAAAGACCA ATACCTTACC AGAACCTCAT GTTTATAAAA CGTAAAAAAA AATGCCCCTA 
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0 
TGCTCAAGCT TTCACATCTG ATAGAGGATC CATGTTTAAG ATCTGTGCCA ACCAGTGCCA 
ACGAGTTCGA AAGTGTAGAC TATCTCCTAG GTACAAATTC TAGACACGGT TGGTCACGGT 
4 3 0 4 4 0 4 5 0 4 6 0 4 7 0 4 8 0 
GCCATGATAC AMGCCATGAT TGTGAGACTC CTGCTGGTTT CCAAAGGGCC ACTGTAGTTG 
CGGTACTATG TKCGGTACTA ACACTCTGAG GACGACCAAA GGTTTCCCGG TGACATCAAC 
4 9 0 5 0 0 5 1 0 5 2 0 5 3 0 5 4 0 
GATGATGGTG GCATACAAAT GGATCACCCC ATACATGTGT TTTAGAAAGT TGTCCTTTTG 
CTACTACCAC CGTATGTTTA CCTAGTGGGG TATGTACACA AAATCTTTCA ACAGGAAAAC 
< 
5 5 0 5 6 0 5 7 0 5 8 0 5 9 0 6 0 0 
TTCAACCTTA GAATCCATCA CTTGGTAGAC AAGTATCCTT TGAGAATCCA ACATAGTCAT 
AAGTTGGAAT CTTAGGTAGT GAACCATCTG TTCATAGGAA ACTCTTAGGT TGTATCAGTA 
*************** 






Length of fragment = estimated to be 316 bp (Table 4.3) 
Arbitrary primer used : 5‘ AGA AGT GAA GGC TGG CAT GGC 3' 
1 0 2 0 3 0 4 0 5 0 6 0 
• * * * * * • * * • • * • * * • * • • 
AGTGAAGGCT GGCATGGCGA ACAGAAGGGA AACTCTGGTG GAGGTCCGTA GCGGTCCTGA 
TCACTTCCGA CCGTACCGCT TGTCTTCCCT TTGAGACCAC CTCCAGGCAT CGCCAGGACT 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
CGTGCAAATC GGTCGTCCGA CCTGGGTATA GGGGCGAAAG ACTAATCGAA CCATCTAGTA 
GCACGTTTAG CCAGCAGGCT GGACCCATAT CCCCGCTTTC TGATTAGCTT GGTAGATCAT 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
GCTGGTTCCC TCCGAAGTTT CCCTCAGGAT AGCTGGCGCY CTCGCTCTTT T T T T T T C C C -
CGACCAAGGG AGGCTTCAAA GGGAGTCCTA TCGACCGCGR GAGCGAGAAA AAAAAAGGG-
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
G A P TTTTTTTTTC CCGACGCTCA TCAGACCCCA GAAAAGGTGT 
G A P AAAAAAAAAG GGCTGCGAGT AGTCTGGGGT CTTTTCCACA 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
TGGTTGATAT AGACAGCAGG ACGGTGGCCA TGCCAGCCTT CACT 










Length of the fragment = 340 bp 





i 1 0 2 0 3 0 4 0 5 0 6 0 • * • • * • • * * * * * • * * • * * * • • * * 
I AGAAGTGAAG GCTGGCATGG CGCCTCCAAA TCCTTTCACT TTCTGGAACT TCTTTTCTGG 
TCTTCACTTC CGACCGTACC GCGGAGGTTT AGGAAAGTGA AAGACCTTGA AGAAAAGACC 
70 80 90 100 110 120 > 
CTGCAAAGTG AGTAGTAACC CTGTGCCAGT GCGATTGGCC TGGATGGCCC CGACACTCAG 
GACGTTTCAC TCATCATTGG GACACGGTCA CGCTAACCGG ACCTACCGGG GCTGTGAGTC 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
CTCCATCCGA CGTCCACGTC GAGTGCYCTC GTAACGGCTG AAGGTACCCA GAGCCGGTAA 
GAGGTAGGCT GCAGGTGCAG CTCACGRGAG CATTGCCGAC TTCCATGGGT CTCGGCCATT 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
GGTCACGGGG TCAAGAGAGT CACAGTACGA TGCATTACAG ACACAGACCA CTGAGCTGTA 
CCAGTGCCCC AGTTCTCTCA GTGTCATGCT ACGTAATGTC TGTGTCTGGT GACTCGACAT 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
GCCAAAGCTT TTGGGGATGC AGGGTTGGGC ACCATATGCC CAAGATACCG CCTGAAATAG 
CGGTTTCGAA AACCCCTACG TCCCAACCCG TGGTATACGG GTTCTATGGC GGACTTTATC < 
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0 
GAAGAATCCG ATGAGCCTGG CAGCCATGCC AGCCTTCACT 
CTTCTTAGGC TACTCGGACC GTCGGTACGG TCGGAAGTGA 
* * * * * * * * * * * * * * * * * * * 
f 
p 




Length of the fragment = 301 bp 
Arbitrary primer used : 5'AGA AGT GAA GGC TGG CAT GGC 3' 
1 0 2 0 3 0 4 0 5 0 6 0 • * * * * * * * * * * • • * * * • * * • * * * 
AGAAGTGAAG GCTGGCATGG CGAASCTCAG AGAGTCGTGT AGACCACAGC AGCCTCGCTA 
TCTTCACTTC CGACCGTACC GCTTSGAGTC TCTCAGCACA TCTGGTGTCG TCGGAGCGAT 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 > 
AGATGTCGGA AAAAAAGCCA AAAAGGATAA AGACCCAGTA AATAAATCTG GTGGCAAGGC 
TCTACAGCCT TTTTTTCGGT TTTTCCTATT TCTGGGTCAT TTATTTAGAC CACCGTTCCG 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
CAAGAAGAAG AAGTGGTCCA AAGGCAAGGT TCGGGACAAG TTGAATAATC TTGTCCTGTT 
GTTCTTCTTC TTCACCAGGT TTCCGTTCCA AGCCCTGTTC AACTTATTAG AACAGGACAA 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
CGACAAAGTG ACATACGACA AGCTCTGTAA GGAGGTTCCG AACTATAAGC TCATTACTCC 
GCTGTTTCAC TGTATGCTGT TCGAGACATT CCTCCAAGGC TTGATATTCG AGTAATGAGG 
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
AGCCGTGGTC TCTGAGAGAC TGAAGATTCG CGGTTCCTTG GCCATGCCAG CCTTCACTTC 
TCGGCACCAG AGACTCTCTG ACTTCTAAGC GCCAAGGAAC CGGTACGGTC GGAAGTGAAG < * • • * * • * * * * * • * * * • * * • * • 
I: 














{ Fragment 228/5.6 
i 
! 
i I j 
Length of the fragment = 300 bp 
Arbitrary primer used : 5 ‘ AGA AGT GAA GGC TGG CAT GGC 3 ‘ 
1 0 2 0 3 0 4 0 5 0 6 0 * • • • * * * • • * • * • * * * • * * * • * * * * * > 
GTGAAGGGCT GGCATKGCCA TGCCAAGGTC CATCTGGTTG GCATTGACAT TTTTACTGGG 
CACTTCCCGA CCGTAMCGGT ACGGTTCCAG GTAGACCAAC CGTAACTGTA AAAATGACCC 
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0 
AAGAAATATG AAGATATCTG CCCGTCAACT CATAATATGG ATGTCCCCAA CATCAAACGG 
TTCTTTATAC TTCTATAGAC GGGCAGTTGA GTATTATACC TACAGGGGTT GTAGTTTGCC 
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 
AATGACTTCC AGCTGATTGG CATCCAGGAT GGGTACCTAT CCCTGCTCCA GGACAGTGGG 
TTACTGAAGG TCGACTAACC GTAGGTCCTA CCCATGGATA GGGACGAGGT CCTGTCACCC 
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 
GAGGTACGAG AGGACCTTCG TCTGCCTGAA GGAGACCTTG GCAAGGAGAT TGAGCAGAAG 
CTCCATGCTC TCCTGGAAGC AGACGGACTT CCTCTGGAAC CGTTCCTCTA ACTCGTCTTC 
< -
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0 
TATGACTGTG GAGAAGAGAT CCTGATCACA GTGCTGTCTG CCATGCCAGC CTTCACTTCT 
ATACTGACAC CTCTTCTCTA GGACTAGTGT CACGACAGAC GGTACGGTCG GAAGTGAAGA • * * • * * • * • * * * * * • * • * * * * • • 
:j 
1 210 
Some of the sequences of the fragments were found to be related after analysed 
by Contig Manager of the software DNAsis and by visual examiniations. In 
particular, fragment 172/4.6 and 172/5.8 represented exactly the same sequence 
(Figure 4.4, A). Fragment 172/2.8, 172/3.1, 172/3.2 and 172/3.8 were found to have a 
common stretch of sequence (Figure 4.4, B). Base no. 115-388 of fragment 172/2.8, 
119-393 offragment 172/3.1, 141-413 offragment 172/3.2 and 287-560 of fragment 
172/3.8 represented the same DNA sequences (Figure 4.4, B). For fragment 172/2.8, 
a third stretch of arbitrary primer sequences was found at base no. 365-388 besides the 
two franking the sequences. For fragment 172/3.8, two additional arbitrary sequence 
were found at base 147-170 and 536-560 (see above). 
A. 
1 397 
I ^ 172/4.6 
1 397 
I ^ 172/5.8 
B. 
1 R 147R 287 560 840 
_ 172/3.8 
1 R 141 413 
卜 _| ^ 172/3.2 
1 119 393 
卜--| •! 172/3.1 
1 l l 5 388 
I … … •! 172/2.8 
Figure 4.4. Fragment analysis by DNAsis Contig Manager. A. The sequence of 172/4.6 
and 172/5.8 were found to be identical. B. Fragment 172/2.8, 172/3.2, 172/3.1 and 172/3.8 
were found to be related sequences. indicates identical sequence, 
^ indicates unique sequence. R is a stretch of sequence that happened twice in 172/3.8 and 
once in 172.3.2. The numbers on top of the lines indicate the base number (section 4.4.2). 
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4.4.3 BLASTN search result 
By feeding the fragment sequence in ASC II format into the BLASTN 
program. Four main sections of results were generated. The first section was a 
histogram reporting the number of database sequences satisfying various expectation 
thresholds (i.e. the E or expect parameter). The second section was a hit list showing 
a summary of the database sequence that satisfies the expect parameter (i.e. 0.75 in 
our search). This section contained 7 items including the database designation, 
accession number, locus name, description of the sequence, alignment score, p value 
(probability) and the number of high-scoring segment pair (HSP). The third section 
showed the actual alignment; the number of alignments shown was governed by the 
parameter V. The final section was a summary of all the search parameters and query 
details. The following is a typical search having significant matches with some ofthe 
sequences in the database (Figure 4.5). The example was done by using the fragment 
sequence of 228/5.2. A summary of the matching result among all the fed-in 
sequences was tabulated (Table 4.4). Only 5 out of the 17 sequences were matched 
significantly with known sequences in the database. The exact alignments in the 






Database: Non-redundant GenBank+EMBL+DDBJ+PDB sequences 
230,088 sequences； 314,684,217 total letters. 
Searching done 
Observed Numbers of Database Sequences Satisfying 
Various EXPECTation Thresholds (E parameter values) 




V Observed Counts--> 
10000 652 214 |===================================================== 
6310 438 170 |========================================== 
3980 268 77 | = = = = = = = = = = = = 
2510 191 63 I = = = = = = = = = = 
1580 128 23 1===== 
1000 105 30 1====== 
631 75 15 I=== 
398 60 12 1=== 
251 48 9 1 = 
158 39 9 1== 
100 30 3 I ： 
63.1 27 9 1== 
39.8 18 2 I : 
25.1 16 2 I: 
15.8 14 2 I : 
10.0 12 0 I 





Sequences producing High-scoring Segment Pairs: Score P(N) N 
gb|M24119|MUSGCB Mouse glucocerebrosidase mRNA, comple... 1593 2.2e-125 1 
gbIK02920|HUMGCBL Human lysosomal glucocerebrosidase mR... 1086 5.2e-83 1 
dbj|Dl3286|HUMGCA HumanmRNAfor glucocerebrosidase, co... 1086 5.7e-83 1 
gb！Ml92851HUMGCBPRC Human glucocerebrosidase mRNA, comple... 1077 3,2e-82 1 
gb|Ml6328|HUMGCB Human glucocerebrosidase mRNA, comple... 1077 3.3e-82 1 
gb|l09351| Sequence 1 from Patent WO 8905850 1005 2.9e-76 1 
gbIJ030591HUMGCBl Human glucocerebrosidase (GCB) gene, ... 678 1.2e-66 2 
gbIJ03060|HUMGCB2 Human glucocerebrosidase p s e u d o g e n e ' … 258 4.3e-35 4 
gb|M89949|MUSGBA BALB/c glucocerebrosidase (Gba) gene,... 302 2.3e-15 1 
gbIM202481HUMGCBDA Human glucocerebrosidase gene, 5‘ end. 231 6.3e-10 1 





>gb|M24119|MUSGCB Mouse glucocerebrosidase mRNA, complete cds. 
Length = 1684 
Minus Strand HSPs: 
Score = 1593 (440.8 bits), Expect = 2.2e-125, P = 2.2e-125 
Identities = 324/332 (97%), Positives = 325/332 (97%), Strand = Minus / Plus 
I 
! Q u e r y ： 3 3 3 G C T G G C A T G G C T G C C A G G C T C A T C G G A T T C T T C C T A T T T C A G G C G G T A T C T T G G G C A T A T 2 7 4 
i I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I Sbjct: 81 GGTGTCATGGCTGCCAGGCTCATCGGATTCTTCCTATTTCAGGCGGTATCTTGGGCATAT 140 
i 
1 
Query: 273 GGTGCCCAACCCTGCATCCCCAAAAGCTTTGGCTACAGCTCAGTGGTCTGTGTCTGTAAT 214 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
! S b j c t : 1 4 1 G G T G C C C A A C C C T G C A T C C C C A A A A G C T T T G G C T A C A G C T C A G T G G T C T G T G T C T G T A A T 2 0 0 
I 
I Query: 213 GCATCGTACTGTGACTCTCTTGACCCCGTGACCTTACCGGCTCTGGGTACCTTCAGCCGT 154 
I ! I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I i I I I I I I I I I I I I I I I I 
S b j c t : 2 0 1 G C A T C G T A C T G T G A C T C T C T T G A C C C C G T G A C C T T A C C G G C T C T G G G T A C C T T C A G C C G T 2 6 0 
Query: 153 TACGAGRGCACTCGACGTGGACGTCGGATGGAGCTGAGTGTCGGGGCCATCCAGGCCAAT 94 
I I I I I 1 + 1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 2 6 1 TACGAGAGCACTCGACGTGGACGTCGGATGGAGCTGAGTGTCGGGGCCATCCAGGCCAAT 3 2 0 
Q u e r y : 9 3 CGCACTGGCACAGGGTTACTACTCACTTTGCAGCCAGAAAAGAAGTTCCAGAAAGTGAAA 3 4 
I I I I I I I I I I I I I I I I I I I I I 1 I I I I I I I I I I I I I ！ I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 3 2 1 CGCACTGGCACAGGGTTACTACTCACTTTGCAGCCAGAAAAGAAGTTCCAGAAAGTGAAA 3 8 0 
Query: 33 GGATTTGGAGGCGCCATGCCAGCCTTCACTTC 2 
I I I I I I I I I I I I I I I I I I I I I I I I I I I Sbjct: 381 GGATTTGGAGGCGCCATGACAGACGCCACTGC 412 
>gbIK02920|HUMGCBL Human lysosomal glucocerebrosidase mRNA, complete cds. 
Length = 1792 
Minus Strand HSPs: 
Score = 1086 (300.5 bits), Expect = 5.2e-83, P = 5.2e-83 
Identities = 261/317 (82%), Positives = 262/317 (82%), Strand = Minus / Plus 
Query: 328 CATGGCTGCCAGGCTCATCGGATTCTTCCTATTTCAGGCGGTATCTTGGGCATATGGTGC 269 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 45 CATGGCTGGCAGCCTCACAGGATTGCTTCTACTTCAGGCAGTGTCGTGGGCATCAGGTGC 104 
Query: 268 CCAACCCTGCATCCCCAAAAGCTTTGGCTACAGCTCAGTGGTCTGTGTCTGTAATGCATC 209 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 105 CCGCCCCTGCATCCCTAAAAGCTTCGGCTACAGCTCGGTGGTGTGTGTCTGCAATGCCAC 164 
Query: 208 GTACTGTGACTCTCTTGACCCCGTGACCTTACCGGCTCTGGGTACCTTCAGCCGTTACGA 149 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 165 ATACTGTGACTCCTTTGACCCCCCGACCTTTCCTGCCCTTGGTACCTTCAGCCGCTATGA 224 
Query: 148 GRGCACTCGACGTGGACGTCGGATGGAGCTGAGTGTCGGGGCCATCCAGGCCAATCGCAC 89 
| + | I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 225 GAGTACACGCAGTGGGCGACGGATGGAGCTGAGTATGGGGCCCATCCAGGCTAATCACAC 284 
Query: 88 TGGCACAGGGTTACTACTCACTTTGCAGCCAGAAAAGAAGTTCCAGAAAGTGAAAGGATT 29 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 285 GGGCACAGGCCTGCTACTGACCCTGCAGCCAGAACAGAAGTTCCAGAAAGTGAAGGGATT 344 
Query: 28 TGGAGGCGCCATGCCAG 12 
I I I I I I I I I I I I I I I 












Query As Used Computed 
Strand MatID Matrix name Lambda K H Lambda K H 
+1 0 +5,-4 0.192 0.173 0,357 same same same 
-1 0 +5,-4 0.192 0.173 0.357 same same same 
Query 
Strand MatID Length Eff. Length E S W T X E2 S2 
+1 0 340 340 0.75 128 11 N/A 73 0.023 76 
-1 0 340 340 0.75 128 11 N/A 73 0.023 76 
Statistics: 
Query Expected Observed HSPs HSPs 
Strand MatID High Score High Score Reportable Reported 
+1 0 122 (33.8 bits) 120 (33.2 bits) 0 0 
-1 0 122 (33.8 bits) 1593 (440.8 bits) 16 16 
Query Neighborhd Word Excluded Failed Successful Overlaps 
Strand MatID Words Hits Hits Extensions Extensions Excluded 
+1 0 325 24262 1955 21486 821 0 
-1 0 325 26406 2265 23259 882 0 
Database: Non-redundant GenBank+EMBL+DDBJ+PDB sequences 
Release date: March 22, 1996 
Posted date: 3:31 AM EST Mar 22, 1996 
# of letters in database: 314,684,217 
# of sequences in database: 230,088 
# of database sequences satisfying E: 11 
No. of states in DFA: 224 (224 KB) 
Total size of DFA: 232 KB (256 KB) 
Time to generate neighborhood: 0.02u 0.01s 0.03t Real: 00:00:00 
No. of processors used: 4 
Time to search database: 20.07u 2.19s 22.26t Real: 00:00:09 
Total cpu time: 20.11u 2.23s 22.34t Real: 00:00:09 
Figure 4.5. A typical BLASTN search result demonstrated by fragment 228/5.2. The 
results had four parts, namely, A. histogram of number of database sequences; B. hit list; 
C. alignments of the query with the database sequence; D. the search details (see also text). 
^ 
l'.v 







A. Fragment 44/3.1 (Length estimated to be 870 bp, Table 4.3) 
• • 
>gb|M22664 |MUSMTREPA Mouse MT repetitive element DNA. 
Length = 400 
Minus Strand HSPs: 
Score = 1183 (328.6 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121 
Identities = 254/277 (91%), Positives = 255/277 (92%), Strand = Minus / Plus 
Query: 662 TGTCTTAGTCAAGGTCTCTATTCCTGCACAAACATCATGACCAAGAAGCGAGTTGGGGAG 603 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 2 TGTCTTAGTCAGGGTCTCTATTCCTGCACAAACATCATGACCAAGAAGCAAGCTGGGGAG 61 
Query: 602 GAAAGGGTTTATTTGGCTTACACTTCCATGCTGCTGTTCATCACC7^AAGGAAGTCAGGCC 543 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 62 GAAAGGGTTTATTCGGCTTACACTTCCATGCTGCTGTTCATCACCAAAGGAAGTCAGGAC 121 
Query: 542 TGGAACTCAAGCAGGTCAGGAAGCAGGAGCTGATGCAGAGGCCATGAAGGGATGTTCCTT 483 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 122 TGGAACTCAAGCAGGTCAGAAAGCAGGAGCTGATGCAGAGGCCATGGAGGGATGTTCCTT 181 
Query: 482 ACTATCTTGCCTCCCCTGGCTTGCTCAGCCTGCTCTCTTATAGAACCCAAGACTGCCAGT 423 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 182 ACTAGCTTGCCTCCTCTGGCTTGCTCAGCCTGCTCTCTTATGGAATCCAAGACTGCCAGC 241 
Query: 422 CCAGAGATGGTCCCMCCCACAAGGGGCCTTTCCCCCT 386 
I I I I I I I I I I I +1 I I I I I I I I I I I I I I Sbjct: 242 CCAGAGATGTCCCACCCACAAGGGGCCCTTCCCCCTT 278 
Score = 344 (95.6 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121 
Identities = 74/82 (90%), Positives = 74/82 (90%), Strand = Minus / Plus 
Query: 413 GTCCCMCCCACAAGGGGCCTTTCCCCCTTGATCACTAATTGAGAAAATGCCTTACAGCTA 354 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 250 GTCCCACCCACAAGGGGCCCTTCCCCCTTGATCACTAATTGAGAAAATGCCTTACAGTTG 309 
Query: 353 GATCTCATGGGGGBHTTTCCAC 332 
I I I I I I I I I I I I I I I I I I 
Sbjct: 310 GATCTCATGGAGGCATTTCCTC 331 — 









B. Fragment 228/5.1 (Length estimated to be 316 bp, Table 4.3) 
>emb|X00525|MMRNA02 Mouse 28S ribosomal RNA 
！ Length = 4712 
Plus Strand HSPs: 
Score = 727 (201.2 bits), Expect = 1.2e-74, Sum P(2) = 1.2e-74 
Identities = 150/157 (95%), Positives = 151/157 (96%) , Strand = Plus / Plus 
Q u e r y : 1 1 GGCATGGCGAACAGAAGGGAAACTCTGGTGGAGGTCCGTAGCGGTCCTGACGTGCAAATC 7 0 
I I I S 1 I 1 I I ! ! I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 1 3 5 6 GGCAGGGCGAAGCCAGAGGAAACTCTGGTGGAGGTCCGTAGCGGTCCTGACGTGCAAATC 1 4 1 5 
Query: 71 GGTCGTCCGACCTGGGTATAGGGGCGAAAGACTAATCGAACCATCTAGTAGCTGGTTCCC 130 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 1416 GGTCGTCCGACCTGGGTATAGGGGCGAAAGACTAATCGAACCATCTAGTAGCTGGTTCCC 1475 
Q u e r y : 1 3 1 TCCGAAGTTTCCCTCAGGATAGCTGGCGCYCTCGCTC 167 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I 1 + 1 I I I I I I Sbjct: 1476 TCCGAAGTTTCCCTCAGGATAGCTGGCGCTCTCGCTC 1512 
Score = 314 (86.9 bits), Expect = 1.2e-74, Sum P(2) = 1.2e-74 
Identities = 66/70 (94%), Positives = 66/70 (94%), Strand = Plus / Plus 
Q u e r y : 1 8 8 TCCCGACGCTCATCAGACCCCAGAAAAGGTGTTGGTTGATATAGACAGCAGGACGGTGGC 2 4 7 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 1 7 1 9 TGCCGACGCTCATCAGACCCCAGAAAAGGTGTTGGTTGATATAGACAGCAGGACGGTGGC 1 7 7 8 
Query: 248 CATGCCAGCC 257 
I I I I I I I 
Sbjct: 1779 CATGGAAGTC 1788 
>gblM30952|ORARGITX Orangutan 28S ribosomal RNA gene fragment. 
Length = 2487 
Plus Strand HSPs: 
Score = 717 (198.5 bits), Expect = 3.5e-74, Sum P(2) = 3.5e-74 
Identities = 148/155 (95%), Positives = 149/155 (96%), Strand = Plus / Plus 
Query: 11 GGCATGGCGAACAGAAGGGAAACTCTGGTGGAGGTCCGTAGCGGTCCTGACGTGCAAATC 70 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 1220 GGCAGGGCGAAGCCAGAGGAAACTCTGGTGGAGGTCCGTAGCGGTCCTGACGTGCAAATC 1279 
Query: 71 GGTCGTCCGACCTGGGTATAGGGGCGAAAGACTAATCGAACCATCTAGTAGCTGGTTCCC 130 
‘ I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 1280 GGTCGTCCGACCTGGGTATAGGGGCGAAAGACTAATCGAACCATCTAGTAGCTGGTTCCC 1339 
Query: 131 TCCGAAGTTTCCCTCAGGATAGCTGGCGCYCTCGC 165 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I +1 I I I I 
Sbjct: 1340 TCCGAAGTTTCCCTCAGGATAGCTGGCGCTCTCGC 1374 
Score = 314 (86.9 bits), Expect = 3.5e-74' Sum P(2) = 3.5e-74 
Identities = 66/70 (94%), Positives = 66/70 (94%)' Strand = Plus / Plus 
Query: 188 TCCCGACGCTCATCAGACCCCAGAAAAGGTGTTGGTTGATATAGACAGCAGGACGGTGGC 247 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I s b j c t : 1 5 9 0 TGCCGACGCTCATCAGACCCCAGAAAAGGTGTTGGTTGATATAGACAGCAGGACGGTGGC 1 6 4 9 
Query: 248 CATGCCAGCC 257 
I I I I I I I 




I, ! i 
, 217 
C, Fragment 228/5.3 (Length = 301) 
>embIX62482|RRRPS25 R.rattus mRNA for ribosomal protein S25 
'i L e n g t h = 4 6 6 
:丨 Plus Strand HSPs: 
^ Score = 914 (252.9 bits), Expect = 3.4e-71, P = 3.4e-71 
Identities = 206/235 (87%), Positives = 206/235 (87%), Strand = Plus / Plus 
1 Query: 60 AAGATGTCGGAAAAAAAGCCAAAAAGGATAAAGACCCAGTAAATAAATCTGGTGGCAAGG 119 
j I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 6 8 AGGATGCCGGAAAGTCGGCCAAAAAAGACAAGGACCCAGTAAATAAATCTGGTGGCAAGG 1 2 7 
> 
^ Query: 120 CCAAGAAGZ^GAAGTGGTCCAAAGGCAAGGTTCGGGACAAGTTGAATAATCTTGTCCTGT 179 
j I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 1 2 8 CCAAAAAGAAGAAGTGGTCCAAAGGCAAAGTTCGGGACAAGCTGAACAATCTCGTCCTGT 1 8 7 
I Q u e r y : 180 TCGACAAAGTGACATACGACAAGCTCTGTAAGGAGGTTCCGAACTATAAGCTCATTACTC 2 3 9 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 1 8 8 T T G A C A A A G C T A C T T A C G A C A A A C T T T G T A A G G A A G T T C C C A A C T A T A A G C T T A T T A C T C 2 4 7 
‘ Query: 240 CAGCCGTGGTCTCTGAGAGACTGAAGATTCGCGGTTCCTTGGCCATGCCAGCCTT 294 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I ！ I I I I I I I 
S b j c t : 2 4 8 C A G C T G T G G T C T C C G A G A G A C T G A A G A T T C G A G G T T C C T T G G C C A G G G C A G C C C T 3 0 2 
Minus Strand HSPs: 
< Score = 172 (47.6 bits), Expect = 0.00017, P = 0.00017 Identities = 40/47 (85%), Positives = 40/47 (85%), Strand = Minus / Plus 
Q u e r y : 5 6 G A G G C T G C T G T G G T C T A C A C ( 3 A C T C T C T G A G S T T C G C C A T G C C A G C C 1 0 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 2 G T G G C T G C A G T G G T C C A C A C T A C T C T C T G A G T T T C G C C A T G C C G C C C 4 8 
>gbIU10900IKNU10900 Rattus norvegicus Sprague-Dawley alcohol dehydrogenase 
class I (ADH3) gene, 5‘ region, and ribosomal protein S25 
pseudogene, complete cds. 
Length = 3113 
Plus Strand HSPs: 
Score = 869 (240.5 bits), Expect = 7.5e-65, P = 7.5e-65 
Identities = 201/235 (85%), Positives = 201/235 (85%), Strand = Plus / Plus 
Query: 60 AAGATGTCGGAAAAAZ^GCCAAAAAGGATAAAGACCCAGTAAATAAATCTGGTGGCAAGG 119 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 2544 AGGATACCGGAAAATCGGCCAAAAAAGACAAAGACCCAGTAAATAAATCTGGTGGCAAGG 2603 
Query: 120 CCAAGAAGAAGAAGTGGTCCAAAGGCAAGGTTCGGGACAAGTTGAATAATCTTGTCCTGT 179 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I ！ I I I 
Sbjct: 2604 CCAAAAAGAAGAAGTGGTCCAAAGGCAAAGTTTGGGACAAGCTGAACAATCTTGTCCTAT 2663 
Query: 180 TCGACAAAGTGACATACGACAAGCTCTGTAAGGAGGTTCCGAACTATAAGCTCATTACTC 239 
‘ I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct: 2 664 TTGACAAAGCTACTTAGGACAAACTTTGTAAGGAAGTTTCCAACTATAAGCTTATTACTC 2723 
Q u e r y : 240 CAGCCGTGGTCTCTGAGAGACTGAAGATTCGCGGTTCCTTGGCCATGCCAGCCTT 294 
‘ I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 2724 CAGCTGTGGTCTCCGAGAGACTGAAGATTCGAGGTTCCTTGGTCAGGACCTACTT 2778 
Minus Strand HSPs: 
Score = 201 (55.6 bits), Expect = 7.3e-07, P = 7.3e-07 
球 Identities = 48/59 (81%)‘ Positives = 49/59 (83%), Strand = Minus / Plus 
Query: 68 CGACATCTTAGCGAGGCTGCTGTGGTCTACACGACTCTCTGAGSTTCGCCATGCCAGCC 10 
‘ I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I +1 I I I I I I I I I I I I 
f S b j c t : 2 4 6 6 CGACATCTTAGTGTGGTTGCAGTGGTCCACACTACTCTGTGAACTTCGCCATGCCGCCC 2 5 2 4 








D. Fragment 228/5.6 (Length = 300 bp) 
>gb|M23419|HUMEIF4D Human initiation factor 4D 9eIF 4D) mRNA, complete cds. 
Length = 558 
Plus Strand HSPs: 
Score = 1287 (356.2 bits), Expect = 2.4e-102, P = 2.4e-102 
Identities = 270/287 (94%), Positives = 271/287 (94%), Strand = Plus / Plus 
Q u e r y : 3 GAAGGGCTGGCATKGCCATGCCAAGGTCCATCTGGTTGGCATTGACATTTTTACTGGGAA 62 
I I I I I I 1 I +! I I I 1 I I I I S I I I I I I I I I I I I I I I I I I I I I ! I I I I I I I I I I I 
S b j c t : 184 GACTGGCAAGCACGGCCACGCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAA 2 4 3 
Query: 63 GAAATATGAAGATATCTGCCCGTCAACTCATAATATGGATGTCCCCAACATCAAACGGAA 122 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 2 4 4 GAAATATGAAGATATCTGCCCGTCAACTCATAATATGGATGTCCCCAACATCAAAAGGAA 3 0 3 
Q u e r y : 1 2 3 T G A C T T C C A G C T G A T T G G C A T C C A G G A T G G G T A C C T A T C C C T G C T C C A G G A C A G T G G G G A 1 8 2 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 3 0 4 TGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGCGGGGA 3 6 3 
Q u e r y : 1 8 3 G G T A C G A G A G G A C C T T C G T C T G C C T G A A G G A G A C C T T G G C A A G G A G A T T G A G C A G A A G T A 2 4 2 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 3 6 4 G G T A C G A G A G G A C C T T C G T C T C C C T G A G G G A G A C C T T G G C A A G G A G A T T G A G C A G A A G T A 4 2 3 
Query: 243 TGACTGTGGAGAAGAGATCCTGATCACAGTGCTGTCTGCCATGCCAG 289 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I Sbjct: 424 CGACTGTGGAGAAGAGATCCTGATCACGGTGCTGTCTGCCATGACAG 470 
>gbIS72024|S72024 eif-5A=eukaryotic initiation factor 5A {clone cos 9.1} 
[human, placenta, Genomic, 558 nt] 
Length = 558 
! 
i Plus strand HSPs: 
I 
Score = 1269 (351.2 bits), Expect = 7.5e_101, P = 7.5e-101 
Identities = 268/287 (93%), Positives = 269/287 (93%), Strand = Plus / Plus 
Query- 3 GAAGGGCTGGCATKGCCATGCCAAGGTCCATCTGGTTGGCATTGACATTTTTACTGGGAA 62 
‘ I I I I I I I I +1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 184 GACTGGCAAGCACGGCCACGCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAA 243 
Query: 63 GAAATATGAAGATATCTGCCCGTCAACTCATAATATGGATGTCCCCAACATCAAACGGAA 122 
“ I I I I I I I I I I I I I I I I I I I I I I ！ I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 244 GAAATATGAAGATATCTGCCCATCAACTCATAATATGGATGTCCCCAACATCAGAAGGAA 303 
Query: 123 TGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCCCTGCTCCAGGACAGTGGGGA 182 
‘ I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 304 TGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGTGGGGA 363 
Q u e r y : 1 8 3 G G T A C G A G A G G A C C T T C G T C T G C C T G A A G G A G A C C T T G G C A A G G A G A T T G A G C A G A A G T A 2 4 2 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 364 GGTACCAGAGGACCTTCGTCTCCCTGAGGGAGACCTTGGCAAGGAGATTGAGCAGAAGTA 423 
Query: 243 TGACTGTGGAGAAGAGATCCTGATCACAGTGCTGTCTGCCATGCCAG 289 




L :. k-1 
219 
>gb|S72038|S72038 {pseudogene} eif-5A=eukaryotic initiation factor 5A {clone 
cos 7.2} [human, placenta, Genomic, 558 nt] 
Length = 558 
Plus Strand HSPs: 
Score = 1148 (317.7 bits), Expect = 9.1e-91, P = 9.1e-91 
Identities = 255/288 (88%), Positives = 256/288 (88%), Strand = Plus / Plus 
j 
Query: 2 TGAAGGGCTGGCATKGCCATGCCAAGGTCCATCTGGTTGGCATTGACATTTTTACTGGGA 61 
I I I I I I I I I +1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 183 TGACTGGCAAGCACGGCCATGCCAAGGTCCACCTGGTTGGTACTGACATCTTTACTGGGA 242 
Query: 62 AGAAATATGAAGATATCTGCCCGTCAACTCATAATATGGATGTCCCCAACATCAAACGGA 121 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 243 AGAAATATGGAGATATCTGCCTGTCAACTCATAACATGGATGTCCCCAGCATCAAAAGGA 302 
Query: 122 ATGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCCCTGCTCCAGGACAGTGGGG 181 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 303 ATGACTTCCAGCTGATTGGCATCCAGGATGGGCACCTATCACTGCTCCAGGACAGCATGG 362 
Query: 182 AGGTACGAGAGGACCTTCGTCTGCCTGAAGGAGACCTTGGCAAGGAGATTGAGCAGAAGT 241 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct: 363 AGGTGCGAGAGGACTTTCGTCTGCATGAGGGAGACCTTGGCAAAGAGACTGAGCAGAAGT 422 
Query: 242 ATGACTGTGGAGAAGAGATCCTGATCACAGTGCTGTCTGCCATGCCAG 289 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I Sbjct: 423 ACAGCTGTGGAGAAGAGATCCTGATCATGGTGCTGTCTGCCATGACCG 470 
Figure 4.6. BLASTN search result (alignments) of fragment 44/3.1 (A), 228/5.1(B), 
228/5.3(C) and 228/5.6 (D). Only significant alignments were shown. In the case where the 
same genes or sequences of different species were matched with the query sequences, only 











Table 4.4. Summary of matching results by feeding the fragment sequences into the 
BLASTN program. 
Gene fragment Matching result 
**44/3.1 MT sequence repetitive element DNA 
1 
S j 
I **228/5.1 Mouse 28S ribosomal RNA 
i 
Orangutan 28S ribosomal RNA gene fragment 
I Chimpanzee 28S ribosomal RNA gene 
I 
I Human 28S ribosomal RNA gene 
j 
j 
*228/5.2 Mouse glucocerebrosidase mRNA, complete cds. 
Human lysosomal glucocerebrosidase mRNA, complete cds. 
I Human mRNA for glucocerebrosidase mRNA, complete cds. 
**228/5.3 R. rattus mRNA for ribosomal protein S25 
Rattus norvegicus Sprague-Dawley alcohol dehydrogenase Class I (ADH3) gene, 
5'-region, and ribosomal protein S25 pseudogene, complete cds. 
Human ribosomal protein S25 mRNA, complete cds. 
**228/5.6 Human initiation factor 4D (eIF 4D) mRNA, complete cds. 
eif-5A=eukaryotic initiation factor 5A{clone cos9.1} 
{pseudogene} eif-5A=eukaryotic initiation factor 5A {clone cos 7.2} [human, 
placenta, genomic, 558 nt] 
Five o f t h e gene fragments matched with known sequences in the Genbank (44/3.1, 228/5.1, 
228/5.2, 228/5.3 and 228/5.6) were shown while others showed many insignificant matches 
(147/1.4, 172/2.8，172/3.1, 172/3.2, 172/3.8, 172/4.6, 172/5.2, 172/5.6 and 172/5.8) or no 
matches (147/1.5, 147/1.6 and 172/4.1) at all under the current cutoff scores and parameters 











4.4.4 Primer design of the sequenced fragments 
Primers for RT-PCR (section 4.4.5) were designed with the help of the 
software OLIGO™ C^^ational BioSciences). False priming, internal stability, primer-
dimer formation and self-complementarity were checked. The melting temperature of 
the primers were calculated from 2 ^C (A+T) + 4 ^C (G+C) as shown in Table 4.5. 
The expected product sizes were also shown. Gene fragments 228/5.1 matched with 
28S ribosomal RNA were neglected for the moment. 
Table 4.5. Summary of designed primers based on sequencing result in section 
4.4.2. 
Fragment no. Sequence (5，to 3，) Tm Product 
CO* size 
44 /3 .1 u p p e r p r i m e r 1 ~ TAA ATG AGG TAA CTG ATG TGG GA 64 ~ ^ 
lower p r i m e r 1 CTT AGT GAT CAG AGA AAT GCA A A ^ 64 
u p p e r p r i m e r 2 CCC CCA TGA GAT CTA GCT GTA 64 ~ ~ ^ 
lower p r i m e r 2 CCT GCA CAA ACA TCA TGA CCA A ~ 64 
147/1 .4 u p p e r p r i m e r CAT GTG GTT GCT GGG A T T TGA A — 6 4 ~ ~ W l 
lower p r i m e r CAT GTG GTT GCT GGG ATT TGA A — 64 
147/1.5 u p p e r p r imer CCC CCA AAA TCA GAG TAG ACA TA 66 >286 
l ower p r imer GCT TCT GGC TGC TCT CCC TC 66 
147/1 .6 u p p e r p r imer _AGC ACC ACT CTC AGG GGA ATC 一 66 ~ ~ ^ ~ ~ 
lower p r i m e r TCC AAA CAG TAC TAC CCC ATG C — 6 6 
228 /5 .2 u p p e r p r imer TTC TGG CTG CAA AGR GAG TAG TA “ 6 6 2 l 5 
lower p r imer CCC AAC CCT GCA TCC CCA AAA 6 6 
228 /5 .3 u p p e r p r imer CTC GCT AAG ATG TCG GAA AAA AA — 6 4 ~ ~ ~ ^ 
lower p r imer AAC CGC GAA TCT TCA GTC TCT C 6 6 
228 /5 .6 u p p e r p r imer CAT CTG GTT GGC ATT GAC ATT T T T 6 6 — ~ ~ ~ ^ ~ ~ ~ 
lower p r imer GAT CTC TTC TCC ACA GTC ATA CT “ ^ ~ 
172/3.2 u p p e r p r imer TTG CTG GAA GAA GTG CGT CAC 64 3 0 3 
lower p r imer GTC CTG ATC CAT GCA ACA CAA ~ ~ ^ ~ 
172/4.1 uppe r p r imer AGA GGA GGC GGC TGC GGA AA 6 6 H 5 
lower p r imer GAG TTC CTG AAG CTG GCC TGA ~ " ^ ~ ~ 
172/5.2 uppe r p r imer GAA ACC ACA GAG ATC TAA CCG G 66 2 2 2 
lower p r imer GGG GAA GAG CAG TGT ATT ACC T ^ ~ 
172/5.6 u p p e r p r i m e r TGG AGG CAG GGC TTT GGG G ~ 6 4 ~ ~ 4 8 8 
lower primer TTT CTA AAA CAC ATG TAT GGG G T ~ 62 
172/4.6 u p p e r p r imer CTG TGG GAG TGG GCT TTG AGA 66 — ~ ~ ^ ~ ~ ~ 
172/5.8 lower p r imer GAA AAG GCT CTG AAA TGG GGG 66 ~~| 
*Tm was calculated from the formula 2 °C (A+T) + 4 � C (G+C) 
I These primer sequences were selected internal to the arbitrary primer sequence used in RAP-
PCR. See also section 4.4.2 for the exact positions of these primers in the subcloned gene 
I 
fragments. 
I • i (• 
f 
: 222 
4.4.5 Expression profile of isolated genes in midazolam-, biochanin 
A-induced JCS cells and mouse embryos 
RT-PCR were performed on RNA samples from JCS cells incubated with 
midazolam (10 ^ig/ml) for 0, 1, 5, 18 and 48 hours, JCS cells treated with 50 ^M 
biochanin A for 0，1，5, 18 and 46 hours, and mouse embryo at different 
I 
I developmental stages (7.5, 9.5, 11.5, 15.5 and 17.5 dpc). Two to three different cycle 
i 
! numbers ranging from 20-35 were performed. For some samples, touchdown PCR 
I protocol was necessary to increase the specificity of primer annealing (Figure 4.7). 
j 
i 
The expression profiles of the isolated genes (in the form of short fragments) 
i 
i 
1 during the midazolam-induced JCS cell differentiation can be divided into 6 types 
I 
I (Figure 4.7, column 1, Table 4.6). Expression patterns type A and B described genes 
that were down-regulated during the midazolam-induced differentiation. The 
expression patterns of three genes belonged to type A. They were down-regulated 
starting at the time point 5 hour (Figure 4.7 A). The expression patterns of other two 
genes belonged to type B where a more gradual decrease in expression was observed 
(Figure 4.7 B). Expression patterns type C and D described genes that were up-
regulated after midazolam treatment. One gene having type C expression pattem was 
observed; it was transiently up-regulated at 1 hour after midazolam induction (Figure 
4.7 C). On the other hand, two genes belonging to type D expression pattem showed 
a steady increase in expression level throughout the midazolam-induced 
differentiation (Figure 4.7 D). Finally, type E and F expression patterns indicated 
‘false positives' of this investigation. Two genes showed no change in expression 
level (type E) during the midazolam-induced differentiation (Figure 4.7 E). Two other 
genes belonging to type F expression pattem showed very low, if any, expression level 
as examined by 50 cycles of RT-PCR (Figure 4.7 F). Type A-D expression patterns 
were also found in the second cDNA probe screening in section 3.4.7 (Figure 3.9). 
Comparing the expression profile of these genes determined by RT-PCR and by the 
|i second round cDNA probe screening, we found that, ofthe 12 gene fragments studied 
by RT-PCR, the expression pattem of 7 gene fragments could be predicted in advance 
by analyzing the hybridization signals in the 2nd round screening (Table 4.6). 
(. 





i confirmed to be differentially expressed (i.e. genes that had expression patterns A-D) 
I during midazolam-induced differentiation (Table 4.6). These isolated genes were then 
I 
I named according to their fragment numbers for the rest of the discussion, 
i 
Table 4.6. Expression profiles of the isolated gene (in the form of short fragments) in 
midazolam-induced JCS cells studied by RT-PCR and predicted by the second round 
cDNA probe screening in section 3.4.7 
Types of expression profile in Genes represented by the Genes represented by the 
midazolam-induced JCS cells isolated fragments showing isolated fragments 
the type of expression showing the type of 
profile determined by RT- expression profile in the 
PCR 2nd round screening 
—XreSnstitut^v^rei^sTorTat ―™™"^^i@j^'jp^i:g;p7^^5"^""""";^;^];T^^;^Ui[r^^^n^ 
very early hour of 172/4.6 (=172/5.8), 
midazolam treatment, 172/4.1, * 172/5.2, 
down-regulation occurred * 172/5.6 
at the time point 5 hour. 
B. Late and gradual down- *147/1.5, 172/4.6 (172/5.8) *147/1.5, 147/1.6 
regulation 
C. Transient up-regulation at * 172/32 172/2.8, 172/3.8 (related to 
early hour (at 1 hour) * 172/3.2) 
D. Steady up-regulation *228/5.2, *228/5.3 147/1.4, *228/5.2， 
*228/5.3,228/5.6 
E. No change in expression as 172/4.1, 228/5.6 not applicable 
observed in 25 cycles of 
RT-PCR 
F. No expression or very low 147/1.4, 147/1.6 not applicable 
expression as determined 
by 50 cycles o fRT-PCR 
* Gene fragments with the corresponding genes that showed the same expression pattem 
determined by both RT-PCR and predicted by the second round screening. The genes 
represented by 8 fragments (A-D) were confirmed to be differentially expressed in 
•b 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A. Genes down-regulated at 5 hours in midazolam-treated JCS cells 
Genes 44/3.1，172/5.2 and 172/5.6 showed a constitutive expression in 
j untreated JCS cells and in cells treated with midazolam (10 ^ig/ml) for 1 hour. After 5 
\ hour incubation with midazolam, the expression of the genes was decreased and 
remained at that low level thereafter (Figure 4.7 A, column 1, Table 4.7). On the 
other hand, the expression profiles of these genes in biochanin A-treated samples and 
at different stages of embryonic development were very different. The three genes 
also showed distinct expression profiles from one another in these samples (Figure 4.7 
A, column 2 and 3, Table 4.7). In contrast to the expression profile of midazolam-
treated samples, the gene 44/3.1 had a basal expression in untreated JCS cells and JCS 
cells treated with 50 ^M biochanin A for 1, 5 and 18 hours. However, the expression 
level was up-regulated significantly after incubation with biochanin A for 46 hours. 
The expression pattem of genes 172/5.2 and 172/5.6 in biochanin A-treated samples 
were similar; both ofthem were transiently down-regulated at 1 hour after incubation 
with biochanin A. During embryonic development, genes 44/3.1 and 172/5.2 were 
more alike in their expression profile, where biphasic expression peaked at 11.5 and 
17.5 dpc were observed. For gene 172/5.6, the expression level was up-regulated after 
9.5 dpc and sustained at that elevated level throughout the rest of the development. 
B. Genes steadily down-regulated in midazolam-treated JCS cells 
The expression levels of two genes 147/1.5 and 172/4.6 (=172/5.8) were 
down-regulated by midazolam at late hours in a gradual manner (Figure 4.7 B, column 
1, Table 4.7). The down-regulation in expression was notable at 48 hours for both 
genes. Despite their similar expression profiles in midazolam-treated cells, the 
expression patterns of the two genes were completely different in biochanin A-treated 
JCS cells and during embryonic development (Figure 4.7 B, column 2 and 3, Table 
4.7). While the expression level of the gene 147/1.5 was down-regulated in 
midazolam-treated samples, its expression level was up-regulated significantly at 46 
hours after incubation with biochanin A. In contrast, the gene 172/4.6 (=172/5.8) had 
a closer expression pattern in both types of samples; the expression level was down-
229 
regulated in both midazolam- and biochanin A-treated samples. However, the change 
was more gradual and in a smaller degree in midazolam-treated JCS cells. During 
embryonic development, the expression of the gene 172/4.6 (=172/5.8) showed no 
change throughout the process. On the contrary, the expression of the gene 147/1.5 
was particularly high at 9.5 and 17.5 dpc. 
C. Gene transiently up-regulated at 1 hour m midazolam-treated JCS cells 
The unique gene 172/3.2 was transiently up-regulated at 1 hour in midazolam-
treated samples (Figure 4.7 C, column 1, Table 4.7) but transiently down-regulated at 
I 1 hour in biochanin A-treated samples. It also showed a steady increase in expression 
1 
I level during embryonic development (Figure 4.7 C, column 2 and 3, Table 4.7). 
^ 
D. Genes steadily up-regulated in midazolam-treated JCS cells 
！ The expression levels of genes 228/5.2 and 228/5.3 were only slightly and 
i 
i steadily increased in midazolam-treated JCS cells (Figure 4.9 D, column 1, Table 4.7). 
The expression level of 228/5.2 was essentially constant in biochanin A-induced JCS 
cells and during embryonic development. The expression of the gene 228/5.3 was 
slightly increased during embryonic development and a remarkable increase in 
expression was observed in biochanin-A treated samples at 46 hours (Figure 4.7 D， 
column 2 and 3, Table 4.7). 
E. Genes showing constitutive expression in midazolam-induced JCS cells 
Genes 172/4.1 and 228/5.6 showed no change in expression level in 
midazolam-treated samples (Figure 4.7 E, column 1, Table 4.7) and in biochanin A-
treated JCS cells (Figure 4.7 E, column 2, Table 4.7). The expression level of gene 
172/4.1 was also unchanged during embryonic development but a very marginal 
decrease in expression was found for 228/5.6 during embryonic development (Figure 
4.9 E, column 3，Table 4.7). 
230 
F. Genes showing no/Iow expression in midazolam-treated JCS cells 
No or very low level of expression was found in midazolam-treated samples 
for genes 147/1.4 and 147/1.6 (Figure 4.7 F, column 1, Table 4.7) The same 
observation was also found in biochanin A-treated cells and during embryonic 
development. The expression of the gene 146/1.6 was barely detectable after 50 
cycles ofRT-PCR during embryonic development and an increased expression peaked 
! at 11.5 dpc followed by a decrease in expression was observed (Figure 4.7 F, column 





































































































































































































































































































































































































































































































































































































































































































































































































4.5.1 Sequence analysis of isolated gene fragments 
Sequence analysis is important in determining whether the genes are known or 
previously unknown. In addition, it provides information for designing specific 
primers for further expression pattem analysis. 
The sizes of the subcloned fragments were in the range of about 300-900, 
comparable to other reports of RAP-PCR. On analysis, some of these subcloned 
fragments were related (Figure 4.4 A). The parent fragment 172/4 and 172/5 were 
adjacent bands on RAP-PCR gel (not shown). Thus, we suspected that their derived 
fragment 172/4.6 and 172/5.8 were the same contaminated species in the gel slices. In 
contrast, the relationship between 172/2.8, 172/3.1, 172/3.2 and 172/3.8 were more 
difficult to determine. Again, 172/2 and 172/3 were close fragments on the gel (not 
shown). However, their derived fragments were only identical by a stretch of short 
sequence (Figure 4.4 B). The longer sequence 172/2.8 or 172/3.8 was not detected on 
gel analysis of the re-amplified products (not shown) before subcloning. They 
contained additional arbitrary primer sequence other than the two flanking the 
fragment. From the location of the arbitrary primer sequence, these long fragments 
did not appear to be generated from ligation of two short fragments. These long 
fragments were possible artifacts generated during the subcloning procedures or by 
recombination events in the bacterial host. Since the four fragments 172/2.8, 172/3.1, 
172/3.2 and 172/3.8 were related, only one of them 172/3.2 having proper arbitrary 
primer sequence on both ends was further analyzed. 
In homology search, a few fragments matched with the known sequences in 
the Genbank. Fragment 44/3.1 contained a stretch of sequence (-359 bp) that 
matched the whole Mouse Transcript (MT) sequence while the rest of the fragment 
sequence being unique (Heinlein et al, 1986). The MT family consist of short 
interspersed repetitive sequence (SINEs) with structural features of retroposons; a 400 
bp consensus sequence was established (Bastien and Bourgaux, 1987). Of the 400 bp 
233 
I 
consensus, 44/3.1 (part of its whole sequnece) matched very well along the whole 
sequence with 90-91 % identities (Figure 4.6，A). The alignment only interrupted at 
the 'gap' of undetermined sequences. This strongly suggested 44/3.1 is a member of 
the MT family. MT sequences have been found in the 5, region of rat cytochrome 
P450 oxidoreductase gene (Gonzalez and Kasper, 1983) and the mouse Ins sequences 
(Sylla et al, 1984). The copy number of MT sequence within mouse genomic DNA 
was determined to be 4-9 X 10^  per haploid genome. Although there is no study on 
the expression of MT sequence in hematopoietic tissues, the expression of the 
sequences was found to be transcribed preferentially in the brain in comparison to 
other tissues like kidney (Heinlein et al, 1986). MT sequence was also found to be 
the most abundant repetitive sequence in the brain (Heinlein et al, 1986). No hints on 
the function of the sequence or the corresponding gene can be deduced from the 
current findings. Thus, studying the expression profile of the gene 44/3.1 in 
midazolam-induced JCS cells may yield us insights into the role of the MT family 
genes and /or the particular member gene that fragment 44/3.1 represents. 
Fragment 228/5.2 was homologous with glucocerebrosidase mRNA. The 
whole fragment aligned with the gene with 97% identities (Figure 4.5, C). As 
glucocerebroside is a glycolipid which may contribute to cell-cell interactions or 
signaling, regulation of glucocerebrosidase may affect the expression of these 
glycolipids and the response of JCS cells to external stimuli. 
Two other fragments, 228/5.1 and 228/5.3 matched with 28S ribosomal RNA 
and S25 ribosomal protein mRNA sequences respectively. The whole fed-in sequence 
228/5.1 matched with ribosomal 28S RNA with 94-95% identities (Figure 4.6, B). 
Since rRNA is expected to be more relevant to the functional aspects than to the 
differentiation program, we did not proceed further to analyze the gene. Fragment 
228/5.3 had a good match with rat S25 ribosomal protein mRNA or its psuedogene 
(85-87% identities) (Figure 4.6 C). Finally, fragment 228/5.6 had high homology with 
the human initiation factor (94% identities) (Figure 4.8 D). The gene, together with 
28S rRNA and S25 ribosomal protein, are the basic machinery of translation. The 
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direct relation of these gene with myeloid cell differentiation commitment was not 
seen. 
The remaining fragments did not have significant matches with sequences in 
the database. However, it is still too early to conclude that all these fragments 
belonged to novel genes as the fragments may fall in the region outside the coding 
sequence. Sequences of untranslated region are not always be reported in the 
Genbank. Thus, characterized genes may not be detected during homology search 
using these RAP-PCR fragments. Hence, no conclusion can be made without first 
obtaining the full-length cDNA. Full-length cDNA can be obtained by conventional 
cloning method or by a more effective method ‘rapid amplification of cDNA ends 
(RACE)’ (Frohman^r al, 1988). 
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4.5.2 Expression proHles of the isolated genes 
Gene specific primers were designed for the expression profile study by RT-
PCR of each isolated gene. 
Fragment 44/3.1 was suggested to be a member of the MT gene family (Table 
4.4 and Figure 4.6 A). Although the exact gene has not been determined, down-
regulation ofthe gene or genes that 44/3.1 represents correlated with the midazoIam-
induced monocytic/granulocytic differentiation (Figure 4.7，A). On the other hand, no 
down-regulation but rather an up-regulation of the gene was accompanied with 
biochanin A-induced monocytic differentiation after 46 hours. Since midazolam- and 
biochanin A-induced differentiation were different in lineage specification, the 
difference in expression pattem of the gene may be important in lineage commitment. 
Nevertheless, we cannot exclude the possibility that these changes are inducer-
specific. During embryonic development, the gene was specially increased in 
expression from 7.5 to 11.5 dpc, slight decrease in expression at 15.5 dpc and 
increased again at 17.5 dpc. From this temporal expression pattem, the gene may be 
required particularly in organogenesis and late fetal growth. The gene may also be 
specially required in the development of hematopoietic tissue, as 11.5 dpc marked the 
time when fetal liver erythropoiesis, myelopoiesis and lymphopoiesis started. At 17.5 
dpc, the major site of hematopoiesis has switched to the bone marrow (reviewed in 
Paulson and Bemstein, 1995) (Figure 4.7 A). 
Like 44/3.1, down-regulation of the gene 172/5.2 was observed in midazolam-
treated samples at the 5th hour. Transient down-regulation of the gene was also 
detected in biochanin A-treated JCS cells at 1 hour followed by a late increase in 
expression level. These suggested that down-regulation of the gene may be 
commonly required for both biochanin A- and midazoIam-induced differentiation at 
early hours but a later increase in gene expression may only be required for biochanin 
A- but not midazoIam-induced differentiation. Again, specifically higher expression 
level of the gene was found at 11.5 and 17.5 dpc during embryonic development. This 
suggested that the gene may be important in late organogeneisis (11.5 dpc) and late 
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fetal growth and development (17.5 dpc) and/or responsible for liver hematopoiesis 
(11.5 dpc) and bone marrow hematopoiesis (17.5 dpc) (Figure 4.7A). 
172/5.6 was down-regulated during the midazolam-induced JCS cell 
differentiation. Similar to 172/5.2, this gene was only transiently down-regulated at 1 
hour by biochanin A and up-regulated at a later time point. This may imply that 
down-regulation of the gene was not specific to one inducer and down-regulation of 
the gene was important for both types of differentiation. However, a later rebound in 
expression level was specific to biochanin A-induced differentiation. Unlike the 
expression shown by the two genes mentioned above, 172/5.6 was induced after 9.5 
dpc during embryonic development. This suggested the gene may be involved in 
embryogenesis starting from early organogenesis (9.5 dpc) towards the end of the 
embryonic development (Figure 4.7 A). 
147/1.5 was down-regulated slightly during the midazolam-induced 
differentiation. Conversely, the gene was up-regulated significantly after incubation 
with biochanin A for 46 hours. The degree of change (slight increase) in midazolam-
induced samples and the expression pattem (late up-regulation) in biochanin A-
treated samples did not suggest a contribution of the gene in the differentiation 
commitment. However, the gene may be responsible for some functional aspects of 
monocytes as the gene is specifically enhanced in the biochanin A-induced cells 
which were committed entirely towards the monocytic pathway. Interestingly, the 
gene was highly expressed at 9.5 dpc and 17.5 dpc in comparison to other 
developmental stages during embryogenesis. These time points coincided with 
organogenesis and hematopoietic precursor cell activities in AGM region (9.5 dpc) as 
well as late fetal growth and bone marrow hematopoiesis in the embryo (17.5 dpc) 
(Paulson and Bemstein, 1995) (Figure 4.7 B). 
172/4.6 was down-regulated in differentiation initiated by midazolam. The 
same type ofchange was more obviously shown in differentiation caused by biochanin 
A under the same PCR cycle number amplification. This suggested the change in 
gene expression (down-regulation) was an event common to both typs of 
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differentiation. During embryonic development, the gene was constitutively 
expressed at different stages indicating that the gene was not developmentally 
regulated but required at all stages during embryogeneisis (Figure 4.7 B). 
The gene 172/3.2 was transiently up-regulated at 1 hour in midazolam-treated 
JCS samples. Interestingly, transient down-regulation at 1 hour of the gene was 
observed in biochanin A-induced JCS samples. Such specific expression profiles 
reflected the different lineage preference of the cells triggered by different inducers. 
However, whether this ‘opposite, expression pattem is deterministic in lineage choice 
needs further direct proof. In embryo, the gene was expressed at a higher level at 17.5 
dpc but not in other stages suggesting that the gene may be more important for late 
development of embryo/fetus (Figure 4.7 C). 
Fragment 228/5.2 has been aligned with glucocerebrosidase (mRNA sequence) 
(Figure 4.7 C) which was slightly enhanced in expression during midazolam-induced 
differentiation. On the other hand, the expression was unchanged in biochanin A-
induced differentiation. Thus, the increased expression of glucocerebrosidase may be 
specific to the monocytic/granulocytic differentiation caused by midazolam or to the 
differentiation pathway initiated by midazolam. During embryonic development, the 
expression ofthe gene was roughly the same (Figure 4.7 D). 
Fragments 228/5.3 and 228/5.6 were matched with ribosomal protein S25 
mRNA (and its psuedogene) and initiation factor sequence respectively (Figure 4.6 B 
and C). Although the expression of the gene 228/5.3 was increased slightly in the 
midazolam-treated samples and a more obvious increase in expression was found in 
biochanin A-treated sample at 46 hour, we do not expect such changes be relevant to 
the differentiation commitment (Figure 4.7 D). For gene 228/5.6 (initiation factor 
gene), the expression was unaltered in both midazolam- and biochanin A-induced JCS 
cell differentiation (Figure 4.7 E). Taken together, the translation machinery may be 
enhanced during the differentiation through the increase in the S25 ribosomal 
proteins. Also, the isolated fragment 228/5.6 was a false positive of this investigation. 
The gene it represents was predicted to be up-regulated during midazolam-induced 
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differentiation in the second cDNA probe screening but this expression pattem was 
shown 'not true' by RT-PCR (Table 4.6). In embryo, the change in expression of 
these two genes was also negligible at different stages confirming the ‘house-keeping’ 
nature of these genes. 
Gene 172/4.1 was found constitutively expressed during the midazolam- and 
biochanin A-induced differentiation. This result was opposed to the prediction in the 
second screening (false positive). Continued expression of the gene was also found 
throughout the embryonic development (Figure 4.7 E). 
The expression of gene 147/1.4 was not detected by 50 cycles of RT-PCR 
during midazolam-induced or biochanin A-induced JCS cells. No expression of the 
gene was found during embryonic development as well. The expression of 147/1.6 
was undetectable in midazolam-induced JCS cells but a barely detectable expression 
was found at 46 hours of biochanin A-treated sample. Despite the low expression 
level of 147/1.6, the expression was peaked at 11.5 dpc during embryonic 
development. This suggested a possible role of the gene during organogenesis in 
embryonic development (Figure 4.7 F). 
In conclusion, 8 out of the 12 gene fragments (omitting the identical and 
related fragments) selected after the second round screening were confirmed to be 
differentially expressed genes during midazolam-induced cell differentiation. This 
statistics was comparable to, if not better than other reports using similar methods. 
For example, in Liang et al (1993), 5 out of 15 fragments were confirmed to be 
differentially expressed, 4 fragments were false positives and 6 failed to show 
expression as examined by northem blot. Besides, in this report, all of the fragments 
except 147/1.4 representing genes that were expressed in normal tissues (embryo) as 
well as in leukemia cells. Since little can be concluded from the present studies on the 
nature and function of the isolated gene fragment in both myeloid differentiation and 
in embryogenesis, further work must be carried out. In particular, whether the 
corresponding genes of the isolated gene fragments with differential expression are 
essential to the differentiation of JCS cells is our main concem. Further work can also 
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be done to see ifthe genes can initiate JCS cell differentiation by over-expressing the 
genes. Also, investigation can be carried out to elucidate those genes that showed 
differential expression during embryonic development. The genes may be involved in 
the development of hematopoietic tissue specifically and/or in non-hematopoietic 
tissues in general. 
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Chapter Five General Discussion 
5.1 Studies on leukemic cell differentiation 
5.1.1 Differentiation pathways revealed by different inducers 
On the way to delineate the underlying mechanism of hematopoiesis and its 
control, we started by studying the induced cell differentiation of a newly-developed 
myeloid leukemia cell model, WEHI-3B JCS (Mak et al, 1993). Like many other 
well-characterized models, this cell line could be induced to differentiate by a 
repertoire ofdefined inducers such as PKC activator (phorbol 12-myristate 13-acetate, 
PMA), bacterial product (lipopolysaccharide, LPS) and growth factors (IL-la, IL-lp, 
TNF-a, TNF-a + IL-4, TNF-a+ IFN-y) (Chan et al, 1995; Leung et al, 1994; Mak et 
al ’ 1993, 1994). Only recently, biochanin A and midazolam were also shown to be 
potent inducers ofJCS cells (personal communication with Dr, N.K. Mak). 
Despite the use of these different inducers, JCS cells may have followed the 
same differentiation pathway. It was found that endogenous TNF-a mRNA 
production was triggered during both the TNF-a- and PMA-induced JCS cell 
differentiation. Neutralizing antibodies against TNF-a could abrogate both of these 
induced differentiation (Mak et al, 1993; Chan et al, 1995). Besides, pertussis toxin 
(a modulator of G protein) had enhanced effect on TNF-a- as well as LPS- and PGE2-
stimulated differentiation (Mak et al, 1994，authors' unpublished data). These 
findings suggested that some common steps in differentiation are triggered by 
different inducers. Similarly, the same immediate early response genes and tyrosine 
phosphorylation were triggered by both IL-6 and LIF during Ml cell differentiation 
(Lord et al, 1991). 
In contrast to the above observations, different inducers have been shown to 
mediate differentiation by distinct pathways. For instance, both IFN-y and vitamin D3 
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were able to induce differentiation of THP-1 cells. However, IFN-y but not vitamin 
D3 induced cytokine (IL-ip, TNF-a and IL-6) production (Vey et al, 1992). Also, the 
differentiation-inducing agents PMA and retinoic acid of THP-1 cells had different 
effects on the src family tyrosine kinase genes and c-myb expression. PMA but not 
retinoic acid mediated THP-1 cell differentiation through AP-1 (Matikainen and 
Hurme, 1994). In TNF-a-induced JCS cell differentiation, the expression levels of 
IL-la, IL-lp, TNF-a and IFN-y were enhanced (Chan et al, 1995) at 18 hours. In the 
current study, however, JCS cells triggered either by biochanin A or midazolam failed 
to increase the production of IL-la, IL-ip nor TNF-a significantly. While IL-la 
mRNA level was increased at 46 hours in biochanin A-treated cells, there was no 
detectable level of IL-la in midazolam-treated cells. The expression of IL-ip was 
increased at 46 hours after incubation with biochanin A but reduced after incubation 
with midazolam in JCS cells. TNF-a gene expression was also slightly increased in 
JCS cells when triggered by biochanin A but remained unchanged when induced by 
midazolam. Taken together, TNF-a, biochanin A and midazolam have stimulated 
unique pathways for JCS cell differentiation. 
Autocrine production of IL-ip and TNF-a and their effects on myeloid cell 
differentiation have been shown not only in leukemia cells (Chan et al, 1995; 
Magrinat et al, 1992) but also in normal hematopoietic progenitors (Witsell and 
Schook, 1992; Watari et al, 1996). This suggested that the endogenously produced 
cytokines may be involved in the regulation of normal hematopoiesis. Since biochanin 
A and midazolam appeared to have bypassed the differentiation pathway mediated by 
endogenous TNF-a and IL-ip, other differentiation pathway may exist. Hence, to 
extend our study on cytokine involvement in myeloid cell differentiation, the gene 
expression of LIF, LIF-R and IL-4 in JCS cells were studied. IL-4, LIF-R (both 
membrane and soluble forms) showed no expression in either biochanin A- or 
midazolam-induced JCS cells whereas the expression of LIF was up-regulated by 
biochanin A and unaltered by midazolam. Accordingly, the autocrine effect of LIF 
and IL-4 on JCS cell differentiation triggered by biochanin A and midazolam can be 
ruled out. 
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5.1.2 Lineage preference during differentiation 
一 „ 一 一 „ 
granulocytes (Leung et al, 1994; Mak et al, 1993，1994, 1996). So far, all the 
defined inducers reported (Leung et al, 1994; Mak et al” 1993, 1994) and biochanin 
A (personal communication with Dr. N. K. Mak) led the cells towards the monocytic 
lineage. In contrast, midazolam was able to drive JCS cells to produce both 
granulocytes and monocytes (personal communication with Dr. N. K. Mak). A 
balance between exogenous cytokines have been suggested to bias the lineage choice 
(monocytic or granulocytic) of myeloid progenitor (Snoeck et al, 1996). Thus, it is 
丨 possible for JCS cells to follow different lineage pathway through the autocrine action 
1 .; 
\: of endogenously produced cytokine. Comparing the cytokine and cytokine receptor 
gene expressions of biochanin A-induced (monocytic) and midazolam-induced 
(granulocytic and monocytic) differentiation may provide us insight into lineage 
i commitment. 
f-' 
Most of the cytokine and cytokine receptor gene expression studied were 
changed differently during the induced differentiation of JCS cells having different 
lineage preference (Table 2.3). Up-regulation of IL-ip and IL-3 expression levels 
I were found in the biochanin A-induced JCS cells but down-regulation of their 
y 
|l expression levels were observed in midazolam-induced cells. LIF and IL-3Ra gene 
i' t, 
I expression was increased during the differentiation of biochanin A-induced cells but 
f unchanged during the differentiation of midazolam-induced cells. IL-lRtI and IL-3Rp 
i 
\ were unchanged in expression levels in JCS cells after incubation with biochanin A 
i while increase in expression levels was observed after incubation with midazolam. 
I The gene expression of IL-la was induced during the differentiation of biochanin A-
:j 
\ treated cells but not during the differentiation of midazolam-treated cells. Finally, the i 
J expression pattem of IL-lRtII remained unchanged after incubation with biochanin A 
but transiently decreased at 18 hours after incubation with midazolam. These results 
revealed that the cytokine and cytokine receptor mRNA phenotypes were very 
different between cells under two different treatments. 
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Nevertheless, these cytokines may not be responsible for lineage commitment 
if we consider also the degree of change in expression level and the time point at 
which the change occurred. The change of cytokine mRNA level at late time point 
(46 or 48 hours) might be associated with cell maturation and function. For example, 
IL-1 and LIF are readily produced by monocytic cells. The expressions ofthese genes 
were induced and increased only after 46 hour incubation with biochanin A, coincided 
with the time when the cells started to exhibit their maturing phenotypes. IL-1 has 
been reported to mobilize neutrophils. In the current investigation, the mRNA level 
of IL-lR (type I) was increased significantly in midazolam-induced JCS cells 
\ consisting of a considerable percentage of granulocytes (neutrophils). Hence, the 
enhanced level of IL-lR may be related to the response of the cells to IL-1 during the 
r-
I recruitment of mature neutrophils to the inflammatory site. Lastly, it is important to 
r 
I be reminded that these changes in gene expression pattem may simply be inducer-








5.2 Differentiation program triggered by midazolam 
5.2.1 Signaling pathways initiated by biochanin A and midazolam 
Little is known about how biochanin A and midazolam initiate their signals for 
differentiation. It was demonstrated in this report that several important cytokines (by 
autocrine production) for myeloid cell as well as JCS cell differentiation were not 
involved. 
Biochanin A was suggested to be an inhibitor of tyrosine protein 
phosphorylation (Besterman and Schultz, 1990). Protein tyrosine kinases have been 
？ 
implicated in the regulation ofcell transformation and cell growth. Their activities are 
probably the earliest biochemical change that can be measured after ligand-receptor 
binding. The enzymes are usually responsible for phosphorylation of specific tyrosine 
residues in the cytoplasmic domains of receptors or receptor-associated signal-
transducing subunits. This leads to the clustering of SH2-containing protein at the 
membrane. The tyrosine kinases (receptor-associated) can further phosphorylate the 
tyrosine residues on these SH2-containing proteins and activate them. A cascade of 
changes involving cytoplasmic calcium and protein kinase C or further SH2-
containing proteins, GTP-binding protein and serine/threonine kinase may be initiated. 
Finally, transcription of the responder genes by transcriptional factors like AP-1, c-
yyiyc {s triggercd. By inhibiting the required tyrosine kinase for excessive proliferation 
signal or suppressing the over-expressing tyrosine kinase in leukemia cells may 
somehow restore the differentiation capacity ofJCS cells. 
Although the binding of midazolam onto the peripheral benzodiazepine 
receptors (PBR) has not been demonstrated, the anti-proliferative (Wang et al, 1984a) 
and differentiation-inducing effects (Ishiguro et al, 1987) through high and low 
affinity PBRs respectively have been proposed. Peripheral active benzodiazepines 
were also able to super-induce specifically c-fos that associated with the 
differentiation process (Curran and Morgan, 1985). PBRs are widely distributed in 
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monocytic cells and increase in expression upon maturation (Canat et al. 1993); it 
follows that midazolam may effect its differentiation-inducing action through PBRs. 
The important component of PBRs was suggested to be associated with a voltage 
dependent anion channel and an adenine nucleotide carrier but the effector system of 
the receptors has not been established (Parola et al, 1993). Interestingly, a distant 
relative ofbiochanin A, chrysin (5,7-dihydroxyflavone) has been shown to bind to the 
central benzodiazepine receptor (CBR) (Wolfman et al, 1994). Although CBR and 
PBR (section 1.3.3) are entirely different receptors, some ligands like diazepam do 
bind to both receptors. As a result, we could not exclude the possibilities that both 
midazolam and flavonoids like biochanin A accomplish their biological effects 
through PBRs. 
All of these, however, are only speculation of how biochanin A and 
midazolam act in differentiation. It is still a long way to dissect the exact effector 
system initiated by the two molecules. 
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5.2.2 Differentially expressed genes during midazolam-induced 
differentiation 
To search for genes that are central to the genetic program for JCS cell 
differentiation, we started by seeking genes that showed differential expression during 
the differentiation of JCS cells. In order to gather more information, we employed 
materials (RNA) from JCS cells induced by midazolam as it drove the cells not only 
to monocytic but also to granulocytic differentiation. We examined the gene 
expression ofthe differentiating cells at 0, 1, 5, 18 and 48 hours after incubation with 
midazolam. This time course study should encompass the expressions of immediate 
early response genes (e.g. c-fos, c-myc) to early response genes (e.g. c-myb) (1, 5 
hours) and early to late response genes (e.g. some surface markers) (18, 48 hours). 
To facilitate a time course study, we employed a modified protocol of RNA 
fingerprinting by arbitrarily-primed polymerase chain reaction (RAP-PCR), instead of 
using conventional methods like differential screening or subtractive hybridization. 
The current modified method is suited for a random search of a pool of genes that are 
differentially expressed among different samples. The problem of non-reproducibility 
and false positives ofthe original protocol (Welsh et al, 1992) were greatly alleviated 
by employing two rounds of cDNA probe screening in this new protocol. 142 
differentially amplified fragments were obtained initially from the fingerprints. At the 
end ofthe second round screening, only 12 subcloned fragments of distinct sequences 
remained. Among these 12 fragments, 8 fragments represented differentially 
expressed genes confirmed by reverse-transcription polymerase chain reaction (RT-
PCR) (Figure 4.6 A-D). Only three out of these 8 fragments aligned with known 
sequences in the Genbank. These known sequences were MT sequence repetitive 
element DNA (44/3.1), mRNA for glucocerebrosidase (228/5.2), and ribosomal 




5.2.3 Expression patterns of the isolated differentially expressed 
genes in midazolam- and biochanin A-induced JCS cells 
A gradual increase in expression ofglucocerebrosidase (228/5.2) was observed 
in midazolam-induced JCS cells and suggested an increased requirement for 
glycolipids (Figure 4.9 D). As a result, cell-cell interaction or other cell functions of 
JCS cells may be affected after incubation with midazolam. However, the expression 
level of this gene remained the same in JCS cells incubated with biochanin A 
suggesting no involvement ofthis gene in biochanin A-mediated differentiation. The 
！ expression of ribosomal protein (228/5.3) gradually increased during midazolam-
mediated differentiation (Figure 4.9 D) but was increased more rapidly during 
biochanin A-mediated differentiation. This indicated that the translation machinery is 
generally enhanced to meet the demand during differentiation. Genes having MT 
sequences were found preferentially transcribed in the brain (Heinlein et al, 1986) but 
the expressions in the hematopoietic tissue have not been studied. In this report, a 
gene belonging to the MT sequence family (44/3.1) was down-regulated significantly 
in JCS cells at 5 hours after midazolam incubation (Figure 4.9 A). This indicated that 
the gene may be specifically involved in the midazolam-induced or 
monocytic/granulocytic cell differentiation. The view is further supported by the fact 
that the gene expression was unaltered by biochanin A at early hours but only 
increased after incubation with biochanin A for 46 hours. Since down-regulation of 
the gene was associated with the differentiation event, this gene could be a negative 
regulator for midazolam-induced differentiation. 
Besides these known genes, two of the unknown genes (172/5.2 and 172/5.6) 
showed marked down-regulation ofexpression at 5 hours after midazolam treatment. 
Interestingly, these two genes were only transiently down-regulated at 1 hour when 
treated with biochanin A (Figure 4.9 A). The expressions of two other unknown 
genes 147/1.5 and 172/4.6 were decreased gradually during the midazolam-induced 
differentiation. On the other hand, gene 147/1.5 was increased markedly in mRNA 
level at 46 hours while gene 172/4.6 was down-regulated sharply in JCS cells after 
incubation with biochanin A (Figure 4.9 B). Moreover, 172/3.2 was transiently up-
regulated at 1 hour after induction by midazolam while a transient down-regulation of 
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s the expression level at 1 hour was observed in biochanin A-treated cells (Figure 4.9, 
C)� 
Most of the genes found differentially expressed in midazolam-induced JCS 
cells have quite a different pattem of expression in JCS cells induced by biochanin A. 
This observation is consistent with the cytokine gene expression studied earlier. As 
stated before, biochanin A and midazolam-treated cells have different lineage 
preference during differentiation. By comparing the gene expression pattem in the 
two systems, we may be able to locate genes that are specific to a certain lineage. It is 
not uncommon to find genes that have different effects on different cell lineages. One 
ofthe notable examples was the zinc finger protein egr-l. While egr-1 was found up-
regulated during monocytic differentiation, no induction of expression was found 
during granulocytic differentiation. Also, egr-1 is essential for monocytic 
differentiation and suppresses granulocytic differentiation (^guyen et al, 1993). 
Thus, it is likely that genes isolated in this study, having different expression patterns 
in biochanin A and midazolam-induced JCS cells, would have different effects on 
lineage commitment to monocytic or monocytic/granulocytic differentiation. 
However, all these changes may also be inducer-specific changes irrelevant to cell 
differentiation. Thus, careful interpretation and further investigation are necessary. 
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5.2.4 Myeloid genes in embryonic development 
A number of genes involved in or essential to myeloid cell differentiation are 
also important in embryonic development. These genes code for either growth factors 
and their receptors or transcription factors (reviewed in Hogan et al, 1994; Paulson 
and Bemstein, 1995; Simeone et al, 1995). In particular, c-myb which was down-
regulated upon myeloid cell differentiation also showed a distinct expression pattem 
during embryonic development. In embryo, the expression of c-myb was very low 
before 10.5 dpc. The expression was detected from 10.5 dpc and persisted throughout 
the rest ofthe developmental stage. In situ hybridization revealed that the gene was 
expressed not only in hematopoietic organs but also in non-hematopoietic tissues 
(Sitzmann et al, 1995). This highly suggested that genes which were differentially 
expressed during midazolam-induced differentiation may also played a role in 
embryonic development. A study of the expression pattem of our newly identified 
genes during embryonic development should give us insight into the functions ofthe 
genes in both hematopoietic and non-hematopoietic systems. 
In this study, some isolated genes that are differentially expressed during the 
JCS cell differentiation triggered by midazolam (and biochanin A) also appeared to be 
developmentally regulated as examined from the expression pattem (Table 4.7). For 
example, genes 44/3.1 (MT family sequence) and 172/5.2, with distinct patterns of 
expression in midazolam- and biochanin-A-induced cells, had enhanced expression 
particularly at 11.5 dpc and 17.5 dpc (Figure 4.9 A). These time points 11.5 dpc and 
17.5 dpc coincided with the time of organogenesis (and the beginning of fetal liver 
hematopoiesis) and late fetal growth (and the beginning of adult-type hematopoiesis in 
fetus) in mouse development respectively. Similarly, gene 147/1.5 had expression 
peaked at 9.5 and 17.5 dpc (Figure 4.9 B). Thus, it is likely that the gene played a role 
in early organogenesis (and de novo hematopoiesis in AGM region), late fetal growth 
(and fetal hematopoiesis). 
On the other hand, gene 172/5.6 was expressed at high level during the later 
stage of development (9.5-17.5 dpc) suggesting a general requirement in late growth 
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and development of the embryo (Figure 4.9 A). The expression level of the gene 
( 
172/3.2 was significantly higher at 17.5 dpc indicating that the gene may be specially 
required in fetal growth. 
Whether the changes in gene expression levels described above are specifically 
involved in (or essential to) myelopoeisis in embryos or are also associated with the 
development ofother tissues cannot be concluded from these results. Perhaps to solve 
this problem, it is a good idea to perform in situ hybridization on embryos at different 
developmental stages, c-myb, a myeloid gene, was located not only in the 
hematopoietic organs like fetal liver and thymus in embryo but also in the neural 
retina and epithelia ofthe respiratory tract as studied by in situ hybridization technique 
(Sitzmann et al” 1995). In contrast, c-jun which initiates differentiation ofmonocytic 
cells (Li Qt al, 1994c) may play no part in fetal hematopoiesis. Its expression was 
limited to cells in the developing cartilage, gut and central nervous system in the 
embryos as examined by in situ hybridization (Wilkinson et al, 1989). Although 
further speculation on function of our isolated genes in embryonic development and 
their relation with myeloid cell differentiation were limited, this study nevertheless 
provides some basic information about the isolated genes. This will be particularly 




5.3 Future studies of the isolated fragments 
There are many approaches that can be used for isolating genes that are 
important in myeloid cell differentiation. Among the possibilities, we have chosen to 
correlate the expression profiles of a number of randomly selected genes with the 
differentiation event. From these differentially expressed genes, those that are 
important and essential for myeloid cell differentiation will be identified. However, 
because of the limited scope and time of this study, the project have to be stopped 
after the isolation of a couple of differentially expressed genes. However, the studies 
would not be meaningful until we have directly proved that the genes are also 
essential to or involved in myeloid cell differentiation. 
Starting from the subcloned fragments obtained in this study, it may be 
beneficial to obtain the full-length cDNA to which the fragment belonged. Since the 
subcloned fragments may represent sequences of the non-coding region, the coding 
sequences must be known for further investigation. To prove whether an isolated 
gene is essential for JCS or myeloid cell differentiation, gene function studies are 
inevitable. Direct strategy by micro-injection of antibody against the target gene 
product may be one ofthe choices. Useful information about the functions ofvarious 
oncogenes have been obtained (reviewed in Kovary, 1995). Increasingly important 
strategies like inducible expression system (Labow, 1995) and antisense techniques 
(Robinson-Benion and Holt, 1995) may still be better choices as our starting materials 
are the DNA sequences. 
Inducible expression system (e.g. lac activator protein system) allowed precise 
control of the exogenous gene expression at a particular time. There are several 
isolated gene fragments (44/3.1, 172/5.2, 172/5.6) in this report that are down-
regulated at 5 hours in JCS cells after midazolam incubation. Some important 
information ofthe genes may be revealed if we extend the expression ofthese genes 
beyond the 5 hour point. That is, if down-regulation of these genes are essential for 
JCS cell differentiation, the cells will continue to proliferate without differentiation 
even in the presence of midazolam. Alternatively, if the down-regulation are 
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important for lineage commitment, the cell may differentiate but with a different 
lineage preference. On the other hand, if the cells differentiate without any change 
under the enforced expression of these genes, there could be two interpretation : (1) 
The genes are not essential to the differentiation and lineage selection program ofJCS 
cells. (2) The genes need other co-operative genes for function. 
Alternatively, antisense techniques can be used to suppress the expression of 
these genes in untreated JCS cells. If the cells differentiate or alter their lineage 
choices upon inhibition of the gene by the antisense construct, the gene is probably 
very important negative regulator and sufficient factor for JCS cell differentiation or 
lineage development. On the contrary, if the cells does not differentiate upon 
antisense treatment or change in lineage specificity, the gene probably is not as crucial 
as predicted. 
For up-regulated genes like 172/3.2 during the differentiation of JCS cells 
initiated by midazolam, antisense construct (preferentially with inducible regulation) 
can be used to see ifthe differentiation can be blocked or lineage choice can be altered 
in the presence of midazolam. Again, controlled expression of the gene in untreated 
JCS cells can be used to check if the gene is sufficient to initiate the differentiation 
program of JCS cells. 
Instead of using ectopic expression or antisense techniques, gene targeting and 
knock-out techniques can be adopted in JCS cells, hematopoietic stem cells or in a 
whole animal for gene function study. The technique involves an introduction of a 
genomic DNA fragment ofthe desired gene or a non-functional gene which will then 
locate and recombine with the endogenous homologous sequences. The effect of 
excessive expression of a gene or no expression of a gene can be investigated 
accordingly. 
As a recapitulation, it is absolutely important to prove the role of the isolated 
genes in this study by some direct strategies . Although the function of many genes 
(Table 1.1) can be predicted correctly by their expression patterns, there are far more 
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unsuccessful examples. For instance, the role of some protein kinases like src, hck 
and/gr in myeloid cell differentiation as predicted from their expression pattem was 
misleading. Both the mRNA and protein product of the c-/gr were shown to increase 
in expression during the induced differentiation of myeloid leukemia cells (U937, HL-
60) and normal myeloblasts (Willman et al, 1991). In addition, transfected c-/gr was 
also able to induce monocyte-specific enzyme in heterologous cells. However, it was 
found that homozygous knockout mice for c-fgr has no functional defect. Similar 
observations were also shown for c-src and c-hck (Varmus and Lowell, 1994). In 
other cases, genes that showed distinct pattem of expression during differentiation 
were finally proved to be involved in apoptosis, anti-proliferation or maturation. For 
example, the expression of c-fes (cytoplasmic tyrosine kinase) was increased upon 
differentiation of cells into monocytes or granulocytes. However, antisense 
techniques revealed that the gene has a function on programmed cell death 
(Manfredini et al, 1993). 
Assays for gene function are not without problems. First, members of the 
same gene family may compensate each other in functions. That is, the function of 
one gene abrogated by either anti-sense or knock-out techniques can be restored by 
some other members ofthe gene family. To suppress all the genes ofthe same kind 
may not be at all possible, partly because we may not be able to locate all the genes 
with redundant functions. Also, blocking all these genes may be lethal to the cell or 
the animal. 
Second, it appears that myeloid differentiation is not entirely dependent on one 
master gene (transcription factor). Combination of transcription factors (master 
genes) may be required for the expression of other differentiation-related genes 
(responder genes). For example, c-myb and C/EBPp are both required to induce the 
myeloid-specific gene mim-1 OSfess et al, 1993). Thus, if we study each gene in 
isolation, the crucial action of these genes may not be readily seen. Such problem 
may be able to be circumvented by studying functions of genes in combination. For 
example, where down-regulation of genes are associated with the differentiation 
event, like in the case of c-myc and max in Ml cells, their gene expression could be 
inhibited concomitantly by antisense technique. Such study clearly demonstrated that 
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terminal differentiation ofthe cells are only possible when expression ofboth but not 
either gene are blocked O^guyen et al, 1995). Hence, studying functions of genes in 
combinations may be more fruitful, especially for genes that may have interactions 
with one another (e.g. dimerization and competition for binding site). 
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5.4 Conclusion 
In this report, we have found that biochanin A and midazolam mediated 
distinctive differentiation pathways of WEHI-3B JCS cells. The pathways do not 
involve the action ofendogenously produced IL-1, TNF-a, IL-4 nor LIF. In addition, 
eight genes were isolated and confirmed to be differentially expressed during the 
midazolam-induced granulocytic and monocytic differentiation. Five of them were 
down-regulated and three of them were up-regulated during the midazolam-induced 
differentiation. All of these genes also showed different expression patterns in 
biochanin A-induced cells, suggesting different roles of the genes in the biochanin-
induced monocytic differentiation. Besides the roles in myeloid differentiation, the 
genes may also be involved in embryonic development. To confirm the exact role of 
these isolated genes in myeloid cell differentiation, either acting alone or in 
combination with other genes, gene functional studies are suggested. 
Hopefully, the results obtained in this project and in the follow-up studies, 
when compared with that from other myeloid cell models (both normal and leukemic) 
and in vivo studies, can lead to a greater appreciation of the hematopoietic system. 
This will in tum influence the concepts of leukemogenesis and perhaps, novel 
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A2. Myeloid cell lines 
Cell line Origin Brief description 
32Dcl3 Bone-marrow derived Murine myeloid cell, generation time of 18 hours, 
myelomonoblastic IL-3 dependent, differentiates into granulocyte (6-14 
murine cell line days) upon stimuation with G-CSF in the absence of 
IL-3 
HEL Human, Induced to differentiate along erythroid or monocytic 
erythroleukemia lineages 
HL-60 Human promyelocytic Expresses surface receptors for Fc fragment and 
leukemia complement, differentiates into monocytes triggered 
by PMAor Vitamin D3 and into granulocytes 
stimulated by GM-CSF, DMSO, or RA, induced to 
produce TNF-a, activation of c-ras by point 
mutation and amplified expression of c-myc 
K562 Human, blast crisis of Bipotent, induced to differentiate towards erythroid 
chronic myeloid lineage by ara-C and myelomonocytic lineage by 
leukemia TPA 
(progenitor stage) 
KG-1 Human, derived from Consists of a predominant myeloblasts plus other 
patient with cell types, induced to differentiate into monocyte by 
erythroleukemia, PMA 
myeloblast-like 
KG-1 a Derived from KG-1，at Unable to differentiate upon induction of PMA 
a stage more immature 
than its parental line 
Ml (D+) Mouse (SL-strain) Full differentiation into monocytes induced by IL-6 
myeloblastic leukemia and LIF, partial differentiation by IL-1 or LPS and 
anti-proliferation by IFN-p and IFN-y, monocytic 
differentiation upon vitamin D3 induction 
ML-1 Human myeloid cell Monocytic differentiation upon TPA induction 
line 
THP-1 Human monoblastic Readily induced by PMA, vitamin D3, and IFN-y to 
cells produce monocytes 
WEHI-3B(D+) Murine Macrophage-like, secrete IL-3, induced by G-CSF to 
myelomonocytic follow monocytic lineage, unresponsive to LIF 
leukemia 
WEHI-3B(JCS) Murine Balb/c, dervied Induced by TNF-a, IL-1, LPS, PMA and biochanin 
from WEHI-3B (D') A to produce monocytes but induced by midazolam 
to produce cells of monocytic and granulocytic 
lineages 
U937 Human monoblastic PMA, l-2,5-dihydroxyvitaminD3 induced 





A3. Details of manufacturer's products 
1. DIG oligonucleotide 3'end labelling kit Boehringer Mannheim 1362372 
• 5X reaction buffer : lM potassium cacodylate, 125 mM Tris-HCl, 1.25 
mg/ml bovine serum albumin; pH 6.6 (25®C) 
• C0Cl2 solution : 25 mM cobalt chloride (C0Cl2) 
• DIG-11-ddUTP : 1 mM digoxigenin-11-ddUTP (2'3'-dideoxyuridine-5'-
triphosphate coupled to digoxigenin via an 11-atom spacer arm) in 
redistilled water. 
• Glycogen solution : 20 mg/ml glycogen in redistilled water 
• Terminal transferase : 50 U/^il terminal transferase in 200 mM potassium 
cacodylate, 1 mM EDTA, 200 mM KC1, 0.2 mg/ml bovine serum 
albumin; 50% (v/v) glycerol; pH 6.5 
2. DIG luminescent detection kit Boehringer Mannheim 1363514 
• Anti-digoxigenin-AP, Fab fragments 
• CSPD, Disodium 3-(4-methoxyspiro {1,2-dioxetane-3,2,-(5 ’ -chloro) 
tricyclo [3.3.1.1 '^^ ] decan|-4-yl) phenyl phosphate 
• Blocking reagent 
3. MegaprimeTM DNA labelling system Amersham RPN 1606 
• Primer solution : random nanamer primers in aqueous solution 
• Labelling buffer : dATP, dGTP and dTTP in Tris-HCl, pH 7.5, 2-
mercaptoethanol and MgCl2 
• Reaction buffer : 10X concentrated buffer containing Tris-HCl, pH 7.5, 
2-mercaptoethanol and MgCl2 
• Enzyme solution : 1 U/^1 DNA polymerase I Klenow fragment (cloned) 
in 50 mM potassium phosphate pH 6.5, 10 mM 2-mercaptoethanol and 
50% glycerol 
4. 
5. Nick column Pharmacia Biotech 52-2076-00 
• 0.9 X 2.0 cm gel bed containing Sephadex G-50 DNA grade in distilled 
water with 0.15% Kathon CG as preservative. 
iii 
I 5. QIAGEN plasmid midi kit Qiagen 12143 
！ I 1 
] . B u f f e r P1 : 50 mM Tris-HCl, pH 8.0; 10 mM EDTA 
I • Buffer P2 : 200 mM NaOH, 1 % SDS 
• Buffer P3 : 3.0 M Potassium acetate, pH 5.5 
• Buffer QBT : 750 mM NaCl; 50 mM MOPS, pH 7.0; 15% ethanol; 
0.15%TritonX-100 
• Buffer QC : 1.0 M NaCl; 50 mM MOPS, pH 7.0; 15% ethanol 
• Buffer QF : 1.25MNaCl; 50 mM Tris-HCl, pH 8.5; 15% ethanol 
• QIAGEN tips : The tips was regenerated by 5 ml buffer QF and soaked 
with 70% ethanol at 4 °C. A collection of tips was autoclaved at 121 °C 
at 1 kgcm_2 and dried at 60 °C. The regenerated tips were kept at room 
temperature and ready for use. 
i ^ ^ ^ ^ ^ ^ ^ ^ ^ _ ^ ^ ^ _ _ ^ ^ ^ ^ _ « « ^ ^ ^ ^ « « ^ _ « _ « « ^ « ™ « ^ ™ i « « » « « i « > « « ^ " " « " " " ^ " " ~ " " ^ ^ " ~ " - " ^ ~ " ™ ~ ~ ^ ^ " " " ^ ^ " 
i I — 
！ 
6. AutoRead Sequencing Kit Pharmacia XY-056-00-02 
j 
• A mix : 5 i^M ddATP, lmM dATP, lmM dCTP, lmM dTTP, lmM 
c7dGTP, 50 mM NaCl and 40 mM Tris-HCl, pH 7.6 
• C mix : 5 i^M ddCTP, lmM dATP, lmM dCTP, lmM dTTP, lmM 
c7dGTP, 50 mM NaCl and 40 mM Tris-HCl, pH 7.6 
• G mix : 5 ^M ddGTP, lmM dATP, lmM dCTP, lmM dTTP, lmM 
c7dGTP, 50 mM NaCl and 40 mM Tris-HCl, pH 7.6 
• T mix : 5 i^M ddTTP, lmM dATP, lmM dCTP, lmM dTTP, lmM 
c7dGTP, 50 mM NaCl and 40 mM Tris-HCl, pH 7.6 
• T7 DNA polymerase : 8 units/^il in 25 mM Tris-HCl, pH 7.5, 0.25 M 
NaCl, 3 mM DTT and 50 % glycerol 
• Enzyme dilution buffer : 20 mM Tris-HCl, pH 7.5, 5 mM DTT, 10 
‘ ^g/ml BSA and 5% glycerol 
• M13 universal primer : 5'-fluorescein-d[ CGA CGT TGT AAA ACG 
ACG GCC AGT ]-3' in aqueous solution, 1.5 i^M (2.1 pmol; 0.55 A260 
unit/ml) 
• M13 reverse primer : 5'-fluorescein-d[CAG GAA ACA GCT ATG AC]-
3' in aqueous solution, 2.1 ^M (2.1 pmol/^il; 0.42 A260 unit/ml) 
• Annealing buffer : 1 M Tris-HCl, pH 7.6 and 100 mM MgCl2 
• Extension buffer : 304 mM citric acid, 324 mM DTT and 40 mM MnCl2 
• DMSO : Dimethyl sulfoxide 









A4. List of machine and equipment 
ALF ™ DNA Sequencer Pharmacia 
I Bench-top microcentrifuge Eppendorf 5415C 
Bio-Dot microfitration apparatus BioRad SF 
i Centrifuge Beckman J2-M1 
GeneQuant, RNA/DNA calculator Pharmacia 80-2103-68 
Dri-Bath Thermolyne 17600 
Hybridization chamber Hybraid Midi Dual D110 
Imaging Densitometer BioRad GS-670 
pH meter Jenway 3010 顶 
Programmable thermal controller- Peltier effect MJ Research PTC-100 
SpeedVac concentrator Savant SC110 
I Ultracentriftige Beckman XL-80 
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